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Abstract 
Mitochondria are considered the powerhouse of the cell being the major site of ATP 
production but in addition to this function they also regulate ROS production and 
inhibition, calcium handling and apoptosis. Previous studies have reported a 
downregulation in the levels of superoxide dismutase 2 (SOD2), an inhibitor of 
mitochondrial superoxide (O2
-), in osteoarthritic (OA) hip cartilage compared to that 
from healthy joints (neck of femur fracture; NOF). This finding provides the 
opportunity to characterise the functional effects of SOD2 downregulation in OA in 
the context of oxidative damage and mitochondrial dysfunction. 
SOD2 depletion increased the mitochondrial O2
- levels in human articular 
chondrocytes (HAC). Measurement of lipid peroxidation levels in OA and NOF 
cartilage showed that OA cartilage has higher levels of lipid peroxidation compared 
to NOF. SOD2 depletion in a chondrosarcoma cell-line, SW1353, also led to a 
significant increase in lipid peroxidation levels. Additionally, SOD2 depletion led to 
a significant increase in mtDNA strand breaks in SW1353 cells although there was 
no difference detected in OA compared to NOF mtDNA. However, large-scale 
mtDNA deletions were identified in OA cartilage and other OA joint tissues but the 
low levels of mutated mtDNA observed were not considered to be pathologically 
relevant. 
Mitochondrial respiratory function was also determined in OA and NOF isolated 
chondrocytes. OA chondrocytes showed less spare respiratory capacity (SRC), 
higher non-phosphorylating respiration and higher proton leak compared to NOF. 
SOD2-depleted HAC also showed a lower SRC and higher proton leak. 
Additionally, HAC demonstrated a very low mitochondrial/glycolysis ratio, 
suggesting that HAC are highly glycolytic cells. SOD2 depletion caused 
depolarization of the Δψm. 
NLRX1, a mitochondrially localised gene involved in innate immunity signalling was 
also identified to regulate basal levels of matrix metalloproteinase 13 (MMP-13) 
and double stranded RNA- induced ROS levels in chondrocytes. 
These findings suggest that SOD2 depletion in chondrocytes leads to oxidative 
damage and mitochondrial dysfunction caused by increasing ROS levels and can 
potentially lead towards alterations in cell signalling pathways, cellular dysfunction 
and cartilage degradation.  
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1 
Chapter 1. Introduction 
1.1 Mitochondria 
Mitochondria are small organelles that are present in large (but variable) 
numbers in cells of all eukaryotic organisms. Mitochondria are considered the 
powerhouse of the cells as they are the main sites of adenosine triphosphate 
(ATP) production of the cells via oxidative phosphorylation (OXPHOS). 
Mitochondria are also involved in mitochondrial membrane potential (Δψm) 
regulation, Ca2+ handling and apoptosis and in the regulation of cell toxicity by 
mainly regulating reactive oxygen species (ROS) production as well as 
inhibition (Cadenas et al 1977; Landolfi et al 1998; Mitchell, & Moyle 1969; 
Newmeyer et al 1994; Turrens, & Boveris 1980).  In humans, they have their 
own, maternally inherited, 16,569bp extrachromosomal DNA (mtDNA) that 
encodes for 13 polypeptides, 22 tRNAs and 2 rRNAs, which are responsible for 
the translation of those polypeptides (Anderson et al 1981; Andrews et al 1999). 
Mitochondrial functions are regulated both by nuclear and mitochondrial 
transcripts (Lister et al 2005).  
1.1.1 Mitochondrial structure 
Mitochondria have a diameter size of 0.5-1μm and occupy a large portion of the 
volume of the cell cytoplasm (Frey, & Mannella 2000). They are dynamic 
organelles as they can move within cells via microtubules or microfilaments and 
they can also fuse and divide (fission) (Ligon, & Oswald 2000; Morris, & 
Hollenbeck 1995). They normally form a reticular network of fused mitochondria 
or a fragmented arrangement of discrete organelles (Bereiter‐ Hahn 1994). 
These processes are maintained by the co-ordination of fission and fusion 
machinery (Liesa et al 2009; Palmer et al 2011; Westermann 2010). 
Mitochondrial fusion is controlled by three nuclear-encoded proteins; mitofusin 1 
(Mfn1), Mfn2 and optic atrophy 1 (Opa1) (Alexander et al 2000; Chakraborti et 
al 2003; Chen et al 2003; Delettre et al 2000). Dynamin related protein 1 (Drp1) 
regulates mitochondrial fission (division) (Smirnova et al 2001). These 
processes are essential for the maintenance of respiratory activity required by 
the cells as well as to regulate processes such as inheritance and stability of 
Chapter 1                                                                                       Introduction 
 
2 
mtDNA, transmission of energy, cellular differentiation, metabolite maintenance, 
apoptosis, Ca2+ signalling and embryonic development (Chang et al 2006; 
Chen, & Chan 2005; Chen et al 2010; Ishihara et al 2009; Tanaka et al 2010). 
Mitochondria are composed of 2 lipid membranes (inner and outer) and 2 
internal compartments; the intermembrane space and the mitochondrial matrix 
(Figure 1.1). 
 
Figure 1.1 The general organisation of the mitochondrion 
Figure shows the major compartments of the mitochondrion; the outer membrane, the 
intermembrane space, the inner membrane folded into cristae and the mitochondrial matrix. 
(Image taken from of http://micro.magnet.fsu.edu/)   
Outer membrane 
The outer membrane is a porous membrane that allows passive diffusion of low 
molecular weight molecules (less that 5kDa) between the cytosol and the 
intermembrane space (Colombini 1979). This is achieved by the presence of 
porin that forms large aqueous channels through the lipid bilayer of the 
membrane (Colombini 1979; Mihara et al 1982). It also contains enzymes that 
are involved in lipid synthesis, import receptors and the enzymatic machinery 
responsible for division and fusion of the mitochondrion (Heiden et al 2000). 
Inner membrane 
The inner membrane contains enzymes that are essential for the activity of the 
mitochondrial respiratory chain (MRC), the site of OXPHOS of the 
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mitochondrion, to facilitate the production of ATP by ATP synthase. A proton 
gradient has to be established in order for OXPHOS to function and as a result 
the inner membrane is very impermeable compared to the outer membrane, 
especially to ions (Mitchell, & Moyle 1967). It also contains transport proteins to 
facilitate the movement of molecules in and out of the matrix (Voos et al 1999; 
Schleyer, & Neupert 1985). The inner membrane is folded into cristae that 
project into the matrix in order to increase the surface area of the membrane. 
The amount of folding of the membrane is determined by the energy 
requirements of the cell (Daems 1966). 
Intermembrane space 
The intermembrane space is located between the outer and inner membrane 
and facilitates the transfer of ATP molecules out of the matrix and into the 
cytosol (Koehler et al 1998). 
Mitochondrial matrix 
The mitochondrial matrix is enclosed within the inner membrane. It contains 
enzymes required in other processes such as the tricarboxylic acid (TCA or 
Krebs) cycle (carbohydrate metabolism), β-oxidation (fat metabolism) and for 
the oxidation of pyruvate (Frey, & Mannella 2000). The matrix also contains 
mitochondrial ribosomes, tRNAs, multiple copies of the mtDNA as well as 
enzymes required for mitochondrial gene expression. 
1.1.2 Oxidative Phosphorylation (OXPHOS) 
A major process performed by the mitochondria is OXPHOS. It is the production 
of ATP from adenosine diphosphate (ADP) and inorganic phosphate (Pi). It 
generates 15 times more ATP than glycolysis alone. This process takes place 
at the MRC, in the inner membrane. In the mitochondrial matrix, pyruvate 
produced by glycolysis is converted together with fatty acids to Acetyl CoA 
(Krebs, & Eggleston 1940). Acetyl CoA is essential for the initiation of the TCA 
cycle that produces the high-energy electrons that are transferred to the inner 
membrane where they enter the MRC to facilitate OXPHOS. These electrons 
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are carried by NADH and FADH2 molecules and are required by the MRC to 
create the electrochemical gradient to drive ATP synthesis (Mitchell 1961). 
1.1.3 Mitochondrial Respiratory chain and OXPHOS 
As mentioned above, NADH and FADH2 molecules carry the high energy 
electrons produced by the TCA cycle to the MRC at the inner membrane (Vogel 
et al 2007). These electrons are transferred from NADH and FADH2 to oxygen 
by four respiratory enzyme complexes (Complex I-IV) in order to reduce oxygen 
to water (Figure 1.2). Electron transfer from one complex to the next is possible 
due to the fact that each complex along the chain has a greater affinity for 
electrons compared to the previous one (Moser et al 1992). Three of these 
complexes (Complex I, III and IV) also act as proton pumps driven by the 
electron transport, pumping protons to the intermembrane space thus creating 
an electrochemical proton gradient. Proton pumping is coupled to ATP 
synthesis and the proton gradient is utilised by the ATP synthase (Complex V) 
during ATP synthesis (Mitchell 1961). 
 
 
Figure 1.2  OXPHOS in mitochondria 
Schematic representation of OXPHOS taking place at the MRC. Protons are pumped into the 
intermembrane space from complexes I, III and IV to create a net proton gradient that is utilised 
by ATP synthase to produce ATP. 
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Complex I (NADH:ubiquinone oxidoreductase) 
Complex I is the first and largest enzyme complex of the MRC. It has a mass of 
980kDa  and is made up of around 45 polypeptide chains,  seven encoded by 
mitochondrial DNA (mtND1-mtND6, mtND4L)  and the remaining by nuclear 
DNA (Schultz, & Chan 2001). Complex I consists of a hydrophilic and a 
membrane domain. The hydrophilic domain consists of eight subunits and 
contains the non-covalently bound flavine mononucleotide (FMN) and iron-
sulphur (Fe-S) clusters as prosthetic groups (Sazanov, & Hinchliffe 2006; 
Schultz, & Chan 2001). The membrane domain consists of six subunits with 55 
transmembrane helices, which along with conserved polar residues facilitate 
proton translocation from the matrix into the intermembrane space. 
The main function of Complex I is to accept electrons from the oxidation of 
NADH via non-covalent binding of FMN. These electrons are then transferred 
through Fe-S clusters to ubiquinone (Coenzyme Q10) and thus reduce it to 
ubiquinol. In this process, the energy released drives the translocation of four 
protons from the mitochondrial matrix to the intermembrane space thus 
facilitating the accumulation of the electrochemical proton gradient (Ragan, & 
Racker 1973a; Ragan, & Racker 1973b; Efremov et al 2010). The reaction is 
summarized in the equation:  
NADH + Q + 5H+(matrix)  → NAD
+ + QH2 + 4H
+
(intermembrane space) 
It is also considered to be a major site of superoxide (O2
-) production in the 
mitochondria as described in more detail in section 1.1.7 (Cadenas et al 1977; 
Turrens, & Boveris 1980). 
Complex II (Succinate:ubiquinol oxidoreductase) 
Complex II is the second enzyme that enables entry of high-energy electrons to 
the MRC. It is smaller than Complex I as it is composed of four subunits (SDHA, 
SDHB, SDHC and SDHD) and has a mass of 124kDa (Cecchini 2003). It 
contains a covalently bound flavin adenine dinucleotide (FAD), and a 27kDa Fe-
S protein that binds three Fe-S clusters (Ohnishi, & Salerno 1976). Complex II 
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has major differences compared to the other complexes. It is the only enzyme 
of the MRC that is entirely nuclear-encoded. Also, it has a role in both the TCA 
cycle and the MRC processes catalysing the oxidation of succinate to fumarate 
to reduce ubiquinone to ubiquinol shown in the equations (Ackrell et al 1975):  
succinate (C4H6O6) + FAD + Q + 2e
−+ 2H+matrix  → fumarate (C4H4O6)  + 
FADH2  + QH2 
Oxidation of succinate takes place at the SDHA subunit. Then electrons are 
transferred via the SDHB subunit and the Fe-S clusters and then to ubiquinone 
via the SDHC/SDHD subunits (Lemarie et al 2011; Sun et al 2005). Due to the 
low energy released by this reaction, no protons are translocated to the 
intermembrane space (Rich, & Maréchal 2010). 
Complex III (Ubiquinol:cytochrome c oxidoreductase) 
Complex III is a homodimer with each half composed of eleven subunits 
encoded by both nuclear and mitochondrial genes (Berry et al 2000). The 
largest subunit, cytochrome b, is mitochondrially-encoded. Complex III contains 
four redox-active prosthetic groups; an [2Fe–2S] iron-sulphur cluster, haem C 
(cytochrome c) and two haems B (cytochrome b) (Rich, & Maréchal 2010). 
These groups catalyse the oxidation of ubiquinol and the reduction of 
cytochrome c in a reaction known as the Q-cycle, which was first proposed by 
Peter Mitchell (Mitchell 1976). The reaction consumes two protons from the 
matrix and facilitates the translocation of four protons to the intermembrane 
space, contributing to the overall proton gradient. The Q-cycle reaction is 
summarised in the equation: 
2QH2 + 2cyt c
3+ + Q + 2H+(matrix) → 2Q + 2cyt c
2+ + QH2 + 4H
+
(intermembrane space) 
 
Complex IV (cytochrome c oxidase) 
Complex IV is also a homodimer with each monomer composed of thirteen 
polypeptides encoded by both nuclear and mitochondrial genes (Rich, & 
Maréchal 2010). Cytochrome c oxidase subunits I (COI), II (COII) and III  (COIII) 
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are mtDNA encoded while the remaining genes are encoded by nuclear DNA. It 
also houses one copper centre (CuA) where electrons enter the complex, two 
haems, (haem α and haem α3) and a binuclear centre (BNC) where CuB 
interacts with haem α3  to reduce oxygen (Iwata et al 1995; Muramoto et al 
2007). Complex IV is the final electron transporting complex of the MRC and it 
(mainly COI and COII) catalyses the transfer of the electrons from the reduced 
cytochrome c to oxygen (Rich, & Maréchal 2010). The reaction consumes eight 
protons from the matrix and translocates four protons to the intermembrane 
space thus facilitating greatly to the proton gradient (Wikstrom et al 2009; 
Wikstrom 1977). The net reaction is summarised in the equation (Wikstrom 
1977): 
4 cyt c2+ + O2 + 8 H
+
(matrix) → 4 cyt c
3+ + 2 H2O + 4 H
+
(intermembrane space) 
The mechanism for the reduction of O2 to water involves the transfer of 
electrons from cytochrome c to CuA and then to haem α. Then electrons are 
transferred to CuB and haem α3 and subsequently to molecular oxygen. 
ATP synthase (Complex V) 
ATP synthase is the final enzyme of the MRC and the OXPHOS process. It has 
a mass of 500kDa and consists of two functional domains, factor oligomycin, 
(Fo) located in the inner membrane and factor 1 (F1) located in the mitochondrial 
matrix (Abrahams et al 1994; Collinson et al 1994b; Collinson et al 1994a). The 
F1 catalytic domain in the mitochondrial enzyme consists of nine subunits with 
the stoichiometry α3β3γ1δ1ε1. Subunits γ, δ and ε form a central stalk linking the 
α3β3 subcomplex of F1 to the membrane domain, Fo (Stock et al 2000). The α3β3 
subcomplex and Fo are also linked by a peripheral stalk (or stator) that holds the 
α3β3  subcomplex stationary against the torque of the rotating central stalk (Carbajo 
et al 2005; Dickson et al 2006; Rees et al 2009). 
ATP synthase uses the energy created by the electrochemical proton gradient 
to facilitate the phosphorylation of ADP to ATP (Boyer et al 1973). ATP 
synthase provides a hydrophilic pathway across the inner membrane to 
facilitate the transfer of protons to the matrix. These protons are used to drive 
the phosphorylation of ADP to ATP, an energetically unfavourable reaction, thus 
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ATP synthase uses physical rotation of its subunits to catalyse the reaction 
(Boyer 1975; Abrahams et al 1994; Yoshida et al 2001).  ATP synthase can 
also function in reverse to hydrolyse ATP and pump protons to the 
intermembrane space (Hisabori et al 1999; Kato-Yamada et al 1998; Noji et al 
1997). This is to maintain the ATP:ADP ratio of the cell and also the Δψm that 
depends on the proton gradient (Schultz, & Chan 2001).   
1.1.4 Proton motive force and Δψm 
The proton translocation across the inner membrane, facilitated by the electron 
transport chain and ATP synthase, creates a proton circuit across the inner 
membrane.  This proton circuit can be described in terms of a driving force or 
potential/proton motive force (pmf, in mV) and flux (the proton current in nmol of 
protons/min). The pmf has two major components, ΔpH and Δψm.  The ΔpH 
represents the pH gradient across the inner membrane and Δψm is the 
difference in electrical potential between the cytoplasm and the mitochondrial 
matrix (Mitchell, & Moyle 1969). Other processes that depend on the pmf 
include Ca2+ handling across the mitochondrial inner membrane, metabolite 
transport and protein import (Jouaville et al 1999; Nicholls 2005; Brand, & 
Nicholls 2011). 
1.1.5 Proton leak 
As discussed above, proton pumping is coupled to respiration through ATP 
synthesis. However, this coupling is not complete since protons can leak across 
the membrane and lower the coupling efficiency of the reaction (Figure 1.3). 
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Figure 1.3 Mitochondrial coupling and basal proton leak 
Figure shows a representation of how mitochondrial proton pumping is coupled to ATP 
synthesis. As shown by the black arrows, protons are pumped into the mitochondrial 
intermembrane space, thus creating a proton gradient, which is utilised by the ATP synthase 
during ATP synthesis. However, as shown in by the red arrows, some protons are not utilised 
into ATP production and flow back to the mitochondrial matrix.  
This process is termed as proton leak (Brand et al 1994). There are two types of 
proton leak; basal and inducible leak. Basal proton leak regulation is not fully 
understood. It mainly depends on anion carriers present on the inner 
mitochondrial membrane and on the adenine nucleotide translocase (ANT) 
content (Brookes et al 1998; Brand et al 2005) It is also cell-type specific and 
correlates with the metabolic rate of the cell (Hafner et al 1988; Brand et al 
1991). Basal proton leak contributes significantly to the increase of basal 
metabolic rate of the cells (Brand et al 1991).   
Inducible leak is regulated by ANT and UCPs (uncoupling proteins) and can be 
activated by fatty acids, O2
- or lipid peroxidation products (Parker et al 2008). 
Literature suggests that increased proton leak can be a reaction to counteract 
the effects of increasing ROS levels (Korshunov et al 1997; Longo et al 1999; 
Skulachev 1996)  or even as a consequence of damaged membranes due to 
lipid peroxidation (Kokoszka et al 2001). Inducible leak through UCP1 in 
mammalian brown adipose tissue regulates heat production and can be ROS 
dependent (Dlasková et al 2010; Oelkrug et al 2010). The exact roles of UCP2 
and UCP3 are not yet resolved. UCP3 has been identified to reduce ROS 
production in isolated mitochondria (Toime, & Brand 2010). Also, UCP2 has 
recently been suggested to regulate human pluripotent stem cell (hPSC) 
differentiation (Zhang et al 2011). In this study the authors showed that UCP2 
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prevented mitochondrial glucose oxidation by inhibiting the utilisation of 
pyruvate from the KREBS cycle (thus inhibiting OXPHOS) and converting it to 
lactate instead, promoting glycolysis. This process also inhibits hPSC 
differentiation. Upon differentiation, UCP2 is repressed, glycolysis is decreased 
and mitochondrial glucose oxidation is either constant or increased. 
1.1.6 Mitochondrial genetics 
mtDNA is a 16,569 bp, double-stranded, circular molecule and the mtDNA 
sequence was first deduced in humans in 1981 (Anderson et al 1981). It is the 
only extrachromosomal DNA within the mammalian cell and there are multiple 
copies of it in every mitochondrion (Steuerwald et al 2000). The two mtDNA 
strands are different in terms of their base composition. The heavy strand is rich 
in guanines and the light strand is rich in cytosines. Human mtDNA is inherited 
exclusively through the maternal line, with only one case of paternal inheritance 
been reported in only muscle tissue of the subject (Schwartz, & Vissing 2002). 
Mitochondria-encoded genes and their function 
The mitochondrial genome encodes for 37 genes. For 28 of them the heavy 
strand is the sense strand and for 9 the light strand (Figure 1.4). mtDNA 
encodes for 13 polypeptides that are synthesised in mitochondrial ribosomes, 
all related to the OXPHOS process as they encode for subunits of the MRC 
complexes. It also encodes for 22 tRNAs and 2 rRNAs that are responsible for 
the translation of those polypeptides. The mitochondrial genome contains very 
little non-coding regions and completely lacks introns (Anderson et al 1981). 
The coding sequences of each gene are very close to each other and in some 
cases overlap (ATPase 6 and ATPase 8). The displacement (D) loop region is 
the only non-coding region of the mtDNA. 
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Figure 1.4 mtDNA map 
Figure shows a representation of a mtDNA molecule. On the outside circle it shows the genes 
encoded with the heavy strand as a sense strand and on the inside circle the genes that are 
encoded with the light strand as a sense strand. Complex I genes are shown in blue, complex III 
in dark blue, complex IV in green and ATP synthase genes are in red. tRNAs and rRNAs are 
shown in single letters. The origins of replication OH and OL are also shown. (Figure adapted 
from MITOMAP ([NO STYLE for: Mitomap 2006])). 
mtDNA replication 
mtDNA is replicated by polymerase γ (POLG), which also functions as a repair 
enzyme. In addition to POLG, mitochondrial replication requires TWINKLE, a 5’-
3’ helicase (Korhonen et al 2003) and the mitochondrial single-stranded binding 
protein (mtSSB). Reconstruction of a minimal mtDNA replisome in vitro 
confirmed biochemically the need for both POLG and TWINKLE, as a helicase, 
in order to form ssDNA molecules from dsDNA (Korhonen et al 2004). However, 
this reaction can only synthesise about 2kb of ssDNA. In the same study, the 
authors showed that addition of the mtSSB stimulates replication further thus 
generating molecules of about 16kb, the size of the mammalian mtDNA 
molecule, at a rate of 180bp/min compared to 270bp/min calculated for in vitro 
replication (Korhonen et al 2004; Clayton 1982).  
However, the exact mechanism of mtDNA replication has been an unclear and 
controversial topic. There are two main theories of mtDNA replication; strand-
asynchronous replication (Robberson, & Clayton 1972; Yasukawa et al 2006) 
and coupled leading-lagging strand (synchronous) replication (Figure 1.5) (Holt 
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et al 2000). In brief, the strand asynchronous replication model (or strand 
displacement) proposed by Robberson et al in 1972 suggests that replication 
begins at the OH origin of replication and displaces the light-lagging strand from 
the heavy-leading strand and the leading strand synthesis occurs in the 
absence of lagging strand synthesis (Robberson, & Clayton 1972). Lagging 
strand synthesis begins in the opposite direction when the OL origin of 
replication is exposed from the leading strand synthesis. This suggests that 
leading and lagging strand replication are uncoupled. The process ends with the 
creation of two daughter molecules made of two linked DNA rings. The coupled 
leading-lagging strand replication model suggests that similarly to nuclear DNA 
replication, mtDNA replication takes place in both directions from a specific 
replication site, the zone of replication (OriZ) and thus requires the synthesis of 
short fragments on the lagging strand (Okazaki fragments) (Holt 2009; Holt et al 
2000). 
 
Figure 1.5 Illustration of the strand asynchronous and coupled leading-lagging strand 
(synchronous) replication models   
(a–c) Strand-asynchronous replication. (a) mtDNA replication begins at the OH  and displaces 
the light-lagging strand from the heavy-leading strand and leading strand synthesis takes place. 
The lagging strand synthesis starts when the  leading strand exposes OL. (b,c) Lagging strand 
replication starts in the opposite direction until both strands have been fully replicated. 
(d).Synchronous or coupled replication. Replication begins from a zone of replication (OriZ) on 
the genome and replicates in both directions via conventional coupled leading- and lagging-
strand synthesis thus requiring the formation of short (Okazaki) fragments on the lagging strand.  
(adapted from Krishnan et al, (Krishnan et al 2008)) 
mtDNA transcription 
mtDNA gene transcription is initiated at three initiation sites, two on the heavy 
strand and one on the light strand to generate polycistronic transcripts of 
mRNA, tRNA and rRNA molecules (Montoya et al 1982).  The promoters for 
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each strand, heavy (HSP) and light strand promoters (LSP), each includes a 
short (15 bp) consensus sequence that is essential for transcription (Chang 
1984). Transcription of the heavy strand initiates at nucleotide 561 within the 
HSP or less often at nucleotide 638, whereas light strand transcription initiates 
at nucleotide 407 within the LSP (Parisi, & Clayton 1991; Chang 1984). For 
transcription to take place, a mitochondrial RNA polymerase (POLRMT) is 
recruited alongside mitochondrial transcription factor A (TFAM), and one of the 
transcription factor B1 (TFB1M) or B2 (TFB2M) (Falkenberg et al 2002; Fisher 
et al 1987).  Transcription termination is facilitated by the mitochondrial 
transcription termination factor 1 (MTERF1), which affects elongation by stalling 
transcription downstream of the mitochondrial rRNA genes (Fernandez-Silva et 
al 1997; Kruse et al 1989). Another member of the MTERF family, MTERF3, 
has also been linked with transcriptional regulation however, MTERF3 
negatively regulates mtDNA transcription initiation (Park et al 2007).   
mtDNA translation 
mt-mRNA is translated in the mitochondrial matrix by the mitochondrial 
ribosome which is composed of mitochondrially encoded 12S and 16S rRNAs 
and more than 85 ribosomal proteins encoded from the nucleus (Matthes et al 
1982). mt-tRNAs punctuate the mRNA to mediate its processing (Ojala et al 
1981). Translation is suggested to start directly after the mt-tRNA sequence as 
mt-mRNA lacks the 5’ non-coding (5’UTR) sequences and the 7-
methylguanylate cap that enable ribosome binding and recognition in nuclear 
RNA (Grohmann et al 1978; Montoya et al 1981).  Translation termination in the 
mitochondria takes places  when  the mitoribosomes facilitate a -1 frameshift at 
the AGA and AGG codons, which have previously been predicted to terminate 
the open reading frames (ORFs) of MTCOI and  MTND6 respectively 
(Temperley et al 2010; Barrell et al 1979). Consequently, both ORFs terminate 
at the standard UAG stop codon (Temperley et al 2010). 
mtDNA deletions, point mutations and repair 
mtDNA is prone to mutations. Due to the high gene density of the 
mitochochondrial genome, there is a high chance that a mutation will affect the 
coding sequence of mitochondrial genes.  Furthermore, mtDNA has no histones 
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and therefore the DNA is exposed and thus prone to damage from molecules 
such as ROS. mtDNA is close to the MRC machinery and free radical 
production sites and therefore directly exposed to oxidative damage as 
described in more detail in section 1.1.7 (Beckman, & Ames 1999). 
The mitochondrial genome, due to its polyploid nature, is exposed to 
homoplasmy and heteroplasmy. Homoplasmy refers to the situation where all 
copies of the mitochondrial genome are identical, whereas heteroplasmy is 
when there is coexistence of two (or rarely more) stable mitochondrial 
genotypes within the same cell, tissue, or organism. When some mutations 
affect all copies of the mtDNA they are referred as homoplasmic mutations, 
while when they only occur in some copies of the mitochondrial genome they 
are referred as heteroplasmic mutations. Evidence suggests that mtDNA 
constantly acquires mutations, which undergo clonal expansion and then 
extinction (Coller et al 2001). It is evident that there is variability between the 
mtDNA of siblings as well as different tissues (Lightowlers et al 1997). Different 
cells, tissues or organisms can have different levels of mutated (and stable) and 
wildtype mtDNA. Studies have suggested that the mutated form of mtDNA is 
functionally recessive and for a biochemical phenotype to be apparent, a 
threshold (on average 60% of the mtDNA has to contain a mutation) for mutated 
mtDNA must be exceeded (Chinnery et al 1997; Sciacco et al 1994).  
Errors in mtDNA repair have been linked with the higher mutation rate in ageing 
tissues. POLG is a nuclear encoded mtDNA polymerase responsible for 
copying and proofreading of mtDNA and the only one targeted to the 
mitochondria (Hansen et al 2006). Experiments on mice with an error-prone 
POLG, resulted in a 3-8 times higher number of somatic mtDNA mutations in 
most tissues compared to the wildtype. They have also shown premature 
ageing features such as kyphosis, hair loss and graying and a loss of muscle 
mass (sarcopenia) and reduced lifespan (Trifunovic et al 2004; Trifunovic et al 
2005; Kujoth et al 2005).  Despite the fact that MRC deficiencies have been 
identified in these mice, there was no increase in the amount of ROS produced 
in these cells and only a minor increase in oxidative damage (Trifunovic et al 
2005; Kujoth et al 2005). These data suggest that errors in the repair process of 
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mtDNA affect the function of the MRC but do not result in an increase in 
oxidative damage in the cells.   
In tissues composed of mitotic cells, e.g. kidney, spleen, skin and liver, mtDNA 
point mutations are more common than deletions (Cortopassi et al 1992). In 
addition, accumulation of mtDNA point mutations in human colonic crypt stem 
cells results in MRC deficiency in their progeny however, no mtDNA deletions 
were observed (Taylor et al 2003). 
Deletions are the primary cause of somatic mtDNA mutation in post-mitotic 
tissues, e.g. skeletal muscle, heart and brain possibly due to the fact that these 
cells are non-dividing and therefore less exposed to purifying selection of 
mtDNA deletions (Cortopassi et al 1992). Purifying selection of mtDNA refers to 
the condition where mutated mtDNA from a mother cell is not transferred to the 
daughter cell, and it most commonly associated with mitotic cells and inherited 
mtDNA mutations, especially via the maternal germ line (Stewart et al 2008a; 
Stewart et al 2008b). The higher levels of ROS in these tissues due to their high 
metabolic rate might also contribute to the higher incidence of mtDNA deletions 
(Cortopassi et al 1992). What causes somatic mtDNA deletions is also currently 
controversial. The main theories describing the mechanism of mtDNA deletions 
are recombination (Schon et al 1989; Mita et al 1990), slip-replication (Shoffner 
et al 1989) and double-strand break repair (Krishnan et al 2008). The common 
features of deletions created by these mechanisms are that most are located in 
the major arc of the mtDNA, and approximately 85% are flanked by direct 
repeat sequences, suggesting that these repeats have a role in the generation 
of these deletions. However, recently a study analysing the incidence of the 
13bp repeat sequence in the common mtDNA deletion, has suggested that 
mtDNA deletions are not caused by direct repeats but due to stable secondary 
structures that can form between distant segments of the mitochondrial genome 
(Guo et al 2010).  Alternatively, the same study suggested that the deletions 
depend on long and stable duplexes between distant mtDNA segments and the 
fact that there were variations in the breakpoint distribution implies that different 
mechanisms could be involved in mtDNA deletion generation.  
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mtDNA deletions can be observed more often in aged post-mitotic tissues and 
individuals with neurodegenerative diseases like Parkinson disease (Bender et 
al 2006; Kraytsberg et al 2006; Cortopassi et al 1992). Defects can also be 
caused by nuclear DNA mutations in genes involved in mitochondrial nucleotide 
metabolism, mtDNA maintenance, copy number and MRC function (Hudson, & 
Chinnery 2006).   
MtDNA haplogroups 
mtDNA haplogroups are defined as single nucleotide polymorphisms (SNP) in 
the mtDNA that are fixed in the normal population. There are 38 major human 
mtDNA haplogroups identified and they reflect the evolution of a particular 
maternal linage and ultimately can be traced back to a common matrilineal 
ancestor, or Mitochondrial Eve, that lived approximately 200 000 years ago in 
Africa (Behar et al 2008; [NO STYLE for: Phylotree 2009]; Oven, & Kayser 
2009). Different haplogroups have been associated with a number of 
polymorphisms (Torroni et al 1997) and different predisposition towards the 
ageing process (Benedictis et al 2000). 
1.1.7 Reactive oxygen species 
ROS include hydrogen peroxide (H2O2), O2
-, hydroxyl free radical (•OH) and 
peroxynitrite (ONOO-), which is formed from the reaction of nitric oxide with 
H2O2. ONOO- is sometimes regarded as a reactive nitrogen species (RNS) but 
for the purpose of our discussion we will consider RNS as ROS.  
ROS production 
Mitochondrial ROS production accounts for approximately 90% of the total ROS 
production in a cell (Balaban et al 2005). Mitochondrial complex I and complex 
III are the major sites of ROS production in the mitochondria (Murphy 2009; Ott 
et al 2007; Turrens, & Boveris 1980; Cadenas et al 1977). Complex II has also 
been reported as a site of O2
-  production however its contribution to the overall 
ROS levels is minor (Zhang et al 1998).  O2
- is the major ROS produced at 
these sites by the single electron reduction of O2. O2
- is then dismutased to 
H2O2  in a reaction catalyzed by the superoxide dismutases (SOD).  
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2 O2
− + 2 H2O → O2 + H2O2 + 2 OH
− 
H2O2 is scavenged by catalase (CAT) in the cytosol or glutathione peroxidase 
(GPx) and decomposes into water in the reaction represented by the equation: 
2 H2O2 → 2 H2O + O2 
Oxidative damage 
Reactive oxygen species (ROS), when present in excess amounts, are the main 
source of oxidative damage in the cell. ROS production and ROS-induced 
damage increase with age in humans. Also, ROS have been shown to be 
triggered by cytokines, growth factors and hormones such as interleukin-1β (IL-
1β), IL-3, IL-6, tumour necrosis factor a (TNF-α), transforming growth factor β 
(TGF-β) and angiotensin II (ANGII) (Thannickal, & Fanburg 2000). ROS have 
the capacity to oxidize proteins, lipids, nuclear and mtDNA (Golden, & Melov 
2001; Beckman, & Ames 1999). Oxidative damage from ROS includes base 
modifications, single and double strand breaks and cross-linking.  
Complex I is thought to be responsible for most of the increased O2
- production 
in ageing and Parkinson’s disease and is also the main source of O2
- in the 
brain under normal physiological conditions (Barja, & Herrero 1998; Turrens 
2003). The decline in the activity of antioxidant enzymes Cu/ZnSOD, CAT and 
GPx with age as well as a decrease in the activity of MnSOD at a later stage 
(after approximately 65 years) also contribute to the increased ROS levels (Lu 
et al 1999). 
Complex III is the primary source of O2
- in heart and lung mitochondria 
(Turrens, & Boveris 1980; Turrens 2003). Excess ROS production occurs due to 
alterations in the normal function of enzymes of the MRC and it is also related 
to the concentration of potential electron donors in the mitochondria (Murphy 
2009). 
There are different mechanisms in which ROS can cause DNA damage. The 
hydroxyl radical (OH) can react with the DNA by the addition to double bonds 
of DNA bases, e.g. by reacting with the C5-C6 double bond of pyrimidines 
leading to C5-OH- and C6-OH- adduct radicals and abstraction of an H atom 
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from thymine resulting in allyl radicals (Cooke et al 2003). The redox properties 
of adduct radicals can differ since C5-OH adduct radicals are reducing and C6-
OH adduct radicals oxidising (Steenken 1987).  
 
Figure 1.6 Diagrammatic representation of the reaction of OH with C5-C6 double bonds of 
pyrimidines 
OH reacts with C5-C6 double bond of cytosine and depending on the localisation of the radical 
and the OH, the product is either reducing or oxidising. Also the percentage of reducing and 
oxidising adducts produced from the reaction is show. (Figure adapted from Steenken S, 
(Steenken 1987)) 
OH also reacts with the sugar moiety of DNA by the mechanism of abstraction 
of an H atom to form DNA strand breaks and altered sugars as end groups 
(Beesk et al 1979). Another reaction of base radicals is the addition to an 
aromatic amino acid of proteins leading to DNA-protein crosslinking (Dizdaroglu 
et al 2002). A thymine-tyrosine cross-link was reported in mammalian chromatin 
in vitro and in cells exposed to H2O2 (Olinski et al 1992; Dizdaroglu et al 1989). 
The mechanism involves the addition of the allyl radical of thymine to the 
carbon 3 position of the tyrosine ring in a protein, followed by oxidation of the 
adduct radical (Margolis et al 1988; Dizdaroglu et al 1989).   
ROS can also attack polyunsaturated fatty acid residues of phospholipids on 
cell and mitochondrial membranes, which are extremely sensitive to oxidation,  
thus forming unstable peroxyl radicals (ROO•) that are precursors of the final 
and more stable product of the peroxidation process, malondialdehyde (MDA) 
(Valko et al 2007). This process is defined as lipid peroxidation (Figure 1.7). 
The process is a chain reaction that is initiated by the reaction of unsaturated 
lipids with ROS (such as OH and hydroperoxyl (HO2) radicals)  thus producing 
unstable lipid radicals. These radicals react with oxygen to produce an unstable 
lipid peroxyl radical. The lipid peroxyl radical undergoes an intermediate 
cyclisation step and either by a second cyclisation or by the reaction with 
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unsaturated lipids it produces  a lipid peroxide, and another lipid radical that 
contributes to the continuation of the chain reaction (if it reacts with unsaturated 
lipids). MDA is a more stable product of the lipid peroxidation process.  
 
Figure 1.7 Diagrammatic representation of lipid peroxidation reaction 
An unsaturated lipid is oxidised by ROS to an unstable lipid radical, which then reacts with O2 to 
produce a lipid peroxyl radical. The peroxyl radical then, via an intermediate cyclisation step, 
reacts with itself through a second cyclisation event or with an unsaturated lipid to produce an 
unstable lipid peroxide. The peroxide, through chemical conversion of the bicyclic peroxide 
group, forms the more stable MDA and another fatty acid by-product.  (Figure adapted from 
Marnett LJ (Marnett 1999)) 
MDA has been shown to be mutagenic in mammalian cells and carcinogenic in 
rats as it reacts with DNA to form adducts to deoxyguanosine and 
deoxyadenosine (Fedtke et al 1990; Wang et al 1996; Marnett 1999). 4-
hydroxy-2-nonenal (HNE) is another major product of lipid peroxidation but its 
mutagenic effect is weaker than MDA (Valko et al 2007; Siems et al 1995). 
ROS in intracellular signalling 
ROS are not simply involved in oxidative damage in cells. When at normal 
physiological levels, ROS can act as signalling molecules and stimulate several 
intracellular pathways, which include mitogen-activated protein kinase (MAPK) 
signalling, HIF-1, NF-κB and AP-1 signalling pathways (Dröge 2002; Valko et al 
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2007), many of which have important roles in controlling chondrocyte phenotype 
(section 1.2.5).  
Mitochondrial ROS (mtROS) have been reported to inhibit the activity of 
different phosphatases including protein tyrosine phosphatase 1B, phosphatase 
& tensin homolog (PTEN) and MAPK phosphatases (Kwon et al 2004; Lee et al 
1998; Levinthal, & Defranco 2005; Meng et al 2002). mtROS can also induce 
TNF-α-mediated cell death in the absence of active NF-κB, however, when 
active, NF-κB-induced SOD2 counteracts this effect (Kamata et al 2005).  
ROS can also regulate tumour initiation, maintenance and metastasis and have 
also been suggested as a possible anti-cancer treatment (Gao et al 2007; 
Ishikawa et al 2008; Ma et al 2009).  
Pattern recognition receptors (PRRs) are recruited as part of an innate immune 
response to detect microbial motifs upon infection. They include Toll-like 
receptors (TLRs), C-type lectins (CTLs) and NOD-like receptors (NLRs), which 
recognize pathogen-associated molecular patterns (PAMPs) (Schroder, & 
Tschopp 2010). Some PRRs assemble into high-molecular weight, caspase-1-
activating platforms called ‘‘inflammasomes’’ that control maturation and 
secretion of interleukins such as IL-1b and IL-18, thus regulating host 
responses to infection and injury (Martinon et al 2002; Schroder, & Tschopp 
2010). The NLRP3- inflammasome is activated by PAMPs and ROS to trigger 
innate immune responses in the cell (Zhou et al 2011). 
Three recent studies pointed out the role of ROS as signalling molecules in both 
NLRP3-inflammasome dependent and independent pro-inflammatory cytokine 
release (IL-6, IL-1β and IL-18) and caspase activation (Bulua et al 2011; 
Nakahira et al 2011; Zhou et al 2011). Bulua et al demonstrate that mtROS 
induce MAPK activation (increased levels of phosphorylated p38 and JNK) and 
also regulate transcription of IL-6 in a NLRP3 inflammasome independent 
manner (Bulua et al 2011). Alternatively, two other studies by Nakahira et al and 
Zhou et al, suggest that autophagy (or mitophagy in this case) reduces immune 
responses by “self-digestion” of damaged mitochondria thus inhibiting NLRP3 
inflammasome and ROS induced release of mtDNA in the cytoplasm and 
subsequent IL-1β and IL-18 secretion and caspase activation (Nakahira et al 
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2011; Zhou et al 2011). Therefore, mitophagy inhibition is required for damaged 
mitochondria to accumulate thus increasing mtROS levels, for mtDNA to be 
released in the cytoplasm, and for the NLRP3 inflammasome to be activated in 
order activate proinflammatory signalling. ROS levels have also been shown to 
be regulated by NOD-like receptor X1 (NLRX1) in response to TNF-α, Shigella 
infection and double stranded RNA (dsRNA or poly(I:C), a dsRNA mimic) 
treatment  resulting in amplified NF-κB and JUN dependent signalling pathways 
thus suggesting that NLRX1 is a positive regulator of the innate immunity  
signalling (Tattoli et al 2008). The role of NLRX1 in innate immunity is further 
described in section 1.1.10.  
1.1.8 Antioxidant mechanisms 
ROS levels are regulated mainly by three superoxide dismutases (SODs), 
catalase (CAT) and Glutathione peroxidase (GPx). The SODs encode for 3 
different superoxide dismutases; SOD1 encodes for the cytosolic Cu/ZnSOD, 
SOD2 for the mitochondrial MnSOD and SOD3 for the extracellular EC-SOD.  
All three SODs spontaneously dismutase O2
- to H2O2 at an approximate rate of 
2x 109 M-1 s-1 (Klug et al 1972; Rotilio et al 1972).  Glutathione peroxidase and 
catalase scavenge the H2O2 at the mitochondrial matrix and the cytosol 
respectively, to produce H2O. 
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Figure 1.8 ROS production and scavenging in the cell and mitochondria 
(i) and (ii) O2
- is mainly produced at complex I and complex III of the MRC and released into the 
mitochondrial matrix, the intermembrane space and the cytosol. (iii) MnSOD (SOD2) catalyses 
the dismutation of O2
- to H2O2 in the mitochondrial matrix and (iv) Cu/Zn SOD (SOD1) catalyses 
the dismutation of O2
- to H2O2 in the cytosol. H2O2 is scavenged by (v) GPx in the mitochondrial 
matrix and by (vi) catalase in the cytosol, to produce H2O. (Figure adapted from Poyton et al, 
(Poyton et al 2009)) 
1.1.9 Superoxide Dismutase 2 (Manganese superoxide dismutase) 
As mentioned above, SOD2 is localized in the mitochondrial matrix and 
dismutases O2
-  to the less reactive H2O2 in a spontaneous reaction. 
Human SOD2 gene expression 
SOD2 is located on chromosome 6q25.3. It encodes for three transcript 
variants, two for isoform A (NM_000636.2 and NM_001024465.1) and one for 
isoform B (NM_001024466.1). Isoform A and isoform B transcripts translate to 
222 amino acid and 183 amino acid proteins respectively. The SOD2 gene has 
five exons interrupted by four introns. 
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Figure 1.9 Organisation of the SOD2 gene (Entrez gene ID #6648) 
Solid blue boxes and the associated numbers indicate exons and the exon size in base pairs. 
Lines and numbers between each exon indicate introns and the corresponding size.  The 
regulatory elements identified in the 5′ flanking region and the second intron of the human sod2 
are expanded and shown at the bottom. Corresponding positive and negative numbers indicate 
their location relative to the start site, which is designated +1. (Figure was adapted from Miao et 
al, (Miao, & Clair 2009)) 
The promoter of the SOD2 gene lacks TATA and CAAT boxes but contains GC-
rich motifs and binding sites for several transcription factors. An intronic 
enhancer found within the second intron of the SOD2 gene also regulates 
SOD2 gene expression (Xu et al 1999; Miao, & Clair 2009). SOD2 has one NF-
κB binding site in its proximal promoter and one found in the intronic enhancer 
region (Xu et al 1999). NF-κB is one of the major transcription factors regulating 
SOD2 gene expression upon cytokine stimulation. On the contrary, p50 (a 
member of the NF-κB family) negatively regulates SOD2 expression upon 
exposure to the tumour promoter 12-O-tetradecanoylphorbol-13-acetate 
possibly due to the formation of p50-p50 homodimers that inhibit NF-κB 
signalling (Dhar et al 2007). This indicates that NF-κB mediated SOD2 
expression is differentially regulated depending on the stimulus and as a result 
it can both promote and inhibit SOD2 expression. A binding site for the forkhead 
transcription factor FOXO3a is also found on the SOD2 proximal promoter and 
it has been shown that it increases SOD2 expression to protect cells from 
oxidative stress (Kops et al 2002). In a separate study the interaction of 
FOXO3a with PGC-1α has been shown to be required for the activation of 
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SOD2 (Olmos et al 2009). Several Sp1 binding sites are also found in the SOD2 
promoter region and are needed to induce SOD2 expression via the proximal 
promoter and the intronic enhancer element. An 11-G (guanine) single-stranded  
loop is found in the SOD2  promoter region. Nucleophosmin (NPM), an RNA-
binding protein, binds to this loop structure (due to its G-rich nature) and 
intergrades the SOD2 response to Sp1 and NF-κB. Disruption of the loop 
structure alters SOD2 transcription (Xu et al 2007). The SOD2 promoter has 
one binding site for the AP-1 transcription factor and several sites for the AP-2 
transcription factor. AP-1 activated via the JNK and MAPK pathway increases 
SOD2 expression whereas AP-2 decreases SOD2 expression by inhibiting SP-
1 dependent transcription (Qadri et al 2004; Zhu et al 2001).  
Structure of human MnSOD 
MnSOD (SOD2) protein has a mass of 32kDa and assembles into a tetramer, 
by the formation of a dimer of asymmetric dimers to create two identical four-
helix bundles. Each subunit has one N-terminal helical hairpin domain that is 
made up of a loop and two α helices and one C-terminal α/β domain made up of 
five  α helices and three β strands  (Figure 1.10A) (Borgstahl et al 1992). Its 
active site is located between the N and C terminal domains of each subunit. It 
contains a single manganese ion and it is stabilised in a five-coordinate trigonal 
bipyramidal structure  by two N-terminal and two C-terminal amino acids  and 
by one water molecule  (Figure 1.10B) (Borgstahl et al 1992).  The manganese 
ions (Mn2+) are located near the dimer interface site (Figure 1.10C). The O2
- 
reaches the active site through a narrow tunnel that limits the access to the 
active site to small ions (Figure 1.10D). O2
- is attracted by the net positive 
charge of the tunnel side chains (Borgstahl et al 1992; Perry et al 2010). 
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Figure 1.10  Stereo diagrams of human MnSOD subunit fold, active site geometry and tetramer 
assembly 
Mn
2+
 are shown as light pink spheres. (A) MnSOD subunit. The N terminal domain (bottom) is 
made up of a loop (blue) and two α helices (α1-α2; purple). The C-terminal α/β domain (top) is 
made up of five α helices (α3-α7; blue) and three β strands (β1-β3; yellow). Mn
2+
 lies between 
the two domains. (B) Active site geometry of MnSOD. The active site is located between the N 
and C terminal domains of each subunit. The manganese ion (pink) is stabilised in a five-
coordinate trigonal bipyramidal structure (ball and stick) by two N-terminal (His-26 and His-74) 
and two C-terminal (Asp-159 and His-163) amino acids and by one water molecule (blue 
sphere). (C) Tetrameric structure of MnSOD. Each subunit is coloured differently. Mn
2+
 are 
located near the dimer interface (blue-purple dimer; yellow-green dimer). (D) Tetrameric 
structure of MnSOD showing the positively charged tunnel from when O2
- reaches the active 
site. The C terminal domain (yellow β-sheets and blue α-helices and loops) surrounds the 
central tunnel. (Figure adapted from Borgstahl et al, (Borgstahl et al 1992)) 
SOD2 role in cell physiology 
SOD2 is important for cell homeostasis as well as cell survival since 90% of the 
ROS are produced at the MRC. SOD2 (-/-) mice experience prenatal (C57BL/6J 
background) or neonatal lethality (CD1, DBA/2J and B6D2F1 backgrounds), 
associated with severe neurological and cardiac phenotypes and metabolic 
acidosis (Huang et al 2001; Li et al 1995; Lebovitz et al 1996). These 
differences in phenotype between strains can be attributed to the different 
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sensitivities and mitochondrial damage caused by the increased levels of O2
- in 
the mitochondria of SOD2 (-/-) mice. Lipid accumulation in the liver and skeletal 
muscle as well as metabolic acidosis (indicating impairment of fatty acid 
metabolism) and reduction in succinate dehydrogenase (complex II) activities 
have been reported in SOD2 (-/-), CD1 background, mice lacking exon 3 which 
encodes 39 amino acids involved in homodimerisation and manganese binding 
(Li et al 1995). Homozygous SOD2 mutant mice (of the same CD1 genetic 
background) exhibit decreased Complex I and II activity, high levels of oxidative 
DNA damage in the form of oxidative base modifications (8-oxo-
guanine/adenine/cytosine) as well as deficiencies of the tricarboxylic acid cycle 
enzyme aconitase in brain and heart (Melov et al 1999). mtDNA damage was 
also reported in livers of SOD2 heterozygous mice (C57BL/6 background) at 2–
4 months of age (Williams et al 1998). Higher levels of lipid peroxidation were 
also reported in heterozygous SOD2 mutant mice from the C57BL/6 genetic 
background (Strassburger et al 2005). Treatment of SOD2 null CD1 mice with 
SOD2 mimetics increases their lifespan and attenuates spongiform 
encephalopathy and mitochondrial defects (Melov et al 2001; Melov et al 1998). 
These findings indicate the importance of tight regulation of mitochondrial O2
- 
levels, as it is essential to maintain normal cell homeostasis. 
1.1.10 Mitochondria and their role in innate immunity 
Mitochondria have been identified as a signalling platform that regulates 
different processes and signalling events such as Ca2+ signalling and handling, 
ROS signalling, apoptosis and innate immunity signalling. 
Ca2+ signalling 
Mitochondria maintain and dictate cytosolic Ca2+ concentrations through their 
ability to accumulate, buffer and release Ca2+ into and from the cytoplasm. Ca2+ 
uptake by the mitochondria increases ATP production (Jouaville et al 1999). 
Active ATP production by the mitochondria is also required for the Ca2+ uptake 
by the endoplasmic reticulum (ER) (Landolfi et al 1998; Dumollard et al 2004). 
Ca2+ handling in the ER and the mitochondria relies on mitochondrial-ER 
interactions that are regulated by p38 MAPK and PKD (Szanda et al 2008; 
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Koncz et al 2009). Ca2+ has also been suggested to regulate mitochondrial 
biosynthesis by increasing PGC-1α expression (Handschin, & Spiegelman 
2006). 
Apoptosis 
Mitochondria play a major role in apoptosis. “Death signals” such as TNF-α, IL-
1β and NF-κB activation, facilitate the recruitment of members of the Bcl-2 
family of proteins such as Bid and Bad (Kamata et al 2005; Wachlin et al 2003). 
These proteins are activated by undergoing conformational changes and 
translocate to the mitochondria where they inhibit the anti-apoptotic Bcl-XL and 
activate Bax and Bax-like proteins thus facilitating release of cytochrome c into 
the cytoplasm (Desagher et al 1999; Eskes et al 2000; Griffiths et al 1999). 
Cytochrome c then activates caspase-9 by binding to Apaf-1 and dATP and 
thus inducing other downstream caspases and apoptosis (Newmeyer et al 
1994). 
Innate Immunity signalling 
Mitochondria have recently been linked with signalling pathways associated 
with anti-viral responses. In 2005, four different groups identified a protein, the 
‘virus-induced signalling adapter’ (VISA/IPS-1/MAVS/Cardif) to play a role in 
regulating interferon α (IFNα) and IFNβ production through the NF-κB, 
Interferon regulatory factor 3 (IRF3) and IRF7 pathways as a response to viral 
dsRNA (Seth et al 2005; Kawai et al 2005; Meylan et al 2005; Xu et al 2005). 
dsRNA is sensed by TLR3 (Toll-like receptor 3) or two retinoic acid inducible 
gene 1-like receptors (RLRs), RIG-I (retinoic acid inducible gene 1) and MDA5 
(melanoma differentiation associated gene 5). VISA is found on the 
mitochondrial outer membrane, it interacts with RIG-I and MDA5 and recruits 
IKKα, IKKβ and IKKε kinases leading to NF-κB and IRF3 activation in a RLR 
dependent pathway (Kawai et al 2005; Kawai, & Akira 2006). VISA has also 
been suggested to interact with TRIF and TRAF6 to mediate activation of the 
TLR3 mediated activation of NF-κB and IRF3 pathways (Xu et al 2005). 
Activation of VISA has recently been suggested to be regulated by NLRX1, a 
newly identified member of the NOD-like receptor family (NLR). NLRX1 is also 
localized on the mitochondrial outer membrane and negatively regulates the 
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activity of VISA and thus downregulating the RLR dependent anti-viral response 
described above (Tattoli et al 2008; Moore et al 2008). NLRX1 has also been 
identified to increase ROS production in response to TNF-α, Shigella infection 
and dsRNA stimulation, resulting in amplified NF-κB and JNK dependent 
signalling pathways and therefore suggesting that NLRX1 is additionally a 
positive regulator of the immune system (Tattoli et al 2008). Controversially in 
2009, the same group suggested that NLRX1 is localized in the mitochondrial 
matrix thus speculating that it does not interact with VISA to block signaling 
(Arnoult et al 2009). Another recent report, using NLRX1 knockout mice, has 
shown that NLRX1 deficiency does not alter VISA-dependent responses but 
identified a mitochondrial complex III subunit to be binding with NLRX1 thus 
suggesting that NLRX1 can regulate the activity of the MRC and alter ROS 
production (Rebsamen et al 2011). 
NF-κΒ has likewise been identified as a positive regulator of the SOD2 activity 
upon stimulation with TNF-α and IL-1β (Xu et al 1999; Miao, & Clair 2009). This 
suggests a link between NLRX1, ROS levels and SOD2 in the context of 
NLRX1 regulating the ROS levels directly and also indirectly via the NF-κΒ 
pathway.   
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Figure 1.11 NLRX1 and TLR3 in innate immunity signalling   
Graphical representation of the role of TLR3 dependent and independent pathways (NLRX1 
and VISA), in innate immunity signalling regulation. 
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1.2 Osteoarthritis 
1.2.1 Disease pathology 
Osteoarthritis (OA) is a degenerative joint disease that causes progressive loss 
of joint function. It is characterised by the loss of articular cartilage but also from 
changes to the periarticular bone, synovial lining and adjacent connective tissue 
elements (Brandt et al 2006). It is strongly associated with ageing since it 
affects mostly people over the age of 65. The most commonly affected joints 
are the knees, hips, hands and the spine. The symptoms of OA include 
inflammation, pain, stiffness and loss of mobility (Hunter, & Felson 2006). There 
are a number of risk factors associated with OA  including age, obesity, injury, 
previous surgery, bending and lifting, joint instability, peripheral neuropathy, 
muscle, weakness as well as genetic factors (Hunter, & Felson 2006; Goldring, 
& Goldring 2007). OA can be detected mainly using radiographs and magnetic 
resonance imaging (MRI) by quantifying changes of articular cartilage 
morphology, volume and thickness (Goldring, & Goldring 2007). 
1.2.2 Cartilage 
Cartilage is the tissue that covers and protects the ends of bones in synovial 
joints and enables friction-less movement between the joints (Figure 1.12). It is 
elastic, filled with fluid and supported by a layer of calcified cartilage and bone 
(Lane et al 1977). Cartilage is composed of two main extracellular matrix (ECM) 
macromolecules, aggrecan and type II collagen along with a resident single cell 
type, the chondrocyte. Type II collagen, a fibrillar collagen, is the predominant 
form of collagen present in the cartilage and provides the resistance of the 
tissue to tensile and shear forces. Aggrecan is responsible for the resistance of 
cartilage to compression by hydrating and swelling against the type II collagen 
scaffold. Aggrecan with highly sulfated glycosaminoglycan content (chondroitin 
sulfate and keratin sulfate) forms proteoglycan aggregates in association with 
hyaluronan and link protein, that stabilises the interaction of aggrecan and 
hyaluronan (Roughley 2001; Doege et al 1991).   
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Figure 1.12 Representation of a knee joint and cartilage with its extracellular matrix and 
chondrocytes 
Figure shows the main parts of a knee joint and concentrates on the structure of cartilage and 
the subchondral bone as well as the structure of the extracellular matrix of cartilage with the 
chondrocytes. (Figure adapted from David A. Young, unpublished figure) 
Chondrocytes only make up 5% of the volume of the cartilage (Stockwell 1967). 
They are the main sites of production of the components of the ECM. There is a 
fine balance between the anabolic (synthetic) activity of the chondrocytes and 
their catabolic (degradative) activity. Catabolic events are mediated by pro-
inflammatory agents whereas the anabolic events are mediated by anti-
inflammatory agents. These events are controlled by the production of growth 
factors and cytokine cascades as well as physical factors, for example 
mechanical stress (Rowan, & Young 2007). 
In OA there is a change in the molecular structure and the composition of the 
ECM (Buckwalter, & MANKIN 1997). There is an increase in the production of 
matrix metalloproteinases (MMPs) and inflammatory mediators, for example IL-
1, IL-8, IL-6, prostaglandin E2 (PGE2) and nitric oxide (NO) as well as an 
increase in the ECM-degrading proteins and the pro-inflammatory cytokines 
(Pelletier et al 2001). The net result is a decrease of the anabolic, or synthetic, 
activity of the chondrocytes and an increase of the catabolic, or degradative, 
activity (Aigner et al 1997; Aigner et al 2001; Fay et al 2006). Proteoglycans are 
lost and newly synthesized proteoglycans are smaller, therefore the water 
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concentration of the matrix is decreased and the collagen network is broken 
down and as a result, cartilage has less resistance to compression. The 
replacement of chondrocytes and the ECM is a very slow process, especially of 
type II collagen, leaving cartilage prone to damage accumulation with age and 
could be partially responsible for the development of OA (Yudoh et al 2005; 
Loeser et al 2002). 
1.2.3 Matrix metalloproteinases 
MMPs 
Matrix metalloproteinases (MMPs) comprise a family of 23 Zinc-dependent and 
calcium dependent endopeptidases that modulate interactions between cells 
and between cells and the ECM (Murphy et al 2002). Together the enzyme 
family is able to degrade all components of the ECM. They are regulators of cell 
differentiation, migration, proliferation and survival (Baker et al 2002). They 
have been associated with osteoarthritis and rheumatoid arthritis (RA), 
cardiovascular diseases and cancer. In cartilage, chondrocytes in response to 
the biomechanical stresses as well as traumatic injuries secrete MMPs, thus 
regulating the turnover of matrix components and the production of 
inflammatory cytokines (Goldring, & Goldring 2007; Kurz et al 2005; Fitzgerald 
et al 2004). There are 5 main groups of MMPs (Murphy et al 2002): 
collagenases, gelatinases, stromelysins, metrilysins and membrane type MMPs, 
all involved in the cleavage and degradation of different ECM components. 
MMPs (except membrane bound MMPs) are secreted by both the resident cells, 
e.g. chondrocytes in cartilage, and invading cells e.g. neutrophils. MMPs are 
first synthesized as inactive precursors (Pro-MMPs) and outside the cell 
become activated by proteolytic cleavage of an N-terminal polypeptide 
(Knäuper et al 1996; Eeckhout, & Vaes 1977). MMPs are also able to cleave 
aggrecan (Fosang et al 1996; Struglics et al 2006). 
Collagenases 
Triple helical fibrillar collagens include type I collagen, type II collagen and type 
III collagen and consist of three α chains that wind around each other in a right-
handed twist to form a triple helical structure (Murphy et al 2002; Nagase, & 
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Fushimi 2008). There are three collagenases; collagenase-1 (MMP-1), 
collagenase-2 (MMP-8) and collagenase-3 (MMP-13). Collagenases consist of 
three major domains; a propeptide that keeps the enzymes in a latent state and 
two domains that are required for collagen hydrolysis: a catalytic domain that 
contains the catalytic zinc and via a linker region is linked at the C-terminal of a 
hemopexin (Hpx) domain (Nagase, & Fushimi 2008).  
 
Figure 1.13 Domains of collagenases MMP-1, MMP-8 and MMP-13.  
Domain components of collagenases are indicated by different shades. SS: signal peptide; pro: 
propeptide; Hpx: hemopexin. (Figure adapted from Nagase et al, (Nagase, & Fushimi 2008)). 
They act by first unwinding triple helical collagen to present each α chain to the 
active site in a mechanism that involves contact of the catalytic and Hpx domain 
with collagen (Chung et al 2004). Then the α chains of the unwound collagen 
are cleaved at a single site approximately three-quarters from the N-terminus, 
thus generating one-quarter and three-quarter fragments (Miller et al 1976; 
Mitchell et al 1996). 
 
Figure 1.14 Triple helical collagen cleavage by collagenases 
Collagenases bind to collagen and unwind collagen to present the three α chains to the active 
site. The unwound α chains are then cleaved at a single site approximately three-quarters from 
the N-terminus. (Figure adapted from Nagase et al, (Nagase, & Fushimi 2008)) 
172 H. NAGASE ET AL.
FIG. 2. Steps involved in collagenolysis by collagenase. Collagenase binds to
triple helical collagen and unwinds collagen. Unwoundα-chain is then presented
to the active site of the enzyme for peptide hydrolysis.
ADAMTS-4 by Kashiwagi et al. [28] showed that the full-length
TS4–1 has the greatest ability to cleave aggrecan and the deletion
of the Sp doma reduces only about 20% of th activity.
Further deletion of the CysR decreased the activity by about
60%. However, the form consisting of the catalytic domain and
the Dis domain had only 3% of the full activity. A similar
pattern of decrease of aggrecanolytic activity also was reported
for ADAMTS-5, although ADAMTS-5 had about 1,000-times
more activity against aggrecan than ADAMTS-4 [29].
ADAMTS-4 and -5 are thought to be processed intracellu-
larly by furin and other proprotein convertases [30] and active
forms of the enzymes are secreted from the cell. Recombinant
full-length ADAMTS-4 and -5 expressed in chondrosarcoma
cells were found to be bound to the cell surface and the
ECM and were not released into the medium [28, 29]. Since
full-length ADAMTS-4 and -5 are released into the medium in
the presence of heparin, it is likely that they are bound to sulfated
proteoglycans of the cell surface and the ECM. Domain deletion
studies indicated that ECM-binding sites are located within
the Sp domain of ADAMTS-4 [28] and the CysR domain of
ADAMTS-5 [29].
An interesting observation made by Kashiwagi et al. [28]
and by Gao et al. [31] was that the C-terminal Sp domain of
ADAMTS-4 inhibited its activity to cleave the Glu373-Ala374
bond, but the activity at the cleavage site in chondroitin
sulfate-rich region 2, as represented by the cleavage of the
Glu1480-Gly1481 bond, was not inhibited [28]. Upon removal
of the Sp domain, by proteolysis [31] or mutagenesis [28],
ADAMTS-4 gained the ability to cleave the Glu373-Ala374
bond and other protein substrate such as S-carboxymethylated
transferring (Cm-Tf), fibromodulin, and decorin [28]. Gao et
al. [31] found that MT4-MMP (MMP-17) on the cell surface
process the C-terminal Sp domain and activate ADAMTS-4 to
cleave the Glu373-Ala374 bond. 100
However, our recent studies indicated that the suppressed
aggrecanase activity of full-length ADAMTS-4 was due to
the presence of heparin that was used to prevent the enzyme
from binding to ECM. When heparin was chromatographically
removed from full-length ADAMTS-4 preparation, it possessed
about 20-times more activity than TS4–2 lacking the Sp domain
(Table 1). It was found that heparin greatly suppresses the
activity of TS4–1 containing the Sp domain, particularly on
the Glu373-Ala374 bond but is less effective on its activity at the
Glu1480-Ala1481 site. Table 1 shows the corrected activities of
FIG. 3. Sites cleaved by ADAMTS-4 and -5 in the aggrecan core protein. Neoepitope antibodies that recognize the N-terminal 374ARGSV- and the C-terminal
–GELE1480 were used to identify the site of cleavage in References [28, 29].
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ADAMTS 
The ‘A disintergrin and metalloproteinase with thombospondin motifs’ 
(ADAMTS) family of secreted proteases comprises 19 genes in humans. 
ADAMTS are responsible for collagen processing as procollagen-N-propeptide, 
cleavage of aggrecan (aggrecanases) as well as processes such as inhibition of 
angiogenesis, blood coagulation homeostasis, inflammation and fertility. As a 
result, they have been linked with arthritis and cancer (Porter et al 2005). A 
major subgroup of ADAMTS is the aggrecanases (ADAMTS-1, 4, 5, 8, 9, 15). 
They have a major role in cartilage aggrecan cleavage, with ADAMTS-5 being 
identified as the major aggrecanase in murine OA (Glasson et al 2005; Stanton 
et al 2005). ADAMTS expression is dysregulated in OA cartilage. The 
aggrecanases ADAMTS-1,5,9 and 15 have been shown to be downregulated 
whereas a number of other ADAMTSs (ADAMTS-2,12,14 and 16) are 
upregulated (Kevorkian et al 2004). ADAMTS and membrane-bound MMPs 
have furin recognition motifs that facilitate activation to occur through the 
endoplasmic reticulum and Golgi apparatus thus enabling secretion of an active 
proteinase in the extracellular matrix. This mechanism ideally localises these 
proteinases to effect proteolysis close to the cell, an event thought to occur in 
arthritic disease (Itoh, & Seiki 2006; Basbaum, & Werb 1996). 
TIMPs 
The activity of MMPs and ADAMTS is also regulated by inhibition mainly by the 
tissue inhibitors of metalloproteinases (TIMPs) and α2-macroglobulin. There are 
four TIMPs (1-4) and they bind metalloproteinases to control their activity. They 
are secreted proteins but they can also be found at the cell surface in 
association with other membrane bound proteins. In general most MMPs and 
ADAMTS-1, 4 and 5 can be inhibited by TIMPs although the extent of inhibition 
varies (Baker et al 2002; Kashiwagi et al 2001; Rodriguez-Manzaneque et al 
2002). α2-macroglobulin is synthesized in the liver and inhibits endoproteinases 
like MMPs and ADAMTS. It is also a major inhibitor of MMPs in the plasma 
(Baker et al 2002). TIMP-2 has also been identified to be involved in proMMP-2 
activation by forming a complex with MT1-MMP and pro-MMP-2 at the cell 
surface (Butler et al 1998; Wang et al 2000; Worley et al 2003). 
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1.2.4 Cartilage destruction and disease 
Cartilage destruction by collagen breakdown is considered a slow and 
irreversible process that occurs at latter stages of disease pathology. Aggrecan 
degradation is a faster process and occurs early in the cartilage degradation 
process (Little et al 2002; Caterson et al 2000). Collagenases MMP-1, MMP-8 
and MMP-13 degrade collagen in cartilage. However, not all collagenases are 
predominant in all cartilage-related diseases. MMP-8 is not expressed highly by 
human chondrocytes but is expressed highly by neutrophils in septic arthritis 
(Rajasekhar et al 2004). Both MMP-1 and MMP-13 are expressed by 
chondrocytes. However, MMP-1 is considered more predominant in RA where 
MMP-13 is presumed as the major collagenase in OA (Tetlow et al 2001; 
Billinghurst et al 1997). A recent study has demonstrated convincing evidence 
of the role of MMP-13 in OA by demonstrating reduced OA cartilage lesions in 
MMP-13 deficient mice (Little et al 2009). In the same study, aggrecan loss was 
high throughout the experiment, but cartilage erosion was not detected on the 
MMP-13 deficient mice suggesting that aggrecan depletion cannot drive 
cartilage erosion by itself. An earlier study on ADAMTS-5 deficient mice 
demonstrated the role of ADAMTS-5 in cartilage breakdown (Glasson et al 
2005). Also, Little et al identified the interglobular domain (IGD) of aggrecan is 
an important cleavage site by ADAMTS-5 (Little et al 2007). In this study, they 
generated mice with a knockin mutation that provided resistance of the IGD to 
ADAMTS-5 cleavage. This mutation reduced aggrecan loss and cartilage 
erosion in mouse model of surgically induced osteoarthritis and a model of 
inflammatory arthritis and also appeared to stimulate cartilage repair following 
inflammation.  
1.2.5 Regulation of MMP-13 and MMP-1 gene expression in cartilage 
In arthritic disease, several pro-inflammatory mediators have been associated 
with the induction of collagenase gene expression. These include IL-1, IL-17 
and TNF-α. Although OA is considered a non-inflammatory disease, many of 
these molecules are released by articular chondrocytes following mechanical 
stress, thus inducing MMP gene expression (Mitchell et al 1996). Other 
molecules that are involved in the induction of MMP-1 and MMP-13 include IL-6 
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and oncostatin M (OSM). Both work in synergy with IL-1, IL-17 and TNF-α to 
stimulate collagenase expression and collagen breakdown in RA but probably 
not OA (Manicourt et al 2000; Catterall et al 2001; Heinrich et al 2003; Hui et al 
2003; Hui et al 2005; Koshy et al 2002). Cytokines mediate their effect by 
activating several intracellular signalling pathways that regulate MMP activation 
and repression. The major pathways associated with arthritic disease include 
the MAPK (Malemud 2004), NF-κB (Feldmann et al 2002), and the Janus 
kinase/ signal transducers and activators of transcription (JAK/STAT) pathway 
(Heinrich et al 2003; Ivashkiv 2003).  
MAPK 
The MAPK family consists for three serine/threonine kinases; c-Jun N-terminal 
kinases (JNKs), the extracellular signal-regulated kinases (ERKs) and the p38 
kinases (Vincenti, & Brinckerhoff 2002). Τhe MAPK pathway in chondrocytes 
can activate the AP-1 family members, c-Jun and c-Fos and therefore activate 
expression of MMPs (Rowan, & Young 2007). Both JNKs and ERKs activate c-
Jun, which dimerises with c-Fos to induce MMP expression (Karin 1995).  
NF-κB 
Both IL-1 and TNF-α signal via the NF-κB pathway. In chondrocytes, NF-κB 
mainly regulates MMP-13 expression (Liacini et al 2002; Liacini et al 2003). In a 
recent study, AP-1 was also identified to regulate MMP-13 expression by 
binding an evolutionary conserved region approximately 20kb 5’ of relative to 
the MMP-13 transcription start site (Schmucker et al 2012). In the same study, 
the authors suggest that chromosome looping brings this region close to the 
MMP-13 transcriptional start site. Despite the presence of an NF-κB binding site 
on its promoter, it is not clear whether MMP-1 expression is regulated by NF-κB 
in chondrocytes (Catterall et al 2001) (Rowan, & Young 2007). 
JAK/STAT 
As with the NF-κB pathway, OSM and IL-6 members (plus leptin) signal via the 
JAK/STAT pathway to induce MMP-1 and MMP-13 expression (Heinrich et al 
1998; Li et al 2001). IL-6 has also been shown to activate STATs and ERK to 
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drive MMP-1 and MMP-13 expression in bovine chondrocytes (Legendre et al 
2005). However, it has also been suggested that OSM does not or only 
modestly induces MMP-1 mRNA expression (Catterall et al 2001).  
1.2.6 OA and ageing 
OA has been strongly associated with the ageing process. Alterations in the 
size of proteoglycan aggregates have been observed with increasing age 
(Martin, & Buckwalter 2002). This is due to both increased proteoglycan 
degradation and altered proteoglycan synthesis leading to a shorter aggrecan 
protein core and chondroitin sulfate chains, thus decreasing the resistance of 
cartilage to compression (Martin, & Buckwalter 2002; Thonar et al 1986). 
Chondrocytes have been shown to undergo senescence with age. Cartilage is a 
long-lived tissue and it has a slow turnover of cells and type II collagen (Verzijl 
et al 2000). Premature senescence and chondrocyte apoptosis can result from 
the increase in ROS and NO production (Loeser 2006; Afonso et al 2007). A 
report by Martin et al, suggested that mechanical stress promotes the release of 
ROS, which then induce senescence in chondrocytes with age (Martin et al 
2004). It has been reported that excess levels of peroxynitrite induce telomere 
erosion and extrinsic senescence in chondrocytes (Yudoh et al 2005). Telomere 
erosion beyond the main length necessary for replication (5-7kb) also induces 
cell cycle arrest and replicative senescence of chondrocytes (Martin, & 
Buckwalter 2002).   
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1.3 Mitochondria in cartilage and OA 
In recent years the involvement of mitochondria in the pathogenesis of OA has 
been considered. Their direct role in ROS regulation, ATP production, 
senescence and apoptosis has been linked to cartilage degeneration.  
1.3.1 Mitochondrial activity in healthy cartilage 
The activity of mitochondria and ATP production in chondrocytes, although not 
very extensively studied, has been a topic of interest but with contradicting 
results. Chondrocytes have no blood supply due to the absence of blood 
vessels in articular cartilage. Therefore, the major source of nutrients and 
oxygen comes from the synovium and the bone vessels on either side of joint 
with oxygen possibly transferred to the cells by diffusion of water from the 
synovium (Greenwald, & Haynes 1969; Lim et al 2006; Mauck et al 2003; 
O'Hara et al 1990). Chondrocytes can survive for many days without oxygen, 
however the rates of matrix synthesis and energy production are reduced in an 
oxygen tension dependent manner (Grimshaw, & Mason 2000). Oxygen tension 
was estimated, using knee synovial fluid samples, to be between 20 and 80 mm 
Hg at the surface of articular cartilage (Falchuk et al 1970). Further studies 
suggested that an oxygen gradient exists across articular cartilage since 
chondrocytes at the surface of cartilage receive 5-10% oxygen compared to 
approximately 1-2% at the deepest regions (Grimshaw, & Mason 2000; Marcus 
1973; Zhou et al 2004). As a result ATP production in cells in the superficial and 
middle zones of articular cartilage by OXPHOS is 18 times more efficient than 
glycolysis (Blanco et al 2004). However, although mitochondrial OXPHOS in 
chondrocytes is active, 80% of glucose is metabolized by glycolysis (Blanco et 
al 2004). Similarly, it has been reported that OXPHOS is not entirely inactive in 
chondrocyte mitochondria and is responsible for 25% of the chondrocytes’ ATP 
production as well as to maintain the Δψm (Stockwell 1983; Lee, & Urban 
1997). The rate of glycolysis is reduced under anoxic conditions (64% less 
lactate production compared to aerobic condition) suggesting the presence of a 
negative Pasteur effect in bovine articular cartilage (Lee, & Urban 1997). The 
negative (or reverse) Pasteur effect describes the situation in which 
carbohydrate breakdown is suppressed under anoxia and as a result could 
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make the chondrocytes prone to a shortage of energy due to a reduction in O2 
supply (Lee, & Urban 1997). Another study performed on chicken epiphyseal 
growth plate cartilage suggests that in the same population, cells with and 
without mitochondrial activity were detected suggesting that chondrocytes utilize 
OXPHOS as well as glycolysis for their ATP production (Yamamoto, & Gay 
1988). Human normal chondrocytes in culture have also been shown to have 
activity of the MRC similar to other mesenchymal cells (Maneiro et al 2003; 
Blanco et al 2004). Additionally, a 20-fold increase in the concentration of 
mitochondrial transcripts for cyt B, CO II and CO III has been reported in 
chondrocytes in culture compared to the levels in cartilage suggesting that the 
mitochondrial properties of chondrocytes change when transferred in an 
artificial culture environment (Mignotte et al 1991). 
In general, the information available and the number of studies performed on 
mitochondrial respiratory activity of chondrocytes are limited and therefore it is 
difficult to reach any conclusions regarding OXPHOS in chondrocytes without 
more extensive studies. 
1.3.2 Mitochondrial dysfunction and OA 
A decrease in complex II and III activity has been observed in OA chondrocytes 
as well as an increase in the mitochondrial mass, possibly as a mechanism to 
compensate for the decrease in the MRC activity. In OA, there are more 
chondrocytes with depolarised mitochondria than in healthy chondrocytes and 
this can be due to the lower activity of the mitochondrial complex III possibly 
due to the reduced proton pumping from complex III into the mitochondrial 
matrix during electron transport along the MRC (Maneiro et al 2003). 
Depolarisation can lead to swelling of the mitochondria, disruption of the outer 
mitochondrial membrane and therefore alteration of physiological functions of 
the mitochondria as described previously; the release of pro-apoptotic factors 
such as cytochrome c and as a result apoptosis and ATP-depletion can take 
place (Susin et al 1999; Liu et al 1996). 
Inflammatory cytokines have also been associated with mitochondria 
dysfunction. TNF-α and IL-1β have been shown to regulate the function of 
mitochondria in chondrocytes by inhibiting complex I activity either due to 
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modification of complex I proteins or due to reduced substrate availability. 
Mitochondrial depolarization was observed as well as an increase in mRNA and 
protein expression of the genes of the Bcl-2 family, indicating a possible role of 
TNF-α and IL-1β in apoptosis and cartilage degradation (López-Armada et al 
2006). Inhibition of complexes III and V of the MRC in human chondrocytes lead 
to an NF-κB mediated increase of cyclo-oxygenase 2 and prostaglandin E2 
(PGE2), both of which are inflammatory mediators involved in the joint tissue 
inflammation (Cillero-Pastor et al 2008). 
Another study has shown that the OA chondrocytes have a diminished mtDNA 
repair capacity as well as decreased mtDNA integrity (Grishko et al 2008). OA 
chondrocytes were shown to be more sensitive to ROS and NO-induced mtDNA 
oxidative damage. Also, the mtDNA repair capacity (following oxidative 
damage) of the chondrocytes in general, and especially OA chondrocytes is 
limited (Grishko et al 2008). In OA knee cartilage as well as non-OA aged 
tissue, accumulation of a 4977bp (nucleotide positions 8468 - 13446) mtDNA 
deletion (a common deletion identified in mtDNA) has been observed, 
suggesting a role of mtDNA deletions in the development and progression of 
OA (Chang et al 2005; Cortopassi et al 1992; Schon et al 1989; Shoffner et al 
1989). This deletion is considered a common cause of Pearson’s syndrome, a 
childhood multisystem disorder, Kearns-Sayre syndrome (KSS), the symptoms 
of which include external ophthamoplegia, mitochondrial myopathy, ptosis and 
retinitis pigmentosa, and chronic progressive external ophthalmoplegia (CPEO), 
a late-onset KSS (Goto et al 1990; Lestienne, & Ponsot 1988; McShane et al 
1991; Mita et al 1989; Rötig et al 1990). It has also been associated with 
neuromuscular dysfunction in ageing (Cortopassi et al 1992). The evidence of 
the 4977bp common deletion in OA mitochondria can support and can be 
supported by the hypothesis that mtDNA deletions in post-mitotic tissues (like 
cartilage) arise during inefficient mtDNA repair (Krishnan et al 2008).  
Another interesting observation is that different mitochondrial haplogroups have 
different risks of OA progression and therefore could be used as biomarkers for 
OA. Two studies using subjects from the Spanish population, representing the 
European population, have identified that carriers of haplogroup J might have a 
decreased risk of knee and hip OA progression due to odds ratios (OR, odds of 
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carrying each allele in OA patients as compared with controls) of 0.460 (knee 
OA) and 0.661 (hip OA) (Rego-Perez et al 2008; Rego et al 2009). Also, 
carriers of haplogroup J might also have a decreased risk of developing high 
severity knee OA compared to low severity knee OA (OR=0.351) (Rego-Perez 
et al 2008). Conversely, the same study suggested that carriers of haplogroup 
U might have an increased risk for a more severe progression of knee OA (OR= 
1.788).  
More recently, the same group assessed the influence of mtDNA haplogroups  
on the serum levels of collagenases and type II collagen markers (ELISA 
assays) (Rego-Perez et al 2010; Rego-Perez et al 2011). OA patients carrying 
haplogroup H had 33% higher serum levels of MMP-3 compared to OA patients 
carrying haplogroup J (Rego-Perez et al 2011). Analysis of type II collagen 
markers identified that OA patients carrying haplogroup H had higher serum 
levels of type II collagen (89% and 85%), nitrated type II collagen (230% and 
178%) and procollagen type II C-terminal propeptide (200% and 165%) 
compared to OA patients carrying haplogroup J and U respectively (Rego-Perez 
et al 2011). Carriers of haplogroup H had 19% higher serum levels of MMP-13 
compared to haplogroup J carriers as well 27% higher levels of type II collagen, 
28% higher levels of nitrated type II collagen, 135% higher levels of a C-
terminal neoepitope generated by the collagenase-mediated cleavage of type II 
collagen and 96% higher levels of procollagen type II C-terminal propeptide 
(Rego-Perez et al 2010). Taken together, these findings suggest that carriers of 
haplogroup H also have an increased risk of OA progression and could possibly 
be used, in combination with other markers, as a biomarker for OA (Rego-Perez 
et al 2010; Rego-Perez et al 2011). 
1.3.3 Chondrocyte Senescence 
It has been demonstrated in other cell types (fibroblasts and melanocytes) that 
oxidatively damaged mitochondria can lead to growth arrest and replicative 
senescence (Toussaint et al 2000). As mentioned before, premature 
senescence could result from the increase in ROS and NO production (Afonso 
et al 2007; Loeser 2006). The number of senescent human chondrocytes has 
been shown to increase with age. The chondrocytes have shortened telomeres 
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as well as high levels of senescence-accumulated β-galactosidase and their 
replicative capacity is decreased (Martin, & Buckwalter 2003; Price et al 2002). 
By treating the human articular chondrocytes with the anti-oxidant ascorbic acid, 
telomere length and lifespan remained constant with time (Yudoh et al 2005). 
1.3.4  Chondrocyte apoptosis 
Chondrocyte apoptosis has been linked to the reduced number of cells in OA 
cartilage and is considered to contribute to cartilage degradation (Blanco et al 
1998; Hashimoto et al 1998; Stockwell 1967). Hashimoto et al, reported that 
22% of OA chondrocytes undergo apoptosis and they are mostly localised in 
the superficial and middle zones of cartilage (Hashimoto et al 1998). Blanco et 
al, reported that 51% of OA chondrocytes undergo apoptosis and that the 
majority are also localised in the superficial and middle zones of cartilage 
(Blanco et al 1998). However, a later study contradicted these findings and 
suggested that apoptosis does not play a role in OA as they identified very low 
levels of apoptotic chondrocytes (Aigner et al 2001). An alternative hypothesis 
was suggested, chondroptosis, a variant of apoptotic cell death in chondrocytes 
(Roach et al 2004). Chondroptosis shares some features with classical 
apoptosis, such as cell shrinkage, chromatin condensation and involvement of 
caspases. However, in chondroptotic cells, the plasma membrane is deformed 
and the Golgi and ER are degraded, whereas in apoptotic cells, the plasma 
membrane and the organelles shrink but are intact. Also they suggest that there 
is no formation of apoptotic bodies in chondroptosis and therefore the degraded 
cellular material is left as debris. Some degradation also takes place into 
autophagic vacuoles suggesting a mechanism involving autophagy as well. Two 
recent reports associate autophagy with OA, suggesting that activation of 
autophagy by rapamycin inhibits chondrocyte apoptosis and ROS levels, 
reduces IL-1β-induced MMP-13 and ADAMTS-5 expression and also recovers 
IL-1β-mediated reduction of COL2A1 and aggrecan expression (Caramés et al 
2011; Sasaki et al 2011).   
The poor repair capacity of ROS induced mtDNA damage in OA chondrocytes 
compared to healthy chondrocytes correlates with increased susceptibility of OA 
chondrocytes to ROS- induced apoptosis compared to healthy chondrocytes 
Chapter 1                                                                                       Introduction 
 
43 
(Grishko et al 2008). Previous studies from the same group suggested that 
targeting DNA repair enzymes (8-oxoguanine DNA glycosylase/apurinic lyase 
(OGG1), endonuclease III and endonuclease VIII) into mitochondria could 
enhance the repair of mtDNA damage and also increase the viability of the 
treated cells and protect them against apoptosis (Rachek et al 2002; Rachek et 
al 2004). Cells overexpressing Bcl-2 have been show to be resistant to 
apoptosis induced by serum withdrawal or retinoic acid (Feng et al 1998). An 
increase in chondrocyte apoptosis has been linked with a decrease in the Bcl-2 
expression in OA (Kim et al 2000). The regulation of Bcl-2 has also been 
associated with TGFβ1. ΤGFβ1 has a possible anti-apoptotic effect on 
chondrocytes by acting via protein phosphatase A and thus increasing the Bcl-
2:Bax ratio by increasing Bcl-2 expression (Lires-Dean et al 2008). TGFβ1 
supplementation has also been shown to enhance cartilage repair, however 
side effects like fibrosis and osteophyte formation were observed (Blaney 
Davidson et al 2007). Caspase inhibitors have been suggested as a possible 
therapy as they have been shown to inhibit apoptosis induced by mechanical 
injury in human cartilage and horse cartilage discs (D'Lima et al 2001; Huser et 
al 2006). 
1.3.5 ROS and MMPs 
Reactive oxygen species have also been implicated in matrix degradation 
(Henrotin et al 2005) and have been shown to lead to the cleavage of collagen 
and hyaluronan (Gao et al 2008; Petersen et al 2004). OH can react with 
proline residues and lead to peptide bond cleavage in collagen (Schuessler, & 
Schilling 1984). Also O2
- has been reported to directly cleave peptide bonds 
(Monboisse et al 1988). MMP-1 activation can also be regulated indirectly by 
the effect of H2O2 on the MAPK pathway. Proinflammatory cytokines, such as 
IL-1 and TNF-α, increase SOD2 activity and therefore SOD2 can generate more 
H2O2 (Ranganathan et al 2001). H2O2 enhances the phosphorylation and 
activation of MAPKs, including ERK 1/2, JNK and p38 (Clerk et al 1998). JNK 
then phosphorylates c-Jun and JunD, whereas ERK 1/2 phosphorylates c-Jun 
and Fos family members (such as c-Fos) (Han et al 2001). Dimerization of Jun–
Jun or Jun–Fos factors, promotes translocation of these transcription factors 
into the nucleus where they regulate MMP-1 transcription (Han et al 2001; 
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Nelson, & Melendez 2004). MMP-1 transcription has also been reported to be 
enhanced by SOD2 via the H2O2 dependent activation of AP-1. 
Analysis of murine MMP-13 expression in SOD1 -/- mice suggested that ROS 
regulate collagen degradation in murine fibroblasts via the ROS-induced 
phosphorylation of MAPK kinases (ERK, JNK and p38) and the subsequent 
transcriptional activation of MMP-13. A study by the same group suggested that 
H2O2 regulates senescence-associated MMP-1 expression in human lung 
fibroblasts via JNK phosphorylation and recruitment of c-Jun to the MMP-1 
promoter (Dasgupta et al 2010). Additionally, type-I collagen fragmentation has 
been shown to promote ROS production and ROS-mediated MMP-1 expression 
in aged human skin fibroblasts via AP-1 and α2β1 integrin (a cell surface 
receptor for ECM) activation (Fisher et al 2009). H-Ras, NADPH oxidase and 
ROS have also been shown to mediate IL-1 and TNF-α-induced MMP-13 gene 
and protein expression in human chondrocytes via a mechanism that possibly 
involves the MAPK, AP-1 and NF-κB pathways (Ahmad et al 2011).  
1.3.6 Nitric oxide 
iNOS (inducible NO synthase) is up-regulated in OA, resulting in production of 
NO (Amin et al 1995). NO also inhibits proteoglycan and collagen synthesis 
(Taskiran et al 1994). Maneiro et al, (Maneiro et al 2005), have shown that nitric 
oxide mediates apoptosis by increasing caspase 3 and 7 levels and decreasing 
Bcl-2 levels. In the same study NO has also been demonstrated to inhibit the 
activity of the complex IV in human articular chondrocytes and to contribute to 
the depolarization of the Δψm. Elevated levels of nitrotyrosine, which is oxidized 
tyrosine in the presence of nitrous oxide (a product of NO+ROS), have been 
identified in OA and aged cartilage from human subjects and macaques (Loeser 
et al 2002). NO’s interference with the mitochondrial function has also been 
demonstrated. A gradual 2-fold increase in NO levels in guinea pig 
chondrocytes has resulted in a 50% decrease in the levels of ATP produced 
(Johnson et al 2004). In the same study, to confirm that the cause of ATP 
depletion was mitochondrial dysfunction, they found an increase in the lactate: 
pyruvate ratio, a compensation reaction to mitochondrial dysfunction. A different 
study also showed that treatment with the antioxidant N-Acetyl-cysteine 
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prevents NO-Induced apoptosis and cartilage degradation in a white rabbit 
chondrocyte model of OA (Nakagawa et al 2010). Nitric oxide has also been 
shown to affect OA synoviocytes. Cillero Pastor et al demonstrated that NO 
induced mitochondrial depolarization and cell death in human OA synoviocytes 
(Cillero-Pastor et al 2011). Also NO induced the activities of mitochondrial 
complex I and III possibly as an adaptive response to produce more energy. 
However, NO treatment also reduced mitochondrial mass and ATP turnover 
and decreased Bcl-2, Mcl-1 and pro-caspase-3 protein expression in the same 
cells (Cillero-Pastor et al 2011). 
1.3.7 ROS inhibitors and OA 
All three major inhibitors of O2
- in the cell, superoxide dismutase 1 (SOD1), 
SOD2 and SOD3, have decreased expression in OA cartilage compared to 
control both at the mRNA and protein level (Scott et al 2010; Ruiz-Romero et al 
2009; Aigner et al 2006). SOD2 downregulation in OA could be partially 
explained by the increase in the number of partially methylated CpG sites in OA 
compared with NOF cartilage. An increase of intracellular ROS levels in OA 
chondrocytes compared to healthy chondrocytes has also been reported, 
suggesting that this is a consequence of the decrease of SODs in OA and 
therefore higher O2
- levels (Ruiz-Romero et al 2009).  
As described in detail in section 1.1.9, SOD2 deficiency increases mitochondrial 
O2
- levels in mice and leads to prenatal or neonatal lethality. This phenotype is 
associated with severe neurological and cardiac phenotypes and linked to 
decreased Complex I and II activity as well as mitochondrial aconitase 
deficiencies, lipid peroxidation and oxidative gDNA damage in brain, heart, 
skeletal muscle and liver (Huang et al 2001; Li et al 1995; Lebovitz et al 1996; 
Melov et al 1999; Morten et al 2006). Treatment of SOD2 null CD1 mice with 
SOD2 mimetics increases their lifespan and attenuates spongiform 
encephalopathy and mitochondrial defects (Melov et al 2001; Melov et al 1998). 
The effect of exercise on cartilage in heterozygote SOD2-deficient mice 
(C57BL/6 x Sv129/Ola background) was recently assessed (Baur et al 2011). 
Elevated levels of 15-F2t-isoprostane (17%) and nitrotyrosine (25%) were 
detected in articular cartilage of SOD2 +/- mice compared to wild type possibly 
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due the increased O2
- levels in SOD2 +/- mice. The levels of these molecules in 
articular cartilage were increased in both SOD2 +/+ (15-F2t-isoprostane: 40%; 
nitrotyrosine: 33%) and SOD2 +/- (15-F2t-isoprostane: 40%; nitrotyrosine: 29%) 
after aerobic running exercise due to the fact that ROS levels were possibly 
induced by electron leakage from the MRC during aerobic exercise (Baur et al 
2011). However, these changes had no effect on cartilage morphology, 
structure and function and both SOD2 +/+ and SOD2 +/- mice did not show any 
features of OA. 
EC-SOD (or SOD3) levels have been shown to have a 4-fold reduction in OA 
chondrocytes compared to normal chondrocytes (Regan et al 2005). SOD3 
levels are also reduced in synovial joint fluid of OA subjects compared to normal 
(Regan et al 2008). 
Pro-inflammatory cytokines IL-1/4/6 and TNF-α are potent activators of SOD2. 
IL-1β reduces type II collagen expression and increases MMP-1 and MMP-3 
expression. It also stimulates NO production and as a consequence (provided 
ROS are present) peroxynitrite expression that can target the telomeres 
(guanine repeats) and can induce extrinsic senescence (Yudoh et al 2005; 
Afonso et al 2007). IL-1β stimulation in bovine cartilage enhanced SOD2 and 
GPX gene expression but decreased the expression of SOD1 (Cu/Zn SOD), 
SOD3 and CAT, suggesting a possible role of IL-1β in ROS production (Mathy-
Hartert et al 2008). However, depletion of SOD2 in human chondrocytes 
reduced basal MMP-1 and IL-1α induced MMP-1 and MMP-13 mRNA levels 
(Scott et al 2010) possibly due to reduced H2O2 levels, a known MMP-1 inducer 
(Ranganathan et al 2001). This can suggest that the reduction of SOD2 levels 
in OA has a potential chondroprotective role. 
A study evaluating the relationship of oxidative stress and age reported that 
increased oxidative stress with ageing makes chondrocytes more susceptible to 
ROS-mediated cell death (Carlo, & Loeser 2003). They studied this by 
assessing the levels of GSH (Glutathione), a ROS scavenger with anti-oxidative 
activity, in human chondrocytes. GSH affects the ECM of articular cartilage via 
regulation of H2O2 production, which has been shown to inhibit hyaluronic acid 
and proteoglycan synthesis (Bates et al 1985b; Bates et al 1985a). Additionally, 
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a decrease in GSH causes a decrease in proteoglycan and hyaluronic acid 
synthesis (essential components of the ECM) (Carlo, & Loeser 2003). GSSH, 
the oxidized form of GSH, was 4-fold increased in chondrocytes from older 
donors compared to chondrocytes from young donors, while the levels of GSH 
remained constant. The overall GSSH:GSH ratio was double in old donors 
compared to young donors and this could contribute to the increased ROS 
levels and oxidative stress in aged chondrocytes (Carlo, & Loeser 2003). 
 
Figure 1.15 Mitochondrial dysfunction in osteoarthritic cartilage.  
(a) SOD2 is downregulated in OA and its inhibition is related to MMP regulation in fibroblasts. 
(b) Complex II and Complex III activity is downregulated and inhibition of complex III causes 
mitochondrial depolarization. (c) NO inhibits complex IV and interferes with ATP production. (d) 
4977bp mt DNA deletion found in osteoarthritic mitochondria. (e) Bcl-2 is downregulated in OA 
and is also thought to be regulated by TGF-β. TGF-β regulation is also altered in OA. 
 
1.3.8 OA, TLRs and mitochondria 
As described in section 1.1.7, PRRs are recruited by the innate immune system 
to detect microbial motifs as a response upon infection. They include TLRs, 
CTLs and NLRs, which recognize pathogen-associated molecular patterns 
(PAMPs) (Schroder, & Tschopp 2010). Toll-like receptor 3 (TLR3) is, as 
mentioned before, a positive regulator of the NF-κB signalling. In a recent study, 
TLR3 expression has been shown to be significantly increased in OA cartilage 
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compared to normal healthy (NOF, neck of femur) cartilage (Zhang et al 2008). 
In the same study, TLR3 ligands have been shown to upregulate NF-κB 
mediated MMP-1 and MMP-13 induction suggesting a role in matrix 
degradation. As described in section 1.1.10, ΤLR3-independent NF-κΒ 
activation by dsRNA is thought to be regulated by the mitochondrial localized 
VISA (Seth et al 2005; Kawai et al 2005; Meylan et al 2005; Xu et al 2005). 
Another mitochondrial localised protein, NLRX1, was identified to be involved in 
non-TLR3 dependent dsRNA stimulation via the inhibition of VISA (Tattoli et al 
2008; Moore et al 2008). Other studies have linked NLRX1 with the regulation 
of TNF-α, Shigella infection and dsRNA induced ROS production thus 
amplifying the NF-κB and JNK pathways in a non-VISA dependent response 
thus suggesting that NLRX1 does not inhibit VISA but it is just a regulator of 
ROS levels upon infection (Tattoli et al 2008; Rebsamen et al 2011; Arnoult et 
al 2009). Two studies from our laboratory reported differential expression of 
both NLRX1 and TLR3 in OA and NOF cartilage and that TLR3 activation 
induced MMP-13 expression in chondrocytes, suggesting a possible role of 
these proteins in end-stage OA (Zhang et al 2008)(David A. Young, 
unpublished data). 
1.3.9 Mitochondria and RA 
Mitochondrial dysfunction and excess ROS have also been associated with RA 
(Filippin et al 2008). SOD1 and SOD3 are inhibited by TNF-α in RA leading to 
an increase in ROS production. An increase in peroxynitrite increased MMP-3 
and MMP-13 activity and decreased TIMP levels as well as type II collagen 
production (Afonso et al 2007). Also, more amino acid changing mutations 
where identified in MTND1 in RA synovium samples compared to OA synovium 
controls (Sylva et al 2005). DaSylva et al, also suggested that there are 5 
possible peptides that are altered due to mitochondrial mutations and can be 
presented by MHCII and recognized as non-self thus inducing an inflammatory 
response (Sylva et al 2005). Mitochondrial depolarization, increased levels of 
lipid peroxidation as well as high levels of lactate dehydrogenase (indicator of 
cytotoxicity) have also been observed in lymphocytes and serum samples from 
RA patients compared to non-RA controls (Moodley et al 2008). 
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1.4 Scope of this thesis 
SOD2 mRNA and protein expression has been demonstrated to be 
downregulated in OA cartilage compared to NOF (Scott et al 2010; Ruiz-
Romero et al 2009; Aigner et al 2006). The functional role of SOD2 depletion in 
OA has been examined in terms of MMP-1 and MMP-13 mRNA expression 
(Scott et al 2010). Also, intracellular ROS levels have been shown to be 
upregulated in OA chondrocytes compared to healthy chondrocytes (Ruiz-
Romero et al 2009). The effects of SOD2 depletion in mice have been 
previously characterized in terms of life expectancy, organ failures, 
mitochondrial dysfunction and oxidative damage due to increased O2
- levels 
(Huang et al 2001; Li et al 1995; Lebovitz et al 1996; Melov et al 1999; 
Strassburger et al 2005; Melov et al 2001; Williams et al 1998). Recently, it has 
been reported that SOD2 depletion decreases mitochondrial spare respiratory 
capacity (SRC) in mouse synaptosomes (Flynn et al 2011). Mitochondrial 
dysfunction and mtDNA damage have been identified in OA chondrocytes 
compared to healthy controls (Maneiro et al 2003; Grishko et al 2008; Chang et 
al 2005). Inflammatory cytokines have also been associated with mitochondria 
dysfunction in OA (López-Armada et al 2006; Cillero-Pastor et al 2008). ROS 
have also been shown to regulate MMP-1 and MMP-13 expression in human 
and murine lung fibroblasts as well as human chondrocytes (Ahmad et al 2011; 
Dasgupta et al 2010; Dasgupta et al 2009; Nelson, & Melendez 2004).  
In this thesis the functional effects of SOD2 downregulation in OA will be further 
examined, in the context of oxidative damage and mitochondrial dysfunction. 
The effect of SOD2 depletion on mitochondrial O2
- levels will be assessed in 
HAC. This will provide a basis for examining the downstream effects of SOD2 
downregulation in chondrocytes. OA cartilage will be screened for mtDNA 
damage and lipid peroxidation levels, which can be potentially caused by SOD2 
depletion and compared to NOF cartilage. Since SOD2 is vital in regulating 
oxidative damage in the cells, the effect of SOD2 depletion on lipid peroxidation 
and mtDNA damage will also be examined. Also mitochondrial function will be 
assessed in NOF and OA chondrocytes and SOD2-depleted chondrocytes in 
order to determine differences in mitochondrial function in NOF and OA 
chondrocytes and then assess the possible role of SOD2 in the regulation of 
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mitochondrial function in chondrocytes. In addition, the potential role of 
mitochondria as an innate immunity signalling platform in chondrocytes will be 
assessed by examining the role of NLRX1 in the regulation of MMP-13 
expression and ROS production. Also the effect of dsRNA and NLRX1 in the 
regulation of the differential expression of SOD2 in OA and NOF will be 
assessed.
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Chapter 2. Materials and Methods 
2.1 Materials 
2.1.1 Antibodies 
MnSOD (SOD2) rabbit polyclonal antibody (#110E) was purchased from 
Stressgen Bioreagents (Cambridge, UK). Alexa Fluor® 488 goat anti-rabbit IgG, 
(A-11034) was purchased from Invitrogen (Paisley, UK). NLRX1 mouse 
polyclonal antibody was kindly donated by Dr Stephen Girardin (University of 
Toronto, Canada). 
2.1.2 SW1353 cell line 
The SW1353 chondrosarcoma cell line was initiated from a primary grade II 
chondrosarcoma of a 72-year-old female Caucasian in 1977. SW1353 cells 
(HTB-94) were purchased from the (American Type Culture Collection) ATCC. 
SW1353 chondrosarcoma cells are considered a substitute for a chondrocytic 
experimental system. However, a study comparing the gene expression profile 
of SW1353 cells and HAC reported that SW1353 cells have very limited 
similarities in gene expression compared to HAC (Gebauer et al 2005). The 
authors suggested that SW1353 cells could be used to study the induction of 
MMPs however their potential to mimic HAC function is limited. The results 
acquired in this thesis using SW1353 chondrosarcoma cells as a model system 
for chondrocytes have to be interpreted carefully in terms of their relevance to 
mimic the function in HAC and the use of these cells in some experiments is a 
limitation of this thesis and therefore the use of this cell line was minimal and 
restricted to the optimisation of methods and when HAC availability was limited. 
2.1.3 Cell Culture Reagents 
DMEM medium and foetal bovine serum (FBS) were obtained from Invitrogen 
(Life technologies, Paisley, UK). Penicillin-streptomycin solution (10000 U/mL 
and 10 mg/mL respectively), L-glutamine solution (200 mM), Nystatin 
suspension (10000 U/mL), trypsin-EDTA solution (0.5g porcine trypsin and 0.2g 
EDTA per L), hyaluronidase (from bovine testes, 439 U/mg), trypsin (from 
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porcine pancreas, 1020 U/mg) and collagenase (from Clostridium histolyticum 
type I) were obtained from Sigma-Aldrich Ltd (Poole, UK). Phosphate buffered 
saline (PBS) was purchased from Lonza (Wokingham, UK). Tryptone, yeast 
extract and bacto-agar were purchased from Difco Laboratories (Detroit, MI, 
USA). 
2.1.4 Commercially Available Kits 
QIAquick® GelExtraction Kit and QIAquick DNA extraction kit were purchased 
from Qiagen (Crawley, UK). The TOPO TA Cloning® Kit for sequencing 
pCR®4-TOPO® vector was purchased from Invitrogen. E.Z.N.A Tissue DNA 
extraction kit was purchased from Omega Bio-Tek (Norcross, GA, USA). 
TBARS assay kit was purchased from Cayman Chemical (Ann Arbor, MI, USA)  
2.1.5 Molecular Biology Reagents 
GeneRuler™ 100kb and 1kb DNA ladders, EcoRI, BglII and HindIII were 
purchased from Fermentas Life Sciences (York, UK). Deoxyribonucleotide 
triphosphate (dNTP) and 5-bromo-4-chloro-3-indolyl β-D-galactopyranoside (X-
GAL) were purchased from Bioline (London, UK). VECTASHIELD mounting 
medium with DAPI was purchased from Vector Labs. Cryo-M-Bed compound 
was purchased from Bright (Huntingdon, UK) and SuperFrost® Plus Gold slides 
by Menzel Glaser were purchased from Fisher Scientific (Loughborough, UK). 
pGL3-Basic Vector (E1751) was purchased from Promega (Southampton, UK). 
Advantage® GC 2 PCR Kit, TITANIUM™ Taq DNA Polymerase and LA Taq 
were purchased from Takara Biomedicals (Wokingham, UK). Accuprime Pfx, 
TMRM and Mitosox Red were purchased from Invitrogen. Paraquat dichloride, 
N-Acetyl-L-cysteine, Antimycin A from Streptomyces sp., rotenone and Saponin 
from quillaja bark were purchased from Sigma-Aldrich Ltd (Poole, UK). 
All other standard laboratory chemicals and reagents, unless otherwise 
indicated, were commercially available from Sigma-Aldrich Ltd, Fisher Scientific, 
Invitrogen or BDH Chemicals (Poole, UK). 
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Methods 
2.2 Human Articular Cartilage sample collection 
Human articular cartilage samples were obtained from patients undergoing joint 
(hip or knee) replacement surgery due to end-stage osteoarthritis. Normal 
cartilage (NOF) was obtained from neck of femur fracture patients (with no 
history of osteoarthritis) undergoing joint replacement surgery. This study was 
performed with ethical committee approval from Oxford Radcliffe Hospitals NHS 
Trust and Newcastle and North Tyneside Health Authority and all patients 
provided informed consent. 
Cartilage was processed to extract chondrocytes or dissected and snap-frozen 
in liquid nitrogen or super cooled isopentane for DNA extraction and 
immunohistochemistry respectively. 
For OA chondrocyte cultures, cells were extracted from the remaining cartilage 
present on end-stage OA knee or hip specimens and therefore included lesions 
as well as macroscopically normal areas. Human cartilage used for 
immunohistochemistry was obtained from end-stage OA knee or hip specimens 
and exhibited differing degrees of damage. 
A difference of the OA and NOF cartilage is that the majority of the surface layer 
of cartilage is missing in OA samples due to disease progression. As a result, 
only surface layer HAC, which have higher mitochondrial activity compared to 
the middle and deep layers, could be isolated from NOF cartilage and not OA  
(Blanco et al 2011). Additionally, NOF patients are not completely “normal” and 
healthy, however due to their similar age to OA patients they were the best 
controls available for comparison. These are limitations of the sampling and 
have to be taken into consideration when analysing the results. 
2.2.1 Human articular chondrocyte (HAC) extraction 
Reagents: 
 PBS containing 200IU/mL penicillin, 200μg/mL streptomycin and 
40IU/mL Nystatin 
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 DMEM culture medium containing 10% FBS, 2mM L-glutamine, 
200IU/mL penicillin, 200μg/mL streptomycin and 40IU/mL Nystatin 
Method: 
Macroscopically normal cartilage was removed from the subchondral bone and 
washed in PBS. Cartilage was cut in small pieces and sequentially digested 
with 1mg/mL hyaluronidase in PBS for 15 min at 37C, 2.5mg/mL trypsin in 
PBS for 30 min at 37C and 2.5mg/mL collagenase (from Clostridium 
histolyticum type I) in DMEM for 16 hours at 37C. Cartilage pieces were 
washed three times in either PBS or DMEM between each of the incubations. 
Following digestion, cell suspensions were left for 15 min to allow undigested 
material to settle and the supernatant was removed and spun at 250 x g in a 
bench top centrifuge to pellet the cells. The cell pellet was washed with PBS 
and re-suspended in culture medium. HAC were seeded at an appropriate 
density in vented tissue culture flasks prior to experimentation, approximately at 
the density of 4 x 104 cells/cm2 in a T25 cm2 or T75 cm2 culture flask. 
2.2.2 Preparation of frozen sample blocks for sections 
Cartilage sections were used to identify cytochrome c oxidase (COX) -positive 
and COX-negative chondrocytes by the COX-SDH assay described in section 
2.6.1 and then their mtDNA screened for deletions.  
Method: 
Cartilage chips were snap frozen in super-cooled isopentane prior to sectioning. 
Samples were then mounted onto the stage using Cryo-M-Bed embedding 
compound. 
2.2.3 Homogenisation of tissue for DNA extraction 
Cartilage total DNA was screened for mtDNA deletions, mtDNA strand breaks 
and mtDNA copy number. 
Method: 
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Cartilage was weighed and 1.0-1.5g ground in a pre-cooled mixer mill (Retsch 
MM200, Retsch UK ltd, Castleford, West Yorkshire, UK). Cartilage was ground 
for 4 cycles of 1.25 min grinding at an impact frequency of 20 Hz and 2 min 
cooling in liquid nitrogen. 
2.3 Cell culture 
2.3.1 Routine cell culture 
HAC 
Reagents: 
 HAC culture medium- DMEM culture medium containing 10% FBS, 2mM 
L-glutamine, 200IU/mL penicillin, 200μg/mL streptomycin and 40IU/mL 
Nystatin. 
Method: 
Cells were cultured in vented T25 cm2 or T75 cm2 flasks in a humidified 
incubator with 5% CO2 (v/v) at 37C  (Scott et al 2010). Cells were cultured until 
they reached 70% - 80% confluency. Cell monolayers were washed with PBS 
before incubation with trypsin-EDTA solution to release the cells. Cells were 
split into appropriate culture vessels for experimentation.  
SW1353 chondrosarcoma cell line 
Reagents: 
 SW1353 culture medium- DMEM culture medium containing 10% (v/v) 
FBS, 2mM L-glutamine, 100IU/mL penicillin, 100μg/mL streptomycin 
 Freezing medium containing 90% (v/v) FBS and 10% (v/v) DMSO. 
Method: 
SW1353 cells were cultured like HAC. Cells were split into appropriate culture 
vessels for experimentation or into further T25 cm2 or T75 cm2 flasks to 
continue the cell lines  (Zhang et al 2008).  
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Excess SW1353 cells were frozen down for long term storage in liquid nitrogen 
by re-suspending cell pellets in freezing medium. Cells were transferred to 
cryovials and frozen slowly (1C /min) in a cell freezing container overnight 
at -80C prior to transfer to liquid nitrogen store. 
2.3.2 siRNA transfection 
Cells were seeded in appropriate culture vessels at a density of 1.5 x 104 
cells/cm2 or 2.5 x 104 cells/cm2 for SW1353 and HAC respectively. The 
following day, cells were transfected with 100nM of the appropriate siRNA or 
siGENOME non-targeting siRNA pool #2 (siControl2) using DharmaFECT® 1 
according to manufacturer’s instructions (Dharmacon, Lafayette, CO, USA) as 
described previously (Zhang et al 2008). After 48 hours cells were used for the 
experimentation or were washed with PBS and incubated in serum-free medium 
for a further 24 hours and stimulated with 0.5ng/ml Interleukin-1α (IL-1α) or 
poly(I:C). SOD2-targeting siRNA sequences (sense and antisense) and the 
NLRX1 and VISA target sequences are shown in Table 2.1. 
SMARTpool® Duplex Target Strand Sequence 
SOD2- 1 Sense 
Antisense 
5’-GGACAAACCUCAGCCCUAAUU 
5’-PUUAGGGCUGAGGUUUGUCCUU 
SOD2- 2 Sense 
Antisense 
5’-GGAGCACGCUUACUACCUUUU 
5’-PAAGGUAGUAAGCGUGCUCCUU 
SOD2- 3 Sense 
Antisense 
5’-AAAGAUACAUGGCUUGCAAUU 
5’-PUUGCAAGCCAUGUAUCUUUUU 
SOD2- 4 Sense 
Antisense 
5’-GUAAUCAACUGGGAGAAUGUU 
5’-PCAUUCUCCCAGUUGAUUACUU 
NLRX1- 1 Target sequence 5’-GCACGGGACUUUGUAGUGA 
NLRX1- 2 Target sequence 5’-CAUCAGAGCUCCUUGACCA 
NLRX1- 3 Target sequence 5’-GAUCUGCGGUUUCUCUGAU 
NLRX1- 4 Target sequence 5’-GCACAUCUUCCGUCGGGAU 
VISA- 1 Target sequence 5’-AAGUAUAUCUGCCGCAAUU 
VISA- 2 Target sequence 5’-GCUGUGAGCUAGUUGAUCU 
VISA- 3 Target sequence 5’-CAAGAGACCAGGAUCGACU 
VISA- 4 Target sequence 5’-AGAAUGAGUAUAAGUCCGA 
Table 2.1 Table Sequences of SOD2, NLRX1 and VISA-targeting siGENOME® SMARTpool® 
siRNA (Scott et al 2010). 
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2.3.3 Plasmid transfection 
NLRX1 was overexpressed in SW1353 cells and its effect on NF-κB activity was 
assessed after IL-1α and poly(I:C) stimulation. 
Method: 
SW1353 cells were seeded in 6 well or 48 well plates at a density of 1.5 x 104 
cells/cm2. The following day, cells were transfected for 24 hours with 0.3μg/ml 
NLRX1- mammalian expression plasmid DNA (Tattoli et al 2008). For luciferase 
assays cells were co-transfected for the same 24 hours with 0.15μg/ml NF-κB-
luciferase reporter using 3 μl Fugene HD (Promega) per 1μg of DNA. Cells 
were washed with PBS and incubated in serum-free medium for a further 24 
hours and stimulated with 0.5ng/ml IL-1α or poly(I:C) for 6 hours. 
2.3.4 dsRNA stimulation and transfection 
dsRNA mimic poly(I:C) is a ligand for TLR3 and potentially the RIG-I like 
receptors (RLR) MDA5 and RIG-I. Stimulation with extracellular (naked) 
poly(I:C) has been shown to activate TLR3, whereas transfected poly(I:C) 
bypasses TLR3 activation and activates RIG-I or MDA5 in a cell-type specific 
manner (Kato et al 2005; Kato et al 2006; Gitlin et al 2006). poly(I:C) was used 
to determine the effect of innate immunity signalling on MMP-13 and SOD2 
expression and ROS production in HAC and SW1353 cells. 
Method: 
Cells were stimulated with 0.5μg/ml poly(I:C) or transfected with 0.5μg/ml 
Poly(I:C) for 24 hours using Lyovec (or Lipofectamine 2000) dsRNA mimics and 
ligands of TLR3 and MDA5/RIG-I respectively (Zhang et al 2008). Cells were 
then washed twice in cold PBS and lysed in Ambion Cells-II-cDNA buffer to 
analyse mRNA expression as described in section 2.4.7 or cell-lysis buffer for 
protein extraction as described in section 2.5.1. 
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2.4 Nucleic Acid extraction and analysis 
2.4.1 Extraction of total DNA from cartilage homogenates 
DNA from OA and NOF cartilage was screened for deletions and strand breaks 
in the major arc of the mtDNA and mtDNA copy number was assessed as 
described later on in this section. 
Method: 
DNA was extracted from powdered cartilage homogenate using the E.Z.N.A. 
DNA/RNA Isolation Kit (Omega Bio-Tek Inc, Norcross, GA, USA). The DNA 
extraction procedure was performed according to the manufacturers 
instructions. DNA samples were quantified using the NanoDrop® 
spectrophotometer (NanoDrop Technologies, Wilmington, Delaware, USA) and 
stored at -20°C. 
2.4.2 Extraction of total DNA from cell cultures 
Total DNA from SW1353 cells was screened for strand breaks in the major arc 
of the mtDNA. 
Method: 
Cells were trypsinised, washed in serum containing media to neutralise the 
trypsin and then washed twice in PBS. DNA was extracted from using the 
QIAmp DNA mini kit (Qiagen, Crawley, UK). The DNA extraction procedure was 
performed according to the manufacturers instructions. DNA samples were 
quantified using the NanoDrop® spectrophotometer (NanoDrop Technologies, 
Wilmington, Delaware, USA) and stored at -20°C. 
2.4.3 Total DNA extraction from single cells 
Total DNA from single cells was screened for deletions in the major arc of the 
mtDNA and also mtDNA copy number was assessed in the same samples. 
Method: 
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Freshly extracted HAC were cytospun on membrane-microscope slides for 
10min at 250 x g. Single cells were isolated using laser capture microdissection 
as described in section 2.4.4. Cells were lysed using a 15μl single cell lysis 
buffer prepared as follows: In a total volume of 500µl, 250µl 1% (v/v) Tween 20 
(0.5% (v/v) final concentration), 195µl dH2O, 50µl 0.5M Tris-HCl pH 8.5 (50mM 
final concentration) and 5µl Proteinase K (200μg/ml final concentration). Lysate 
was used for mtDNA deletion and mtDNA copy number analysis described 
below. 
2.4.4 Laser capture microdissection 
This technique was used to isolate single cells that were selected according to 
their COX activity in order for their mtDNA to be screened for large-scale 
deletions.  
Method: 
Cells were cytospun on PEN-membrane slides and stained for COX and SDH 
as in section 2.6. Cells were then visualized using the Leica AS LMD system 
and COX-positive or COX- negative cells were selected (Krishnan et al 2010). 
These cells were then isolated using the laser capture tool of the Leica AS LMD 
system and placed into 0.5ml Eppendorf tubes in order to be lysed as described 
in 2.4. 
2.4.5 DNA isolation from Bacterial artificial chromosome (BAC) 
BAC containing the RP-11 56L9 region of the human DNA, which includes the 
SOD2 gene, was used in order to isolate the SOD2 promoter region to identify 
the changes that lead to differential SOD2 expression in NOF and OA. 
Bacterial cell culture 
Reagents: 
 Luria Broth (LB) containing 10 g NaCl, 10 g tryptone and 5 g yeast 
extract per litre dH2O. Adjust pH to 7.5 with NaOH. 
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 LB Agar – 10 g NaCl, 10 g tryptone, 5 g yeast extract and 15 g agar per 
litre dH2O. Adjust pH to 7.5 with NaOH. 
Method: 
A 100μL aliquot of Escherichia coli (E.coli) cells containing a BAC with the 
human RP-11 56L9 DNA region, that contained the human genetic locus 
including SOD2 gene promoter DNA, was spread on LB-agar plates containing 
12μg/mL chloramphenicol. Plates were incubated for 16 hours at 37C in order 
for colonies to develop. A single isolated bacterial colony was selected and 
added to 2mL of LB media supplemented with 60μM chloramphenicol. Cultures 
were shaken at 220 rpm and 37C for 16 hours in an orbital shaker. 
DNA isolation 
Reagents: 
 P1 (filter sterilized, 4C) 
 15mM Tris-HCl, pH 7.5 
 10mM EDTA 
 10μg/mL RNase A  
 P2 (filter sterilized, room temperature) 
 P3 (autoclaved, 4C) 
Method:  
Cultures were centrifuged at 4000 x g for 10 min and the supernatant discarded. 
Each pellet was resuspended in 100μL P1 solution by gently tapping the tubes. 
100μL P2 was then added, the contents were mixed thoroughly by inverting the 
tubes 5 times and let to stand for 5 min. 100 μL P3 was then added while 
shaking the tubes gently to mix thoroughly and the tubes were placed on ice for 
5 min. The contents were centrifuged for 10 min at 13000 x g at 4C and the 
supernatant mixed with 0.8mL ice-cold isopropanol. Samples were placed on 
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ice for 5 min and then centrifuged for 15 min at 13000 x g at 4C. Supernatant 
was removed mixed with 0.5 mL 70% ethanol to wash the DNA pellets. The 
tubes were centrifuged for 5 min at 13000 x g at 4C, and the pellets allowed to 
air-dry before resuspension in 50μL dH2O. 
BAC DNA digestion 
Method: 
To confirm the presence of the SOD2 gene in the RP-11 56L9 sequence, a 
12.5μL aliquot of each DNA isolation was digested using the restriction 
enzymes BamHI and HindIII in separate reactions. DNA was combined with 
25U restriction enzyme (2.5μL), 5μL 10x restriction enzyme buffer appropriate 
for each reaction and dH2O in a final volume of 50μL and incubated at 37C for 
2 hours. A 20μL aliquot of each digest was electrophoresed on a 1% (w/v) 
agarose-TAE (x1, Tris/Acetate/EDTA) gel as described in section 2.4.6. 
2.4.6 Agarose gel electrophoresis 
Reagents: 
 x1 Tris-acetate-ethylenediamine tetra-acetic acid (TAE) containing 0.04 M 
Tris (pH 7.5), 5.7% (v/v) glacial acetic acid and 0.001M EDTA. 
 Loading buffer containing Tris 0.125 M (pH 7.5), 2% (w/v) SDS, 10% (v/v) 
glycerol and 0.001% (w/v) bromophenol blue. 
Method: 
0.8-3% (w/v) agarose gels are prepared by dissolving the required amount of 
agarose in x1 TAE buffer through boiling. 10mg/ml ethidium bromide (3,8-
Diamino-5-ethyl-6-phenylphenanthridinium bromide) solution was added to 
cooled agarose at a final concentration of 0.2 µg/mL. Gels were poured, 
allowed to set and the required amount of DNA loaded in loading buffer. 
Amplicons were separated at 100V for approximately 40 min and visualised on 
a ChemiGenius II BioImager (Syngene, Cambridge, UK). 
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2.4.7 Extraction of total RNA from HAC and SW1353 cells and reverse 
transcription 
RNA was extracted from HAC and SW1353 cells and the reverse transcribed to 
cDNA in order to assess differential gene expression by real-time polymerase 
chain reaction (PCR) after specific treatments as described later in this section.  
Ambion Cells-II-cDNA Kit 
Method: 
The Cells-to-cDNA™ II Kit was used for cell numbers of less than 1 x 104 
seeded in a 96-well plate (Zhang et al 2008). Cell monolayers were washed 
with ice-cold PBS and lysed directly by addition of 30 µL Cells-to-cDNA™ II Cell 
Lysis Buffer. Lysates were mixed briefly, transferred to an ice-cold 96-well PCR 
plate and incubated at 75°C for 15 min to inactivate RNases. DNA digestion 
was performed by addition of 2 U DNase I per well followed by incubation at 
37°C for 15 min and 75°C for 5 min. 
Reverse transcription PCR (RT-PCR) 
Method: 
An 8µL aliquot of each RNA sample was transferred to a new 96-well PCR plate 
for reverse transcription. RNA samples were combined with 0.625 mM dNTP 
and 0.2 µg p(dN)6 and incubated at 70°C for 5 min. Samples were placed on ice 
and a reaction mixture containing 10 mM DTT, 100 U M-MLV, 4 µL 5X First-
Strand Buffer (Invitrogen) and 1.5 µL dH2O added to each sample giving a final 
reaction volume of 20 µL. The reactions were incubated at 37°C for 50 min and 
then 75°C for 15 min. Samples were diluted by addition of 30 µL dH2O for 
quantification of target genes and 5 µL aliquots where further diluted 1:10 in 
H2O for quantification of housekeeping genes (Zhang et al 2008). The cDNA 
was stored at -20°C prior to analysis and 5 µL aliquots were used in real-time 
PCR reactions as described in section 2.4.8.  
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2.4.8 Polymerase Chain Reaction  
Conventional PCR 
SOD2 promoter amplification 
The human SOD2 promoter would be isolated in order to subclone it into a 
luciferase reporter plasmid pGL3-Basic (Promega). Transcriptional activation of 
the promoter generates luciferase enzyme from the reporter and when 
incubated with substrate luciferase results in the production of light. The 
intensity of the light produced is proportional to the amount of enzyme produced 
and therefore gene activation. This construct would be used to identify 
signalling changes that cause differential expression of SOD2 in OA and NOF. 
Primer design 
A series of primers were designed to amplify a highly CpG rich region of the 
SOD2 promoter sequence as well as the 342bp NF-κB-responsive enhancer 
I2E within the second intron of the SOD2 gene. Forward primers SOD2- 2987, 
SOD2- 1605, SOD2- 1240, SOD2- 555 and SOD2- 210 and reverse primer 
SOD2R +24 were taken from a previous publication (Xu et al 1999) and both 
the forward and reverse primers had the Bgl II and Hind III restriction site 
sequence respectively attached to them. Primers SOD2 F1-F7, SOD2 R1-R7 
and SOD2 I2E F and SOD2 I2E R were designed using the PrimerSelect 
software (DNAstar, Madison, WI, USA) and were based on the GenBank 
reference assembly sequence NC_000006.10. Primers SOD2 I2E F and SOD2 
I2E R had a SalI were synthesised with a SalI restriction site at the 5’ end along 
with an additional number of random nucleotides. All primer sequences are 
shown in Table 2.2. 
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Primer 
Pair 
Name Primer Primer sequence 
1 sod2-2987 Forward 5’-CGGAGATCTGACCATGAGGCAGCTTTGAAGACA-3’ 
 SOD2R +24 Reverse 5’-CGGAAGCTTGCCGAAGCCACCACAGCCACGAGT-3’ 
2 sod2-1605 Forward 5’-CGGAGATCTAGATCACTTGAGGTCAGGCGTTCG-3’ 
 SOD2R +24 Reverse 5’-CGGAAGCTTGCCGAAGCCACCACAGCCACGAGT-3’ 
3 sod2-1240 Forward 5’-CGGAGATCTCCTGTTGTGAAGCCAAGTTCAGGT-3’ 
 SOD2R +24 Reverse 5’-CGGAAGCTTGCCGAAGCCACCACAGCCACGAGT-3’ 
4 SOD2 I2E F Forward 5’-CGGGTCGACCGGGGTTATGAAATTTGTTGAGTA-3’ 
 SOD2 I2E R Reverse 5’-CGGGTCGACCCACAAGTAAAGGACTGAAATTAA-3’ 
5 SOD2-F1 Forward 5’-ACTGTGGTTGGATCTGTTACTGG-3’ 
 SOD2-R1 Reverse 5’-CTCCGTTTTCTTTTTCTTTTTGTC-3’ 
6 SOD2-F2 Forward 5’-ACATGAGCCCAGCAAGTCG-3’ 
 SOD2-R2 Reverse 5’-AGTGGTTTTTCAGGCAAGGTGGTC-3’ 
7 SOD2-F3 Forward 5’-AGACCACCTTGCCTGAAAAACCAC-3’ 
 SOD2-R3 Reverse 5’-AACAGTCAGGCGAAGAGGAACCAC-3’ 
8 SOD2-F4 Forward 5’-GGTTCCTCTTCGCCTGACTGTTTT-3’ 
 SOD2-R4 Reverse 5’-ACGACGTGCCCGAGACTGC-3’ 
9 SOD2-F5 Forward 5’-GCACCTGCTACCTTCCATCAT-3’ 
 SOD2-R5 Reverse 5’-AGCGCCCTTCCAACCCGTATTCAG-3’ 
10 SOD2-F6 Forward 5’-TTAGGCAGCCGGTGGGGACAAAG-3’ 
 SOD2-R6 Reverse 5’-CCAGGGCACGGGAGAAAGGAG-3’ 
11 SOD2-F7 Forward 5’-ACCAGCAGCTAGGCCCCGTCTTC-3’ 
 SOD2-R7 Reverse 5’-CTCAACATGCTGCTAGTGCTGGTG-3’ 
Table 2.2 Sequences of primers used for analysis of SOD2 promoter 
 
Optimisation of cycling conditions 
Method: 
SOD2 promoter amplification was firstly attempted using primer pairs 1-3. 
However, due to unsuccessful amplification, different sections of the promoter 
region were amplified using primer pairs 5-11. Primers pairs 5-10 amplified the 
SOD2 promoter region successfully however primer pair 11 did not amplify the 
SOD2 promoter region fully and deletions were present possibly due the 
presence of GC-rich regions (section 6.4.8 and (Xu et al 2007)).  
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For primer pairs 1-3 and 5-10, different 20μL PCR reactions were performed by 
combining the BAC RP-11 56L9 DNA and the Advantage® GC 2 PCR Kit (1-3) 
or TITANIUM™ Taq DNA Polymerase kit (5-10) following the manufacturer’s 
recommended concentrations and cycling conditions. A 5μL aliquot of each 
reaction was electrophoresed on a 1% (w/v) agarose-TAE (x1) gel (section 
2.4.6) to determine the optimal annealing temperature and other conditions to 
amplify the PCR product. Optimum amplification of primer pairs 1-3 was 
achieved using the GC-2 PCR kit under the following cycling conditions: 94C 
for 3 min, 35 cycles of [94C for 30 sec, 68C for 3 min], 68C for 3 min. 
Optimum amplification of primer pairs 5-10 was achieved using the 
TITANIUM™ Taq DNA Polymerase kit and the following cycling conditions: 
95C for 1 min, 35 cycles of [95C for 30 sec, 60C for 30 sec, 68 for 2min], 
68C for 5 min. 
For primer pair 11, 20μL PCR reactions were performed by combining the BAC 
RP-11 56L9 DNA and the TITANIUM™ Taq DNA Polymerase kit and 5% or 
10% DMSO or 1.25M betaine. Optimum amplification was achieved following 
the manufacturer’s recommended concentrations, and using 1.25M betaine and 
the following cycling conditions: 95C for 1 min, 35 cycles of [95C for 30 sec, 
67 or 68C for 30 sec, 68 for 2min], 68C for 5 min. 
For primer pair 4, 20μL PCR reactions were performed by combining the BAC 
RP-11 56L9 DNA and the Accuprime Pfx kit. Optimum amplification was 
achieved following the manufacturer’s recommended concentrations and using 
the following cycling conditions: 94C for 2 min, 30 cycles of [94C for 15 sec, 
60C for 30 sec, 68 for 90 sec], 68C for 5 min. 
PCR product purification 
Method: 
SOD2 PCR products obtained were purified using the QIAquick Gel extraction 
Kit according to manufacturer’s instructions. PCR products were 
electrophoresed a 1% (w/v) agarose-TAE (x1) gel (section 2.4.6) and the 
required amplicon was excised. Gel was dissolved in Buffer QG and the PCR 
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products extracted and purified using QIAquick spin columns prior to elution in 
30μL dH2O.  
Long amplification PCR (LA-PCR) 
LA-PCR was used to amplify a 9.9kb fragment of the mtDNA (major arc). In the 
presence of large-scale deletions in this region, the size of the PCR product is 
smaller than 9.9kb. This can suggest the presence of mtDNA deletions in the 
samples. However, this technique is not quantitative since the reaction 
preferentially amplifies smaller fragments instead of larger fragments.  
mtDNA deletions 
Method: 
PCR analysis was performed using the Takara LA PCR System (Krishnan et al 
2010). In order to amplify mtDNA, each PCR reaction was prepared by 
combining 2.5 U (0.5 µL) Takara LA Taq™, 5 µL 10x LA PCR™ Buffer II (Mg2+ 
plus), 0.4 mM dNTP, 300nM Long 10F primer, 300nM Long 10R primer and 
50ng DNA sample in a final volume of 50 µL. The primers used were designed 
to amplify a 9.9Kb region (9,931 bp) of the mitochondrial genome (GenBank ID 
NC_001807) between nucleotides 6222 and 16153 (see Table 2.3). PCR 
reactions were performed using a GeneAmp® PCR system 9700 (Applied 
Biosystems). Cycling conditions were: 94°C for 1 min, 35 cycles of [94°C for 30 
sec, 58°C for 30 sec, 68°C for 11 min], 72°C for 10 min. A 25µL aliquot of each 
PCR reaction was electrophoresed on a 0.8% (w/v) agarose-TAE (x1) gel as 
described in section 2.4.6. Single amplicons smaller than 9.9kb were gel 
purified and cloned into a TOPO-TA vector (Invitrogen) and chemically 
transformed into Mach-I competent cells following the manufacturer’s protocol. 
A 100µL aliquot of each transformation was spread onto a pre-warmed agar 
plate containing 100µg/mL ampicillin. 40μl of 40mg/ml X-gal were spread on the 
plate to select for colonies containing an insert. Plates were incubated at 37°C 
for 16 hours in order for colonies to develop. Single colonies were picked for 
overnight cultures and then quick minipreps were performed as described in 
section 2.4.10. A 2μL aliquot from each miniprep was digested using EcoRI and 
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if positive for the insert sequenced and analysed using the CLC sequence 
Viewer software. 
Primer name Primer Primer sequence Position 
Long 10F Forward 5’-CCCTCTCTCCTACTCCTG-3’ 6222-6239 
Long 10R Reverse 5’-CAGGTGGTCAAGTATTTATGG-3’ 16133-16153 
Table 2.3 Primers used to amplify part of the major arc of the mitochondrial genome 
 
mtDNA strand breaks 
In order to assess mtDNA strand breaks a modification of the LA-PCR reaction 
was performed. An 11Kb amplicon was amplified using a real-time PCR 
method. 
Method: 
SW1353 cells were seeded in 6cm dishes at a density of 1.5 x 106/dish. After 24 
hours cells were transfected with 100nM siRNA as in section 2.3.2 for 48 hours 
and serum starved for 16 hours. Cells were also treated with 200nM H2O2 for 1 
hour as a positive control for the reaction. Cells were checked and looked 
normal after treatment with H2O2 and then trypsinised, washed and a dry cell 
pellet was collected. Total DNA was extracted using the QIAmp DNA mini kit as 
described in section 2.4.2. Extracted DNA was equalised using the Nanodrop 
system and the levels of mtDNA damage were assessed by real-time PCR by 
the amplification of part of the major arc of the mtDNA using the primers in 
Table 2.4. The long PCR was performed in 50µl reactions using the Expand 
Long Template PCR System (Roche). PCR reaction mixture contained: 200ng 
template DNA, 10mM buffer, 10µM primer, 5x SYBR Green, high grade PCR 
water, 10mM dNTP and 3.75U of Expand Long Template enzyme. Cycling 
conditions were as follows: 94°C for 2 mins, 10 cycles of 15 seconds 
denaturation at 94°C, 30 seconds annealing at 60°C and 9 mins extension at 
72°C; then 25 cycles of 15 seconds denaturation at 94°C, 30 seconds 
annealing at 60°C and 8.5 mins extension (+10 seconds/cycle) at 68°C. 
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MTND1 was used as a housekeeping marker. Real-time products were then 
subjected to 0.8% (v/v) agarose gel electrophoresis to screen for large mtDNA 
deletions.  
This method has been previously validated by Dr Matthew Birket in the 
Dermatology Department, Newcastle University and is published (Passos et al 
2007). 
Primer name Primer Primer sequence Position 
OLA Forward 5’-ATGATGTCTGTGTGGAAAGTGGCTGTGC-3’ 5756-5781 
D1B Reverse 5’-GGGAGAAGCCCCGGCAGGTTTGAAGC-3’ 282-255 
Table 2.4 Primers used to amplify the part of the major arc of the mitochondrial genome to 
screen for mtDNA strand breaks 
 
Real time RT-PCR 
Fluorescence-based, real-time reverse transcription PCR (RT-PCR) was used 
to measure steady-state mRNA expression in cells through real-time detection 
of sequence amplification. In real-time PCR, the amount of PCR product is 
measured at each cycle by the use of fluorescent markers that are incorporated 
into the PCR product and therefore enables accurate detection of the initial 
amount of target.  
When analysed with a stably expressed gene, e.g. 18S, the relative expression 
of a gene of interest was determined. Both the TaqMan probe-based and SYBR 
Green real-time PCR detection systems were used. 
Real-Time RT-PCR Primer Design 
Method: 
Primers and probes used for the TaqMan® probe-based RT-PCR method were 
designed using Primer Express 1.0 software from Applied Biosystems unless 
indicated otherwise. Primers used for the SYBR® Green real-time RT-PCR 
method were designed using ProbeFinder software (available at Universal 
ProbeLibrary Assay Design Centre and based on Primer3) from Roche 
Chapter 2                                                                       Materials and Methods 
 
69 
Diagnostics unless indicated otherwise. The 18S ribosomal RNA (rRNA) gene 
was used as an endogenous control (unless otherwise specified) and measured 
using a TaqMan probe-based reaction (with FAM™ reporter and TAMRA 
quencher) (Zhang et al 2008). All primers were designed to span an intron-exon 
boundary where possible, to prevent amplification of any contaminating DNA. 
TaqMan® Probe-Based Real-Time RT-PCR 
The TaqMan® system requires a pair of PCR primers in addition to a probe. 
The probe is designed to bind to the sequence amplified by the primers. In 
addition the probe contains a 5’ reporter dye and, in some cases a 3’ quencher 
dye attached which when intact and bound to the DNA template, emit 
fluorescence.  
Method: 
PCR reactions were prepared by combining 3µL cDNA with 5µL of TaqMan® 
Gene Expression Master Mix (Applied Biosystems), 300nM of each primer and 
150nM probe in a final volume of 10 µL. Cycling conditions were: 50°C for 2 
min, 95°C for 10 min and 40 cycles of [95°C for 15 sec, 60°C for 1 min]. The 
primers and probes for 18S and MMP-13 amplification were taken from from a 
previous publication (Zhang et al 2008) and are shown in Table 2.5. 
Primer name Primer Primer sequence 
MMP-13 Forward 5’-AAATTATGGAGGAGATGCCCATT-3’ 
 Reverse 5’-TCCTTGGAGTGGTCAAGACCTAA-3’ 
 Probe 5’-FAM-CTACAACTTGTTTCTTGTTGCTGCGCATGA-TAMRA-3’  
18S Forward 5’-CGAATGGCTCATTAAATCAGTTATGG-3’ 
 Reverse 5’-TATTAGCTCTAGAATTACCACAGTTATCC-3’ 
 Probe 5’-FAM-TCCTTTGGTCGCTCGCTCCTCTCCC-TAMRA-3’  
Table 2.5 MMP-13 and 18S TaqMan real time PCR primers and probes 
 
SYBR® Green Real-Time qRT-PCR 
SYBR® Green dyes bind to dsDNA. The intensity of the fluorescent signal is 
very little in solution since its intensity depends to the amount of dsDNA present 
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in the reaction. Therefore as dsDNA accumulates, the dye, when excited, emits 
a fluorescent signal proportional to the amount of dsDNA present. 
Method: 
PCR reactions were prepared by combining 3 µL cDNA with 4.8 µL SYBR® 
Advantage® qPCR Premix (Clontech Laboratories Inc, Mountain View, CA, 
USA), 0.2 µL ROX Reference Dye II, and 400 nM of each primer in a final 
volume of 10 µL. Cycling conditions were: 95°C for 10 min and 40 cycles of 
[95°C for 15 sec, 60°C for 1 min], standard dissociation curve. A dissociation 
curve analysis was performed at the end of the reaction to ensure amplification 
of one specific product. Final PCR products were also electrophoresed a 3% 
(w/v) agarose-TAE (x1) gel (section 2.4.6) to confirm the presence of a single 
product. Primers for SOD2 amplification were taken from a previous publication 
(Scott et al 2010) and are shown in Table 2.6. 
Primer name Primer Primer sequence 
SOD2 Forward 5’-CTGGACAAACCTCAGCCCTA-3’ 
 Reverse 5’-TGATGGCTTCCAGCAACTC-3’ 
Table 2.6 SOD2 SYBR Green real-time PCR primers 
 
TaqMan gene expression assays 
TaqMan gene expression assays are made of a ready mix of primers and probe 
required for real-time PCR detection that is based on the Taqman Probe-based 
real-time RT-PCR system described above. The method and reaction 
conditions are the same as described previously in the Taqman Probe-based 
real-time RT-PCR section. NLRX1 and VISA gene expression was assessed 
using this method (FAM reporter), and the product codes of the TaqMan assays 
(Applied Biosystems) used are “Hs00226360_m1 NLRX1” and 
“Hs_00325038_m1 VISA” for NLRX1 and VISA respectively.  
Gene expression analysis 
For both TaqMan® probe-based and SYBR® Green qRT-PCR methods the 
relative quantification of gene expression was performed using the ABI PRISM 
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7900HT Sequence Detection System (Applied Biosystems). Target gene 
expression was normalised to the level of 18S gene expression using the 
calculation 2-ΔCT, were ΔCT represents CT (target gene) – CT (18S). 
mtDNA deletions from single cells 
HAC were screened for mitochondrial respiratory activity using the COX/SDH 
activity protocol as in section 2.6.2. Single cells were then isolated using laser 
capture microdissection (section 2.4.4), lysed and were screened for deletions 
in the major arc of the mtDNA. This experiment would be used to identify 
differences in the mtDNA of COX-positive and COX-negative cells and also 
differences between NOF and OA mtDNA. 
Method: 
Chondrocytes were extracted from cartilage as described in section 2.2.1 and 
total DNA isolated as in section 2.4.3. Real Time PCR was performed on DNA 
extracts and mtDNA standards (102-109 MTND1 and MTND4 molecules per μL) 
using primers and probes for MTND1 and MTND4, two mitochondrial encoded 
genes (Krishnan et al 2010). MTND1 was used as the control and MTND4 as 
the deletion marker as it is more commonly deleted in post-mitotic tissues 
(MITOMAP) ([NO STYLE for: Mitomap 2006]). Wildtype blood DNA was used 
for normalisation. A multiplex qPCR reaction was then performed using two 
different probes (VIC and FAM) for the two genes of interest. The amount of 
deleted DNA (MTND4) was normalised to MTND1 levels and the blood control 
(supplied by Dr Kim Krishnan) using the calculation (1-2-ΔCT) x 100%, where 
ΔCT represents CT (MTND4) – CT (MTND1) -CT (blood control, ΔCT of MTND4 - 
MTND1). The primer and probe sequences are shown in Table 2.7 (Krishnan et 
al 2010). 
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Primer name Primer Primer sequence 
L3485-ND1 Forward 5’- CCCTAAAACCCGCCACATCT -3’ 
H3532-ND1 Reverse 5’- GAGCGATGGTGAGAGCTAAGGT -3’ 
 Probe 5’-VIC- CCATCACCCTCTACATCACCGCCC -3’  
L12087-ND4 Forward 5’- CCATTCTCCTCCTATCCCTCAAC -3’ 
H12170-ND4 Reverse 5’- CACAATCTGATGTTTTGGTTAAACTATATTT -3’ 
 Probe 5’-FAM- CCGACATCATTACCGGGTTTTCCTCTTG- 3’  
Table 2.7 MTND1 and MTND4 primers and probes 
 
mtDNA copy number 
This experiment was performed in order to identify differences in the mtDNA 
copy number between NOF and OA hip cartilage and also compare it to the 
mtDNA copy number of OA knee cartilage and other joint tissues.  
Single cells 
Method: 
Single chondrocytes were isolated as described in 2.2. Fifty cells were pooled 
and then lysed with 15μL lysis buffer (0.5% Tween 20, 50mM Tris-HCl pH8.5, 
200μg/ml Proteinase K) to extract the DNA. Real Time PCR was performed on 
DNA extracts and mtDNA standards (102-109 MTND1 molecules per μL) using 
primers and probes for MTND1 (Krishnan et al 2010). The copy number per 
sample was then calculated according to the standard curve derived from the 
amplification of the standards (102-109 MTND1 molecules per μL). 
Whole tissue 
Method: 
DNA from OA and NOF cartilage homogenates was isolated as described 
previously in section 2.4.1. MTND1 was used as the mitochondrial marker and 
β-2-microglobulin (B2M) as a nuclear reference gene (Krishnan et al 2010). 
Primers used for the preparation of B2M templates (used to prepare the 
standards) and standards and SYBR Green real-time PCR amplification are 
shown in Table 2.8. 
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Primer name Primer Primer sequence 
B2M (standards) Forward 5’- CGCAATCTCCAGTGACAGAA -3’ 
 Reverse 5’- GCAGAATAGGCTGCTGTTCC -3’ 
B2M (real-time PCR) Forward 5’- CACTGAAAAAGATGAGTATGCC -3’ 
 Reverse 5’- AACATTCCCTGACAATCCC -3’ 
Table 2.8 B2M primers for template and standards preparation and real-time PCR amplification  
Template and standards preparation 
Standard curves were prepared for each primer set to ensure the efficiency of 
each reaction and to allow accurate quantification.  
Method: 
PCR templates covering the region to be amplified by qPCR were generated 
using standard PCR techniques and gel extracted and purified. DNA was then 
quantified using the NanoDrop 1000 spectrophotometer and the number of DNA 
copies was calculated using the following equation, where C is DNA 
concentration in g/L, L is the amplicon length in bp and A is Avogadro’s number. 
Copy number = [C ÷ (L x 2 x 330)] x A 
Templates were serially diluted 1/10 with H2O to generate standard curves with 
109 to 102 copies of MTND1 and B2M. 
2.4.9 Purification of PCR products 
QIAquick Gel purification kit 
Method: 
SOD2 PCR products obtained were purified using the QIAquick Gel extraction 
Kit according to manufacturer’s instructions. PCR products were 
electrophoresed a 1% (w/v) agarose-TAE (x1) gel (section 2.4.6) and the 
required amplicon was excised. The gel was dissolved in Buffer QG and the 
PCR products extracted and purified using QIAquick spin columns prior to 
elution in 30μL dH2O.  
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2.4.10 Cloning of PCR products 
Ligation 
Method: 
Purified PCR products were cloned using the appropriate vector. For the 
products from primers 1-3 the pGL3 basic vector was used. In brief, purified 
DNA and pGL3 basic vector were digested in separate reactions. 30ng DNA 
was combined with 10U (1μL) of BglII restriction enzyme and 10U (1μL) of 
HindIII restriction enzyme, 6μL 10x restriction enzyme buffer M and dH2O in a 
final volume of 60μL. 5μL pGL3 basic vector (5μg/μL) was combined with 10U 
(1μL) of BglII restriction enzyme and 10U (1μL) of HindIII restriction enzyme, 
6μL 10x restriction enzyme buffer M and dH2O in a final volume of 60μL. The 
two reactions mixtures were incubated for 3 hours at 37C and then heat 
inactivated at 68C for 15 min. Then ligation reactions were prepared by 
combining 10ng digested vector, 4μL 5X Ligase Buffer, 1U T4 DNA Ligase 
(Invitrogen, Paisley, UK), 5μL digested DNA and dH2O in a final volume of 
20μL. Ligations were incubated at room temperature for 16 hours. 
For the PCR products from primer pair 11, the TOPO TA Cloning® pCR®4-
TOPO® vector was used according to manufacturer’s instructions.  
Transformation 
Method: 
For pairs 1-3, 5 µL of the ligation reaction was added to 50 µL Mach1™-T1® 
chemically competent E. coli. Reactions were incubated on ice for 30 min prior 
to transformation by heat-shock at 42°C for 2 min followed by immediate 
removal to ice. Using sterile technique, a 250 µL aliquot of S.O.C. medium 
(Invitrogen, Paisley, UK), a nutrient-rich bacterial growth medium, was added to 
each vial and cultures were shaken (220 rpm) at 37°C for 1 hour. A 100µL 
aliquot of each transformation was spread onto a pre-warmed agar plate 
containing 100 µg/mL Ampicillin. Plates were incubated at 37°C for 16 hours in 
order for colonies to develop. 
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For pair 11, 5µL of the ligation reaction was added to 50 µL One shot® 
DH5α™chemically competent E. coli. The same protocol was performed as with 
pairs 1-3. A 100µL aliquot of each transformation was spread onto a pre-
warmed agar plate containing 100µg/mL ampicillin as well 40µg/mL X-GAL in 
dimethylformamide (DMF) and 100mM IPTG spread on each plate. Plates were 
incubated at 37°C for 16 hours in order for colonies to develop. 
Preparation of Overnight Cultures 
Method: 
White colonies were selected and added to 5 mL LB containing 100 µg/mL 
Ampicillin. Cultures were shaken at 220 rpm and 37°C for 16 hours in an orbital 
shaker. 
Quick Minipreps of Plasmid DNA 
Method: 
A 1.5 mL aliquot of a bacterial culture was transferred to an Eppendorf and 
centrifuged for 15 sec at 12000 x g. The supernatant was discarded and cells 
resuspended in 100 µL Buffer P1 (Qiagen) by vortexing. Subsequently, 200 µL 
Buffer P2 (Qiagen) was added to cells and mixed thoroughly by inverting 6 
times. A 150 µL aliquot of Buffer P3 (Qiagen) was then added and mixed 
immediately by inverting 6 times. Lysates were centrifuged for 3 min at 12000 x 
g and the supernatant removed to a new Eppendorf containing 1 mL 100% (v/v) 
ethanol. Samples were vortexed for 10-15 sec to mix thoroughly and 
centrifuged for 10 min at 12000 x g. All ethanol was removed and pellets 
allowed to air-dry before resuspension in 50 µL dH2O. 
Restriction endonuclease digestion 
Method: 
A 2µL aliquot of each miniprep was restriction endonuclease-digested, in order 
to identify any DNA insert, using the appropriate restriction enzymes. Plasmid 
DNA was combined with 2.5 U of the appropriate restriction enzyme, 1.5 µL 10x 
of the appropriate buffer and 11 µL dH2O and incubated at 37°C for 1 hour. 
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10µL of each digest was electrophoresed on a 1% (w/v) agarose-TAE (x1) gel 
(section 2.4.6) to determine if it contained an insert of the correct size compared 
to 1kb DNA ladder (Bioline, London, UK). 20μL aliquots of the isolated DNA 
were sent for DNA sequencing using the appropriate sequencing primer 
(generally SP6, GATTTAGGTGACACTATAG). Sequencing results were 
analysed using the CLC sequence Viewer software. 
2.5 Protein isolation and analysis 
Protein levels were assessed using western blotting and fluorescent 
immunocytochemistry and compared to the different conditions used in the 
experiments. 
2.5.1 Preparation of Cell Lysates 
Reagents: 
Lysis buffer containing 50 mM Tris-HCl (pH 7.5), 10% (v/v) glycerol, 1 mM 
EDTA (pH 8), 1 mM EGTA, 1 mM Na3VO4, 5 mM NaF, 10 mM β glycerol 
phosphate, 5 mM Na4P2O7, 1% (v/v) Triton X-100, 1 μM microcystin-LF and 1x 
Complete -EDTA free mini protease inhibitor cocktail tablet (Roche Diagnostics, 
Burgess Hill, UK) 
Method: 
Total protein was isolated from cells in a 6-well plate (approximately 2.5 x 104 
cells/cm2) (Scott et al 2010). After the experimental period, culture medium was 
removed and cells were washed with ice-cold PBS. Cells were scraped into ice-
cold lysis buffer added to cells at a volume of 100 µL/well. Lysates were 
transferred to a 1.5ml Eppendorf, mixed for 20 min at 4°C using a rotary mixer 
and centrifuged for 3 min at 10,000 x g and 4°C. Supernatants were removed 
and stored at -80°C prior to use. 
2.5.2 Bradford protein assay 
Method: 
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A 2mg/ml stock bovine serum albumin (BSA) protein standard solution (Pierce 
& Warriner, Chester, UK) was diluted to 0.4mg/ml BSA in dH2O. A range of 
standards from 0-4mg/ml, with 0.4mg/ml increment increases, was added to a 
flat-bottomed 96-well plate. Cell lysates and equal qualities of cell lysis buffer to 
act as blanks, were added to the 96-well plate. Bradford assay reagent was 
then added to all the wells according to the manufacturer’s instructions. The 
samples were then gently mixed upon a flat-bed vortex, left to stand for 5 
minutes and the absorbance read at 595nm using a Tecan Sunrise microplate 
absorbance reader and protein levels measured based on the standard curve 
(Scott et al 2010).  
2.5.3 Western blotting 
Reagents: 
 Laemmli sample buffer containing 0.1 M Tris-HCl (pH 7.5), 0.35 M SDS, 
20% (v/v) glycerol, 0.01% (w/v) bromophenol blue and 5% (v/v) β-
mercaptoethanol. 
 Transfer buffer containing 20 mM Tris-HCl (pH 7.5), 0.6 M glycine and 
20% (v/v) methanol. 
 TBS-Tween (TBS-T) containing 150 mM NaCl, 10 mM Tris-HCl (pH 7.5) 
and 0.1% (v/v) Tween-20. 
 4% (w/v) paraformaldehyde in PBS 
Method: 
Cell lysates were thawed on ice and combined with Laemmli sample buffer in a 
5:1 ratio. Lysates were heated to 100°C for 5 min, cooled on ice and 
electrophoresed on appropriate 10 or 12.5% SDS-polyacrylamide gels at 180V 
for approximately 1 hour. Proteins were transferred to polyvinylidene fluoride 
(PVDF) membrane using a Scie-Plas V20-SDB 20 x 20cm semi-dry blotter for 
1.5 hours at 1mA/cm2 in transfer buffer. Membranes were incubated in a 
blocking buffer containing 5% (w/v) non-fat dry milk powder in TBS-T for 1 hour. 
Membranes were subsequently washed 3 times in TBS-T prior to incubation 
with primary antibody solution overnight at 4°C with gentle agitation. Primary 
antibody solutions were prepared according to manufacturer’s instructions. 
Chapter 2                                                                       Materials and Methods 
 
78 
Following incubation, membranes were washed for 3 x 5 min in TBS-T and then 
incubated with a horseradish peroxidase (HRP)-conjugated secondary antibody 
for 1 hour at room temperature. Secondary antibodies were diluted in a solution 
of 5% (w/v) milk powder in TBS-T. The membranes were washed 3 x 5 min in 
TBS-T before visualisation on high-speed X-ray film (Sigma-Aldrich) using 
Amersham ECL detection reagents (GE healthcare, Little Chalfont, UK) 
according to manufacturer’s instructions. 
2.5.4 Immunocytochemistry 
SOD2 
Reagents: 
 PBG-Triton solution containing 0.2% (v/v) fish skin gelatine, 0.5% (w/v) 
BSA and 0.5% (v/v) Triton-X-100 in PBS. 
 PBG-Saponin solution containing 0.2% (v/v) fish skin gelatine, 0.5% (w/v) 
BSA and 0.5% (v/v) Saponin in PBS. 
Method: 
Cell monolayers were washed twice in PBS for 5 min and then fixed for 10 min 
in ice cold 4% (w/v) paraformaldehyde in PBS at room temperature. Cells were 
permebilised and blocked with PBG-Saponin solution for 10 min or PBG- Triton 
solution for 45 mins at room temperature. Cells were incubated with anti-human 
SOD2 primary antibody at a final concentration of 1μg/ml for 45mins. Cells were 
then incubated with a secondary antibody (Alexa 488) diluted in 1:1000 (v/v). 
Cells were washed twice in between the antibody incubations with PBG-
Saponin or PBG-Triton. Slides were washed twice in PBS and mounted in 
Vectashield with DAPI. Cells were visualised using confocal and fluorescent 
microscopy and their fluorescence was analysed as described in section 2.10. 
2.6 Cytochrome C oxidase/ Succinate Dehydrogenase (COX/SDH) 
reaction 
COX/SDH sequential histochemistry reveals respiratory-deficient cells 
harbouring mtDNA mutations. An active COX produces a brown reaction 
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product whereas when COX is not active (possibly due to mtDNA mutations) 
cells can react with (nuclear-encoded) SDH and produce a blue product 
(Krishnan et al 2010).  
Reagents: 
 Cytochrome c oxidase (COX) incubation medium containing 100 µM 
cytochrome c, 4 mM diaminobenzidine tetrahydrochloride (DAB) in 0.2 M 
phosphate buffer (pH 7.0). 
 Succinate dehydrogenase (SDH) incubation medium containing 130 mM 
sodium succinate, 200 µM phenazine methosulphate, 1 mM sodium azide 
and 1.5 mM nitroblue tetrazolium in 0.2 M phosphate buffer (pH 7.0). 
2.6.1 Cartilage Sections 
Cartilage chips were snap frozen in super-cooled isopentane prior to sectioning. 
Samples were mounted in Cryo-M-Bed embedding compound and 12 µm serial 
sections were prepared through the full thickness of each sample using a HM 
560 Cryo-Star cryostat (MICROM International, Welwyn Garden City, UK). 
Sections were then mounted onto SuperFrost® Plus Gold slides and allowed to 
air-dry for 1-2 hours. 
Sequential histochemical reactions for COX and SDH were performed on 12μm 
cartilage sections. Attempts at optimal reactions were determined by incubating 
cartilage sections at 37°C for 40, 50, 60, 70, 80, 90 or 120 min with either COX 
incubation medium or SDH incubation medium. Sections were washed for 3 x 5 
min in PBS and subsequently dehydrated in a graded ethanol series (2x 99%, 
95%, 70% and 50% (v/v)), cleared in 2 changes of Histoclear II (National 
Diagnostics, GA, USA) and mounted in DPX (Distrene-80, Plasticiser 
Xylene)(Sigma Aldrich, Poole, UK).  
COX or SDH activity could not be detected in cartilage sections at any time 
point.  
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2.6.2 Human Articular Chondrocytes 
HAC were enzymatically extracted from the macroscopically normal cartilage as 
described previously in section 2.2.1. 
Cultured HAC 
HAC were seeded at a density of 2 x 104 per well of a chamberslide and left to 
adhere for 24 hours. After 24 hours media was removed and cells washed twice 
with PBS. All PBS was removed and cell monolayers allowed to air-dry for 30 
min before the COX-SDH reaction. This procedure lysed the cells and they 
became fixed to the chamberslide. Optimal incubation times were determined 
as with the cartilage sections. Optimal COX reactivity was achieved by 
incubating for 90 min, 37°C and SDH reactivity when incubating for 50min, 37°C 
although cell morphology was altered after the COX reaction. Cells, which had 
exhibited COX activity, produced a brown reaction product whereas those 
deficient in COX produced a blue product. Cells were then visualized under a 
brightfield microscope. 
Freshly extracted HAC 
Freshly extracted cells were cytospun at a density of 1x104 cells per slide and 
washed twice in PBS. Optimal reaction times were determined by incubating 
HAC at 37°C for 60, 70, 80, 90 min with COX incubation medium and for 35, 45, 
55 and 65 mins with SDH incubation medium. Optimum reactivity was achieved 
when incubating for 60 minutes at 37°C with COX medium and 65 minutes at 
37°C with SDH medium. Cells were then visualized under a brightfield 
microscope and COX-positive and COX-negative cells were microdissected as 
described in section 2.4.4. Then cells were lysed and analysed for mtDNA 
deletions as described in section 2.4.8. 
2.7 Reactive oxygen species analysis 
2.7.1 Mitosox staining 
Mitosox-Red is a cationic dye that is rapidly oxidized by O2
- but not by other 
reactive oxygen species (ROS) and reactive nitrogen species (RNS). The 
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oxidized product is highly fluorescent upon binding to nucleic acid. Due its 
lipophilic and cationic nature it is specifically attracted in the mitochondria and 
therefore oxidised by O2
- specifically in the mitochondria. Mitosox-Red was 
used to assess the O2
- levels in chondrocytes mitochondria after SOD2 
depletion. 
Reagents: 
 5mM Mitosox Red in DMSO 
Microscopy 
Method: 
Cells were seeded into chamberslides at a density of 2 x 104 cells/ cm2. After 24 
hours cells were either transfected with targeted siRNA against SOD2 or serum 
starved for 16 hours overnight and stained the next day. Cell monolayers were 
stained with different concentrations of mitosox-red (1μM, 2.5μM and 5μM) in 
serum free media for 15 min at 37C. Cell monolayers were washed twice in 
PBS for 5 min and then fixed in 4% (w/v) cold preparation of paraformaldehyde 
in PBS for 10 min at room temperature. Slides were washed two times in PBS 
and mounted in Vectashield with DAPI. Cells were visualised using confocal 
and fluorescent microscopy. 
Flow cytometry 
Method: 
Cells were serum starved 16 hours before experimentation, washed with 
Trypsin-EDTA for 5 min, resuspended in serum free media and split into 1.5ml 
Eppendorf tubes at a density of 1x106cells/ml. Cells were spun at 250x g in 
between stainings and washes. Cells were then stained with 1μM and 5μM 
concentrations of mitosox-red in serum free media for 15 min at 37C, washed 
twice in PBS and then fluorescence was assessed using flow cytometry (FL-3 
channel, red) as described in section 2.11. 
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2.7.2 Dihydrorhodamine 123 (DHR-123) 
DHR-123 is an uncharged and nonfluorescent ROS indicator that can passively 
diffuse across membranes where it is oxidized by H2O2 and to cationic 
rhodamine 123, which localizes in the mitochondria and exhibits green 
fluorescence. 
Reagents: 
 5mM DHR-123 in DMSO 
Method: 
Cells were seeded into chamberslides at a density of 2 x 104 cells/ cm2. After 24 
hours cells were serum starved for 16 hours overnight and stained the next day. 
Cell monolayers were stained with 75μM DHR-123 in serum free media for 30 
min at 37C. For live cell imaging, cells were washed twice with warm media 
and visualised immediately. For analysis of fixed cells, cell monolayers were 
washed twice in PBS for 5 min and then fixed in 4% (w/v) cold preparation of 
paraformaldehyde in PBS for 10 min at room temperature. Slides were washed 
two times in PBS and mounted in Vectashield with DAPI. Cells were visualised 
using confocal and fluorescent microscopy. 
2.7.3 Reactive oxygen species stimulation and inhibition 
ROS production was stimulated or inhibited in order to assess the efficiency of 
the Mitosox-Red dye and its responsiveness to changes in ROS levels within 
cells. 
Method: 
Cells were seeded into chamberslides at a density of 3 x 104 cells/ cm2. After 24 
hours cells were serum starved for 16 hours overnight. Cells were then 
stimulated with 3 different ROS inducers and one ROS scavenger in serum free 
media and then stained with 2.5μM Mitosox Red. The concentrations and times 
of stimulation are shown in Table 2.9. Cell monolayers were washed twice in 
PBS for 5 min and then fixed in a cold preparation of 4% (w/v) 
paraformaldehyde in PBS for 10 min at room temperature. Slides were washed 
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two times in PBS and mounted in Vectashield with DAPI. Cells were visualised 
using confocal microscopy and their fluorescence analysed as described in 
section 2.10. 
Reagents Inducer/ 
Inhibitor 
Mode of action Final 
concentration 
Incubation time 
Paraquat Inducer Paraquat redox 
reaction 
100μM and 200 
μM 
1 hour 
Antimycin A Inducer Complex III 
inhibition 
10μM and 100 μM 1 hour 
Rotenone Inducer Complex I 
inhibition 
2.5 μM and 10 μM 24 hour 
N-Acetyl-L-
Cysteine 
Inhibitor Increases levels 
of ROS 
scavengers 
5mM and 10mM 24 hour 
Table 2.9 ROS inducers and inhibitors 
2.7.4 Mitochondria superoxide and SOD2 dual staining 
This technique was used to allow simultaneous visualization of Mitosox-Red 
and SOD2 protein levels in chondrocytes where SOD2 expression was depleted 
using RNAi to mimic the downregulation of SOD2 in OA compared to NOF 
(Scott et al 2010; Ruiz-Romero et al 2009; Aigner et al 2006).  
Reagents: 
 PBG-Saponin and PBG-Triton solutions 
 Mitosox Red 5mM in DMSO.  
Microscopy 
Method: 
Mitosox Red has been reported to be non-fixable and can leak into the nucleus 
and the cytoplasm after triton-mediated permebilisation (Robinson et al 2008), 
therefore a dual Mitosox-SOD2 staining protocol had to be established that 
retains Mitosox-Red in the mitochondrial after fixation, in order to be able to 
compare O2
- and SOD2 levels simultaneously. The criteria for selecting the 
Chapter 2                                                                       Materials and Methods 
 
84 
optimum time were sufficient antibody staining as well as clear and specific 
Mitosox-Red staining within the same cells. 
Cells were seeded into chamberslides at a density of 2 x 104 cells/ cm2. After 24 
hours, cells were serum starved for 16 hours overnight and stained the next 
day. Cell monolayers were washed twice in PBS for 5 min and then cells were 
stained with 2.5μM Mitosox-red in serum free media for 15 min at 37C.  
Cell monolayers were washed twice in PBS for 5 min and then fixed in a cold 
preparation of 4% (w/v) paraformaldehyde in PBS for 10 min at room 
temperature. Optimal permebilisation and blocking times for PBG-Saponin and 
Triton-X buffer were determined by incubating the cells with PBG-Saponin or 
Triton at room temperature for 5, 10, 15, 45 min. Optimal permeabilisation was 
achieved and cells were permebilised and blocked with PBG-Triton or PBG-
Saponin solution for 45 min and 10 min respectively at room temperature.  
Optimal incubation times for primary and secondary antibodies diluted in PBG-
Saponin or Triton were determined by incubating the cells for 30, 45 and 60 
min. For SOD2 antibody staining, a final SOD2 antibody concentration of 
1μg/ml was used. Secondary antibody (Alexa 488) was diluted in 1:1000 (v/v). 
Cells were washed twice in between the antibody incubations with 
permeabilising buffer. Optimal antibody incubation times in Saponin buffer were 
achieved at 45 min for each antibody (primary and secondary). Triton 
permeabilisation and antibody incubation resulted in non-specific mitochondrial 
staining. Slides were washed twice in PBS and mounted in Vectashield with 
DAPI. Cells were visualised using confocal and fluorescent microscopy and 
their fluorescence was analysed as described in section 2.10. Detailed results 
of the antibody optimisation are shown in section 3.4.4. 
Flow cytometry 
Method: 
Cells were serum starved 16 hours before experimentation, washed with 
Trypsin-EDTA for 5 min at room temperature, resuspended in serum free media 
and split into 1.5mL Eppendorf tubes at a density of 1x106cells/mL. The same 
Chapter 2                                                                       Materials and Methods 
 
85 
optimised staining procedure was followed as described before in this section. 
Cells spun at 250x g in between stainings and washes. Fluorescence was 
assessed using flow cytometry as described in section 2.11, and confocal 
microscopy on cells spun onto a microscope slide using a cytospin and 
mounted in Vectashield with DAPI. Fluorescence of cytospun cells was 
analysed as described in section 2.10.  
2.8 Lipid peroxidation analysis 
Cell and mitochondrial lipid peroxidation is a reaction that takes place due to 
high levels of ROS in cells. In order to assess the levels of lipid peroxidation in 
OA and NOF cartilage as well as to establish the role of SOD2 depletion lipid 
peroxidation in SW1353 cells, the thiobarbituric acid reactive substances 
(TBARS) assay was performed. This assay quantifies the levels of 
malondialdehyde (MDA) in tissues or cells. MDA is a stable byproduct of lipid 
peroxidation and under acidic conditions and high temperatures (90-100C) it 
forms adducts with Thiobarbituric acid (TBA) that can be measured 
spectrophotometrically. Other assays that measure 4-HNE levels are also 
available however they were not used, as the effect of 4-HNE on lipid 
peroxidation is weaker than the effect of MDA (Valko et al 2007; Siems et al 
1995). Therefore, the TBARS assay was chosen as the most appropriate 
method for measuring lipid peroxidation in cartilage and cells. 
Reagents: 
 Supplied by manufacturer 
o Colour reagent (contains TBA, it is acidic and is used in the 
detection of MDA as it changes colour according to MDA 
concentration) 
 Thiobarbituric acid (TBA) 
 TBA acetic acid 
 TBA sodium hydroxide 
o TBA MDA standard 
o TBA SDS solution 
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 RIPA buffer (50mM Tris-HCl pH 7.0, 150mM NaCl, 1% (v/v) Triton-X 100, 
0.5% (v/v) sodium deoxycholate, 0.1% (v/v) SDS, 1mM EDTA, 1x 
Complete -EDTA free mini protease inhibitor cocktail tablet) 
2.8.1 TBARS assay on tissue homogenates 
Method: 
The tissue was homogenized and the assay was performed following the 
manufacturer’s instructions. In brief, 250μl of RIPA buffer was added to the 
cartilage in a 1.5ml Eppendorf tube. The samples were sonicated for 3x5 
seconds over ice. The tubes were centrifuged at 1600x g for 10mins at 4C. 
Standards of 0μM, 0.625μM, 1.25μM, 2.5μM, 5μM, 10μM, 25μM, and 50μM 
MDA concentration were also prepared according to manufacturer’s protocol. 
100μl of the supernatant or each standard were then transferred into a 15ml 
falcon tubes and 100μl of SDS was added to each sample and standard. 4ml of 
the colour reagent were added into each sample and the tubes were added to 
boiling water for 1 hour. Samples were incubated on ice for 10mins and then 
centrifuged at 1600x g for 10 mins at 4C. 150μl (in triplicate) were loaded from 
each vial to a 96-well plate. Absorbance was measured at 535nm and MDA 
concentration was determined using the standard curve.  
Assay optimisation 
In order to determine the optimum quantity of cartilage homogenate required to 
obtain readings within the standard curve, 10mg, 50mg and 100mg of cartilage 
were assessed for MDA levels as described above. As shown in section 3.4.7, 
50mg of cartilage showed the highest MDA concentration, and it was within the 
lower range of the standard curve. However, the presence of cartilage in the 
supernatant probably could have inhibited the reactions. Therefore, 50mg were 
selected as the optimum amount of cartilage to be assayed however, extra care 
was taken in order to avoid the presence of any cartilage in the supernatant.  
MDA levels in OA compared to NOF 
11 OA and 11 NOF cartilage samples (50mg each) were assayed as described 
above. Absorbance was measured at 535nm and MDA concentration was 
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determined using the standard curve. Statistical significance of the difference in 
MDA levels between NOF and OA cartilage samples was evaluated using the 
Mann-Whitney U test.  
2.8.2 TBARS assay on SW1353 cells treated with targeted siRNA against 
SOD2 
Method: 
SW1353 cells were seeded in 75cm2 flasks at a density of 1.5 x 106 cells/flask. 
After 24 hours cells were transfected with 100nM of targeted siRNA against 
SOD2 or with a non-targeting control as described in section 2.3.2. Cells were 
then trypsinised, washed in PBS, counted and 4 x 106 cells were re-suspended 
in 200μl of PBS. Cells were then sonicated for 3x5 seconds over ice. The whole 
homogenate was used in the assay and PBS was used as a sample blank. The 
assay was then performed as described above (after and including the addition 
of 100μl of SDS). Absorbance was measured at 535nm and MDA concentration 
was determined using the standard curve. Statistical significance of the fold 
difference in MDA levels between cells treated with siRNA against SOD2 and 
controls was evaluated using the Mann-Whitney U test. 
2.9 Mitochondrial bioenergetics 
2.9.1 Mitochondrial respiration 
Respirometry was used to evaluate differences in mitochondrial respiratory 
activity between NOF and OA chondrocytes and also the effect of SOD2 
depletion on mitochondrial respiration in chondrocytes. 
Reagents 
 Galactose containing media [500ml DMEM (no glucose, Gibco catalog 
no. 11966.25), 10% Fetal Bovine Serum, 450mg galactose, 1mM sodium 
pyruvate, 1ml uridine (25mg/ml stock solution), 5ml non essential amino 
acids] 
 MRC inhibitors 
o 5mM oligomycin (ATP synthase inhibitor) 
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o 10mM Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone 
(FCCP, Protonophore, uncoupler)  
o 10mM Rotenone (Complex I inhibitor) 
o 25mM Antimycin A (Complex III inhibitor) 
Oroboros Oxygraph- 2K 
The Oroboros Oxygraph-2K respirometer is based on the Clark electrode 
system where the cells are placed in a closed chamber and their oxygen 
consumption is assessed using the decay of oxygen concentration in the 
chamber.  
Method: 
Primary human chondrocytes were extracted from NOF and OA femoral heads 
as in section 2.2.1. Cells were plated in 75cm2 flasks and cultured for 96 hours. 
Cells were then washed with Trypsin-EDTA for 5 mins and resuspended in 
galactose containing media [500ml DMEM (no glucose), 10% Fetal Bovine 
Serum, 450mg galactose, 1mM sodium pyruvate, 1ml uridine (25mg/ml stock 
solution), 5ml non essential amino acids]. Chambers were washed sequentially 
with 70% and 100% (v/v) ethanol and then with water. 2.5ml galactose media 
was then added into each chamber and the respirometer calibrated according to 
manufacturer’s protocol. In brief oxygen levels are measured prior to the 
addition of cells in the chamber at 37oC and this was set as the background 
oxygen consumption in the software and was substracted from the oxygen 
consumption values calculated. Cells were then added in each chamber 
(1x106/chamber) and then counted using a haemocytometer to normalise 
respiration values. 2.5μM oligomycin, a titration of 0.5μΜ FCCP (until peaks no 
longer increase), 0.5μΜ Rotenone and 2.5μΜ Antimycin A were added in the 
chamber and the oxygen consumption/flow recorded. The oxygen levels in the 
chamber were checked in order to remain higher than 150nmol/ml. Oxygen flow 
values after each treatment were analysed further as described later on in this 
section. 
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Seahorse XF-24 
Seahorse XF-24 is a multi-well plate based respirometry system that measures 
oxygen consumption and pH levels by lowering a piston-like probe into each 
well to amplify the changes in oxygen concentration and pH.  
Method: 
Primary human chondrocytes were extracted from NOF and OA femoral heads 
as in section 2.2.1. Cells were plated in Seahorse XF-24 plates at a density of 
1.5x105 cells/well and cultured for 96 hours. 4 wells were left empty for 
calibration purposes according to the manufacturer’s instructions. A Seahorse 
cartridge was rehydrated 24 hours before the experiment. Cells were washed 
before the experiment in seahorse media and incubated for 1 hour in Seahorse 
media containing 5% Fetal Bovine serum and 1mM/10mM pyruvate in 0% (v/v) 
CO2 incubator for 1 hour. The machine was then calibrated according to 
manufacturer’s instructions. In brief, the fluorescent intensities within each well 
were normalized to the oxygen levels of each well before the addition of cells at 
37oC. A special calibration plate containing calibration media was used. The 
system assigns 10000 fluorescence units to ambient oxygen concentration and 
pH during its internal calibration procedure by setting the intensity of the light 
emitting diode used to excite the sensor. The cells were treated sequentially 
with 2.5μM oligomycin, 1.5μM FCCP, 0.5μM Rotenone and 2.5μM Antimycin A. 
Oxygen flow values and pH changes were calculated after every treatment. 
Oxygen flow values were used to assess mitochondrial respiratory activity and 
pH levels were used to assess glycolytic activity. Analysis of oxygen flow values 
was performed as outlined later on this section. 
Effect of SOD2 depletion on mitochondrial respiration 
In order to assess the effect of SOD2 depletion on mitochondrial respiration in 
HAC, cells were plated in the Seahorse plates at a density of 3x104 cells/well 
and transfected as described in section 2.3.2. Respiration was then assessed 
as described above and respiratory activity parameters were calculated to 
determine the effect of SOD2 depletion on different parameters of the 
mitochondrial respiration.  
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The efficiency of the siRNA transfection was assessed by measuring SOD2 
gene expression. RNA was isolated, reverse transcribed and amplified by 
SYBR Green real-time PCR amplification as described in 2.4.8.  
Respiratory activity parameters 
The following respiratory activity parameters were calculated using the oxygen 
flow values from the Oroboros 2K or the Seahorse XF-24 respirometers. SRC 
(spare respiratory capacity) is a ratio calculating how close to full capacity the 
MRC is functioning at. SRC is also referred to the difference between the 
uncoupled and basal respiration however by calculating as a ratio enables 
direct comparison between different samples as it normalizes for cell number. 
RCR (cell respiratory control ratio) is a measure of non-phosphorylating 
respiration and general mitochondrial function taking into account the proton 
leak and SRC. Proton leak is a measure of non-phosphorylating respiration, i.e. 
respiration that is not coupled to ATP production. ATP production is a measure 
of ATP generating respiration, i.e. respiration that is coupled to ATP production. 
The respiratory parameters were calculated as followed (Non-mitochondrial 
respiration (NMR) was subtracted from all the values) and shown graphically in 
Figure 2.1: 
Spare respiratory capacity (SRC ratio) = FCCP/Resting 
Cell Respiratory control ratio (RCR) =(FCCP-Oligomycin)/Resting) 
Proton leak = Oligomycin insensitive respiration 
ATP production= Oligomycin sensitive respiration= Resting-Oligomycin 
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Figure 2.1 Respiratory parameters determined by mitochondrial respiration analysis 
 
2.9.2 Mitochondrial membrane potential 
These techniques were used to identify the effect of SOD2 depletion on Δψm. 
JC-1 
JC-1 in cells with normal Δψm forms J-aggregates, which are complexes with 
red fluorescence. In cells with depolarized mitochondria, JC-1 remains in its 
monomeric form that shows only green fluorescence. 
Method: 
Adherent cells were treated with 2μΜ FCCP (depolarisation) or 0.01% DMSO 
control for 10mins to alter the Δψm in order to be able to assess the dye. Cells 
were then treated with 50nM JC-1 for 15mins to assess the colour changes in 
response to mitochondrial depolarisation (more green, less red). Fluorescence 
was assessed with live cell confocal microscopy using the 510/527nm and 
585/590nm (excitation/emission) channels. 
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Tetramethyl Rhodamine Methyl Ester (TMRM) 
TMRM is a cationic probe that is selectively localized in the mitochondrial matrix 
due to the presence of a net negative charge caused by the proton gradient. 
Any variations in the Δψm change the intensity but not the spectra of the probe.  
Method: 
Adherent cells were stained with 10nM TMRM (non-quench mode). In order to 
estimate higher or lower Δψm, the ratio of the basal TMRM+ levels against the 
non-mitochondrial fluorescence (after complete mitochondrial depolarisaton by 
FCCP in the presence of oligomycin) was calculated. These values can only 
indicate differences in membrane potential but exact values cannot be 
calculated using this method.  
2.10 Image analysis 
Method: 
The fluorescence detected and shown in the images was analysed using 
ImageJ analysis software (Wayne Rasband, NIH, USA). Individual cells were 
selected and the average amount of fluorescent staining present in the cells 
(per area) calculated. Average background levels of the stain were also 
measured and deducted from the cell staining values. Net values were analysed 
as in section 2.12. 
2.11  Flow cytometric analysis 
Method: 
All flow cytometric analysis was performed using BD PharMingen FACScan and 
CellQuest software. Threshold, FSC and SSC parameters were set using 
unlabelled controls. Compensation was set prior to acquisition using single 
stained cells and ensuring that the positively stained population was aligned 
horizontally or vertically with the negative population on the relevant fluorescent 
channel dot plots. The maximum fluorescence intensities of negative and 
positive populations were measured in different channels. Data was analysed 
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using FlowJo v8.7.1 software (Tree Star, Oregon, US). Raw fluorescence 
values were extracted from the software and analysed as in section 2.12. 
2.12 Statistical analysis 
The Pearson correlation coefficient was used to determine the correlation and 
regression values of the SOD2-Mitosox dual staining readings.  
Relative RNA levels were normalized against basal levels of housekeeping 
genes and then plotted as the fold induction of target gene expression over 
control levels. Similarly, fold change of differences between NOF and OA 
values and between values from siRNA treated cells and their controls were 
determined in the same way. 
Values were given as mean ± standard error of the mean (SEM). 
The Student’s t-test (unpaired) and the non-parametric Mann- Whitney U test 
were performed between sample groups to determine any significant 
differences. Levels of statistical significance are shown as *p≤0.05, **p≤0.01 
and ***p≤0.001. 
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Chapter 3. ROS and oxidative damage due to SOD2 depletion in 
chondrocytes and cartilage 
3.1 Hypothesis 
SOD2 downregulation causes an increase in the mitochondrial O2
- levels. This 
contributes to an increase in lipid peroxidation and mtDNA damage in 
chondrocytes and cartilage. 
3.2 Introduction 
Reactive oxygen species (ROS) and specifically O2
- are mainly produced as by 
products of OXPHOS in the MRC. The major sites of O2
- production are 
Complex I and Complex III (Turrens, & Boveris 1980; Cadenas et al 1977). 
Complex II has also been reported as a site of O2
- production however its 
contribution to the overall ROS levels is minor (Zhang et al 1998). ROS can act 
as signalling molecules however when at high levels they can cause oxidative 
damage in the form of DNA damage (base modifications, single and double 
strand breaks and DNA-protein crosslinking), protein and lipid oxidation 
(Dizdaroglu et al 2002; Cooke et al 2003; Kokoszka et al 2001; Fedtke et al 
1990). 
There are different mechanisms in which ROS can cause DNA damage. The 
hydroxyl radical (OH) can react with the DNA by reacting with double bonds of 
DNA bases, e.g. by reacting with the C5-C6 double bond of pyrimidines to form 
C5-OH and C6-OH adduct radicals (Figure 1.6) thus leading to base 
modifications and giving them redox properties (Cooke et al 2003; Steenken 
1987). Other reactions of base radicals include the addition to an aromatic 
amino acid of proteins leading to DNA-protein crosslinking (Dizdaroglu et al 
2002). Also ROS can react with DNA by the mechanism of abstraction of an H 
atom leading to DNA strand breaks and altered sugars (Dizdaroglu et al 2002; 
Beesk et al 1979). 
Lipid peroxidation (Figure 1.7) is a process were ROS damage lipid cell and 
mitochondrial membranes by attacking polyunsaturated fatty acid residues of 
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phospholipids on membranes, thus forming unstable peroxyl radicals (ROO•). 
The process is initiated by the reaction of unsaturated lipids with ROS such as 
the OH and hydroperoxyl (HO2) radicals producing unstable lipid radicals. 
These radicals react with oxygen to produce the unstable lipid peroxyl radical. 
The lipid peroxyl radical then reacts with unsaturated lipids to produce an 
unstable lipid peroxide and then malondialdehyde (MDA), a stable lipid 
peroxide. Although, MDA is a more stable product of the lipid peroxidation 
process, it has been shown to have mutagenic and carcinogenic properties thus 
causing membrane and DNA damage (Kokoszka et al 2001; Fedtke et al 1990; 
Wang et al 1996). 
The cell houses defenses against ROS such as the superoxide dismutase 
family (SOD1, 2, 3), catalase and glutathione peroxidase (Zelko et al 2002). 
SOD2, or MnSOD, is localized in the mitochondria and, like the other SODs 
spontaneously dismutases O2
- to H2O2. The rate of dismutation by all three 
superoxide dismutases is approximately 2x 109 M-1 s-1 (Klug et al 1972; Rotilio 
et al 1972).  
The effects of SOD2 deficiencies in mice are described in detail in section 1.1.9. 
In brief, SOD2 (-/-) mice experience prenatal or neonatal lethality, depending on 
the genetic background of the mice, associated with severe neurological and 
cardiac phenotypes and linked to decreased Complex I and II activity as well as 
mitochondrial aconitase deficiencies and oxidative gDNA damage in brain and 
heart (Huang et al 2001; Li et al 1995; Lebovitz et al 1996; Melov et al 1999). In 
addition, lipid accumulation in the liver and skeletal muscle as well as metabolic 
acidosis and reduction in succinate dehydrogenase (complex II) activities have 
also been reported (Li et al 1995). In a separate study, heterozygous mutant 
mice were exposed to high levels of lipid peroxidation and apoptosis in the heart 
(Strassburger et al 2005). mtDNA damage was also reported in livers of SOD2 
heterozygous mice (C57BL/6 background) at 2–4 months of age (Williams et al 
1998). Treatment of SOD2 null mice with SOD2 mimetics increases their 
lifespan and attenuates spongiform encephalopathy and mitochondrial defects 
thus rescuing some of the pathological phenotypes mentioned above (Melov et 
al 2001; Melov et al 1998).  
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All three major inhibitors of O2
-, SOD1, SOD2 and SOD3, have decreased 
expression in OA cartilage compared to control both at the mRNA and protein 
level (Scott et al 2010; Ruiz-Romero et al 2009; Aigner et al 2006). SOD2 
downregulation regulates IL-1 induced mRNA expression of collagenases 
MMP-1 and MMP-13 suggesting that SOD2 downregulation in cartilage, as well 
as a role in ROS and macromolecular damage, may have a chondroprotective 
role. High levels of O2
-and nitrogen oxide (NO) have been reported in OA, 
which lead to higher levels of H2O2 and ONOO
- (Hiran et al 1997; Loeser et al 
2002; Tiku et al 1998). The increase in ROS can potentially lead to increased 
levels of mtDNA and nuclear DNA damage in the form of DNA base 
modifications (8-oxo-guanine) and DNA strand breaks, as reported previously 
(Chang et al 2005; Chen et al 2008; Kim et al 2009). High levels of O2
-, NO and 
inflammatory cytokines have been shown to increase lipid peroxidation and 
regulation of signalling pathways leading to cartilage degradation (Tiku et al 
2000; Shah et al 2005; Loeser et al 2002). Also ROS have been shown to 
cleave collagen and hyaluronan (Gao et al 2008; Petersen et al 2004) in other 
systems. In the same studies EC-SOD (SOD3) attenuates oxidative 
fragmentation by binding directly to both collagen and hyaluronan.  
3.3 Aims 
 Assess the effect of SOD2 downregulation on mitochondrial O2
- levels 
using ROS- indicators and immunocytochemistry 
 Determine the levels of lipid peroxidation and mtDNA strand breaks in 
OA and NOF cartilage 
 Evaluate the contribution of SOD2 downregulation to lipid peroxidation 
and mtDNA damage in chondrocytes 
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3.4 Results 
3.4.1 Effect of SOD2 RNAi on SOD2 expression 
RNAi-mediated depletion of SOD2 mRNA and protein levels was used to study 
the role of SOD2 in the regulation of mitochondrial O2
- levels and determine 
whether its depletion causes mtDNA damage. The optimal transfection 
procedure and duration of siRNA incubation are described in section 2.3.2. 
Transfection of 100nM concentration SOD2 targeted siRNA resulted in 95% 
reduction in mRNA levels and a pronounced decrease in intensity of protein 
levels (Figure 3.1). 
 
 
 
 
Figure 3.1 Effect of SOD2 siRNA knockdown on SOD2 mRNA and protein levels 
(A) HAC isolated from knee cartilage were transfected with 100nM of SOD2 siRNA for 48 hours 
as described in section 2.3.2. Total RNA was extracted, reverse transcribed to cDNA and 
subjected to real-time RT-PCR analysis of SOD2 gene expression as described in section 2.4.8. 
Values were normalised to 18S and plotted as mean fold induction over control ± standard error 
of mean (SEM) (n=5). Statistical significance between siCON and siSOD2 treated cells was 
determined using the Mann-Whitney U test. *** p≤0.001, compared to control. (B) Human 
SW1353 cells were transfected as above. Total protein was extracted, resolved by SDS-PAGE 
and immunoblotted with the SOD2 and β-actin antibodies as described in section 2.5.3. Figure 
A is representative of two independent experiments and figure B is from one experiment but has 
been documented previously (Scott et al 2010). 
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3.4.2 Mitosox-Red concentration optimisation 
Mitosox-Red is a cationic dye that is rapidly oxidized by O2
- but not by other 
reactive oxygen species (ROS) and reactive nitrogen species (RNS). The 
oxidized product is highly fluorescent upon binding to nucleic acid. Due its 
lipophilic and cationic nature it is specifically attracted in the mitochondria and 
therefore oxidised by O2
- specifically in the mitochondria. 
In order to determine the appropriate concentration of Mitosox-Red to be used 
in further experiments, SW1353 chondrosarcoma cells were stained with 
Mitosox-Red at different concentrations and the intensity of the staining was 
assessed by flow cytometry as described in section 2.7.2. Cells were stained 
with 1μM and 5μM of Mitosox Red for 15mins at 37C and 0.001% (v/v) DMSO 
was used as a negative control (Robinson et al 2006; Robinson et al 2008). 
Cells analysed were pre-selected from the viable cell population using forward 
scatter (FSC) and side scatter (SSC) selection using the FACS software. Cells 
treated with just DMSO only showed minor auto-fluorescence similar to 
untreated cells (Figure 3.2A). The population stained with 1μM Mitosox-Red 
showed higher numbers of cells with maximum intensity compared to the 
negative control. As expected the population stained with 5μM Mitosox-Red had 
more cells showing maximum intensity compared to the 1μM population. Cells 
stained with 2.5μM of Mitosox were not stained by flow cytometry. 
In order to test staining saturation, SW1353 cells were also cultured in 
chamberslides and stained with Mitosox-Red at 1μM, 2.5μM and 5μM final 
concentrations for 15mins at 37C (Figure 3.2B). Cells stained with 1μM 
Mitosox-Red showed very low staining intensity whereas cells stained with 5nM 
Mitosox-Red showed very intense staining and possibly the staining was too 
saturated. Cells stained with 2.5μM Mitosox-Red had average amounts of 
staining and minimum saturation. Therefore, in order to avoid saturation of the 
dye, it was decided that 2.5μM concentration of Mitosox-Red to be used in 
further experiments.  
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Figure 3.2 Mitosox concentration optimization 
(A) SW1353 chondrosarcoma cells were resuspended in serum free DMEM media (containing 
phenol) and stained with the two different concentrations of Mitosox Red or 0.001% (v/v) 
DMSO, as a negative control for 15mins at 37C. Cells were then washed twice and 
resuspended in PBS. The maximum fluorescence intensities of negative and positive 
populations were measured in the FL-3 channel (red) as in section 2.11. Cells analysed were 
pre-selected from the viable cell population using forward scatter (FSC) and side scatter (SSC) 
selection using the FACS software. 5000 live cells were analysed per treatment. Data was 
analysed using FlowJo v8.7.1 software. (B) SW1353 cells were cultured in chamberslides and 
stained with three different concentrations of Mitosox-Red for 15mins at 37C. Cells were then 
washed twice in PBS and fixed in 4% paraformaldehyde for 10mins at room temperature. 
Fluorescence was assessed by confocal microscopy at 510/580 nm (absorption/emission).  
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3.4.3 Effect of ROS inducers and inhibitors on mitochondrial superoxide 
levels in chondrocytes 
In order to evaluate whether quantification of mitochondrial O2
- in chondrocytes 
was possible, cells were treated with different ROS inducers and a ROS 
inhibitor and then stained with Mitosox Red. Different concentrations of ROS 
inducers rotenone, antimycin A, paraquat and a ROS inhibitor, N-acetyl-L-
cysteine (NAC) were evaluated in both SW1353 chondrosarcoma cells and 
HAC. The chemicals were incubated for the stated time and then cells were 
stained with Mitosox Red for 15mins. Fluorescence was assessed with confocal 
microscopy and flow cytometry (FACS). 
Confocal Microscopy  
In SW1353 cells (Figure 3.3 and Figure 3.4), incubation with 10μM antimycin A, 
100μΜ paraquat and 2.5μM rotenone for 1 hour resulted in an increase in ROS. 
Increasing the concentration of antimycin A to 100μM caused a further increase 
in ROS. Increasing the concentration of paraquat and rotenone to 200μM and 
10μM respectively caused a reduction in ROS. Incubation with NAC at both 
5mM and 10mM resulted in similar levels of ROS reduction.  
In HAC (Figure 3.6 and Figure 3.6), incubation with 10μM antimycin A resulted 
in a reduction in ROS levels, whereas incubation with 100μM antimycin A did 
not change the ROS levels compared to control. Increasing concentrations of 
paraquat caused increasing levels of ROS similar to SW1353 cells. Similarly, 
increasing concentrations of rotenone increased the ROS levels. Incubation 
with 5mM NAC resulted in reduced levels of ROS whereas incubation with 
10mM NAC caused an increase in ROS levels compared to control.  
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Figure 3.3 Effect of ROS inducers and inhibitors on mitochondrial O2
- levels in SW1353 cells 
SW1353 chondrosarcoma cells were treated with the stated final concentration of antimycin A, 
paraquat and rotenone for 1 hour and NAC for 24 hours. Cells were then stained with 2.5μM of 
Mitosox-Red for 15 mins, fixed in 4% paraformaldehyde and then mounted using Vectashield 
containing DAPI. Fluorescence was assessed using confocal microscopy and images analysed 
with ImageJ. Four images were taken per treatment. Images shown are representative of a 
single complete experiment but individual experiments were repeated multiple times. DAPI is 
shown in blue and Mitosox-Red shown in red. 
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Figure 3.4 Graphical representation of effect of ROS inducers and inhibitors on mitochondrial 
O2
- levels in SW1353 cells 
SW1353 cells were treated with the stated final concentration of antimycin A, paraquat and 
rotenone for 1 hour and NAC for 24 hours. Cells were then stained with 2.5μM of Mitosox-Red 
for 15 mins, fixed in 4% paraformaldehyde and then mounted using Vectashield containing 
DAPI. Fluorescence was assessed using confocal microscopy and images analysed with 
ImageJ. Four images were taken per treatment. Values were plotted as minimum, median and 
maximum fold induction over control ± standard deviation (SD). Statistical analysis was 
performed (Mann Whitney U test) to determine statistical significance between treatments and 
control; *p≤0.05, **p≤0.01, ***p≤0.001 compared to control. Graphs show pooled data analysis 
of three independent experiments.  
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Figure 3.5 Effect of ROS inducers and inhibitors on mitochondrial O2
- levels in HAC 
HAC isolated from knee cartilage were treated with the stated final concentration of antimycin A, 
paraquat and rotenone for 1 hour and NAC for 24 hours. Cells were then stained with 2.5μM of 
Mitosox-Red for 15 mins, fixed in 4% paraformaldehyde and then mounted using Vectashield 
containing DAPI. Fluorescence was assessed using confocal microscopy and images analysed 
with ImageJ. Four images were taken per treatment. Images shown are representative of a 
single complete experiment but individual experiments were repeated multiple times. DAPI is 
shown in blue and Mitosox-Red shown in red. 
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Figure 3.6 Graphical representation of effect of ROS inducers and inhibitors on mitochondrial 
O2
- levels in HAC 
HAC isolated from knee cartilage were treated with the stated final concentration of antimycin A, 
paraquat and rotenone for 1 hour and NAC for 24 hours. Cells were then stained with 2.5μM of 
Mitosox-Red for 15 mins, fixed in 4% Paraformaldehyde and then mounted using Vectashield 
containing DAPI. Fluorescence was assessed using confocal microscopy and images analysed 
with Image J. Four images were taken per treatment. Values were plotted as minimum, median 
and maximum fold induction over control ± standard deviation (SD). Statistical analysis was 
performed (Mann Whitney U test) to determine statistical significance between treatments and 
control; p≤0.05, *p<0.01, ***p≤0.001 compared to control. Graphs show pooled data analysis of 
three independent experiments using three different patient samples.  
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Flow cytometry (FACS) 
The effect of ROS inducers and inhibitor (NAC) on the mitochondrial O2
- levels 
was also assessed with FACS in order to determine which method (FACS or 
microscopy) is better to detect changes in Mitosox-Red levels in response to 
changes in ROS. 
In SW1353 cells (Figure 3.7A and B), incubation with antimycin A and paraquat 
resulted in a small increase in the number of cells with high levels of Mitosox-
Red staining whereas treatment with rotenone increased Mitosox-Red levels in 
more cells than the other inducers. Incubation with NAC resulted in a big 
reduction in the number of cells with high levels of Mitosox-Red staining.  
In HAC (Figure 3.7C and D), incubation with antimycin A, rotenone and 
paraquat did not change Mitosox-Red staining in the cells at all. Incubation with 
NAC resulted in a very small reduction in the number of cells with high levels of 
Mitosox-Red staining. 
These results were not consistent the results that were recorded by confocal 
microscopy. Therefore, some of the cells used in the FACS experiments were 
cytospun onto a microscope slide and their Mitosox-Red staining was assessed 
by confocal microscopy. As shown in the example in Figure 3.8, Mitosox-Red 
staining was not retained in the mitochondria and diffused into the cytoplasm of 
both HAC and SW1353 cells irrespective of the treatment. 
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Figure 3.7 Effect of ROS inducers and inhibitors on mitochondrial O2
- levels in SW1353 cells 
and HAC assessed by FACS 
SW1353 chondrosarcoma cells and HAC isolated from knee cartilage were treated with 100μΜ 
antimycin A, 100μΜ paraquat and 2.5μΜ rotenone for 1 hour and 5mΜ NAC for 24 hours. Cells 
were then resuspended in serum free DMEM media (containing phenol) and stained with 2.5nM 
Mitosox Red as a negative control for 15mins at 37C. Cells were then washed twice and 
resuspended in PBS. The maximum fluorescence intensity was measured in the FL-3 channel 
(red) as in section 2.11. Cells analysed were pre-selected from the viable cell population using 
forward scatter (FSC) and side scatter (SSC) selection using the FACS software. 10000 live 
cells were analysed per treatment. Data was analysed using FlowJo v8.7.1 software. Graphs 
shown are representative of a single complete experiment but individual experiments were 
repeated twice.  
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Figure 3.8 Images of cytospun cells, treated with ROS inducers and inhibitors, used for FACS. 
Images show the non-specific localisation of Mitosox-Red in the mitochondria in SW1353 cells 
treated with antimycin A or ethanol (negative control). Cells were cytospun onto a microscope 
slide as described in 2.7. DAPI is shown in blue and Mitosox-Red shown in red. 
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3.4.4 Optimisation of Mitosox and SOD2 dual staining in HAC 
In order to assess the changes in O2
- and SOD2 levels simultaneously in the 
same cells, a protocol for dual Mitosox-Red and anti-human SOD2 antibody 
staining had to be established. A previous study suggested that mitosox cannot 
be retained in the mitochondria after fixation and permeabilisation with Triton-X, 
procedures essential for further antibody staining (Robinson et al 2008). 
Therefore, in order to analyse Mitosox-Red levels and compare them to SOD1 
levels, the cells were stained firstly with Mitosox-Red and the fluorescence 
levels were recorded by confocal microscopy. The exact position of the cells 
was also recorded (microscope coordinates). The cells were then stained for 
SOD1 antibody. The exact location of the cells assessed previously was 
identified using the confocal microscope and then SOD1 levels were assessed 
in the same cells. In this thesis, this protocol was not feasible due to 
inaccuracies of the confocal microscope’s coordinates and therefore the exact 
cells could not be identified.  
Therefore a protocol that enables simultaneous recording of Mitosox-Red and 
SOD2 antibody levels had to be established. To achieve this, Mitosox-Red had 
to be retained in the cells after fixing and permeabilisation. Two permeabilising 
chemicals were assessed, Triton-X and Saponin. The optimal staining 
procedure and duration are described in section 2.7.4. 
Triton-X permeabilisation resulted in very good SOD2 staining however any 
specific Mitosox-Red staining was not specific to the mitochondria and diffused 
into the cytoplasm (Figure 3.9). 
However, saponin permeabisation (Figure 3.10) at 30mins retained Mitosox 
staining but gave very weak SOD2 staining. At 45mins and 60mins, using 
Saponin as a permeabising agent, Mitosox-Red staining was retained within the 
mitochondria after fixing and permeabilisation and therefore managed to stain 
using the SOD2 antibody without experiencing significant amounts of Mitosox-
red diffusing into the cytoplasm. Therefore, saponin incubation was used as the 
optimal condition for dual Mitosox-Red/SOD2 staining in chondrocytes due to 
the fact that SOD2 staining was satisfactory at 45mins and after permeabisation 
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and antibody incubation, Mitosox-Red staining was retained in the mitochondria 
and did not diffuse into the cytoplasm. 
 
Figure 3.9 SOD2 and Mitosox Dual staining optimisation (Triton permeabilisation) 
HAC isolated from knee cartilage were stained with 2.5μM Mitosox Red for 15 mins and fixed in 
4% paraformaldehyde. Cells were permeabilised using a Triton-X containing buffer as described 
in section 2.7.4. Cells were then incubated with anti-human SOD2 antibody and an Alexa 488 
secondary antibody as described in section 2.7.4. Figures are representative of two 
experiments. 
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Figure 3.10 SOD2 and Mitosox Dual staining optimisation (Saponin permeabilisation) 
HAC isolated from knee cartilage were stained with 2.5μM Mitosox Red for 15 mins and fixed in 
4% paraformaldehyde. Cells were permeabilised using a saponin containing buffer as described 
in section 2.7.4. Cells were then incubated with anti-human SOD2 antibody and an Alexa 488 
secondary antibody as described in section 2.7.4. Figures are representative of two 
experiments. 
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3.4.5 Comparison of mitochondrial superoxide levels and SOD2 protein 
levels in HAC 
During optimisation of the dual staining of Mitosox-Red and SOD2, it was 
noticed that cells that had high levels of SOD2 protein also had low amount of 
Mitosox-Red as shown in Figure 3.11A. Scott et al reported that superficial zone 
chondrocytes appear to express more SOD2 than deep zone chondrocytes 
(Scott et al 2010). Therefore, as in this thesis, HAC are extracted from total 
cartilage, cells are expected to express different levels of SOD2. Therefore we 
decided to test this at a larger scale using HAC from seven different patients 
and evaluate the correlation between the SOD2 protein levels and Mitosox-Red 
(mitochondrial O2
-) levels. As shown in Figure 3.11B, 5 patients showed a small 
negative correlation between SOD2 and Mitosox-Red as the R2 values were 
very low, suggesting that cells with lower SOD2 levels had higher levels of O2
-. 
However, 2 other patients showed a small positive correlation (Figure 3.11C) 
indicating that cells with higher SOD2 levels also had higher O2
- levels. These 
results suggest that the expected negative correlation between O2
- and SOD2 
levels possibly exists in HAC with some exceptions, but this observation is not 
consistent with the whole cell population. This can be due to the differences in 
SOD2 expression in cells from different zones of cartilage tissue. However, as 
noticed previously in 3.4.3 and Figure 3.8, Mitosox-Red is not readily retained in 
chondrocytes after trypsinisation, therefore these results might not be reliable in 
terms of the Mitosox-Red levels recorded. 
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Figure 3.11 Correlation of SOD2 protein levels with Mitosox-Red levels 
(A) HAC isolated from knee cartilage were stained for confocal analysis of SOD2 protein and 
Mitosox-Red levels as described in section 2.7.4 using saponin permeabilisation. Arrows 
indicate cells with low SOD2 levels and high Mitosox-red levels and cells with high SOD2 levels 
and low Mitosox-Red levels. (B and C) HAC were trypsinised and then stained for flow 
cytometric analysis of Mitosox-Red and SOD2 protein levels as described in section 2.7.4. Raw 
fluorescence values for each cell were exported into Microsoft Excel and the Pearson 
correlation coefficient and R
2
 values were calculated. The correlation is also indicated by the 
regression line in each graph. DAPI is shown in blue, SOD2 in green and Mitosox-Red shown in 
red. 
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3.4.6 Effect of SOD2 downregulation on mitochondrial superoxide levels 
in HAC 
As described in section 3.4.3 (Figure 3.8), Mitosox-Red was not retained in 
chondrocyte mitochondria after trypsinisation. This can possibly be due to the 
fact that trypsin and in general cell detachment, causes changes in the 
cytoskeleton and therefore can affect the mitochondria (Kostal, & Arriaga 2011; 
Badley et al 1980). Also, trypsinisation has been shown to increase ROS levels 
(Lim et al 2006; Aoshiba et al 2001). Therefore the Mitosox-Red levels recorded 
by FACS are probably partially cytoplasmic and also can be inaccurate due to 
the effect that trypsin has on ROS levels. Consequently, Mitosox-Red and 
SOD2 levels were only assessed on cells attached onto chamberslides and 
measured by confocal microscopy. 
In order to determine whether a reduction in the protein levels of SOD2 affects 
the mitochondrial O2
- levels in human articular chondrocytes, HAC isolated from 
patient cartilage samples were transfected with siRNA targeted against SOD2 
as in section 2.3.2. Cells were then stained for Mitosox-Red and anti-human 
SOD2 antibody as described in section 2.7.4. Cells were visualized using a 
confocal microscope and images were analysed using ImageJ (Figure 3.12, 
Figure 3.13A). 
SOD2 depletion using RNAi resulted in a significant 33% decrease in SOD2 
protein levels as analysed by confocal microscopy (Figure 3.13B). This 
reduction in SOD2 levels caused a pronounced 1.5-fold increase in Mitosox-
Red staining in HAC (Figure 3.13B). 
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Figure 3.12 Effect of SOD2 downregulation on Mitosox-Red and SOD2 protein levels 
HAC isolated from knee cartilage were transfected with 100nM of SOD2 siRNA for 48 hours. 
HAC were then stained with 2.5μM Mitosox Red for 15 mins and fixed in 4% Paraformaldehyde. 
Cells were permeabilised using a Saponin containing buffer as described in section 2.7.4. Cells 
were then incubated with anti-human SOD2 antibody and an Alexa 488 secondary antibody as 
described in section 2.7.4. Fluorescence was assessed using confocal microscopy. Figure 
shows DAPI staining in blue; Mitosox Red levels in red, SOD2 levels in green and an overlay of 
the three images. Figure is representative of four experiments. 
  
Chapter 3                                               SOD2 depletion and oxidative damage 
 
115 
 
 
Figure 3.13 Effect of SOD2 downregulation on Mitosox-Red and SOD2 protein levels (Summary 
figure) 
HAC from knee cartilage were transfected with 100nM of SOD2 siRNA for 48 hours. HAC were 
then stained with 2.5μM Mitosox Red for 15 mins and fixed in 4% Paraformaldehyde. Cells were 
permeabilised using a Saponin containing buffer as described in section 2.7.4. Cells were then 
incubated with anti-human SOD2 antibody and an Alexa 488 secondary antibody as described 
in section 2.7.4. Fluorescence was assessed using confocal microscopy and the images were 
analysed using Image J. Figure A is representative of four experiments. Figure B is pooled data 
analysis of four independent experiments using four different patient samples. Statistical 
analysis was performed (Student t-test) to determine statistical significance between treatments 
and control ** p≤0.01, *** p≤0.001, compared to control. (Figure adapted from Scott et al, 2010), 
DAPI is shown in blue and Mitosox-Red shown in red. 
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3.4.7 Lipid peroxidation in OA and NOF cartilage and the role of SOD2 in 
the regulation of lipid peroxidation in chondrocytes 
As SOD2 levels are significantly lower in OA compared to NOF and this 
downregulation causes an increase in mitochondria O2
- levels, we assessed the 
level of lipid peroxidation in OA and NOF cartilage by measuring MDA 
concentration using the TBARS assay as described in section 2.8. 
Firstly the amount of cartilage required to acquire results within the range of the 
standard curve suggested by the manufacturer was assessed. The cartilage 
used was from an OA patient. The standard curve was almost perfectly linear 
(Figure 3.14A). 25mg of cartilage gave a very low reading of 1.2μΜ MDA, which 
was very close to the lower end of the standard curve (Figure 3.14B). 50mg of 
cartilage had significantly higher concentration of MDA at 7.2μM, which was 
within the lower range of the standard curve (Figure 3.14B). Using 100mg of 
cartilage resulted in a lower MDA concentration (4.5μM) compared to 50mg. 
This is possibly because in the 100μl of supernatant collected after the lysis 
reaction of 100mg of cartilage, a lot of the cartilage homogenate was collected 
as well and this could have inhibited the reaction. Very small amounts of 
cartilage homogenate (less than the 100mg cartilage reaction) were also 
present in the 50mg supernatant as well so this could have a small impact in the 
reaction. Therefore 50mg of cartilage homogenate was considered optimum to 
measure MDA levels in NOF and OA cartilage, however extra care was taken in 
order to make sure no cartilage impurities were present in the samples. 
11 OA cartilage and 11 NOF cartilage samples were assessed. No cartilage 
homogenate was present in the supernatants of the samples and therefore all of 
the values were well within the standard curve and much higher compared to 
the optimisation experiment. OA cartilage was found to have significantly 6.5% 
higher MDA levels compared to NOF (Figure 3.15). The higher values 
compared to the optimisation experiment can be explained from the fact that no 
cartilage was present in the supernatant.  
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To evaluate whether this increase can be caused by the depletion of SOD2 in 
OA, the same assay was used to evaluate the extent to which RNAi targeted 
depletion of SOD2 causes lipid peroxidation in SW1353 cells.  
RNAi depletion of SOD2 in SW1353 cells resulted to a significant 2.5-fold 
increase of MDA concentration (Figure 3.16) in 3 independent experiment. 
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Figure 3.14 TBARS optimisation assay for cartilage homogenates 
Cartilage was homogenised as described in section 2.8.1 and the assay was performed 
according to the manufacturer’s protocol. (A) MDA standard curve reactions were set-up 
according to the manufacturer’s protocol. (B) Three different quantities of cartilage homogenate 
were assayed to determine the optimum amount to be used. Figures A and B are from one 
independent experiment. 
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Figure 3.15 TBARS assay on human cartilage homogenates 
Cartilage isolated from hip joints was homogenised as described in section 2.8.1 and the assay 
was performed according to the manufacturer’s protocol. MDA standard curves reactions were 
set-up according to the manufacturer’s protocol. 50mg of cartilage homogenates from eleven 
NOF (median age = 75yrs) and eleven OA patients (median age = 74yrs) were assayed. Each 
point on the graph represents the MDA concentration (μΜ/50mg) of each patient sample. 
Statistical analysis was performed (Mann Whitney U test) to determine statistical significance 
between treatments and control *p≤0.05 OA compared to NOF. 
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Figure 3.16 TBARS assay on SW1353 cells transfected with non-targeting siRNA control and 
siRNA against SOD2 
SW1353 cells were seeded in 75cm
2
 flasks at a density of 1.5 x 10
6
/flask. After 24 hours cells 
were transfected with 100nM SOD2-targetted siRNA for 48 hours. Cells were then trypsinised, 
washed and re-suspended in 200μl of PBS and the assay was performed according to the 
manufacturer’s protocol. (A) shows results from three independent experiments. (B) is pooled 
data analysis of the three independent experiments. Statistical analysis was performed (Mann 
Whitney U test) to determine statistical significance between treatments and control * p≤0.05, 
*** p≤0.001, compared to control. 
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3.4.8 mtDNA damage in chondrocytes due to SOD2 depletion 
Previous studies in SOD2 (+/-) mice have identified higher levels of gDNA 
damage in various organs (Melov et al 1999; Williams et al 1998). We 
performed the mtDNA strand break assay, as described in section 2.4.8, in OA 
and NOF cartilage (described in section 4.4.1) as well as cells depleted of 
SOD2 by RNAi to assess the effect that SOD2 downregulation has on mtDNA 
damage in cartilage.  
In order to identify whether SOD2 depletion in chondrocytes caused any mtDNA 
damage, the mtDNA strand break assay was performed in SW1353 cells 
depleted of SOD2 using RNAi as described in section 2.3.2. A fixed amount of 
total DNA was analysed by real-time PCR amplification of part of the major arc 
of the mtDNA. CT values were normalized to the CT values of MTND1 levels. 
RNAi depletion of SOD2 in chondrocytes resulted to a significantly 4.5-fold 
increase in mtDNA strand breaks compared to siCON2 transfected cells. The 
effect of H2O2 was also assessed as a positive control and caused a 42-fold 
increase in mtDNA strand breaks compared to its untreated control. The PCR 
products were subjected to agarose gel electrophoresis to screen for smaller 
fragments of mtDNA that may have been formed after repair of strand breaks, 
which can be used as an indication of large-scale deletions. However, no 
smaller amplicons were observed therefore no large-scale deletions were 
identified in these samples. 
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Figure 3.17 Strand break assay for mtDNA 
SW1353 cells were seeded in 6cm dishes at a density of 1.5 x 10
6
/dish. (A) After 24 hours cells 
were transfected with 100nM siRNA for 48 hours and serum starved for 16 hours. (B) Cells 
were serum starved for 16 hours and then treated with 200nM H2O2 for 1 hour as a positive 
control for the reaction. Cells were then trypsinised, washed and a dry cell pellet was collected. 
Total DNA was extracted using the QIAmp DNA mini kit. Extracted DNA was equalised using 
the Nanodrop system and the levels of mtDNA damage were assessed by real-time PCR as in 
section 2.4.8. MTND1 was used as a housekeeping marker. (C) Real-time PCR products were 
subjected to 0.8% agarose gel electrophoresis to screen for large mtDNA deletions. Figures A 
and B represent the fold change in mtDNA strand breaks after each treatment. Figure A shows 
results of pooled data from four independent experiments. Figure B shows pooled data of 2 
independent experiments. Figure C shows the amplification products of the four experiments. 
*** p≤0.001, compared to control.  
*** 
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3.5 Discussion 
As described in the introduction, the importance of SOD2 in terms of mice 
viability and severe neurological and cardiac phenotypes is highlighted in 
several studies performed using SOD2 null mice from different genetic 
backgrounds (Huang et al 2001; Li et al 1995; Lebovitz et al 1996). These 
phenotypes could be accounted to changes in mitochondrial Complex I and 
Complex II activity, oxidative DNA damage and the presence of lipid 
peroxidation (Melov et al 1999). These studies indicate that the level of O2
- in 
the mitochondria has to be kept under control in order to maintain normal cell 
homeostasis and cell viability.  
As mentioned previously, all major inhibitors of O2
-, SOD1, SOD2 and SOD3, 
are downregulated in OA compared to healthy controls, both at the mRNA and 
protein level (Scott et al 2010; Ruiz-Romero et al 2009; Aigner et al 2006). 
Other studies have also identified high levels of O2
- as well as nitric oxide in OA 
compared to control as well as higher levels of DNA damage in the form of DNA 
base modifications (8-oxo-guanine) and DNA strand breaks (Hiran et al 1997; 
Loeser et al 2002; Tiku et al 1998; Chang et al 2005; Chen et al 2008; Kim et al 
2009). An increase in lipid peroxidation and intracellular signalling changes 
have also been reported due to high levels of O2
-, NO and inflammatory 
cytokines in OA (Tiku et al 2000; Shah et al 2005; Loeser et al 2002). A recent 
study from our group has shown that SOD2 downregulation inhibited the IL-1 
induced MMP-1 and MMP-13 expression in HAC (Scott et al 2010). However, 
no study has addressed the effect of SOD2 downregulation on O2
- levels, lipid 
peroxidation and mtDNA damage in HAC. 
3.5.1 siRNA targeted against SOD2 reduces both SOD2 mRNA and 
protein level 
SOD2 RNAi transfection in HAC achieved successful depletion of the cellular 
levels of SOD2 mRNA and protein. SOD2 mRNA was reduced by 
approximately 95% and there was a prominent decrease in SOD2 protein levels 
(Figure 3.1).  
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3.5.2 Mitosox-Red can detect changes in superoxide levels only in 
attached SW1353 cells and HAC 
Previously, no other study has used Mitosox-Red, a fluorescent probe that is 
activated only by oxidation from O2
- molecules in the mitochondria (Robinson et 
al 2006), to quantify O2
- levels in chondrocyte mitochondria. Prior to the use of 
Mitosox-Red to evaluate the effect of SOD2 depletion on O2
- levels, 
optimisation of Mitosox-Red staining in chondrocytes had to be achieved 
(Figure 3.2). Initial staining was assessed by flow cytometry and increasing 
concentrations of Mitosox-Red resulted in more cells showing maximum 
intensity. Mitosox-Red staining was also evaluated by confocal microscopy. The 
staining was weak at 1μM but very strong at 5μM as a result of saturation of 
Mitosox-Red. 2.5μM of Mitosox Red were also assessed in this experiment and 
the intensity of Mitosox-Red was strong but not saturated. Therefore, the final 
concentration of 2.5μM Mitosox-Red was chosen as the concentration to be 
used in the experiments involving quantification of O2
- levels in the 
mitochondria as it would enable identification of both an increase and a 
decrease in O2
- levels in cells.  
In order to evaluate whether Mitosox-Red staining in chondrocytes correlates 
with the levels of O2
- in the mitochondria, three known ROS inducers, rotenone, 
antimycin A and paraquat, and N-Acetyl-cysteine (NAC), a ROS inhibitor was 
used. Rotenone is a complex I inhibitor and also induces the mitochondrial ROS 
production by complex I (Figure 3.18a) (Votyakova, & Reynolds 2001; Hansford 
et al 1997). Antimycin A (AMA) is a complex III inhibitor and can also induces 
O2
- production by complex III (Figure 3.18b) (Chen et al 2003). In complex III, 
the semiquinone at centre “o”(IIIQo) is the major site of O2
- production 
(Cadenas et al 1977). Paraquat is a herbicide that has been also identified to 
increase O2
- levels. Paraquat is initially reduced by electrons and the reduced 
paraquat then reduces oxygen to O2
- (Figure 3.18c) (Thorneley 1974). NAC is a 
ROS inhibitor that is normally used in the treatment of paracetamol (or 
acetaminophen) overdose (Burgunder et al 1989). It acts by increasing the 
glutathione levels of the cells and also by binding directly to the reactive 
intermediate of acetaminophen (Burgunder et al 1989; Lauterburg et al 1983). It 
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scavenges hypochlorous acid, reacts with the  OH and H2O2 but does not react 
with O2
- (Aruoma et al 1989). However, it has been reported that NAC acts as 
an indirect inhibitor of O2
- as it induced SOD2 expression in septic rat 
diaphragms (Figure 3.18d) (Barreiro et al 2005). 
 
Figure 3.18 ROS regulation by ROS inducers and NAC (ROS scavenger) 
Figure demonstrates the sites of action of different chemicals and how they affect the levels of 
ROS in the cell. (a) Rotenone is a complex I inhibitor that also increases the complex’s O2
- 
production. (b) Antimycin A is a complex III inhibitor that also increases the complex’s O2
- 
production. (c) Paraquat is reduced by electrons. Reduced paraquat is then oxidised by O2 and 
this reaction produces O2
- as a by-product. (d) NAC scavenges H2O2 directly but also increases 
SOD2 levels thus reducing O2
- levels. 
The effect of ROS inducers and NAC was evaluated both in SW1353 
chondrosarcoma cells and HAC initially by confocal microscopy and FACS.  
In SW1353 cells analysed by confocal microscopy (Figures 3.3 and 3.4), 
increasing concentrations of AMA caused an increase in ROS levels compared 
to control. However, the cell density after treatment with 100μM AMA was less 
compared to untreated and cells treated with 10μM AMA. This can suggest that 
high concentration of AMA may be toxic to SW1353 cells. However, this 
assumption was not tested. Treatment of SW1353 with a low concentration of 
paraquat and rotenone resulted in an increase in ROS levels compared to 
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control. Increasing the concentration of paraquat to 200μM caused a decrease 
in ROS levels both compared to the lower 100μM treatment and compared to 
untreated control. The exact cause of this decrease is not clear although, in 
leukocytes treatment with high concentration of paraquat induces SOD2 
expression to dismutase the excess O2
- produced (Niwa et al 1990). Increasing 
the concentration of rotenone also caused a reduction of O2
- levels compared 
to lower concentration but the ROS levels were still significantly higher 
compared to control. The decrease in ROS may be due to the fact that the cell 
density was less after treatment with high doses of rotenone, which suggests 
that rotenone induces apoptosis (Li et al 2003). Treatment of cells with two 
different concentrations of NAC induced a similar level of reduction in the O2
- 
levels compared to control. 
In HAC analysed by confocal microscopy (Figures 3.5 and 3.6), O2
- induction 
by AMA was inconsistent. Low concentrations of AMA resulted in a reduction of 
O2
- levels compared to control, whereas a higher concentration did not alter the 
levels of ROS. This result can possibly be due to the fact that HAC O2
- 
production is primarily dependent on complex I and therefore inhibiting the MRC 
at complex III using AMA does not have a pronounced effect on ROS 
production. However, this assumption has not been tested. Treatment of HAC 
with increasing concentrations of paraquat caused a proportional increase in the 
O2
- levels in the cells. Similarly, increasing concentrations of rotenone caused a 
proportional increase in the O2
- levels. Low concentration of NAC caused a 
reduction in O2
- levels compared to untreated control whereas increasing the 
concentration resulted in an increase in ROS levels compared to control. This 
can be possibly explained with the fact that high concentrations of NAC can be 
toxic to the cells as previously reported (Sprong et al 1998).  
The data suggests that Mitosox-Red levels correlated with the O2
- levels in 
HAC and SW1353 chondrosarcoma cells. Also, we identified that NAC is 
effective at low concentrations in both HAC and SW1353 cells. In addition, in 
HAC, rotenone and paraquat were the most potent inducers of O2
- and 
therefore they can be used for future experiments if needed. 
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ROS levels were then analysed by FACS analysis (Figure 3.7). In SW1353 
cells, only rotenone induced O2
- production significantly whereas, antimycin A 
and paraquat only induced slightly. NAC, however, highly decreased O2
- levels. 
In HAC, O2
- levels were not altered by either of the ROS inducers or by NAC. 
Cells from each treatment were then cytospun on microscope slides and their 
Mitosox-Red levels were also analysed by confocal microscopy in order to 
confirm the FACS results. In most of the cells, Mitosox-Red staining was not 
retained in the mitochondria and diffused into the cytoplasm of both HAC and 
SW1353 cells irrespective of the treatment (Figure 3.8). This can possibly be 
due to the fact that trypsin and in general cell detachment, causes change in the 
cytoskeleton and therefore can affect the mitochondria and as a result Mitosox-
Red does not accumulate into the mitochondria and just diffuses into the 
cytoplasm (Kostal, & Arriaga 2011; Badley et al 1980). 
3.5.3 Mitosox-Red and SOD2 dual staining is possible by saponin 
mediated permeabilisation but not by trypsin mediated 
permeabilisation 
To examine the effect of SOD2 depletion on the O2
- levels in HAC, we had to 
be able to measure the Mitosox-Red and SOD2 protein levels simultaneously 
using confocal microscopy. Previous studies suggested that Mitosox-Red 
cannot be readily fixed due to the fact that its accumulation in the mitochondria 
depends partially on the Δψm and fixing the cells might diminish the membrane 
potential and therefore the dye cannot be retained by the cell and the 
mitochondria (Robinson et al 2006; Robinson et al 2008). In our hands, fixing 
HAC and SW1353 cells did not affect Mitosox-Red staining (data not shown). 
Robinson et al recommended a protocol of staining live cells with Mitosox-Red, 
imaging them and at the same time recording the coordinates of the cells 
position relative on the microscope (Robinson et al 2008). Afterwards cells were 
fixed, blocked and then stained for the primary and secondary antibodies of 
choice. Then the cells were imaged again using the exact recorded coordinates 
(Robinson et al 2008). In this thesis, this protocol was attempted repeatedly 
however it was not successful due to technical difficulties to locate the exact 
position of the cells at the microscope after the antibody staining using the 
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coordinates recorded during the Mitosox-Red image taking. Therefore it was 
decided to attempt staining for both Mitosox-Red and SOD2 antibody and 
image them simultaneously. HAC were stained with Mitosox-Red while alive, 
then fixed, blocked and permeabilised using Triton-X. As described in Robinson 
et al, Mitosox-Red staining was not readily retained by the cell after Triton-X 
permeabilisation (Robinson et al 2008). In this thesis, this result was confirmed 
although SOD2 antibody staining was very clear (Figure 3.9). On the other 
hand, using saponin, Mitosox-Red staining was retained and the SOD2 
antibody staining was satisfactory (Figure 3.10). This can be due to the different 
properties of saponin as a detergent or permeabilising molecule. Saponin acts 
mainly by solubilizing cholesterol to permeabilise the cell membrane without 
destroying it and leaves much of the membrane structure intact (Jacob et al 
1991). The incubation time for saponin permeabilisation was optimized at 45min 
and therefore this protocol was used to simultaneously assess the levels of 
Mitosox-Red and SOD2 protein in HAC by confocal microscopy and flow 
cytometry. 
While optimizing the saponin protocol, it was noticed that some HAC with higher 
SOD2 protein levels had lower Mitosox-Red levels and vice-versa. Therefore, to 
examine this further, HAC were isolated from seven different OA patients, 
stained with Mitosox-Red and anti-human SOD2 antibody and their 
fluorescence was assessed by flow cytometry (Figure 3.11). The result was 
inconclusive as five of the patients indicated a negative correlation between 
SOD2 and Mitosox Red, whereas two patients showed a positive correlation. 
Moreover, the correlation coefficients were very low, ranging from -0.22 to -0.35 
for the five patients that showed a negative correlation, and 0.42 and 0.53 for 
the two patients with positive correlation. These results suggest that the 
expected negative correlation between O2
- and SOD2 levels possibly exists in 
HAC with some exceptions, but this observation is not consistent with the whole 
cell population. This can be due to the differences in SOD2 expression in cells 
from different zones of cartilage tissue (Scott et al 2010). However, as 
mentioned previously (section 3.4.3), Mitosox-Red is not readily retained in 
chondrocytes after trypsinisation, therefore these results might not be reliable in 
terms of the Mitosox-Red levels recorded. 
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3.5.4 SOD2 depletion causes a significant increase in superoxide levels 
in HAC mitochondria 
Due to the nature of the FACS experiment, there was significant loss of HAC 
during the different incubations and washes. Also, the cells required 
trypsinisation prior to treatment with Mitosox-Red and this can also induce ROS 
as identified in other systems where trypsin induced ROS production in mouse 
lymphocytes and human lung fibroblasts (Lim et al 2006; Aoshiba et al 2001). 
Therefore, the assessment of the effect of SOD2 depletion on mitochondrial O2
- 
levels was performed on cells attached onto chamberslides (microscope slides) 
and cells were not treated with trypsin at any point. The fluorescence was then 
evaluated using a confocal microscope. HAC from cartilage of four different OA 
patients were transfected with SOD2 siRNA for 48hours and the effect on O2
- 
levels and SOD2 protein levels was assessed. In all four patients samples 
SOD2 siRNA depletion caused a significant decrease in SOD2 protein levels 
and a significant increase in mitochondrial O2
- levels as measured with Mitosox-
Red (Figures 3.12 and 3.13). Therefore, SOD2 depletion can potentially have 
damaging effects to the cells due to oxidative damage caused by the increase 
in O2
- levels.  
As described previously, SOD2 depletion is in homozygous mice has been 
associated with severe neurological and cardiac phenotypes possibly due to 
decreased Complex I and II activity, increased DNA damage and lipid 
peroxidation that have been linked with increased O2
- levels (Huang et al 2001; 
Li et al 1995; Lebovitz et al 1996; Melov et al 1999; Strassburger et al 2005). In 
OA, high levels of ROS have also been implicated with DNA damage (Chang et 
al 2005; Chen et al 2008), lipid peroxidation and activation of signalling 
pathways leading to increased collagenase expression and cartilage 
degradation (Tiku et al 2000; Shah et al 2005; Loeser et al 2002). Therefore, 
the increase in O2
- levels can lead to severe physiological phenotypes due to 
oxidative damage. As mentioned before, SOD2 depletion has been shown to 
have a chondroprotective effect in cartilage as it decreases IL-1 induced MMP-1 
and MMP-13 expression possibly due to the reduced levels of H2O2 (Scott et al 
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2010). This is the first study that links the depletion of SOD2 in OA cartilage 
with an increase in O2
- in HAC in vitro. 
3.5.5 SOD2 downregulation potentially induces lipid peroxidation in OA 
As mentioned above, lipid peroxidation and DNA damage have been identified 
in OA, however, oxidative damage due to SOD2 depletion has only been 
reported in other systems. Also, the levels of lipid peroxidation in human OA 
and NOF cartilage have not been studied previously. To study this, a protocol 
for using the TBARS assay on cartilage homogenates was optimised (Figure 
3.14). Three different amounts of cartilage were resuspended in the same 
volume of RIPA buffer and sonicated. A fixed volume of the resulting mixture 
was used in the assay. The amount measured from 50mg of cartilage was 
within the standard curve range and was considered optimum to measure MDA 
levels in NOF and OA cartilage samples. However, as mentioned in section 
3.4.7, while transferring the supernatant of each sample after sonication, some 
cartilage homogenate was also transferred into the reaction mixture from the 
50mg samples and a larger amount from the 100mg samples. This can explain 
the lower MDA levels in 100mg of cartilage compared to the MDA levels in 
50mg as the presence of cartilage in the mixture can inhibit the reaction of TBA 
with MDA. Therefore, in order to avoid the presence of any cartilage in the 
samples, extra care was taken in order to transfer just the supernatant from the 
50mg of OA and NOF cartilage samples that were examined. Eleven OA patient 
samples and eleven NOF patient samples were assayed. As expected, because 
of the absence of any cartilage in the reaction mixture, the MDA levels were 
significantly higher and well within the standard curve. OA cartilage samples 
were found to have significantly higher levels (although just 6.5% more) of MDA 
compared to NOF (Figure 3.15). This agreed with previous studies done in vitro, 
suggesting that lipid peroxidation is higher in OA (Tiku et al 2000; Shah et al 
2005). It has been suggested that lipid peroxidation can lead to the oxidation 
and loss of collagen matrix (Tiku et al 2000; Tiku et al 2007). Also, Bonner et al 
demonstrated that lipids, especially polyunsaturated fatty acids, accumulate 
with normal ageing of human articular cartilage (Bonner et al 1975). Therefore, 
the higher levels of lipid peroxidation, can lead to the accumulation of oxidised 
collagen matrix and lead to matrix degradation and OA. 
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We hypothesized that the increase in MDA levels in OA cartilage is caused 
partially due to the decrease in SOD2 levels in OA. Previously it was suggested 
that low levels of SOD2 lead to higher MDA values in other systems 
(Strassburger et al 2005). To test this, SW1353 chondrosarcoma cells were 
treated with SOD2 siRNA and their MDA levels were compared to siControl 
using the TBARS assay protocol for cell cultures. SOD2 depletion led to a 
significant 2.5-fold increase in MDA levels in SW1353 cells suggesting that 
SOD2 downregulation contributes to the overall increase of lipid peroxidation in 
OA cartilage compared to NOF (Figure 3.16).  
3.5.6 SOD2 downregulation can induce mtDNA strand breaks in SW1353 
cells 
Nuclear DNA and mtDNA damage, as mentioned above, has also been 
suggested to be higher in OA and in SOD2 knockout mice. mtDNA damage has 
been reported in livers of SOD2 heterozygous mice at 2–4 months of age 
(Williams et al 1998). However, the role of SOD2 downregulation in mtDNA 
strand break formation in chondrocytes has not been examined previously. 
SW1353 chondrosarcoma cells were treated with SOD2 siRNA and mtDNA 
strand break formation was evaluated and compared to the siControl treated 
cells. H2O2 treated cells were used as a positive control to make sure that the 
assay worked properly. 
This assay was first described by Passos et al in 2007 (Passos et al 2007). In 
brief, a 11kb fragment of the major arc of the mtDNA was amplified using a 
long-range real-time PCR reaction. Any strand breaks in this region of the 
mtDNA prevent amplification of the full product by the Taq DNA polymerase and 
therefore a higher CT value is recorded. This method can provide a quick 
indication of whether there are deletions present in the sample however it is not 
very helpful in terms of determining where the mutations are and whether they 
have a functional effect on mitochondrial respiration.  
H2O2 induced a 42-fold mtDNA strand break formation compared to untreated 
control indicating that our assay worked (Figure 3.17). SOD2 depletion caused 
a significant 4.5-fold increase in mtDNA strand breaks, suggesting that SOD2 
downregulation in chondrocytes contributes to oxidative mtDNA damage (Figure 
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3.17). The difference on the effect of H2O2 compared to the SOD2 RNAi 
treatment on mtDNA strand break formation could be due to the high 
concentration of H2O2 used in this assay although the duration of this treatment 
was much less compared to the RNAi treatment (one hour compared to 48 
hours). The real-time PCR products were also screened for the presence of 
smaller fragments of mtDNA that could be formed from the repair of mtDNA 
molecules. Their presence could suggest the formation of large-scale mtDNA 
deletions, however no amplicons were observed. The presence of mtDNA 
deletions and strand breaks in OA cartilage, possibly caused by SOD2 
downregulation in OA, was also assessed and it will be described in Chapter 4. 
 
3.6 Conclusions 
In summary, these results show that SOD2 depletion increases mitochondrial 
O2
- levels in HAC. As a result, the increase in O2
- levels induces higher levels 
of lipid peroxidation. Since, lipid peroxidation was higher in OA cartilage 
compared to NOF, these results suggest that SOD2 downregulation in OA can 
potentially induce lipid peroxidation in OA cartilage. Also, SOD2 depletion 
contributes to the formation of mtDNA strand breaks in SW1353 mitochondria 
however no large-scale deletions have been identified. When taken together, 
these results suggest that the SOD2 downregulation observed in OA cartilage 
compared to NOF can lead to oxidative damage in terms of lipid peroxidation 
and mtDNA damage that can potentially contribute to oxidation and loss of 
collagen and mitochondrial and cellular dysfunction, leading to cartilage 
degradation. 
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Chapter 4. Large-scale mtDNA deletions and mtDNA copy 
number in cartilage and other joint tissues 
4.1 Hypothesis 
Reduced expression of SOD2 causes long term accumulation of large-scale 
mtDNA deletions in cartilage due to increased ROS levels. This in turn may 
alter the mtDNA copy number in cartilage. 
4.2 Introduction 
In the previous chapter it was demonstrated that SOD2 downregulation resulted 
in increased levels of mitochondrial O2
-. This downregulation also caused 
increased levels of lipid peroxidation in chondrocytes that was also apparent in 
OA cartilage, where SOD2 is reduced, compared to NOF (Scott et al 2010; 
Ruiz-Romero et al 2009; Aigner et al 2006). SOD2 depletion also caused 
mtDNA damage in the form of strand breaks in chondrocytes. As a result, 
mtDNA strand breaks might accumulate in OA cartilage compared to NOF. In 
addition, damage in mtDNA can be in the form of large-scale deletions, 
especially in post-mitotic tissue such as cartilage (Aigner et al 2001; Henrotin et 
al 2005). Also the mtDNA copy number could alter to compensate for the 
damage caused by SOD2 depletion. 
mtDNA is close to the MRC machinery and the major free radical production 
sites (complex I and complex III) and therefore directly exposed to oxidative 
damage (Beckman, & Ames 1999). It has no histones and as a result the DNA 
is exposed and thus prone to damage from molecules such as ROS. Errors in 
mtDNA repair have been linked with the higher mutation rate in ageing tissues. 
Experiments on mice with an error-prone POLG, resulted in a 3-8 times higher 
number of somatic mtDNA mutations in most tissues compared to the wildtype. 
The mutant mice have deficiencies in the MRC, premature ageing features and 
reduced lifespan (Trifunovic et al 2004; Trifunovic et al 2005; Kujoth et al 2005). 
mtDNA damage was also reported in livers of SOD2 heterozygous mice 
(C57BL/6 background) at 2–4 months of age (Williams et al 1998). 
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Deletions are the primary cause of somatic mtDNA mutation in post-mitotic 
tissues, e.g. skeletal muscle, heart and brain, possibly due to the fact that these 
cells are non-dividing and therefore less exposed to purifying selection of 
mtDNA deletions (Cortopassi et al 1992). mtDNA deletions can be observed 
more often in aged post-mitotic tissues and individuals with neurodegenerative 
diseases such as Parkinson disease (Bender et al 2006; Kraytsberg et al 2006; 
Cortopassi et al 1992). As described in section 1.1.6, the mechanisms for 
mtDNA deletion generation include recombination (Mita et al 1990), slip-
replication{Shoffner 1989), and double-strand break repair (Krishnan et al 2008) 
and these involve direct repeats, flanking the breakpoint, in mtDNA (Figure 1.5). 
Recently, a study has suggested that mtDNA deletions are not caused by direct 
repeats but by stable secondary structures that can form between distant 
segments of the mitochondrial genome (Guo et al 2010).  
In OA, mtDNA deletions were reported in relation to the accumulation of the 
4977bp (common deletion) (Chang et al 2005; Schon et al 1989; Shoffner et al 
1989; Cortopassi et al 1992). The occurrence of this deletion was found to be 
higher in OA cartilage compared to healthy controls and was also higher in 
aged non-OA cartilage compared to young non-OA cartilage (Chang et al 
2005). IL-1β and TNF-α have been shown to regulate apoptosis in OA 
chondrocytes by the induction of mtDNA damage and reduction in mitochondrial 
transcription and ATP production (Kim et al 2009). In the same study, NO and 
O2
- were also induced by IL-1β and TNF-α however NO was suggested as the 
main factor responsible for mtDNA damage accummulation after cytokine 
exposure. The authors also reported that OA chondrocyte mitochondria were 
more susceptible to mtDNA damage compared to NOF. It has been suggested 
that chondrocytes, especially OA chondrocytes, have reduced mtDNA repair 
capacity and cell viability following exposure to ROS (Grishko et al 2008). This 
evidence can support and can be supported by the hypothesis that mtDNA 
deletions in post-mitotic tissues, such as cartilage (Aigner et al 2001; Henrotin 
et al 2005), arise due to inefficient mtDNA repair (Krishnan et al 2008). 
However, the presence of other large-scale mtDNA deletions in cartilage and 
other joint tissue has not been studied extensively and any changes in mtDNA 
copy number in OA compared to healthy controls remain undefined. 
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4.3 Aims 
 Evaluate the levels of mtDNA strand breaks in OA and NOF cartilage 
 Determine changes in the functionality of the MRC potentially due to the 
mtDNA damage in chondrocyte mitochondria 
 Identify and quantify mtDNA deletions and copy number in single isolated 
chondrocytes 
 Evaluate mtDNA deletions in OA patient cartilage samples and other joint 
tissue and compare these with cartilage from healthy controls 
 Quantify mtDNA copy number in OA patient cartilage samples and other 
joint tissue and compare these with cartilage from healthy controls 
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4.4 Results 
4.4.1 mtDNA strand breaks in NOF and OA cartilage 
As shown in Chapter 3 (section 3.4.8), SOD2 depletion in SW1353 cells leads 
to a 4.5 fold increase in mtDNA strand breaks (Figure 3.17). Therefore, mtDNA 
strand break accumulation in OA cartilage potentially due to SOD2 
downregulation was evaluated. 12 NOF total DNA samples and 9 hipOA total 
DNA samples from cartilage were screened for mtDNA strand breaks using the 
same assay in order to determine whether SOD2 downregulation causes 
mtDNA damage in OA. 
Total DNA was extracted from NOF and OA hip cartilage using the EZNA 
method as described in section 2.4.1. A fixed amount of total DNA was 
analysed by real-time PCR amplification of part of the major arc of the mtDNA. 
CT values were normalized to the CT values of MTND1 levels (which is not 
commonly deleted) to ensure evaluation of mtDNA strand breaks in equal 
number of mtDNA molecules in each patient sample. 
OA cartilage had 8% higher levels of mtDNA strand breaks compared to NOF, 
however this difference was not statistically significant (Figure 4.1). To ensure 
that the assay can detect mtDNA damage efficiently, H2O2 treated and 
untreated SW1353 cells were also screened for mtDNA strand breaks as in 
section 3.4.8. H2O2 induced a 40-fold mtDNA strand break formation compared 
to untreated control indicating that the assay can detect mtDNA damage (data 
not shown). 
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Figure 4.1 Strand break assay for NOF and OA mtDNA 
Cartilage from OA and NOF femoral head replacement surgery was homogenised and total 
DNA was extracted using the EZNA kit following the manufacturer’s protocol as in section 2.4.1. 
DNA was equalised to 10ng/μl and 50ng of DNA were used to assess the levels of mtDNA 
damage by real-time PCR as described in section 2.4.8. Mitochondrial gene MTND1 was used 
as normalisation reference. mtDNA amplification was normalised to the level of MTND1 using 
the calculation 2
-ΔC
T, were ΔCT represents CT (target gene) – CT (MTND1).Figure represents the 
fold difference in mtDNA strand breaks in OA tissue compared to NOF. (NOF; n=12, median 
age = 79yrs  OA; n=9, median age = 77yrs). No statistical difference was determined between 
NOF and OA samples (Mann Whitney U test). 
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4.4.2 Cytochrome c oxidase- Succinate Dehydrogenase (COX-SDH) 
reaction on cartilage sections and isolated chondrocytes 
COX-SDH reaction indicates the presence of MRC dysfunction. COX is a 
mitochondrial complex (complex IV) with subunits encoded by both the 
mitochondrial and the nuclear genome, while SDH is a MRC complex (complex 
II) that is entirely encoded by the nuclear genome. 3,3'-diaminobenzidine (DAB) 
is added in the COX incubation medium as it is an effective electron donor and 
facilitates the reaction of COX (Seligman et al 1968). Nitroblue tetrazolium salt 
(NBT), an electron acceptor, is added in the SDH incubation media and 
facilitates the reaction of SDH (Old, & Johnson 1989; Cottrell et al 2001). Cells 
with functioning COX produce the brown reaction product associated with COX 
activity and saturate the cells. The presence of the brown, COX positive, 
reaction product suggests normal MRC activity and possibly no mitochondrial 
dysfunction (Old, & Johnson 1989; Johnson et al 1993). Cells with dysfunctional 
COX will not be saturated by the DAB product and therefore allow 
demonstration of SDH activity by the reduction of NBT, to a blue formazan 
product (Old, & Johnson 1989; Johnson et al 1993). Identification of COX-
deficient cells is a useful indicator of mtDNA involvement in mitochondrial 
dysfunction. 
COX-SDH reaction on cartilage sections 
COX-SDH histochemistry was performed on cartilage sections in order to 
assess mitochondrial respiratory activity and determine whether mtDNA 
mutations are present in chondrocytes. However, the reaction did not work 
under any condition investigated. Multiple incubation times of each reagent 
were used as well as sections from different patient samples. This experiment 
was performed multiple times with the same negative result. This could be due 
to low permeability of cartilage to the COX-SDH incubation media or due to low 
expression of the MRC enzymes in those chondrocytes.  
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COX-SDH reaction on cultured HAC  
Since it was not possible to investigate COX-SDH activity of cartilage 
chondrocytes directly on cartilage tissue sections, we decided to carry out the 
experiment on isolated HAC cultured in chamberslides as in section 2.6.2. The 
same COX-SDH histochemistry protocol was performed as on cartilage 
sections. COX positive cells produced a brown reaction product and COX 
deficient cells a blue reaction product (SDH reaction product).  
On adherent cultured HAC, the SDH reaction worked well at 50 minutes but the 
COX reaction required 90 minutes to become visible (Figure 4.2). Sequential 
reaction was not successful possibly due to the lengthy COX-reaction. Cells 
were probably saturated with the very weak DAB reaction product that interferes 
with the binding and reduction of NBT in the SDH incubation media. Five patient 
samples were tested with identical results.  
The COX reaction product was weak possibly due to the fact that HAC are 
considered mainly glycolytic cells and with low mitochondrial respiration 
(Stockwell 1983; Lee, & Urban 1997). Furthermore, the culture of HAC in high 
glucose media can favour glycolysis instead of mitochondrial respiration adding 
to the reason why COX activity is low and hard to detect (Gohil et al 2010). 
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Figure 4.2 COX-SDH activity of adherent cultured HAC. 
HAC were isolated from human knee cartilage and cultured for 10 days as described in section 
2.3.1. Then cells were trypsinised, seeded in chamberslides and left to adhere for 24 hours. 
COX-SDH reaction was performed as in section 2.6.2. COX-positive cells produced a brown 
reaction product and COX-deficient cells produced a blue product. Cells were then visualised 
under a light microscope (x20 magnification). 
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COX-SDH reaction on freshly isolated HAC 
Freshly extracted HAC were then cytospun directly after digestion from cartilage 
and COX-SDH activity was assessed in order to avoid any loss of activity due to 
mitochondrial dysfunction during culturing and the high glucose levels favouring 
glycolysis. On freshly extracted HAC, both reactions were performed efficiently 
(Figure 4.3). The COX reaction was optimised at a smaller incubation time (60 
min) and the SDH reaction was best at 65min as described in section 2.6.2. The 
incubation times for chondrocytes were different to the incubation times 
optimised for a more mitochondrially active tissue such as muscle where the 
COX reaction has been optimised at 50mins and the SDH reaction at 45min 
(Krishnan et al 2010). 
Cells reacted reasonably well for both COX and SDH activity. COX-deficient 
chondrocytes were found but their number was very low (≤1%) compared to the 
COX- positive cells. Cells were then isolated into sterile tubes, according to 
COX activity, using laser capture microdissection, and were screened for 
mtDNA deletions and mtDNA copy number levels. 
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Figure 4.3 COX-SDH activity of freshly extracted cytospun HAC 
HAC were isolated from human knee cartilage as in section 2.3.1 and then cytospun for 10mins 
at 800 x g onto 2μm polyethylene napthalate (PEN)-membrane slides. COX-SDH reactions 
were performed as in section 2.6.2. The optimum reaction conditions are shown in the dual 
reaction images. Cells were visualised under a light microscope. COX positive (brown) and 
COX-deficient cells (blue) were laser microdissected into sterile 0.2ml Eppendorf tubes. Figure 
shows staining from one patient sample and is representative of 5 separate successful 
experiments. 
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4.4.3 mtDNA copy number in COX positive and COX deficient 
chondrocytes. 
Microdissected chondrocytes were pooled (50 cells) and lysed as in section 
2.4.4 and the mtDNA copy number was assessed using real-time PCR 
amplification of MTND1. A standard curve of MTND1 copy number was used to 
quantify the mtDNA copy number (Figure 4.4). Table 4.1 shows the mtDNA 
copy number in COX-deficient and COX positive chondrocytes. Analysis of five 
patient samples suggested that there is no difference in the levels of mtDNA 
copies in COX positive and COX negative HAC. All the values were within the 
range of the standard curve. Three patients had more copies in the COX 
deficient cells (4550- 6800 copies per cell) compared to the COX-positive cells 
(3050-5800 copies per cell). Conversely, two patients had more copies in the 
COX positive cells (5400-6123) compared to the COX-deficient cells (940-
3200). mtDNA copy number was attempted to be measure in single cells 
however the findings were very inconsistent and the Ct values very similar to 
the negative controls, therefore this experiment was not pursued further(data 
not shown). 
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Figure 4.4 MTND1 and MTND4 standard curves 
Real-time PCR reactions to determine standard curves for MTND1 and MTND4 levels were 
performed with every MTND1/MTND4 experiment as described in section 2.4.8. Negative 
controls were also used to ensure there was no contamination in the reaction mixture. 
Templates for both MTND1 and MTND4 were used to determine the standard curve in each 
real-time PCR reaction. The standard curves were used to calculate mtDNA copy number in 
HAC and to assess the presence of deletions. 
 
 mtDNA copies/cell 
Patient ID COX- positive COX- deficient 
N1946 5800 ± 1000 6800 ± 1400 
N1950 4224 ± 800 4550 ± 1600 
N1951 3050 ± 1200 5000 ± 2700 
N2012 5400 ± 1600 3200 ± 500 
N2024 6123 ± 2100 940 ± 45 
Table 4.1 mtDNA copy number in COX positive and COX deficient HAC 
Pools of 50 cells were isolated by laser microdissection and then lysed as in section 2.4.3. Cell 
lysates were used in a real time-PCR reaction as in section 2.4.8. mtDNA copy number was 
calculated using the MTND1 standard curves. Cells from 5 different patients were assessed and 
the reactions were performed in triplicate and the average number of mtDNA copies per cell and 
the standard deviation were calculated.  
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4.4.4 mtDNA deletions in single isolated chondrocytes 
Single microdissected chondrocytes were lysed as in section 2.4.3 and 
screened for mtDNA deletions using real-time PCR amplification of the 
mitochondrial MTND1 and MTND4 regions. A standard curve of MTND1 and 
MTND4 copy number was used to quantify the levels of MTND1 and MTND4 
copies in our samples (Figure). MTND1 is used as the control region since few 
deletions are found in this region of the mtDNA. Conversely, the majority of the 
mtDNA deletions (97% of those listed on MITOMAP) occur in the major arc of 
the mtDNA and remove part or all of MTND4, therefore it was used as a marker 
for mtDNA deletions ([NO STYLE for: Mitomap 2006]). The difference in the 
levels of MTND1 copies compared to MTND4 levels was determined as a 
percentage. A negative value suggests that more MTND1 copies have been 
detected compared to MTND4 copies suggesting the presence of mtDNA 
deletions in the MTND4 region. The results suggest that there is no significant 
difference between the level of deletions found in COX positive and COX-
deficient chondrocytes (Figure 4.5). NOF patient 2030 had average 
heteroplasmy values of -51% in COX-deficient cell compared to -53% in COX-
positive cells. OA patient 2042 had average heteroplasmy values of -40% in 
COX-deficient cells compared to -30% in COX-positive cells. These differences 
were not statistically significant.   
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Figure 4.5 mtDNA deletions in single isolated HAC 
Single HAC were isolated by laser capture microdissection and lysed as in section 2.4.3. Cell 
lysates were used in a multiplexed MTND1 and MTND4 real-time PCR reaction as in section 
2.4.8. MTND1 and MTND4 copy values were calculated using the MTND1/MTND4 standard 
curves. mtDNA heteroplasmy values were calculated using the MTND1 and MTND4 copy 
values as described in section 2.4.8. Seven single cells from 2 different patients were assessed 
and the reactions were performed in triplicate. N2030 and N2042 indicate the patient number 
and COX-positive and COX-positive indicate the COX reactivity of the isolated cells. The scale 
on the y-axis indicates the average percentage heteroplasmy of each cell. Negative values 
indicate the presence of less MTND4 copies compared to MTND1. No statistical significance 
was determined between COX-positive and COX-deficient cells (Mann Whitney U test).  
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4.4.5 mtDNA large-scale deletions in cartilage tissue samples 
Assessment of mtDNA damage based on the COX- activity in isolated 
chondrocytes produced inconsistent results. Therefore, we decided to screen 
for mtDNA deletions in DNA extracted from whole cartilage tissue. mtDNA of 
cartilage from OA knees, OA femoral heads and NOF was amplified using long 
amplification PCR reactions for a 9.9kb region spanning the D-loop of the 
mtDNA as described in section 2.4.8. PCR products were then separated by 
agarose gel electrophoresis (Figure 4.6), with fragments smaller than 9.9kb 
indicative of presence of deletions within the mtDNA. These fragments were 
isolated, cloned and further analysed by sequencing in order to characterise the 
mtDNA deletion breakpoint region. The results are summarized in Figure 4.7 
and Table 4.2. Briefly, two mtDNA deletions were identified in the two OA hip 
patient samples and two deletions were identified in one OA knee patient 
sample. No mtDNA deletions were sequenced in NOF patient samples. 
Sequences were also analysed using BLAST analysis to identify whether there 
was any similarity at the breakpoints of the deletions ([NO STYLE for: BLAST 
1990]). As shown in Table 4.2, only one mtDNA deletion in one patient was 
found to contain a direct repeat in the mtDNA sequence. The flanking regions of 
the deletions in the other two patients showed minor or no homology. 
Additionally, the intensity of the smaller amplicons was lower compared to the 
wildtype PCR amplicon indicating the presence of significantly reduced levels of 
mutated DNA (~1%) compared to wild type. 
Also as shown in Figure 4.6, a 1.6kb amplification product was visible in PCR 
products of patient samples. Sequencing analysis of that amplicon has shown 
that it was an artifact of the PCR reaction as is showed no homology with any 
region of the mtDNA.  
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Figure 4.6 Long-amplification PCR reactions of whole tissue cartilage samples from OA and 
NOF patients 
Cartilage from (A) OA (median age = 77yrs) and NOF (median age = 78yrs) femoral head and 
(B) OA knee (median age = 69yrs) replacement surgery was homogenised and total DNA was 
extracted using the EZNA kit following the manufacturer’s protocol as described in section 2.4.1. 
DNA was equalised to 10ng/μl and 50ng of DNA were used in long-range amplification 
reactions of an approximately 10kb region of the mtDNA as in section 2.4.8. PCR products were 
separated by 0.8% agarose gel electrophoresis. Amplicons that were smaller than the wildtype 
10kb amplicon suggest that deletions are present. Those amplicons were extracted, gel purified 
and analysed by sequencing as described in sections 2.4.9 and 2.4.10. Red boxes show the 
amplicons of samples where deletions have been identified and are shown in Figure 4.7. 
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Figure 4.7 Summary diagram of mtDNA deletions identified in cartilage 
Sequences were analysed using 4 Peaks sequence viewer and BLAST search. Deletions were 
confirmed by sequencing in both directions. (A) Curved lines are showing the position and the 
size of four deletions identified in cartilage from 3 OA patients. (B) The 7425bp deletion 
identified in Patient A. Vertical lines and numbers show the position of the breakpoint and within 
the lines the deleted region. The red and underlined nucleotides indicate the repeat sequences 
flanking the breakpoints. 
Sample ID Joint type Tissue Sex Age 
Break 
points Size 
Breakpoint 
homology/ repeats 
Patient A OA Hip Cartilage Male 85 8648-16073 7425 CATCAACAACCG  
Patient B OA hip Cartilage Female 76 6782-15880 9098 ATTT 
Patient C-1 OA knee Cartilage Male 60 6783-15355 8572 TTT 
Patient C-2 OA knee Cartilage Male 60 6364-15675 9311 None 
Table 4.2 Summary patient information and mtDNA deletions identified in cartilage 
Sequences were analysed for the presence of sequence repeats and homology between the 
breakpoints. Patient A had a 13bp repeat sequence identified between the breakpoints. Patients 
B and C had very minor homology. Patient C had one extra deletion identified that did not have 
any homology between the breakpoints. 
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4.4.6 mtDNA large-scale deletions in other joint tissue samples 
Other joint tissue samples, such as cortical bone, cancellous bone, meniscus, 
synovium, ligament, osteophytes and fat pad from OA patients were also 
screened for large-scale mtDNA deletions. No healthy control samples for these 
tissues were available. As described above, total DNA was extracted from the 
tissues and mtDNA was amplified using long amplification PCR. The products 
were separated by agarose gel electrophoresis (Figure 4.8) and amplicons 
smaller than 9.9kb were isolated and analysed. The results are summarized in 
Figure 4.9 and Table 4.3. Briefly, three mtDNA deletions were identified in 
cortical bone samples from a single patient. Another deletion was identified in 
osteophyte samples from the same patient. A mtDNA deletion was identified in 
synovium samples from two different patients. These deletions were also 
analysed using BLAST for homology between the breakpoint regions. The 
flanking regions of the deletions in all three patients showed minor or no 
homology at all. As with cartilage samples there was amplification of a 1.6kb 
amplicon in the PCR reactions of some patient samples. Sequencing analysis of 
that amplicon has shown that it was a PCR amplification artifact in most of the 
cases due to the presence of sequences of no homology with any region of the 
mtDNA and also due to the absence of the primers used in the PCR reaction. 
Additionally, the intensity of the smaller amplicons was lower compared to the 
wildtype PCR amplicon indicating the presence of significantly reduced levels of 
mutated DNA (~1%) compared to wild type. 
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Figure 4.8 Long-amplification PCR reactions of other joint tissue samples from OA patients 
Tissue from OA replacement surgery was homogenised and total DNA was extracted using the 
EZNA kit following the manufacturer’s protocol. DNA was equalised to 10ng/μl and 50ng of DNA 
were used in long-range amplification reactions of an approximately 10kb region of the mtDNA 
as in section 2.4.8. PCR products were separated by 0.8% agarose gel electrophoresis. 
Amplicons that were smaller than the wildtype 10kb amplicon suggest that deletions are 
present. Those amplicons were extracted, gel purified and analysed by sequencing as 
described in section 2.4.9 and 2.4.10. Red boxes show the amplicons of samples where 
deletions have been identified and are shown in Figure 4.9. 
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Figure 4.9 Summary diagram of mtDNA deletions identified in other OA joint tissues 
Sequences were analysed using 4 Peaks sequence viewer and BLAST search. Deletions were 
confirmed by sequencing in both directions. Curved lines are showing the position and the size 
of 6 deletions identified in joint tissue from 3 OA patients. 
 
Sample ID Joint type Tissue Sex Age Break points Size 
Breakpoint 
homology/ repeats 
Patient D OA hip Cortical bone Male 85 7464-15906 8442 TTA 
Patient D OA hip Cortical bone Male 85 7547-15955 8408 TTTGT 
Patient D OA hip Cortical bone Male 85 7791-15888 8097 GGCAGG 
Patient D OA hip Osteophytes Male 85 10059-15922 5863 GTTTA 
Patient E OA knee Synovium Male 79 7449-15993 8544 CTTT 
Patient F OA Hip Synovium Male 60 7764-15916 8152 None 
 
Table 4.3 Summary patient information and mtDNA deletions identified in other joint tissue 
Sequences were analysed for the presence of sequence repeats and homology between the 
breakpoints. Patients D and E had very minor homology. Patient F did not have any homology 
between the breakpoints. 
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4.4.7 mtDNA copy number in cartilage and other OA joint tissue samples 
mtDNA copy number quantification was performed in the same samples 
analysed above. Total DNA was used in two separate SYBR Green real-time 
PCR reactions amplifying the mitochondrial MTND1 gene and the nuclear β-2-
microglobulin (b2m). MTND1 amplification values were normalized using the 
b2m amplification values from the same samples. As shown in Figure 4.10A, 
there were on average 2000 mtDNA copies/cell (1000 mtDNA copies per b2m 
copy) in NOF cartilage, 1500 mtDNA copies/cell (750 copies/b2m) in OA hip 
and 1700 mtDNA copies/cell (850 copies/b2m) in OA knee. There was no 
significant difference between these groups. 
Other joint tissue samples showed a variable range of mtDNA copies ranging 
from 400 mtDNA copies/cell (200 mtDNA copies per b2m copy) in fat pad to 
4200 mtDNA copies/cell (2100 copies/b2m) in cancellous bone (Figure 4.10B). 
No healthy controls of other tissue samples were available to perform statistical 
analysis. 
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Figure 4.10 mtDNA copy number per β-2-microglobulin copy in cartilage and other joint tissue 
(A) Cartilage and (B) other joint tissue from OA and NOF femoral head and OA knee 
replacement surgery was homogenised and total DNA was extracted using the EZNA kit as 
described in section 2.4.1. 10ng of DNA were analysed for mitochondrial gene MTND1 levels 
and normalised to B2M levels. (NOF; n=18, OA Hip; n=10, OA Knee; n=12, Cancellous Bone; 
n=3, Cortical Bone; n=2, Fat Pad; n=5, Ligament; n=3, Meniscus; n=2, Osteophytes; n=1, 
Synovium; n=2). Lines within the boxes represent the median, the boxes represent the 25th and 
75th percentiles and the lines outside the boxes correspond to the minimum and maximum 
values. 
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4.5 Discussion 
As described in Chapter 3, SOD2 downregulation in chondrocytes resulted in an 
increase in mitochondrial O2
- levels and oxidative damage in the form of high 
levels of lipid peroxidation and mtDNA strand breaks compared to control. 
Evidence of higher lipid peroxidation in OA tissue compared to NOF was also 
demonstrated.  
SOD2 downregulation has been previously associated with DNA damage in in 
SOD2 knockout mice due to higher levels of mitochondrial O2
- (Melov et al 
1999; Strassburger et al 2005). In OA, different studies have identified DNA 
damage in the form of total DNA base modifications (8-oxo-guanine) and strand 
breaks in total DNA however no study has associated DNA damage in OA to 
the reduced SOD2 expression compared to NOF (Chang et al 2005; Chen et al 
2008; Kim et al 2009; Scott et al 2010).  
In this chapter, different methods are employed to evaluate the levels of mtDNA 
damage in OA and NOF cartilage and other OA joint tissues, which are 
potentially acquired due to the decrease in SOD2 levels in OA and the increase 
of O2
- levels in chondrocytes.  
mtDNA is localised in the mitochondrial matrix and is in close proximity to inner 
membrane where the main sites of O2
- production are found (complex I and 
complex III). As a result, it is very prone to oxidative damage from O2
- that can 
lead to mutation. mtDNA can undergo both point mutations and large-scale 
deletions but can also be exposed to strand breaks. In post-mitotic tissue, such 
as cartilage, deletions are primary cause of mtDNA mutation as described in 
studies performed on skeletal muscle, brain and heart (Cortopassi et al 1992). 
Moreover, mtDNA deletions were more common in aged post-mitotic tissue of 
patients with neurodegenerative disease (Bender et al 2006; Kraytsberg et al 
2006; Cortopassi et al 1992). As OA, is a disease that affects cartilage, an aged 
post-mitotic tissue, we hypothesize that large-scale mitochondria DNA deletions 
would be found in OA cartilage. 
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4.5.1 There is no difference in the level of mtDNA strand breaks in OA 
and NOF cartilage 
Firstly, since SOD2 downregulation in SW1353 chondrosarcoma cells induced 
mtDNA strand breaks (section 3.4.8), the levels of mtDNA strand breaks in 
cartilage tissue were assessed. The same assay was used as in (section 3.4.8). 
Total DNA was extracted from OA and NOF cartilage and the levels of mtDNA 
strand breaks were assessed. OA cartilage had 8% higher level of mtDNA 
damage compared to NOF however this was not statistically significant (Figure 
4.1). Therefore from this finding, we can conclude that there is very limited 
mtDNA damage in OA cartilage compared to NOF. However, using this assay 
we cannot determine the exact position of the deletions that might be present at 
low levels and whether they are found in chondrocytes at specific regions of 
cartilage. In a previous study (Chang et al 2005), although the 4977 bp mtDNA 
common deletion was identified in of OA and aged cartilage, the levels of other 
deletions compared to wildtype and the location of those deletions in cartilage 
were not evaluated. 
4.5.2 COX-SDH activity cannot be detected on cartilage sections 
To assess mitochondrial activity and dysfunction in cartilage, sequential 
histochemical reactions of cytochrome c oxidase (COX) and succinate 
dehydrogenase (SDH) activities were performed in cartilage sections. This 
technique is based on detecting cells that contain high levels of mtDNA 
mutation, which have clonally-expanded and may cause detectable MRC 
deficiency (Chinnery et al 2002). When the wild-type mtDNA copy number is at 
a level that is not sufficient to overcome the effect of the mutant mtDNA, 
functioning MRC proteins are less than the dysfunctional proteins encoded by 
the mutated mtDNA thus causing respiratory deficiencies. However, the exact 
mechanism of the how mtDNA mutations expand is currently unknown. One 
proposed mechanism suggests that mutant mtDNA has a replicative advantage 
over the wild-type mtDNA molecules and as a result mutant mtDNA is selected 
and replicated (Yoneda et al 1992). Another study suggested that random 
genetic drift is the main factor responsible for clonal expansion (Elson et al 
2001). In post-mitotic cells such as chondrocytes and neurons, it is possible that 
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only a subpopulation of the mtDNA molecules are being replicated, as there is 
limited or no cell division. Therefore a mechanism that combines both 
mechanisms already described could be possible. Mutant molecules, which are 
selected due to their replicative advantage, expand due to random genetic drift 
since a lower number of replicative molecules can increase the speed of the 
genetic drift (Krishnan et al 2008).  
The COX-SDH assay can be used to identify cells with respiratory deficiencies 
due to mtDNA involvement (Barron et al 2005). The COX complex subunits are 
encoded by both the mitochondrial and nuclear genome, whereas the subunits 
of the SDH complex are encoded entirely by the nuclear genome. Therefore, 
when the mtDNA mutation is at very low levels or absent, cells will have a 
functioning COX and they will react only for COX activity (brown product) and 
will not react for the blue SDH activity (blue product) (Old, & Johnson 1989; 
Johnson et al 1993). However, when the mtDNA mutation has exceeded the 
mutation threshold, cells will have a dysfunctional COX and therefore will not be 
saturated by the DAB product and allow demonstration of SDH activity by the 
reduction of NBT, to a blue formazan product (Old, & Johnson 1989; Johnson et 
al 1993).  
Initially, the COX-SDH reaction was performed on cartilage sections. One 
advantage of performing this assay on cartilage tissue instead of isolated 
chondrocytes is that the location of the dysfunctional cells in the different 
regions of the cartilage can be determined. However, during incubation with the 
COX incubation medium, the sections detached from the microscope slide and 
therefore detection of SDH activity was not possible. This is possibly due to a 
chemical reaction of the cartilage section with the COX incubation medium that 
prevented the section to remain attached to the slide. Slides with a different 
coating were used and the problem was partially solved. However, optimisation 
of the COX-SDH reaction on cartilage sections was not possible as detection of 
neither COX nor SDH activity was achieved. The exact reasons are not clear, 
however it could be due to low permeability of cartilage to the COX-SDH 
incubation media, or due to low expression of the MRC enzymes in those 
chondrocytes. This problem was also encountered before by a previous 
member of our group however, COX immunohistochemistry on cartilage 
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sections has shown COX staining only in the superficial zones of cartilage and 
not in deeper zones (Dr Jenny Scott, unpublished data). One limitation of our 
experiment is that the reaction on cartilage sections with COX-SDH was not 
attempted using PEN-membrane slides instead of standard microscope slides 
as cartilage sections could possibly attach better on the membrane slides.  
4.5.3 Cultured HAC react only for SDH activity but not for COX activity 
To identify whether the COX-SDH reaction was not possible due to the very low 
expression of the mitochondrial respiratory enzymes in HAC, isolated HAC were 
cultured in chamberslides and the same COX-SDH reaction was performed. 
SDH reacted efficiently, however the COX reaction required long incubation 
times in order to produce a visible reaction product (Figure 4.2). As mentioned 
before, lengthy COX incubation interferes with the subsequent SDH reaction 
efficiency as DAB, found in the COX incubation media, can block reduction of 
NBT to produce the blue SDH reaction product. The COX reaction product was 
weak possibly due to the fact that HAC are mainly considered glycolytic cells 
with only low mitochondrial respiratory activity (Stockwell 1983; Lee, & Urban 
1997). Additionally, the culture of cells (10 days) in high glucose media can 
favour glycolysis instead of mitochondrial respiration adding to the reason why 
COX activity is low and hard to detect (Gohil et al 2010). 
4.5.4 COX-SDH activity can be detected in freshly isolated HAC 
Freshly isolated HAC were cytospun on PEN-microscope slides and the COX-
SDH reaction was performed in order to avoid any loss of mitochondrial activity 
as described above. Both reactions worked well and a COX-SDH protocol was 
optimised (Figure 4.3).  
One advantage of the COX-SDH reaction is that single cells can be isolated by 
laser capture microdissection, their total DNA extracted and their mtDNA 
screened for copy number and deletions. Although the amount of COX-deficient 
chondrocytes identified was very low, both COX-positive and COX-deficient 
cells were identified and screened for mtDNA copy number and mtDNA 
deletions. 
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4.5.5 COX activity does not correlate with mtDNA copy number is HAC  
mtDNA copy number was assessed using a real-time PCR reaction amplifying 
the mitochondrial MTND1 gene and quantified using a standard curve of known 
MTND1 copies (Krishnan et al 2010). MTND1 was used to assess copy number 
because it is found in the minor arc of the mtDNA, which is less prone to mtDNA 
deletions compared to the major arc ([NO STYLE for: Mitomap 2006]). By 
analysing cells from 5 patients the results were inconclusive. In 3 patients COX-
deficient cells had more mtDNA copies than COX- positive whereas in 2 
patients the opposite was identified (Figure 4.4). Therefore no real correlation 
between the COX status and mtDNA copy number was identified in 
chondrocytes. Additionally due to the fact that pools of 50 cells were used for 
this analysis, differences in the mtDNA copy number in single cells might have 
been masked due to the high number of cells used. 
4.5.6 COX activity does not correlate with the level of mtDNA deletions in 
HAC 
The levels of mtDNA deletions were assessed using a multiplex real-time PCR 
reaction amplifying the MTND1 gene and the MTND4 gene (He et al 2002; 
Krishnan et al 2007). MTND4 is located in the major arc of the mtDNA. This 
assay relies on the assumption that deletions are more common in the major 
arc of the mtDNA and therefore if a deletion is present it will more likely delete 
MTND4 and not MTND1 and there will be a difference in real-time PCR 
amplification (He et al 2002). Therefore MTND1 has the role of the 
housekeeping marker in this assay. This assay does not allow identification of 
the type of mtDNA deletions however it can provide a good and fast indication 
of whether a deletion if present in the MTND4 region and further 
characterization of those samples can take place using different methods such 
as long amplification PCR (He et al 2002; Krishnan et al 2010).  
In this thesis, COX-positive and COX-deficient were screened for deletions 
using this assay. The heteroplasmy values obtained from the chondrocytes 
analysed ranged from -20% to -30% indicating that some deletions might be 
present in the major arc of the mtDNA (Figure 4.5). However, since the mutation 
threshold required to suggest the presence of a biochemical defect is more than 
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60%, our results possibly suggest that although mtDNA deletions are present, 
there is no physiological effect in these chondrocytes (Chinnery et al 1997; 
Sciacco et al 1994). The studies suggesting the need of mtDNA mutation 
threshold to cause a biochemical defect were performed using muscle fibers, a 
post-mitotic tissue with much higher mitochondrial activity compared to 
chondrocytes (Chinnery et al 1997; Sciacco et al 1994; Blanco et al 2004). As a 
result, the mutation threshold in chondrocytes required to produce a 
biochemical effect might be smaller (less than 60%) due to the chondrocytes’ 
low mitochondrial activity. In addition, as highlighted by Chinnery et al, a mean 
tissue mtDNA mutation threshold must exist for clinical expression of a disease 
therefore mtDNA from total cartilage has to be screened to determine the effect 
that mtDNA mutation load might have in OA (Chinnery et al 1997). 
No significant difference in the levels of mtDNA deletions was detected between 
COX-deficient and COX-positive cells. In other systems, COX-deficient cells 
had higher levels of mtDNA deletions compared to COX-positive cells (Bender 
et al 2006; Taivassalo et al 2006). This finding might suggest that COX-
deficiency in chondrocytes could be due to other reasons other than mtDNA 
deletions such as lower mitochondrial respiratory activity. Additionally, HAC 
from different zones of cartilage have different mitochondrial activity as reported 
previously and in our experiment cells were not isolated according to the 
different zones but from total cartilage (Blanco et al 2004). As a result cells from 
the deeper zones might have less COX activity but the same mtDNA as cells in 
superficial zones. This is a limitation of this thesis and since COX-SDH 
histochemistry on cartilage sections is important in establishing mitochondrial 
function and screening for mtDNA deletions in different cartilage zones in both 
OA and NOF tissue, optimisation of the COX-SDH assay on cartilage tissue will 
be a priority of future work. 
4.5.7 mtDNA large-scale deletions are present at low levels in OA 
cartilage 
Since using the mtDNA strand break assay the exact nature of the damage 
cannot be determined and also since the COX-SDH assay was not very 
consistent in terms of the correlation between the COX activity and the amount 
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of deletions present, the long–amplification (long-range/LA) PCR assay was 
performed on total DNA extracted from OA hip, OA knee and NOF cartilage 
samples as well as other OA joint tissues. Using this assay, small amounts of 
DNA can be screened for the presence of large-scale mtDNA deletions by 
amplifying a region within the major arc. The PCR products are then 
electrophoresed an agarose gel. PCR products smaller than the 9.9kb wildtype 
products indicate the presence of deletions and they can be gel extracted and 
sequenced. However, this is not a quantitative technique since PCR 
preferentially amplifies smaller amplicons, therefore the amount of mtDNA 
deletions might be exaggerated (Krishnan et al 2010). 
Total DNA was extracted from cartilage and other joint tissues and a fixed 
amount was used in the LA-PCR reaction. The wildtype 9.9kb amplicons had a 
higher intensity than the smaller amplicons that indicate that deletions are 
present (Figure 4.6). This also suggests that the levels of deletions are very low 
in cartilage, similar to the results suggested from the strand break assay. 
Amplicons from NOF tissue had a lower intensity than the ones from OA 
suggesting that deletions might be present but at extremely low levels. The 
strength of amplicons from other OA joint tissues had a variable intensity. The 
smaller amplicons were then gel purified and sequenced.  
Due to the nature of the agarose gel electrophoresis reaction performed in this 
experiment, amplicons larger than 7kb could not be isolated and analysed for 
deletions as the intensity of the wildtype amplicon restricted the identification of 
these products. A primer-shift PCR reaction approach could be performed to 
amplify these products at a position closer to the breakpoints. Also the agarose 
gel electrophoresis could be performed for longer to allow the larger amplicons 
to resolve. 
Twenty OA (hip and knee) patient samples and fifteen NOF samples were 
screened for deletions. Two large-scale mtDNA deletions were identified in two 
OA hip samples (one in each patient) and two were identified in one OA knee 
sample (Figure 4.7). The 7425bp deletion identified in patient A is very similar to 
a deletion reported previously in other diseases including cardiomyopathies, 
cirrhotic liver in hepatic tumour, Pearson syndrome and skeletal muscle in 
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chronic fatigue (Hayakawa et al 1992; Rötig et al 1995; Yamamoto et al 1992; 
Zhang et al 1995). No amplicons were sequenced from NOF because the 
amplicons were very faint compared to the OA. Also in our experiments, there 
was amplification of a 1.6kb amplicon in most of the samples. Sequencing 
analysis of the amplicon suggested that is was an artifact of the PCR reaction, 
as the sequences from both primers had no homology to mtDNA.  
None of the deletions identified were the 4977bp mtDNA common deletion 
identified by Chang et al in OA knee cartilage and aged non-OA cartilage 
(Chang et al 2005; Schon et al 1989; Shoffner et al 1989; Cortopassi et al 
1992). In that study, the authors suggest that this deletion may contribute to the 
development of OA, however they did not find a correlation between the 
severity of OA and the incidence of the 4977bp mtDNA deletion. Similarly, in 
this thesis, due to the low levels of mtDNA deletions present compared to wild 
type mtDNA molecules, we predict that the deletions possibly have no 
physiological effect as the amount of mutated mtDNA is below the threshold 
required to cause a biochemical effect and respiratory dysfunction, although in 
chondrocytes the mutation threshold required to produce a biochemical effect 
might be smaller (less than 60%) due to the chondrocytes’ low mitochondrial 
activity compared to other more mitochondrially active cells such as muscle 
fibers. This result can also support the small amount of cells that were COX-
deficient. As in this experiment total cartilage was examined instead of single 
cells, the overall effect of the mtDNA deletion is possibly limited. The low levels 
of deletions identified in OA cartilage can also be due to the loss of cartilage 
tissue during disease progression and therefore the mutation levels are 
decreased.  
4.5.8 Low levels of mtDNA large-scale deletions are present in other joint 
tissues 
Other joint tissue samples, such as cortical bone, cancellous bone, meniscus, 
synovium, ligament, osteophytes and fat pad, from OA patients were screened 
for large-scale mtDNA deletions. One limitation of this experiment was that no 
healthy controls were available for analysis. In this case, three mtDNA deletions 
were identified in cortical bone samples from a single patient. Another deletion 
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was identified in osteophyte samples from the same patient. Two mtDNA 
deletions were identified in synovium samples from two different patients, one in 
each patient (Figure 4.8). The 7449bp breakpoint of the deletion identified in the 
synovium of patient E, has been reported previously in ocular myopathy, 
however the size of the deletion was different to the one identified in this thesis 
(Degoul et al 1991). The identification of a common breakpoint with another 
study performed using a different system, could suggest that the 7449bp 
breakpoint, which is within a tRNA encoding region, might be a mutation hotspot 
although no other large-scale deletions have been reported (Degoul et al 1991; 
[NO STYLE for: Mitomap 2006]). Similar to the cartilage experiment, there was 
amplification of the 1.6kb amplicon, which also in this case it was an artifact. 
4.5.9 Most mtDNA deletions identified do not have direct repeats flanking 
the breakpoints 
All of the sequences of the deletions identified were also analysed for the 
presence of repeat sequences. As described in the introduction, 85% of the 
mtDNA deletions created by slip-replication, recombination or double strand 
break repair, are flanked by direct repeats suggesting a role of the repeats in 
the generation of the deletions (Mita et al 1990; Shoffner et al 1989; Krishnan et 
al 2008). However, a recent study suggested that repeats do not cause 
deletions but deletions can be generated due to long and stable duplexes 
formed between distant segments of the mtDNA thus implying that different 
mechanism can be involved in mtDNA deletion generation (Guo et al 2010). In 
our analysis, only one OA hip sample (patient A) demonstrated a direct repeat 
flanking the deletion thus indicating that the repeat might have had a role in the 
generation of the deletion. This deletion is very similar to a deletion reported 
previously in other diseases (Hayakawa et al 1992; Rötig et al 1995; Yamamoto 
et al 1992; Zhang et al 1995). The only difference compared to the deletion 
identified in this thesis is that in these studies one of 12bp repeat-sequences 
flanking the deleted region is within the deleted fragments whereas in our study 
both repeat sequences were outside the deleted fragment (Figure 4.7B). The 
deletions identified in the rest of the cartilage and other joint tissue samples, 
were flanked by regions with minor or no homology between them, suggesting 
that, as in Guo et al, direct repeats do not have a role in deletion generation and 
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other mechanisms might also be involved such as by stable secondary 
structures that can form between distant segments of the mitochondrial genome 
(Guo et al 2010). 
4.5.10 mtDNA copy number is not different in OA hip cartilage compared 
to NOF 
mtDNA copy number was also assessed in the same cartilage and other OA 
joint tissue samples that were analysed for large-scale deletions. The levels of 
MTND1 were measured using a real-time PCR reaction and were normalized to 
the levels of β-2-microglobulin (B2M). The levels of the mtDNA copies in other 
OA joint tissues varied from approximately 4000 copies per cell in cancellous 
bone samples to 500 copies in fat pad samples. The mtDNA copy number of 
cartilage fat pad identified in this thesis is comparable to that determined in rat 
inguinal fat pads, suggesting that fat pad might not have requirement for high 
mitochondrial activity (Venhoff et al 2009). Cartilage samples did not show a 
significant difference in mtDNA copies per cell (Figure 4.10) although OA hip 
samples had less mtDNA copies compared to NOF (1500 and 2000 copies per 
cell respectively). Comparing the mtDNA copy number of cartilage with other 
tissues we can suggest that cartilage has similar numbers of mtDNA copies 
compared to skeletal muscle (another post-mitotic tissue) but also more than 
pancreatic islets (approximately 600 copies/cell) and less than mouse oocytes 
(more than 10 000 copies/cell) (Cree et al 2008; Menshikova et al 2006). 
Studies in other tissues identified that age is one of the factors that contributes 
to the decline in mtDNA copy number (Cree et al 2008; Menshikova et al 2006; 
Short et al 2005). Reductions in the mtDNA copy number have also been 
associated with mutations in both mitochondrial and nuclear genes in several 
diseases (Blakely et al 2008; Kim et al 2005; Pyle et al 2007).  
4.6 Conclusions 
In this chapter, the levels of mtDNA damage were assessed in OA and NOF 
cartilage and in HAC. No difference in the levels of mtDNA strands breaks 
between OA and NOF cartilage was identified however, low levels of mtDNA 
large-scale deletions are present in OA cartilage. Consequently, these deletions 
possibly have a negligible biological effect in chondrocytes. In addition, no 
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significant difference in the mtDNA copy number was identified between NOF 
and OA cartilage. Taken together, these results suggest that although SOD2 
downregulation can cause mtDNA damage in chondrocytes, this damage does 
not accumulate in OA chondrocytes. However, the absence of mtDNA deletions 
can also be due to the loss of cartilage tissue during disease progression and 
therefore the total mutation levels are decreased. 
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Chapter 5. Mitochondria bioenergetics in OA 
5.1 Hypothesis 
SOD2 downregulation in OA causes mitochondrial respiratory dysfunction due 
to higher O2
- levels and lipid peroxidation 
5.2 Introduction 
In the previous two chapters it was demonstrated that SOD2 downregulation in 
chondrocytes resulted in increased O2
- levels, mtDNA strand breaks and lipid 
peroxidation. Higher levels of lipid peroxidation were also observed in OA 
cartilage, however as shown in the previous chapter the levels of mtDNA 
deletions in OA cartilage are very low and mtDNA copy number was not 
significantly different between OA and healthy controls. Despite the absence of 
changes in mtDNA in OA, the higher O2
- levels and lipid peroxidation observed 
could potentially affect the respiratory activity of mitochondria in chondrocytes. 
The MRC is composed of five large multi-unit complexes, Complex I, II, III, IV. 
All the subunits of the complexes are encoded by both mitochondrial and 
nuclear encoded genes with the exception of complex II that is encoded entirely 
by the nucleus (Lister et al 2005). The MRC is the major site of ATP production 
in the cell, which takes place by the process of OXPHOS. OXPHOS is driven by 
transfer of electrons along electron carriers in the MRC to reduce molecular 
oxygen to water. This process is coupled to the transfer of protons into the 
mitochondrial intermembrane space thus creating a protonmotive force that 
drives ATP synthesis through the ATP synthase (Complex V). However, 
OXPHOS is not completely coupled to ATP synthesis since protons can leak 
across the membrane independently of ATP synthase, a process termed proton 
leak (Brand et al 1994). As described in section 1.1.7, previous studies 
suggested that increased proton leak can be a reaction to counteract the effects 
of increasing ROS levels (Brookes 2005) or even as a consequence of 
damaged membranes due to lipid peroxidation (Kokoszka et al 2001). 
Chapter 5                                                       Mitochondria bioenergetics in OA 
 
167 
Chondrocytes produce approximately 25% of their total ATP production by 
OXPHOS and the remainder by glycolysis (Stockwell 1983; Lee, & Urban 
1997). A decrease in complex II and III activity has been reported in OA 
chondrocytes as well as an increase in the mitochondrial mass, possibly as a 
mechanism to compensate for the decrease in respiratory chain activities. OA 
chondrocytes contain more depolarised mitochondria than normal, which could 
be due to the lower activity of the mitochondrial complex III (Maneiro et al 
2003). Inhibition of complexes III and V of the MRC in human chondrocytes has 
resulted in an NF-κB mediated increase of cyclo-oxygenase 2 expression and 
prostaglandin E2 (PGE2) production thus possibly playing a role in OA 
pathogenesis (Cillero-Pastor et al 2008). 
5.3 Aims 
 To compare the function of the MRC in chondrocytes from NOF and OA 
patients 
 To assess the role of SOD2 in regulating the function of the MRC in 
chondrocytes 
 To assess the role of SOD2 in maintaining the Δψm in chondrocytes 
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5.4 Results 
5.4.1 HAC respiration is very low compared to SW1353 cells 
Human Articular Chondrocytes (HAC) were isolated from patient cartilage 
samples by enzymatic digestion. Initially analysis of respiration was attempted 
at day 0, directly after the enzymatic digestion of cartilage to isolate HAC. 
However, no respiration was recorded (data not shown) possibly due to the 
physiological stresses that the cells were under after the long collagenase 
treatment. Therefore, cells were allowed to rest for 3 days after isolation, then 
trypsinised and resuspended in sodium pyruvate containing media and their 
respiration assessed as described in section 2.9.1.  
The respiration of SW1353 cells was also assessed to compare with HAC 
respiration. SW1353 cells respiration was analysed in the same way as HAC 
(section 2.9.1, Figure 2.1).  
HAC have very low respiration values compared to SW1353 cells as shown in 
Figure 5.1A. SW1353 cells had 6.7-fold higher basal respiration compared to 
HAC (Figure 5.1A). To assess the contribution of proton leak to basal 
respiration, ATP synthase was inhibited by oligomycin. The resulting non-
oligomycin sensitive respiration is accounted to be due to proton-leak. The 
oligomycin sensitive respiration is considered to be due to ATP turnover. 
SW1353 cells had higher respiration (6.8-fold) after inhibition by oligomycin, 
higher uncoupled respiration (4.7-fold) after FCCP treatment and 3.4-fold higher 
non-mitochondrial respiration. 
When assessing different parameters (section 2.9.1, Figure 2.1) of the MRC 
function (Figure 5.1B), HAC have 1.5-fold higher SRC and 1.8-fold higher RCR 
than SW1353 cells. ATP production is much higher (6.6-fold) in SW1353 cells 
compared to HAC suggesting that HAC do not produce as much ATP by 
OXPHOS as SW1353 cells. 
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Figure 5.1 HAC and SW1353 respiration measured using the Oroboros Oxygraph respirometer 
HAC were extracted from digested hip cartilage and cultured in 75cm
2
 flasks for 3 days. Their 
respiration was compared to SW1353 chondrosarcoma cells. The respiration of both HAC and 
SW1353 cells was assessed using the same protocol. Cells were trypsinised and resuspended 
in sodium pyruvate containing media and then inserted in the Oroboros Oxygraph respirometer. 
Respiration was measured under resting conditions and after treatment with oligomycin (2.5μM, 
ATP synthase inhibitor), FCCP titration (Uncoupler), Rotenone (0.5μΜ, Complex I inhibitor) and 
Antimycin A (2.5μΜ, Complex III inhibitor) as in section 2.9.1. (A) shows average O2 flow from 
SW1353 and HAC as measured using the Oroboros Oxygraph respirometer. O2 consumption 
was allowed 10 mins to reach equilibrium after every treatment. Values shown in this graph 
represent equilibrated O2 flow. This figure is representative of one experiment. No statistical 
analysis was performed. (B) shows respiratory parameters as calculated using the respiration 
values after different treatments as described in section 2.9.1. Spare respiratory capacity ratio, 
SRC, (where SRC= FCCP/Resting) and cell respiratory control ratio, RCR, (where 
RCR=(FCCP-Oligomycin)/Resting), Proton leak (Oligomycin) and ATP production (where = 
Resting-Oligomycin) were calculated using respiration values from SW1353 and HAC. Non-
mitochondrial respiration (Antimycin A) was subtracted from all the values before calculating the 
parameters. This figure is representative of one experiment. No statistical analysis was 
performed.  
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5.4.2 OA chondrocytes respire more than NOF however they have higher 
proton leak and lower SRC and RCR 
Both NOF and OA chondrocytes responded similarly to treatment with the 
different inhibitors as shown in Figure 5.2. OA chondrocytes had significantly 
higher basal respiration and higher respiration after oligomycin inhibition 
compared to NOF. Respiration after FCCP, rotenone and antimycin A treatment 
was not significantly different between NOF and OA cells. 
Respiratory parameters were calculated as described in section 2.9.1. These 
parameters enable the thorough examination and identification of mitochondrial 
respiratory dysfunction (Brand, & Nicholls 2011). SRC, RCR, proton leak and 
ATP production were assessed. OA chondrocytes significantly showed 23% 
less SRC than NOF and they also had a 44% lower RCR as well as 93% higher 
proton leak. ATP production was also higher in OA but was not significantly 
different from NOF (Figure 5.3). 
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Figure 5.2 Average respiration values of NOF and OA chondrocytes measured with the 
Oroboros Oxygraph respirometer 
Figure shows average O2 flow (pmol per second per million cells) from NOF (n=8, median age = 
75yrs) and OA (n=7, median age = 68yrs) hip chondrocytes as measured using the Oroboros 
Oxygraph respirometer. Respiration was measured under resting conditions and after treatment 
with oligomycin (2.5μM, ATP synthase inhibitor), FCCP titration (Uncoupler), Rotenone (0.5μΜ, 
Complex I inhibitor) and Antimycin A (2.5μΜ, Complex III inhibitor) as in section 2.9.1. *p≤0.05 
OA compared to NOF (Mann Whitney U test). 
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Figure 5.3 Relative respiratory activity parameters comparing NOF and OA mitochondrial 
respiration measured using the Oroboros Oxygraph respirometer 
HAC isolated from hip cartilage were prepared for respiratory analysis as in section 2.9.1. 
Respiration values were determined as shown in Figure 5.1. Spare respiratory capacity ratio, 
SRC, (where SRC= FCCP/Resting) and cell respiratory control ratio, RCR, (where 
RCR=(FCCP-Oligomycin)/Resting), Proton leak (Oligomycin) and ATP production (where = 
Resting-Oligomycin) were calculated using respiration values from NOF (N=8) and OA (N=7) 
chondrocytes. Non-mitochondrial respiration (Antimycin A) was subtracted from all the values 
before calculating the parameters. Figure shows analysis of pooled data from all the NOF and 
OA experiments. *p≤0.05, **p≤0.01 OA compared to NOF (Mann Whitney U test). 
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5.4.3 Mitochondrial respiration in isolated chondrocytes measured using 
the Seahorse XF-24 extracellular flux analyser 
Due to the fact that mitochondrial respiration in HAC is very low, the Seahorse 
XF-24 extracellular flux analyser was used to confirm the results identified using 
the Oroboros Oxygraph. The advantage of this system is that fewer cells are 
required and therefore multiple replicates per patient sample can be analysed. 
Also there is no requirement for the use of trypsin to harvest the cells for 
analysis since cells are cultured and analysed in the same culture plate. Trypsin 
has been reported to induce ROS production in mouse lymphocytes and human 
lung fibroblasts, therefore it can also potentially alter mitochondrial respiration 
(Lim et al 2006; Aoshiba et al 2001).  
HAC were isolated from different patient samples and plated into Seahorse XF-
24 plates. After 3 days their respiration was assessed as with the Oroboros 
Oxygraph.  
Firstly, the amount of HAC required was determined by seeding cells at different 
densities, 1.75x104, 3.5x104 and 1.5x105 cells/cm2. The requirement was to 
cover the surface of the well completely but without the cells becoming too 
dense after culture. A density of 1.5x105 cells per well was considered to be the 
most appropriate from this experiment as by day 3 the cells covered the plate 
surface fully (data not shown).  
Both NOF and OA chondrocytes responded similarly to treatment with different 
inhibitors as shown in Figure 5.4. OA chondrocytes had significantly higher 
basal respiration and higher respiration after oligomycin inhibition and treatment 
with FCCP compared to NOF. There was no significant difference in the 
respiration between NOF and OA chondrocytes after rotenone and antimycin A 
treatment.  
Cell respiratory control measurements were calculated analysing the SRC, 
RCR, proton leak andATP productionas described in section 2.9.1. OA 
chondrocytes have significantly 32% less SRC than NOF and they also have a 
significantly 35% lower RCR as well as 47% higher proton leak. ATP production 
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was also 65% significantly higher in OA compared to NOF (Figure 5.5 and 
Table 5.1).  
 
Figure 5.4 Average respiration values of NOF and OA chondrocytes measured with the 
Seahorse XF-24 respirometer 
Figure shows average O2 flow/OCR (Oxygen Consumption Rate), pmol/min/well from NOF 
(n=3, median age = 77yrs) and OA (n=3, median age = 74yrs) hip chondrocytes as measured 
using the Seahorse XF-24 respirometer. Respiration was measured under resting conditions 
and after treatment with oligomycin (2.5μM, ATP synthase inhibitor), FCCP titration (1.5μΜ, 
Uncoupler), Rotenone (0.5μΜ, Complex I inhibitor) and Antimycin A (2.5μΜ, Complex III 
inhibitor) as in section 2.9.1. 5 technical repeats were performed for each measurement per 
patient sample. ***p≤0.001 OA compared to NOF (Mann Whitney U test). 
*** 
*** 
*** 
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Figure 5.5 Relative respiratory activity parameters comparing NOF and OA mitochondrial 
respiration measured using the Seahorse XF-24 respirometer 
HAC isolated from hip cartilage were prepared for respiratory analysis as in section 2.9.1. 
Respiration values were determined as shown in Figure 5.4. Spare respiratory capacity ratio, 
SRC, (where SRC= FCCP/Resting) and cell respiratory control ratio, RCR, (where 
RCR=(FCCP-Oligomycin)/Resting), Proton leak (Oligomycin) and ATP production (where = 
Resting-Oligomycin) were calculated using respiration values from NOF (N=3) and OA (N=3) 
chondrocytes. Non-mitochondrial respiration (Antimycin A) was subtracted from all the values 
before calculating the ratios. Figure shows analysis of pooled average data from all the NOF 
and OA experiments. Average respiration parameters of each experiment are shown at the 
table below. 5 technical repeats were performed for each measurement per patient sample. 
*p≤0.05, **p≤0.01 OA compared to NOF (Mann Whitney U test).  
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Sample ID 
Spare respiratory 
capacity 
Respiratory 
control ratio 
Proton 
leak 
 
NOF1 3.29 6.67 7.75 7.00 
NOF2 3.25 5.91 8.15 8.00 
NOF3 2.81 5.38 7.80 6.00 
NOF average 3.12 5.99 7.90 7.00 
NOF st. deviation 0.26 0.64 0.21 1.00 
     
OA1 1.61 3.52 10.50 11.50 
OA2 2.22 4.72 13.75 12.75 
OA3 2.52 3.26 10.80 10.60 
OA average 2.11 3.83 11.68 11.62 
OA st. deviation 0.46 0.77 1.79 1.08 
 
Table 5.1 Average values of respiratory parameters comparing NOF and OA respiration using 
the Seahorse XF-24 extracellular flux analyser 
HAC isolated from hip cartilage were prepared for respiratory analysis as in section 2.9.1. 
Respiration values were determined as shown in Figure 5.4. Spare respiratory capacity ratio, 
SRC, (where SRC= FCCP/Resting) and cell respiratory control ratio, RCR, (where 
RCR=(FCCP-Oligomycin)/Resting), Proton leak (Oligomycin) and ATP production (where = 
Resting-Oligomycin) were calculated using respiration values from NOF (N=3) and OA (N=3) 
chondrocytes. Non-mitochondrial respiration (Antimycin A) was subtracted from all the values 
before calculating the ratios. Table shows analysis of average respiration parameters of each 
patient sample, and the pooled average and standard deviation of the 3 OA and 3 NOF 
patients. 5 technical repeats were performed for each measurement per patient sample.  
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5.4.4 Extracellular acidification rate in HAC measured using the Seahorse 
XF-24 analyser 
Another advantage of the Seahorse XF-24 system is that glycolytic and 
mitochondrial respiration can be assessed simultaneously. Extracellular 
Acidification rate (ECAR) is used as a measurement for glycolysis. Since 
mitochondrial respiration was low in chondrocytes, we decided to assess the 
levels of glycolysis in NOF and OA chondrocytes. 
No difference was observed between NOF and OA, and ECAR did not change 
significantly upon addition of the different inhibitors (Figure 5.6A). By calculating 
the ratio of mitochondrial respiration (OCR) to glycolysis (ECAR) we observed 
resting OCR/ECAR values between 0.8 and 1.6 suggesting that chondrocytes 
depend almost as much on mitochondrial respiration as glycolysis under these 
experimental conditions (Figure 5.6B).  
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Figure 5.6 HAC Extracellular Acidification Rate (ECAR) and OCR/ECAR ratio measured using 
the Seahorse XF-24 respirometer 
HAC isolated from hip cartilage were prepared for respiratory analysis as in section 2.9.1. 
ECAR was measured under resting conditions and after treatment with oligomycin (2.5μM, ATP 
synthase inhibitor), FCCP titration (1.5μΜ, Uncoupler), Rotenone (0.5μΜ, Complex I inhibitor) 
and Antimycin A (2.5μΜ, Complex III inhibitor) as in section 2.9.1. (A) shows rate of change in 
pH levels per patient sample (mpH/min) and (B) shows the ratio of OCR to ECAR in the same 
samples. Both figures are representative of three NOF and three OA experiment. 5 technical 
repeats were performed for each measurement per patient sample. No significant difference 
was determined between NOF and OA chondrocytes (Mann Whitney U test).  
A 
B 
Chapter 5                                                       Mitochondria bioenergetics in OA 
 
179 
5.4.5 Effect of SOD2 downregulation on mitochondrial respiration in HAC 
measured using the Seahorse XF-24 extracellular flux analyser 
In order to determine whether a reduction in the expression levels of SOD2 in 
OA affects mitochondrial respiration in human articular chondrocytes, HAC 
isolated from patient cartilage samples were transfected with siRNA targeted 
against SOD2 as in section 2.3.2. To confirm SOD2 depletion, cells were 
cultured in the Seahorse XF-24 plates, transfected with siRNA against SOD2 or 
non-targeting control for 48 hours and then cells were lysed and SOD2 mRNA 
levels were evaluated by real-time PCR (Figure 5.7). Transfection of 100nM 
concentration SOD2 targeted siRNA resulted in 90% reduction in mRNA levels 
in Seahorse XF-24 plates. 
To assess respiration in SOD2 depleted cells, HAC were then analysed using the same method 
the same method as described above. Both SOD2 depleted chondrocytes and control 
control responded in a similar way to treatment but there was no significant difference in their 
difference in their respiration values (
 
Figure 5.8). By analyzing the respiration parameters, RNAi depletion of SOD2 in 
chondrocytes resulted in 26% lower SRC and 16% higher proton leak compared 
to control, however, no difference was observed in other cell respiratory control 
measurements (Figure 5.9). 
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Figure 5.7 Assessment of SOD2 mRNA knockdown in Seahorse XF-24 plates 
HAC isolated from knee cartilage were seeded in Seahorse XF-24 plates at a density of 3.5 x 
10
4
cells/well. After 24 hours cells were transfected with 100nM siRNA for 48 hours. Total RNA 
was extracted with Cells-to-cDNA lysis buffer as described in section 2.4.7, reverse transcribed 
to cDNA and subjected to real-time RT-PCR analysis of SOD2 gene expression. Values were 
normalised to 18S and plotted as mean fold induction over control ± SD (n=5). *** p≤0.001, 
compared to control. Figure is representative of two independent experiments. 
 
 
Figure 5.8 Average respiration values of siCON and siSOD2 transfected cells measured using 
the Seahorse XF-24 respirometer 
Knee HAC were seeded in Seahorse XF-24 plates at a density of 3.5 x 10
4
cells/well. After 24 
hours cells were transfected with 100nM siRNA for 48 hours. Cells were washed in sodium 
pyruvate containing media and then inserted in Seahorse XF-24 respirometer. Respiration was 
measured under resting conditions and after treatment with oligomycin (2.5μM, ATP synthase 
inhibitor), FCCP titration (1.5μΜ, Uncoupler), Rotenone (0.5μΜ, Complex I inhibitor) and 
Antimycin A (2.5μΜ, Complex III inhibitor) as in section 2.9.1. Figure shows the average O2 
flow/OCR (Oxygen Consumption Rate), pmol/min/well as calculated by pooling values of 4 
independent experiments. 5 technical repeats were performed for each measurement. 
Statistical analysis was performed using the Mann-Whitney non-parametric test to test 
differences between siCON and siSOD2 treated cells. No statistical difference was determined. 
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Figure 5.9 Relative respiratory activity parameters comparing mitochondrial respiration of 
siCON and siSOD2 treated cells measured using the Seahorse XF-24 respirometer 
HAC isolated from knee cartilage were prepared for respiratory analysis as in section 2.9.1. 
Respiration values were determined as shown in
 
Figure 5.8. Spare respiratory capacity ratio, SRC, (where SRC= FCCP/Resting) and cell 
respiratory control ratio, RCR, (where RCR=(FCCP-Oligomycin)/Resting), Proton leak 
(Oligomycin) and ATP production (where = Resting-Oligomycin) were calculated using 
respiration values from siCON and siSOD2 transfected chondrocytes. Non-mitochondrial 
respiration (Antimycin A) was subtracted from all the values before calculating the ratios. 5 
technical repeats were performed for each measurement. Figures show the fold change in SRC, 
RCR, Proton leak andATP productionbetween siCON and siSOD2 transfected cells in 4 
independent experiments. 
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5.4.6 Effect of SOD2 downregulation on glycolysis in chondrocytes as 
measured using the Seahorse XF-24 analyser 
ECAR was measured in cells depleted of SOD2 using siRNA transfection 
against SOD2. HAC isolated from patient cartilage samples were transfected 
with siRNA targeted against SOD2 as in section 2.3.2. Cells were treated and 
respiration was analysed in the same way as described above. RNAi targeted 
depletion of SOD2 in chondrocytes did not significantly effect glycolysis in any 
of our experiments (Figure 5.10). 
 
Figure 5.10 ECAR of siCON and siSOD2 transfected cells measured using the Seahorse XF-24 
respirometer 
HAC isolated from knee cartilage were seeded in Seahorse XF-24 plates at a density of 3.5 x 
10
4
cells/well. After 24 hours cells were transfected with 100nM siRNA for 48 hours. Cells were 
washed in sodium pyruvate containing media and then inserted in Seahorse XF-24 
respirometer. Respiration and ECAR were measured under resting conditions and after 
treatment with oligomycin (2.5μM, ATP synthase inhibitor), FCCP titration (1.5μΜ, Uncoupler), 
Rotenone (0.5μΜ, Complex I inhibitor) and Antimycin A (2.5μΜ, Complex III inhibitor) as in 
section 2.9.1. Graph shows rate of change in pH levels per patient sample (mpH/min) per well 
and is representative of four experiments. 5 technical repeats were performed for each 
measurement. No statistical analysis was performed. 
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5.4.7 Effect of SOD2 depletion on Δψm in chondrocytes 
As reported previously in Maneiro et al, OA chondrocytes are more depolarized 
compared to NOF (Maneiro et al 2003). SOD2 downregulation causes 
membrane potential depolarization in neurons possibly due to increase in 
proton leak and lipid peroxidation (Fukui, & Zhu 2010; Kokoszka et al 2001). In 
this thesis, we wanted to determine whether SOD2 regulates mitochondrial 
depolarization in chondrocytes. Two mitochondrial membrane potential dyes 
were assessed; JC-1 and TMRM. 
Initially, JC-1 was used. In healthy cells, JC-1 stains the mitochondria red. 
Mitochondrial depolarization prevents JC-1 accumulation in the mitochondria 
and therefore it stays in the cytoplasm and possesses a green fluorescence. To 
assess the dye, mitochondria were depolarized by uncoupling respiration using 
FCCP. However, no change in the fluorescence pattern was noted (Figure 
5.11). 
TMRM was then assessed. TMRM is a cationic probe that is selectively 
localized in the mitochondrial matrix due to the presence of a net negative 
charge caused by the proton gradient. Any variations in the Δψm change the 
intensity but not the spectra of the probe. In healthy cells TMRM accumulates 
normally in the mitochondria as it is attracted by their negative charge and emits 
red fluorescence. Mitochondrial depolarization prevents TMRM accumulation in 
the mitochondria due to the collapse of the negative charge and therefore less 
TMRM enters the mitochondrial membrane and the some TMRM stays inactive 
in the cytoplasm. TMRM was more responsive compared to JC-1 and 
fluorescence changed in response to membrane potential changes in 
chondrocytes as membrane potential depolarization was evident after FCCP 
treatment since TMRM levels in the mitochondria were reduced (Figure 5.12). 
RNAi SOD2 depleted cells and control cells were stained with 10nM TMRM 
(non-quench) and their fluorescence was assessed basally and after addition of 
oligomycin and FCCP. Addition of FCCP without oligomycin causes ATP 
synthase reversal and hydrolysis of ATP in order to restore the proton gradient. 
Therefore, oligomycin is added before FCCP to block this effect and allow 
measurement of the effect of FCCP on Δψm. Oligomycin normally causes Δψm 
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hyperpolarisation, which suggests normal respiratory function as it blocks ATP 
synthase from pumping protons back to the matrix during ATP synthesis. As a 
result there is a build up of protons and a net positive charge in the 
intermembrane space and a net negative charge in the matrix, which attracts 
more TMRM (Brand, & Nicholls 2011). If oligomycin causes Δψm depolarisation 
it suggests a dysfunctional respiratory activity (Brand, & Nicholls 2011). The 
mechanism of this process is currently unknown.  
SOD2 depletion caused a Δψm depolarisation basally (Figure 5.13). Oligomycin 
also caused Δψm depolarisation in both SOD2 depleted HAC and controls. 
Mitochondria depolarised further after addition of FCCP but it is not clear 
whether it is due to the FCCP treatment or due to the prior oligomycin treatment 
and its depolarising effect on HAC mitochondria in this experiment. 
 
Figure 5.11 JC-1 Δψm staining in HAC 
HAC isolated from knee cartilage were seeded in 6-well plates at a density of 3x10
5
 cells/well. 
After 24 hours cells were treated with 2μΜ FCCP (depolarisation) or 0.01% DMSO control for 
10mins, to assess the colour changes in response to mitochondrial depolarisation (more green, 
less red). Cells were then treated with 50nM JC-1 for 15mins. Fluorescence was assessed with 
live cell confocal microscopy using the channels shown above. This figure is a representative of 
two independent experiments. 
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Figure 5.12 TMRM Δψm staining assessment 
HAC isolated from knee cartilage were seeded in 6-well plates at a density of 3x10
5
 cells/well. 
After 24 hours cells were stained with 10nM TMRM (non-quench) for 30mins and TMRM 
fluorescent staining was measured in cells treated with 0.01% v/v DMSO (final concentration), 
2.5μM oligomycin (final concentration) and 2μM FCCP (final concentration). Cells were 
visualised live using an inverted fluorescent microscope. Images were analysed using Image J.  
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Figure 5.13 TMRM Δψm staining in HAC treated with siCON and siSOD2 
HAC isolated from knee cartilage were seeded in chamberslides at a density of 1.5x 10
4
 
cells/well. After 24 hours they were transfected with 100nM siCON or siSOD2 for 48 hours. 
Then cells were stained with 10nM TMRM (non-quench) for 30mins and TMRM fluorescent 
staining was measured under basal conditions (time=0) and every one minute after treatment 
with 2.5μM Oligomycin (ATP synthase inhibitor, prevents ATP synthase reversal) at t=0 and 
1.5μΜ FCCP (Uncoupled, induces mitochondrial depolarisation) at t=11. Cells were visualised 
live using an inverted fluorescent microscope. Images were analysed using Image J. (A) shows 
a graphical representation of TMRM levels in siCON and siSOD2 treated HAC. (B) shows 
TMRM levels at specific time points. Background fluorescence was measured and subtracted. 
This figure is representative of 2 independent experiments.  
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5.5 Discussion 
Following the analysis of NOF and OA cartilage and HAC mtDNA for large-
scale mtDNA deletions and mtDNA strand breaks in Chapter 4, the effect of 
SOD2 downregulation on mitochondrial respiration was examined. In particular, 
the downregulation of SOD2 in disease may have altered mitochondrial 
respiration compared to healthy controls. Respiration was therefore assessed in 
HAC from OA and NOF patient samples and the contribution of SOD2 
examined by RNAi.  
Previous reports highlight the role of glycolysis in articular chondrocytes, 
suggesting that approximately 25% of their total ATP is produced by OXPHOS 
(Stockwell 1983; Lee, & Urban 1997). However, mitochondrial respiration is not 
considered to be totally inactive as O2 uptake increased upon treatment with 
protonophore DNP (2,4-dinitrophenol) (Lee, & Urban 1997). Johnson and 
colleagues also suggested that peroxynitrite and nitric oxide donors suppress 
respiration and ATP generation in chondrocytes (Johnson et al 2000). In 
addition, inhibition of the MRC with oligomycin (ATP synthase inhibitor) and 
antimycin (complex III inhibitor) reduced collagen and proteoglycan synthesis in 
the same cells (Johnson et al 2000). In OA chondrocytes, complex II and III 
activity has been shown to be decreased and mitochondrial mass increased 
compared to healthy controls (Maneiro et al 2003). More depolarized 
mitochondria were also identified in OA chondrocytes possibly due to the 
decrease in complex III activity (Maneiro et al 2003). Also, inhibition of complex 
III and IV in HAC resulted in an NF-κB mediated increase of cyclo-oxygenase 2 
expression and prostaglandin E2 (PGE2) production thus possibly playing a role 
in OA pathogenesis (Cillero-Pastor et al 2008). 
As mentioned in chapter 3, SOD2 is one of the most important O2
- scavengers 
in the cell. SOD2 null mice, depending on their genetic background, experience 
embryonic (C57BL/6 J) or neonatal lethality (CD1, DBA/2 J, B6D2F1) 
associated with severe neurological and cardiac phonotypes and metabolic 
acidosis (Huang et al 2001; Li et al 1995; Lebovitz et al 1996). A reduction in 
the catalytic activity of complexes I and II of the MRC was also identified in 
SOD2 null mice (CD1 background) (Melov et al 1999).  
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These results suggest that the increase in ROS, O2
- in particular, due to the 
decrease of SOD2 levels in the mitochondria, can lead to a variety of 
biochemical defects. In this thesis, we have shown that SOD2 downregulation in 
OA can lead to an increase in O2
- levels in HAC and also higher levels of lipid 
peroxidation. The effect of SOD2 downregulation on mitochondrial respiration is 
therefore examined here. 
5.5.1 Freshly isolated HAC do not respire by mitochondrial respiration 
Initially, HAC respiration was assessed at day 0 after the enzymatic digestion of 
cartilage to avoid any loss of cells with dysfunctional respiration. However, 
when the respiration of those cells was measured using the Oroboros Oxygraph 
2k respirometer, no respiration was recorded at all suggesting that the cells 
were dead (data not shown). This observation can probably be accounted to the 
fact that HAC were under extreme physiological stresses after the long 
collagenase treatment that could have affected their respiration. Therefore, it 
was decided to culture the cells for three days in normal culture media to allow 
them to rest and then they were trypsinised, resuspended in sodium pyruvate 
containing media to stimulate their mitochondrial respiration and respiration was 
assessed. However, the increase in respiration after culture of HAC can be 
attributed to a change in the mitochondrial properties of chondrocytes during 
culture as reported previously (Mignotte et al 1991). In this study, a 20-fold 
increase in the concentration of mitochondrial transcripts for cyt B, CO II and 
CO III has been reported in chondrocytes in culture compared to the levels in 
cartilage suggesting that the mitochondrial properties of chondrocytes change 
when transferred in an artificial culture environment. 
5.5.2 HAC and SW1353 chondrosarcoma cells have different 
mitochondrial respiration patterns 
Firstly, the respiration of HAC was compared to SW1353 chondrosarcoma cells 
respiration in terms of oxygen consumption/flow (O2 flow) using the Oroboros 
Oxygraph 2k respirometer. This experiment was performed once in order to 
make sure that the respirometer works and therefore the results are only 
preliminary. SW1353 cells had approximately a 6.7-fold higher basal respiration 
Chapter 5                                                       Mitochondria bioenergetics in OA 
 
189 
compared to HAC (Figure 5.1). SW1353 and HAC basal respiration was also 
compared to other cells based on data from other studies. SW1353 basal 
respiration was 1.5-fold higher, 2.4-fold higher and at similar levels compared to 
2008-ovarian cancer cells, H460 lung cancer cells, MDA-MB468 breast 
cancerous cells (Verschoor et al 2010; Amoêdo et al 2011; Kristiansen et al 
2011). HAC respiration is approximately 3-fold, 5-fold and 4-fold lower 
compared to mouse cortical synaptosomes, neonatal rat ventricular myocytes 
and RMS-13 myoblasts respectively (Flynn et al 2011; Hill et al 2009; Civitarese 
et al 2010).  
Basal respiration is controlled mainly by ATP production and partly by proton-
leak and substrate oxidation (Ainscow, & Brand 1999; Brown et al 1990). 
Therefore those parameters have to also be taken into consideration. In terms 
of substrate oxidation, all the cells were supplied with the same pyruvate and 
glucose containing media in order to keep this parameter constant between 
experiments. To assess the contribution of proton leak to basal respiration, ATP 
synthase was inhibited by oligomycin (Nobes et al 1990; Brand et al 1991). The 
resulting non-oligomycin sensitive respiration is accounted to be due to proton-
leak (Nobes et al 1990; Brand et al 1991) with oligomycin sensitive respiration 
considered to be due to (Nobes et al 1990; Brand et al 1991). SW1353 cells 
had higher respiration (6.8-fold) after inhibition by oligomycin, higher uncoupled 
respiration (4.7-fold) after FCCP treatment and 3.4-fold higher non-
mitochondrial respiration (Figure 5.1). Therefore, it have be concluded that 
SW1353 chondrosarcoma cells respire much more than HAC.  
However, when assessing different parameters of the MRC function, HAC have 
1.5-fold higher SRC and 1.8-fold higher RCR than SW1353 cells (Figure 5.3). 
This suggests that HAC can respond better to changes in energy demands 
compared to SW1353 cells and also they have a more efficient MRC as well 
(Brand, & Nicholls 2011; Choi et al 2009; Yadava, & Nicholls 2007). This can be 
due to the higher levels of proton leak found in SW1353 cells (8.4-fold) 
compared to HAC and therefore SW1353 cells utilize less of their available 
protons for ATP synthesis than HAC. However, due to the higher resting 
respiration in SW1353 cells, and therefore possibly higher ATP demand, ATP 
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production is much higher (6.6-fold) compared to HAC suggesting that HAC do 
not produce as much ATP by OXPHOS as SW1353 cells.  
5.5.3 NOF and OA chondrocytes have different mitochondrial respiration 
patterns, as assessed by the Oroboros Oxygraph-2k 
As mentioned above, a previous study reported that OA chondrocytes have 
lower complex II and complex III activities as well as more depolarized 
mitochondria and more mitochondrial mass (Maneiro et al 2003). However the 
respiratory activity of the cells has not been compared. In order to compare 
mitochondrial respiration between NOF and OA chondrocytes, HAC from both 
NOF and OA cartilage samples were extracted and analysed after three days in 
culture.  
At first respiration was assessed using the Oroboros Oxygraph 2k respirometer. 
OA chondrocytes had a significantly higher basal and oligomycin insensitive 
respiration (Figure 5.2). They also had higher uncoupled respiration than NOF 
however this was not statistically significant. Non-mitochondrial respiration was 
almost identical in NOF and OA chondrocytes. The higher respiration in OA 
might be due to the higher mitochondrial mass reported in OA chondrocytes 
compared to NOF as an adaptive response to the lower complex II and complex 
III activities (Maneiro et al 2003). By assessing different parameters of 
respiratory function, OA chondrocytes had a significantly lower SRC, 
significantly lower RCR and significantly higher proton leak compared NOF 
(Figure 5.3). OA chondrocytes also had higher ATP production but it was not 
statistically significant. These parameters indicate that OA chondrocytes respire 
closer to their bioenergetics limit compared to NOF and therefore cannot 
respond as well to energy changes as NOF chondrocytes. In addition, OA HAC 
have a higher proton leak thus indicating that part of their basal respiration is 
not due to ATP production and also that they utilize less of the proton-gradient 
in the production of ATP compared to NOF. OA chondrocytes also have a lower 
RCR than NOF, which confirms the fact that OA chondrocytes have less SRC 
and more proton leak compared to NOF and suggests possible mitochondrial 
respiratory dysfunction. 
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Assessing mitochondrial respiration using the Oroboros system had some 
drawbacks. Firstly, the cells had to be trypsinised before assessing their 
respiration since the system requires the cells to be in a suspension. This could 
potentially alter the mitochondrial respiration as cells are lifted from their normal 
growth environment and exposed to a suspension environment. Another 
limitation of this system is the large number of cells required per experiment. At 
least 2 million chondrocytes were required in order to obtain sufficient 
respiration to compare between NOF and OA. Furthermore, the number of 
simultaneous technical repeats that can be performed are limited to two due to 
the presence of just two wells on the respirometer. 
5.5.4 NOF and OA chondrocytes have different mitochondrial respiration 
patterns, as assessed by the Seahorse XF-24 analyser 
A different respirometry system subsequently became available, the Seahorse 
XF-24 extracellular flux analyser. Using this system, cells must be able to 
adhere on the surface of the plates provided by Seahorse Inc. Therefore, HAC 
could be cultured directly after extraction in these plates and then examined for 
mitochondrial respiration directly in these plates without the need to use trypsin. 
Another advantage of this system is that twenty wells are available 
simultaneously for experimentation and therefore at least five technical repeats 
were performed per measurement. The number of cells required is significantly 
less compared to the Oroboros system, as 150,000 cells were required per well 
to perform the comparisons between NOF and OA chondrocytes. 
Therefore, the Seahorse XF-24 system was used to confirm the results 
acquired using the Oroboros system. As with the experiments performed using 
the Oroboros system, OA chondrocytes respired significantly more than NOF 
chondrocytes at basal levels, after oligomycin inhibition and after FCCP 
uncoupling as they consumed more O2 than NOF cells at these stages of the 
experiment (Figure 5.4). No significant difference was recorded in the non-
mitochondria respiration measured after sequential rotenone and antimycin A 
treatment.  
Analysis of respiration using the same parameters as with the Oroboros system 
produced similar results (Figure 5.5). OA chondrocytes had a significantly lower 
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SRC and significantly higher proton leak compared to NOF. As before, this 
suggests that OA HAC work closer to their bioenergetic limit compared to NOF 
and therefore have a lower SRC to respond to changes in energy demands. 
Also, they have a higher proton leak, which suggests that they have a larger 
amount of protons that is not utilized in ATP synthesis compared to NOF and 
this contributes to non-phosphorylating respiration. It also suggests that OA 
mitochondria are slightly uncoupled which can be due to changes in the proton 
conductance of the inner membrane and changes in the Δψm. OA 
chondrocytes have been reported to have more depolarized mitochondria 
compared to control, therefore this can partially explain the increase in proton 
leak (Maneiro et al 2003). The net effect is evident in the cell RCR values, 
which take into account both the capacity and proton leak of the cells. OA 
chondrocytes have a lower RCR compared to NOF, which suggests that their 
MRC is more dysfunctional due to the higher proton leak and lower SRC.ATP 
productionwas also significantly higher in OA chondrocytes as a result of the 
increasing respiration possibly due to the mild uncoupling of the MRC.  
5.5.5 There is no difference in glycolysis between OA and NOF 
chondrocytes 
Another advantage of the Seahorse XF-24 system is that it measures the level 
of glycolysis by measuring extracellular acidification rate (ECAR) at the same 
time as measuring the O2 flow since it has two separate sensors. Therefore the 
glycolytic activity of NOF and OA chondrocytes was assessed. No significant 
difference was determined between the glycolytic activity of NOF and OA 
chondrocytes at any point of the experiment (Figure 5.6). An interesting 
observation is the fact that after inhibition of the ATP synthase by oligomycin, 
the glycolytic activity in both NOF and OA increased very slightly. ATP synthase 
inhibition normally induces ATP production by glycolysis (Brand, & Nicholls 
2011). In other systems glycolysis after oligomycin inhibition accelerates 
approximately 10-fold in order to maintain ATP production (Brand, & Nicholls 
2011). In this case, oligomycin induced only a non-statically significant 5% 
increase in both NOF and OA cells. This can due to the fact that oligomycin also 
causes a failure of glycolysis as well failure of fatty acid oxidation and 
catabolism and therefore causes a decrease in respiration or in this case a very 
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minor increase (Brown et al 1990; Nobes et al 1990). This observation could be 
explained by the fact that mitochondrial respiration is not highly active in 
chondrocytes, as suggested previously, and the cells rely massively on 
glycolysis (Lee, & Urban 1997; Stockwell 1983). Therefore, upon inhibition of 
the ATP synthase by oligomycin, glycolysis does not change, as the cells are 
already mainly glycolytic.  
5.5.6 HAC have a low OXPHOS/Glycolysis ratio which confirms that they 
are mainly glycolytic as reported previously 
It has been reported previously that only 25% of the chondrocytes’ ATP is 
produced by OXPHOS and the remainder is by glycolysis (Stockwell 1983; Lee, 
& Urban 1997). By combining our data the ratio between mitochondrial and 
glycolysis was determined in order to assess how much the cells depend on 
OXPHOS in relation to glycolysis for ATP production (Figure 5.6). At basal 
levels, NOF chondrocytes depend more, or almost as much, on glycolysis as 
the OXPHOS/Glycolysis ratio was approximately 0.8 indicating that 
approximately 55% of the total respiration in NOF chondrocytes is due by 
glycolysis and 45% by OXPHOS. In OA chondrocytes the ratio was 1.5 possibly 
due to the higher activity and higher levels of identified in the previous 
experiments. This suggests that OA cells rely more on mitochondrial respiration 
as 60% of the respiration is due to OXPHOS and 40% by glycolysis. The 
comparison between NOF and OA chondrocytes was not statistically significant, 
however the general conclusion is that HAC rely almost as much on the MRC 
and OXPHOS for their ATP production as in glycolysis under the conditions 
examined as reported previously (Lee, & Urban 1997; Stockwell 1983).  
Since in our study, total respiration was used in this calculation, and any 
mitochondrial respiration due to proton leakiness was not subtracted to 
calculate the respiration due to ATP production, the ratio calculated might be 
overestimated. Therefore, the ratio of OXPHOS dependent ATP production to 
glycolytic ATP production is possibly lower (approximately 33% ATP produced 
by OXPHOS and 67% by glycolysis assuming that the ECAR value is only due 
to ATP producing glycolysis) and therefore similar to the 25% ATP production 
by OXPHOS suggested previously (Stockwell 1983; Lee, & Urban 1997). 
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Additionally, the percentage of ATP produced by OXPHOS in chondrocytes as 
measured in this thesis might be exaggerated due to the use of sodium 
pyruvate to stimulate mitochondrial respiration.  
5.5.7 SOD2 depletion causes similar changes in mitochondrial 
respiration pattern as in OA chondrocytes 
The effect of SOD2 depletion on the mitochondrial respiration was also 
assessed. A recent study performed on SOD2 null mice, suggested that SOD2 
depletion leads to a decrease in SRC in cortical synaptosomes due to increased 
levels of oxidative stress in the mitochondria (Flynn et al 2011).  
Reduced SRC has been suggested as a consequence of mild uncoupling of the 
MRC in cerebellar granule neurons in order to reduce O2
- levels in the 
mitochondrial matrix (Johnson-Cadwell et al 2007). A study by the same group 
also suggested that an impaired SRC also regulates glutamate toxicity upon 
complex I inhibition (Yadava, & Nicholls 2007).  
In this thesis, successful SOD2 downregulation was achieved by SOD2 RNAi 
transfection of HAC in the Seahorse XF-24 plates and HAC were analysed for 
their respiration using the Seahorse XF-24 system (Figure 5.7). SOD2 depleted 
HAC had higher (but not statistically significant) respiration compared to siCON 
transfected HAC (Figure 5.8). Subsequent analysis of the respiratory 
parameters showed SOD2 depleted HAC had significantly lower SRC and 
significantly higher proton leak compared to control, similar to the OA 
chondrocytes compared to NOF (Figure 5.9). RCR was lower and ATP 
production was higher in the SOD2 depleted HAC but the values did not reach 
statistical significance. Therefore, in HAC, SOD2 depletion causes SRC 
impairment as with the Flynn et al study, although the level of impairment was 
much lower in our study possibly due to the difference in respiratory 
requirements between HAC and cortical synaptosomes (Flynn et al 2011). 
Combined with the increase in proton-leak, these results suggest that SOD2 
downregulation causes a mild uncoupling of the MRC, possibly to decrease O2
- 
levels in the mitochondrial matrix, however at the same time it caused 
impairment of the SRC which can potentially expose the cells to calcium 
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deregulation and glutamate-induced toxicity reported previously in OA models 
(Jean et al 2006; Johnson et al 2000). 
5.5.8 SOD2 depleted HAC have more depolarised mitochondria compared 
to control 
Another effect of SOD2 downregulation that has been reported in neurons is 
Δψm depolarization possibly due to increase in proton leak and lipid 
peroxidation (Fukui, & Zhu 2010; Kokoszka et al 2001). Similarly, it has been 
reported that OA chondrocytes have more depolarized mitochondria compared 
to healthy controls (Maneiro et al 2003). However, no link has been identified on 
the effect of SOD2 depletion in HAC and whether that resembles the disease 
phenotype. In this thesis, it was initially attempted to optimize the JC-1 Δψm 
stain in HAC, as it was used in Maneiro et al (Maneiro et al 2003). To assess 
the dye, HAC were treated with 0.01% (v/v) DMSO as a control and with 2μM 
FCCP to depolarize the mitochondria. JC-1 in cells with normal Δψm forms J-
aggregates, which are complexes with red fluorescence (Maneiro et al 2003). In 
cells with depolarized mitochondria, JC-1 remains in its monomeric form that 
shows only green fluorescence (Maneiro et al 2003). Therefore, addition of 
FCCP should prevent formation of the red J-aggregates and JC-1 should 
remain in its green monomeric form. In our experiments however, FCCP did not 
induce any shift from red to green and therefore it was concluded that JC-1 was 
not appropriate to study Δψm changes (Figure 5.11). Additionally, JC-1 is prone 
to the formation of artifacts due to occasional red JC-1 speckles within 
individual mitochondria arising from localized J-aggregate formation (Keil et al 
2011; Diaz et al 2000; Brand, & Nicholls 2011).  
TMRM was then evaluated using the same protocol. TMRM is a cationic probe 
that is selectively localized in the mitochondrial matrix due to the presence of a 
net negatively change caused by the proton gradient. Any variations in the Δψm 
change the intensity but not the spectra of the probe. Addition of FCCP induced 
a decrease in the intensity of the TMRM dye, due to depolarization of the 
mitochondrial membrane (Figure 5.12). Addition of oligomycin also induced a 
mild hyperpolarization, in some cases, which was evident by the increase in 
TMRM intensity (Figure 5.12). TMRM was used at non-quench mode in order to 
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avoid aggregation and quenching in the mitochondrial matrix (Nicholls 2006; 
Brand, & Nicholls 2011). Additionally, non-quench mode enables comparison of 
populations of cells with a pre-existing difference in Δψm (Brand, & Nicholls 
2011). Therefore, TMRM was used to assess possible changes in the Δψm due 
to SOD2 downregulation in chondrocytes.  
HAC, transfected with siRNA against SOD2 or with a non-targeting siRNA, were 
stained with TMRM and their fluorescence was assessed at basal levels and 
after sequential oligomycin and FCCP treatment using a fluorescent microscope 
(Figure 5.13). HAC transfected with siRNA against SOD2 had a lower intensity 
compared to controls at basal levels and also after oligomycin and FCCP 
treatment. As TMRM is a slow-response probe, TMRM accumulation was 
allowed to equilibrate for 10mins after each treatment. Oligomycin treatment 
caused depolarization in both siSOD2 and siCON cells which possibly indicates 
a dysfunctional MRC (Brand, & Nicholls 2011). Mitochondria depolarised further 
after FCCP treatment however this effect could be due to the prior oligomycin 
treatment and its depolarising effect on HAC mitochondria in this experiment. 
Therefore, mitochondrial membrane depolarization in OA can potentially be due 
to SOD2 downregulation in HAC (Maneiro et al 2003). For more accurate 
measurement of Δψm, experiments could be performed in the simultaneous 
presence of a fluorescent cation, such as TMRM, and a fluorescence anion 
(PMPI, plasma membrane potential indicator) that enters the cytoplasm as the 
plasma membrane is depolarized (PMPI) (Nicholls 2006). This is required 
because accumulation of fluorescent membrane permeant cations, such as 
TMRM, is influenced by both plasma and mitochondrial membrane potentials 
and therefore measuring both can clear any ambiguity of what causes the 
accumulation of these cations (Nicholls 2006). 
5.5.9 Summary 
By combining the data shown in this chapter and data from chapter 3, it can be 
concluded that SOD2 downregulation increases O2
- levels in HAC mitochondria 
and this increase in O2
- induces oxidative damage and mitochondrial 
dysfunction. Higher ROS levels due to SOD2 downregulation can potentially 
induce higher levels of lipid peroxidation in chondrocytes and possibly in OA 
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cartilage. Increasing ROS levels can also cause mild uncoupling of 
mitochondrial respiration in the form of higher proton leak in order to decrease 
ROS production as shown in other systems (Korshunov et al 1997; Longo et al 
1999; Skulachev 1996). In brief, by increasing the proton leak, the proton-
motive force that drives ATP production is lower, and that can lead to a more 
oxidized ubiquinone pool and a lower concentration of ubisemiquinone. It can 
also increase oxygen consumption rate, as in the case of OA chondrocytes and 
SOD2 depleted chondrocytes, to lower the oxygen tension around the 
mitochondria. Since O2
- production depends on both ubisemiquinone and 
oxygen concentration, lowering the concentration of these two molecules leads 
to lower ROS production.  
Membrane damage, in this case mitochondrial inner membrane damage, due to 
lipid peroxidation can also contribute to the increase in proton leak by 
increasing the proton conductance of the membrane and therefore allowing 
more protons to leak through the inner membrane into the matrix (Kokoszka et 
al 2001). Lipid peroxidation has also been associated with decreasing SRC. In a 
study on cardiomyocytes, induced lipid peroxidation depleted the SRC of the 
cells and induced protein damage and cell death (Hill et al 2009). A later study 
by the same group also showed that NO and H2O2 decreased the SRC in 
endothelial cells and caused cell death, suggesting that SRC is important in cell 
responses to oxidative stress (Dranka et al 2010).  
Higher levels of proton leak can lead to mild uncoupling which can then lower 
the SRC of the cells as we see in OA chondrocytes and siSOD2 chondrocytes 
compared to their control. Proton leak can also depolarize the mitochondrial 
membrane and this was true in this thesis in SOD2 depleted cells as well as in 
Maneiro et al, where OA chondrocytes had more depolarized mitochondria 
compared to controls (Maneiro et al 2003).  
These data suggest that there is mitochondrial dysfunction due to the 
downregulation of SOD2 in OA that can potentially lead to activation of 
apoptotic pathways and inflammatory pathways that can lead to cartilage 
degradation and osteoarthritis (López-Armada et al 2006; Lopezarmada et al 
2006). 
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5.6 Conclusions 
In this chapter mitochondrial and glycolysis was assessed in OA and NOF 
chondrocytes and the role of SOD2 in regulating respiration was evaluated. 
Mitochondrial respiration in HAC is low compared to SW1353 chondrosarcoma 
cells. OA chondrocytes have less SRC and more non-phosphorylating 
respiration, proton leak and ATP production compared to NOF. Also, HAC 
depend as much or even more on glycolysis for their ATP production than 
mitochondrial respiration. The role of SOD2 in mitochondrial respiratory 
regulation was also determined. SOD2 downregulation causes a decrease in 
SRC and increases proton-leak similar to OA however, SOD2 depletion does 
not affect glycolysis. In addition, SOD2 downregulation causes Δψm 
depolarisation similar to OA.  
Taken together, these results suggest that there is mitochondrial respiratory 
dysfunction in OA, partially as consequence of SOD2 downregulation and 
higher O2
- levels. Although these changes may be a response to reduce the 
effect of higher O2
- levels, apoptotic pathways can also be potentially activated 
in chondrocytes and lead to cartilage degradation (Figure 5.14). Chondrocyte 
apoptosis has been linked to the reduced number of cells in OA cartilage and is 
considered to contribute to cartilage degradation (Blanco et al 1998; Hashimoto 
et al 1998; Stockwell 1967). However, a later study contradicted these findings 
and suggested that apoptosis does not play a role in OA as they identified very 
low levels of apoptotic chondrocytes (Aigner et al 2001). Inflammatory pathways 
can also be potentially activated in chondrocytes due to the increase in O2
- 
levels that can lead to collagenase activation and cartilage degradation (Figure 
5.14). 
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Figure 5.14 Potential effects of SOD2 downregulation and mitochondrial dysfunction in OA
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Chapter 6. Mitochondria as an innate immunity signalling 
platform in OA 
6.1 Hypothesis 
Mitochondria act as a signalling platform for innate immunity, which could have 
a role in OA 
6.2 Introduction 
As discussed in more detail in sections 1.1.7 and 1.1.10, mitochondria have 
been considered to act as a signalling platform integrating signals that regulate 
different processes and signalling pathways including Ca2+ signalling and 
handling, ROS signalling, apoptosis and more recently innate immunity 
signalling.  
Mitochondria maintain and dictate cytosolic Ca2+ concentrations through their 
ability to accumulate, buffer and release Ca2+ into and from the cytoplasm 
(Jouaville et al 1999; Landolfi et al 1998; Dumollard et al 2004).  
Mitochondrial ROS (mtROS) have been reported to stimulate TNF-α mediated 
cell death and also inhibit the activity of different phosphatases including protein 
tyrosine phosphatase 1B, phosphatase & tensin homolog (PTEN) and MAPK 
phosphatases (Kamata et al 2005; Kwon et al 2004; Lee et al 1998; Levinthal, & 
Defranco 2005; Meng et al 2002). Studies have described the role of ROS as 
signalling molecules in both NLRP3-inflammasome dependent and independent 
pro-inflammatory cytokine release (IL-6, IL-1β and IL-18) and caspase 
activation (Bulua et al 2011; Nakahira et al 2011; Zhou et al 2011). 
Mitochondria also play a major role in apoptosis. TNF-α, IL-1β release and NF-
κB activation, facilitate the recruitment of members of the Bcl-2 family of pro-
apoptotic proteins such as Bid and Bad which undergo conformational changes 
and translocate to the mitochondria to then facilitate the release of cytochrome 
c into the cytoplasm and trigger caspase 9 activation (Wachlin et al 2003; 
Kamata et al 2005).  
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In recent years, mitochondria have also been linked with regulation of innate 
immunity signalling. VISA has been identified to regulate IFNα and IFNβ 
production through the NF-κB, IRF3 and IRF7 pathways in response to viral 
dsRNA (Seth et al 2005; Kawai et al 2005; Meylan et al 2005; Xu et al 2005). 
dsRNA is sensed by TLR3, RIG-I and MDA5 (Kato et al 2005; Kato et al 2006; 
Gitlin et al 2006). VISA, found on the mitochondrial outer membrane, regulates 
both TLR3 and RLR dependent pathways by interacting with RIG-I (RLR 
dependent) as well as with downstream components of the TLR3 pathway, 
TRIF and TRAF6 (Kawai, & Akira 2006; Xu et al 2005). 
Two independent studies have suggested that NLRX1 is also localized in the 
mitochondria and has a role in both negative (Moore et al 2008) and positive 
(Tattoli et al 2008) regulation of innate immunity signalling via two different 
modes of action. Firstly, it regulates immune signalling by negatively regulating 
the activity of VISA and thus downregulating the activation of the RLR 
dependent anti-viral response described above (Moore et al 2008). The same 
study suggested that NLRX1, like VISA, is localized at the mitochondrial outer 
membrane. Secondly, NLRX1 has also been identified to increase ROS 
production in response to TNF-α, Shigella infection and dsRNA treatment, 
resulting in amplified NF-κB and JUN dependent signalling pathways and 
therefore suggesting that NLRX1 is a positive regulator of the innate immunity 
response (Tattoli et al 2008). In 2009, the same group suggested that NLRX1 is 
localized in the mitochondrial matrix thus speculating that it does not interact 
with VISA to block signaling (Arnoult et al 2009). Another recent report, using 
NLRX1 knockout mice, has shown that NLRX1 deficiency does not alter VISA-
dependent responses but identified a mitochondrial complex III subunit to be 
binding with NLRX1 thus suggesting that NLRX1 can regulate the activity of the 
MRC and alter ROS production (Rebsamen et al 2011). 
As described previously in this thesis (section 1.3.2), SOD2 expression is 
reduced in OA both at the mRNA and protein level compared to NOF (Scott et 
al 2010; Ruiz-Romero et al 2009; Aigner et al 2006). In the previous chapters, 
the effects of SOD2 depletion were demonstrated in terms of oxidative damage, 
mtDNA deletions and changes in mitochondria bioenergetics. However, the 
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mechanisms of SOD2 regulation in chondrocytes and importantly OA have not 
been extremely investigated. 
NF-κB has been identified as a positive regulator of SOD2 activity in VA-13 
human lung fibroblast cells upon stimulation with pro-inflammatory cytokines 
TNF-α and IL-1β (Xu et al 1999; Miao, & Clair 2009). The SOD2 gene promoter 
has two NF-κB binding sites, one in the promoter region and a second located 
within an intronic (intron 2) enhancer (Xu et al 1999).  
In a study performed by our laboratory, TLR3 expression has been shown to be 
significantly upregulated in OA cartilage compared to normal healthy cartilage 
(Zhang et al 2008). In the same study, TLR3 has been shown to upregulate NF-
κB mediated MMP-1 and MMP-13 induction suggesting a role in matrix 
degradation. In a separate study from our laboratory (David A. Young, 
unpublished data) showed differential expression of both NLRX1 and TLR3 in 
OA and NOF cartilage suggesting a possible role of these proteins in OA 
progression (Figure 6.1). 
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Figure 6.1 Real-time PCR data showing differential expression of TLR3 and NLRX1 in OA and 
NOF cartilage (by Dr David A. Young, unpublished data) 
The gene expression levels of genes involved in innate immunity signalling in hip cartilage from 
patients with OA (open bars; n = 9, median age = 72yrs) or NOF (shaded bars; n = 10, median 
age = 76yrs) were and normalised TNFRSF1A and IL6ST expression levels calculated to be the 
most stable using genome analysis (Vandesompele et al 2002). Significant differences between 
the NOF and OA groups were determined using a two-sided Mann–Whitney U test, where 
*p≤0.05, **p≤0.01 and ***p≤0.001. Lines within the boxes represent the median, the boxes 
represent the 25th and 75th percentiles and the lines outside the boxes correspond to the 
minimum and maximum values. 
Mitochondria appear of paramount importance in innate immunity signalling 
events. Therefore, we considered, since mitochondrial dysfunction may be 
important in OA, whether mitochondria regulate these signalling events in 
chondrocytes. Part of the work described in this chapter was performed in 
collaboration with Dr Marta Radwan. 
6.3 Aims 
 Determine the role of mitochondria in chondrocytes as an innate 
immunity signalling platform  
 Identify the role of VISA and dsRNA in regulation of MMP-13 expression 
in chondrocytes 
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 Identify the role of NLRX1 and dsRNA in regulation of MMP-13 
expression and NF-κB activation in chondrocytes 
 Identify the role of NLRX1 and dsRNA in induction of reactive oxygen 
species in chondrocytes 
 Determine the role of NLRX1 and dsRNA in SOD2 expression regulation 
in chondrocytes 
 Cloning of SOD2 promoter region to identify changes that differentially 
regulate its expression in OA and NOF 
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6.4 Results 
6.4.1 siRNA targeted depletion of NLRX1 and VISA 
RNAi-mediated depletion of NLRX1 mRNA and protein levels was used to study 
the role of NLRX1 in the regulation of MMP-13 expression and the activation of 
ROS in chondrocytes. The optimal transfection procedure and duration of 
siRNA incubation are described in section 2.3.2. Transfection of NLRX1 
targeted siRNA resulted in 75% reduction in basal mRNA levels in HAC (Figure 
6.2A). A pronounced decrease in intensity of basal protein levels was identified 
in HAC targeted with siRNA against NLRX1 (Figure 6.2B). In SW1353 cells, 
similar levels of NLRX1 protein and mRNA downregulation were achieved (data 
not shown). 
RNAi-mediated depletion of VISA mRNA and protein levels was used to study 
the role of VISA in the regulation of MMP-13 expression. The optimal 
transfection procedure and duration of siRNA incubation are described in 
section 2.3.2. Transfection of VISA targeted siRNA resulted in 80% reduction in 
basal mRNA levels (Figure 6.2A). A pronounced decrease in intensity of basal 
protein levels was identified in HAC targeted with siRNA against VISA (Figure 
6.2C). 
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Figure 6.2 Effect of NLRX1 and VISA siRNA knockdown on mRNA and protein levels of NLRX1 
and VISA respectively (performed together with Dr Radwan) 
(A) HAC isolated from knee cartilage were transfected with 50nM of NLRX1, VISA or control 
siRNA for 48 hours. Cells were then serum starved for 24 hours. Total RNA was extracted with 
Cells-to-cDNA lysis buffer as described in section 2.4.7, reverse transcribed to cDNA and 
subjected to real-time qRT-PCR analysis of NLRX1 or VISA gene expression. Values were 
normalised to 18S and plotted as mean fold induction over control ± SEM (n=5). (B and C) HAC 
were transfected as above. Cells were then serum starved for 24 hours. Total protein was 
extracted, resolved by SDS-PAGE and immunoblotted as in section 2.5.3 with the (B) NLRX1, 
(C) VISA and (B and C) GAPDH antibodies. * p≤0.05, compared to control. Figures are 
representative of two independent experiments. 
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6.4.2 Effect of poly(I:C) on MMP-13 levels in SW1353 cells 
Stimulation with extracellular dsRNA mimic poly(I:C) has been shown to 
activate TLR3, whereas transfected poly(I:C) bypasses TLR3 activation and 
activates RIG-I or MDA5 (Kato et al 2005; Kato et al 2006; Gitlin et al 2006). 
Also TLR3 and MDA5 preferentially bind to high molecular weight (HMW) 
poly(I:C) (long dsRNA) whereas RIG-I binds to low molecular weight (LMW) 
poly(I:C) (short dsRNA) as long dsRNA stimulates IFN-β production in an MDA5 
dependent manner and short dsRNA stimulates IFN-β production in a RIG-I 
dependent manner (Kato et al 2008). In the same study, RIG-I has been shown 
to recognise dsRNA without 5’- triphosphates however other studies suggested 
the requirement of 5’- triphosphates for dsRNA recognition by RIG-I (Hornung et 
al 2006; Schmidt et al 2009). 
In this experiment, the MMP-13 mRNA expression levels were assessed in 
response to extracellular and transfected poly(I:C) stimulation in SW1353 cells 
(Figure 6.3). Extracellular and transfected HMW poly(I:C) stimulation caused 
similar high levels of MMP-13 mRNA upregulation compared to unstimulated 
controls. Transfected LMW poly(I:C) stimulation also resulted in highly up-
regulated MMP-13 mRNA levels, however extracellular LMW poly(I:C) 
stimulation only marginally increased MMP-13 expression. Poly(I:C) transfection 
of HAC was not as reproducible but provided similar pattern of MMP-13 
expression as to that observed by SW1353 cells.  
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Figure 6.3 Effect of poly(I:C) stimulation (extracellular and transfection) on MMP-13 mRNA 
levels in SW1353 cells (performed by Dr Radwan) 
SW1353 cells were stimulated with 0.5μg/ml HMW or 0.5μg/ml LMW Poly(I:C) for 24 hours. 
Total RNA was extracted with Cells-to-cDNA lysis buffer as described in section 2.4.7, reverse 
transcribed to cDNA and subjected to real-time qRT-PCR analysis of MMP-13 gene expression. 
Values were normalised to 18S and plotted as mean fold induction over control ± SEM (n=6). 
Figure is representative of two independent experiments. Values were normalised to 18S and 
plotted as mean fold induction over control ± SEM. ***p≤0.001 and NS= not statistically 
significant compared to control siRNA (siCON).  
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6.4.3 Effect of VISA depletion on MMP-13 mRNA levels in SW1353 cells 
and HAC. 
VISA has been identified by several studies to regulate IFNα and IFNβ 
production as a response to viral dsRNA (Seth et al 2005; Kawai et al 2005; 
Meylan et al 2005; Xu et al 2005). Therefore, due to its localisation in the 
mitochondria, proposed function in innate immunity signalling and due to its 
suggested interaction with NLRX1, the function of VISA in MMP-13 regulation in 
chondrocytes was assessed in both SW1353 cells and HAC.  
In HAC, VISA depletion significantly decreased basal MMP-13 expression only 
in one set of experiments (Figure 6.4B) whereas in the other two, basal MMP-
13 mRNA levels did not alter significantly. RNAi depletion of VISA in SW1353 
cells significantly reduced basal MMP-13 levels in all of our experiments (Figure 
6.5). Poly(I:C) induced MMP-13 expression did not alter significantly after VISA 
depletion in either HAC (Figure 6.4) or SW1353 cells (Figure 6.5). 
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Figure 6.4 Effect of VISA siRNA knockdown and stimulation with poly(I:C) on MMP-13 
expression levels in HAC (performed together with Dr Radwan) 
HAC isolated from knee cartilage were transfected with 50nM of VISA or control siRNA for 48 
hours. Cells were then serum starved for 24 hours and then (A) stimulated with 0.5μg/ml naked 
HMW poly(I:C), (B) transfected with 0.5μg/ml HMW poly(I:C) using ready to use transfection 
complex poly(I:C) with lyovec or (C) 0.5μg/ml LMW poly(I:C) using lyovec, for 24 hours. Total 
RNA was extracted with Cells-to-cDNA lysis buffer as described in section 2.4.7, reverse 
transcribed to cDNA and subjected to real-time qRT-PCR analysis of MMP-13 gene expression. 
Values were normalised to 18S and plotted as mean fold induction over control ± SEM. Figures 
are representative of pooled results from 5 independent experiments. **p≤0.01 compared to 
control siRNA (siCON). 
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Figure 6.5 Effect of VISA siRNA knockdown and stimulation or transfection with poly(I:C) on 
MMP-13 expression levels in SW1353 chondrosarcoma cells (performed together with Dr 
Radwan) 
SW1353 cells were transfected with 50nM of VISA or control siRNA for 48 hours. Cells were 
then serum starved for 24 hours and then (A) stimulated with 0.5μg/ml HMW, (B) transfected 
with 0.5μg/ml HMW poly(I:C) using lipofectamine 2000 or (C) 0.5μg/ml LMW poly(I:C) using 
lyovec, for 24 hours. Total RNA was extracted with Cells-to-cDNA lysis buffer as described in 
section 2.4.7, reverse transcribed to cDNA and subjected to real-time qRT-PCR analysis of 
MMP-13 gene expression. Values were normalised to 18S and plotted as mean fold induction 
over control ± SEM. Figures are representative of pooled results from 5 independent 
experiments. *p≤0.05, ***p≤0.001 compared to control siRNA (siCON). 
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6.4.4 Effect of NLRX1 downregulation on MMP-13 mRNA levels in 
SW1353 cells and HAC. 
As mentioned above, NLRX1 has been identified to negatively and positively 
regulate innate immunity signalling. Firstly, it was identified as an inhibitor of 
VISA (Moore et al 2008) although some studies have suggested that NLRX1 
and VISA do not interact (Arnoult et al 2009; Rebsamen et al 2011). Secondly, 
NLRX1 has been shown to increase ROS production and amplified NF-κB and 
JNK dependent pathways in HeLa and human embryonic kidney 293 (HEK293) 
cells upon stimulation with TNF-α, Shigella infection and poly(I:C) (Tattoli et al 
2008). Since NLRX1 mRNA is upregulated in OA cartilage compared to NOF, 
its function in chondrocytes was examined in terms of MMP-13 and SOD2 
mRNA as well as ROS regulation.  
In NLRX1-depleted HAC the MMP-13 mRNA levels were upregulated 
significantly under basal conditions (Figure 6.6A, B and C). However NLRX1 
depletion followed by stimulation with poly(I:C) did not significantly change 
MMP-13 expression (Figure 6.6A, B and C). 
The role of NLRX1 depletion in regulating MMP-13 mRNA levels in SW1353 
cells was also examined. As in HAC, NLRX1 depletion resulted in significant 
upregulation of MMP-13 mRNA levels under basal conditions (Figure 6.7A, B 
and C). However NLRX1 depletion followed by stimulation with poly(I:C) did not 
significantly change MMP-13 expression (Figure 6.7A, B and C). 
 
Chapter 6                                            Mitochondria and innate immunity in OA 
 
213 
 
 
Figure 6.6 Effect of NLRX1 siRNA knockdown and stimulation or transfection with poly(I:C) on 
MMP-13 mRNA expression levels in HAC (performed together with Dr Radwan) 
HAC isolated from knee cartilage were transfected with 50nM of NLRX1 or control siRNA for 48 
hours. Cells were then serum starved for 24 hours and then (A) stimulated with 0.5μg/ml HMW 
poly(I:C), (B) transfected with 0.5μg/ml HMW poly(I:C) using lyovec or (C) 0.5μg/ml LMW 
poly(I:C) using lyovec, for 24 hours. Total RNA was extracted with Cells-to-cDNA lysis buffer as 
described in section 2.4.7, reverse transcribed to cDNA and subjected to real-time qRT-PCR 
analysis of MMP-13 gene expression. Values were normalised to 18S and plotted as mean fold 
induction over control ± SEM. Figures are representative of pooled results from 5 independent 
experiments. ***p≤0.001 compared to control siRNA (siCON). 
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Figure 6.7 Effect of NLRX1 siRNA knockdown and stimulation or transfection with poly(I:C) on 
MMP-13 mRNA expression levels in SW1353 cells (performed together with Dr Radwan) 
SW1353 cells were transfected with 50nM of NLRX1 or control siRNA for 48 hours. Cells were 
then serum starved for 24 hours and then (A) stimulated with 0.5μg/ml HMW poly(I:C), (B) 
transfected with 0.5μg/ml HMW poly(I:C) using lipofectamine 2000 or (C) 0.5μg/ml LMW 
poly(I:C) using lyovec, for 24 hours. Total RNA was extracted with Cells-to-cDNA lysis buffer as 
described in section 2.4.7, reverse transcribed to cDNA and subjected to real-time qRT-PCR 
analysis of MMP-13 gene expression. Values were normalised to 18S and plotted as mean fold 
induction over control ± SEM. Figures are representative of pooled results from 5 independent 
experiments. ***p≤0.001 compared to control siRNA (siCON).  
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6.4.5 Effect of NLRX1 overexpression and poly(I:C) and IL-1β stimulation 
on Nf-κb- activation in chondrocytes 
MMP-13 regulation is well recognized as being NF-κB dependent and NLRX1 
has been linked to NF-κB regulation (Schmucker et al 2012). Therefore, we 
examined the effect of NLRX1 and poly(I:C) stimulation on NF-κB promoter 
driven luciferase expression with transient co-transfection of NLRX1 expression 
constructs in SW1353 chondrosarcoma cells. The effect of poly(I:C) and IL-1β 
stimulation on NF-κB activation was also assessed. NLRX1 overexpression 
increased NF-κB -luciferase levels significantly by 2.5 fold under basal 
conditions (Figure 6.8). A 6-hour poly(I:C) stimulation induced NF-κB luciferase 
levels by 2.5-fold (Figure 6.8A) whereas IL-1β stimulation for the same time 
period induced a 17-fold increase in NF-κB luciferase levels (Figure 6.8B). 
However, NLRX1 overexpression did not significantly alter poly(I:C) or IL-1β 
induced luciferase expression. 
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Figure 6.8 Effect of NLRX1 overexpression on NF-κB activity (performed together with Dr 
Radwan) 
SW1353 cells were transfected with the NLRX1 promoter constructs or empty pcDNA 3.1 vector 
for 24 hours as detailed in section 2.3.2. Cells were then stimulated with (A) 0.5μg/ml poly(I:C) 
and (B) 0.5ng/ml IL-1. Total protein was extracted with reporter lysis buffer and assayed for 
luciferase expression as detailed in section 2.3.3. Values were plotted as fold change in light 
units ±SEM. Figures are representative of pooled results from 5 independent experiments. 
**p≤0.01, *** p≤0.001, compared to control. 
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6.4.6 Effect of NLRX1 downregulation on ROS levels in HAC 
Previous studies have suggested that NLRX1 regulates innate immunity 
signalling by increasing ROS levels upon infection{Tattoli 2008; Rebsamen 
2011).  
In order to determine whether NLRX1 regulates the ROS levels in HAC, HAC 
isolated from patient cartilage samples were transfected with siRNA targeted 
against NLRX1 as in section 2.3.2. The effect of dsRNA infection on ROS levels 
in HAC was also assessed by stimulating cells with 0.5ng/ml poly(I:C) for 6 
hours. Cells were then stained with DHR, an uncharged and nonfluorescent 
ROS indicator that can passively diffuse across membranes where it is oxidized 
by cellular H2O2 and and hydroxyl radicals to cationic rhodamine 123, which 
localizes in the mitochondria and exhibits green fluorescence. Cells were 
visualized using a confocal microscope and images were analysed using Image 
J. 
NLRX1 depletion using RNAi did not change the levels of ROS in HAC. 
However, stimulation with poly(I:C) increased ROS levels by 15%. This increase 
in ROS was diminished to approximately the basal levels when NLRX1 was 
depleted (Figure 6.9). 
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Figure 6.9 Effect of NLRX1 downregulation and poly(I:C) stimulation on DHR levels in HAC 
HAC isolated from knee cartilage were transfected with 50nM of NLRX1 or control siRNA for 48 
hours. Cells were then serum starved for 24 hours and then stimulated with 0.5μg/ml HMW 
poly(I:C) for 6 hours. Cells were then stained with 75μΜ DHR-123 for 30 mins and then washed 
with media. Fluorescence was assessed using confocal microscopy and the images were 
analysed using Image J. Figure A is representative of three experiments. Figure B is pooled 
data analysis of three independent experiments using three different patient samples. *** 
p≤0.001, compared to control. DAPI is shown in blue and DHR shown in green. 
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6.4.7 Effect of NLRX1 downregulation and poly(I:C) stimulation on SOD2 
mRNA expression in chondrocytes 
Since NLRX1 regulates poly(I:C) stimulated ROS production in HAC, the 
mechanism of ROS regulation by NLRX1 was evaluated by assessing its role in 
SOD2 regulation in HAC and SW1353 cells. Cells were transfected for 48 hours 
with 50nM siRNA targeted against NLRX1 and subsequently stimulated or 
transfected with 0.5ng/ml poly(I:C) for 24hours. HAC stimulation with poly(I:C) 
stimulated a 2.5 fold increase in the SOD2 mRNA levels (Figure 6.10). 
However, transfection of HAC with poly(I:C) did not alter SOD2 expression at 
all. Additionally, HAC transfection with siRNA against NLRX1 did not alter either 
basal or poly(I:C) stimulated SOD2 mRNA levels. Stimulation and transfection 
of SW1353 cells with poly(I:C) stimulated a respective 25-fold and 7-fold 
increase in SOD2 expression (Figure 6.11) however, the level of SOD2 
induction by poly(I:C) is much lower compared to the MMP-13 induction 
described in section 6.4.2. As with HAC, transfection with siRNA against NLRX1 
did not significantly alter SOD2 expression. 
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Figure 6.10 Effect of NLRX1 downregulation and poly(I:C) on SOD2 mRNA expression in HAC 
HAC isolated from knee cartilage were transfected with 50nM of NLRX1 or control siRNA for 48 
hours. Cells were then serum starved for 24 hours and then (A) stimulated or (B) transfected 
with 0.5μg/ml HMW poly(I:C) for 24 hours. Total RNA was extracted with Cells-to-cDNA lysis 
buffer as described in section 2.4.7, reverse transcribed to cDNA and subjected to real-time 
qRT-PCR analysis of SOD2 gene expression. Values were normalised to 18S and plotted as 
mean fold induction over control ± SEM. Figures are representative of pooled results from 2 
independent experiments. ** p≤0.01, *** p≤0.001, NS= not significant, compared to control. 
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Figure 6.11 Effect of NLRX1 downregulation and poly(I:C) on SOD2 mRNA expression in 
SW1353 cells 
SW1353 cells were transfected with 50nM of NLRX1 or control siRNA for 48 hours. Cells were 
then serum starved for 24 hours and then (A) stimulated or (B) transfected with 0.5μg/ml HMW 
poly(I:C) for 24 hours. Total RNA was extracted with Cells-to-cDNA lysis buffer as described in 
section 2.4.7, reverse transcribed to cDNA and subjected to real-time qRT-PCR analysis of 
SOD2 gene expression. Values were normalised to 18S and plotted as mean fold induction over 
control ± SEM. Figures are representative of 2 independent experiments. *** p≤0.001, NS= not 
significant, compared to control. 
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6.4.8 Cloning of human SOD2 promoter and intronic enhancer 
SOD2 is differentially expressed in OA and NOF (Scott et al 2010; Ruiz-Romero 
et al 2009; Aigner et al 2006). In order to identify changes in signalling 
pathways that are responsible for the differential expression of SOD2 in OA and 
NOF, we attempted to construct a luciferase vector driven by the SOD2 
promoter and enhancer. Firstly, the promoter and the intronic enhancer of 
human SOD2 were attempted to be amplified and isolated. 
Initially isolation of the complete promoter and enhancer regions from a BAC 
containing the complete SOD2 gene was attempted. However, complete 
amplification of the entire promoter region into one amplicon was never 
achieved (data not shown). Therefore, the promoter region was sub-divided into 
seven parts in order to be amplified separately. As shown in Figure 6.12B, six 
out of seven sections of the promoter amplified using conventional PCR 
techniques as well as the intronic (intron 2) enhancer (Figure 6.12C). However, 
the seventh section of the promoter did not amplify. By analysing the sequence 
of that sector it was obvious that the region had a very high GC content, which 
can inhibit the PCR reaction (Xu et al 2007). Therefore, PCR for GC rich 
regions was performed and the majority of that section was amplified (Figure 
6.12D) and analysed by sequencing. However, approximately 70-100bp of 95% 
GC-content were deleted as shown in Figure 6.13. To complete and accurate 
amplification of this region without the deletion has not been successful using 
any PCR-based technique. 
Recently, SOD2 promoter constructs were kindly donated to our laboratory by 
Dr Harry S. Nick (University of Florida) and isolation of the full promoter region 
was performed by Dr Catherine Bui however to date, the sub-cloning into a 
luciferase vector has not been performed.  
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Figure 6.12 sod2 promoter and intronic enhancer amplification 
(A) Primer pairs for amplification of SOD2 promoter region based on Table 2.2. (B) SOD2 
promoter region (Figure 1.9) was amplified using conventional PCR. Amplicons show 7 different 
sections of the SOD2 promoter. (C) SOD2 Intronic enhancer amplification using conventional 
PCR. (D) SOD2 GC-rich region was amplified using GC-rich taq polymerase with the addition of 
10% betaine. PCR products were separated by 1% (v/v) agarose gel electrophoresis. Size 
suggests that there is no deletion but sequencing analysis has shown 70-100bp deletions. 
Figures (B), (C) and (D) are representative of 2, 5 and 2 independent experiments respectively.
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Figure 6.13 Representation of deleted GC-region in the SOD2 promoter as shown by SeqMan software 
Figure shows a representation of the deleted 70 to 100bp GC-rich region of the SOD2 promoter (in red dash lines) indicating the high GC content of this section of 
the promoter sequence. Figure is an example of sequences from two independent bacterial clones of region 7 (primer pair 7) of the SOD2 (-300nt-+40nt) gene.  
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6.5 Discussion 
As discussed previously in this thesis (section 1.1.10), mitochondria have been 
proposed as a signalling platform intergrading different pathways related to 
Ca2+ and ROS signalling, apoptosis and innate immunity signalling (Bulua et al 
2011; Nakahira et al 2011; Zhou et al 2011; Dröge 2002; Valko et al 2007; 
Landolfi et al 1998; Dumollard et al 2004; Wachlin et al 2003; Kamata et al 
2005; Tattoli et al 2008; Moore et al 2008; Meylan et al 2005). Two recent 
studies from our laboratory indicate the importance of innate immunity signalling 
pathways in chondrocytes. In the first study, TLR3 expression was found to be 
upregulated in OA compared to NOF and also increase NF-κB mediated MMP-1 
and dramatically MMP-13 induction (Zhang et al 2008). In the second study, the 
mitochondrially localized gene NLRX1 was also identified to be upregulated in 
OA compared to NOF (David A. Young, unpublished data, Figure 6.1). NLRX1 
has been suggested to inhibit innate immune responses by regulating NF-κB 
activation via inhibition of VISA and the VISA-RIG-I interaction as well as by 
interacting with TRAF6 and IκB kinase (Moore et al 2008; Xia et al 2011; Allen 
et al 2011). However, NLRX1 was also reported as a positive regulator of innate 
immune responses by stimulating ROS production and amplification of NF-κB 
and JNK dependent pathways (Tattoli et al 2008). 
In the previous three chapters, the functional effect of SOD2 downregulation in 
OA was studied in terms of changes in ROS production, lipid peroxidation, 
mtDNA damage and mitochondrial dysfunction in chondrocytes. A general 
observation is that SOD2 downregulation can cause oxidative damage and 
mitochondrial dysfunction thus leading to cellular damage. However, as pointed 
out in Scott et al, SOD2 depletion leads to a reduction in MMP-1 and MMP-13 
mRNA levels possibly due to the decreased levels of H2O2 (Scott et al 2010). 
Therefore, SOD2 depletion can have both a “chondro-protective” and a 
“chondro-damaging” effect. Interestingly, pathways such as NF-κB and MAPK, 
that regulate MMP expression in chondrocytes, can also regulate SOD2 
expression (Karin 1995; Liacini et al 2002; Liacini et al 2003; Xu et al 1999; Xu 
et al 2007; Zhu et al 2001). Furthermore, p50, another member of the NF-κB 
family, has been reported to negatively regulate SOD2 expression (Dhar et al 
2007).  
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As mitochondria appear to have a central role in regulation of these signalling 
events, the functional role of NLRX1 and partly VISA was examined, in terms of 
regulation of MMP-13 and SOD2 expression as well as ROS production in 
chondrocytes.  
6.5.1 SOD2 promoter amplification by PCR results into deletions due to 
GC-rich regions in the promoter  
In order to address the changes in signalling pathways in OA and NOF 
chondrocytes, construction of a luciferase vector driven by the SOD2 promoter 
and enhancer was attempted (Figure 6.12). This vector would then be 
transfected in OA and NOF chondrocytes in order to screen for differential 
SOD2 expression at the transcriptional level. Subsequently, the activity of 
different pathways would be assessed in order to determine the mechanism of 
SOD2 downregulation in OA.  
Isolation of the complete promoter region was not successful whereas, the 
enhancer region was successfully amplified. Analysis of the region that did not 
amplify by conventional PCR techniques revealed that this region had a high 
GC content, which can potentially inhibit the reaction. A previous study 
identified a single stranded nucleotide loop within that GC rich region of the 
promoter that prevents accurate amplification of the sod2 promoter and deletion 
within this region significantly decreases promoter activity (Xu et al 2007). 
Therefore, different PCR reactions specific for GC rich regions were performed 
however 70-100bp of 95% GC-content were consistently deleted from this 
region (Figure 6.13). Since this region is essential for efficient promoter activity, 
the cloning of the complete promoter into a luciferase vector was not performed 
(Xu et al 2007). 
6.5.2 Poly(I:C) stimulates MMP-13 expression in SW1353 cells 
Poly(I:C) has been reported previously to regulate MMP-13 expression in 
chondrocytes (Zhang et al 2008). LMW and HMW poly(I:C) were used to 
assess their effect on MMP-13 expression. As mentioned before, stimulation 
with extracellular (naked) poly(I:C) has been shown to activate TLR3, whereas 
transfected poly(I:C) bypasses TLR3 activation and activates RIG-I or MDA5 in 
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a cell-type specific manner and signal via the mitochondria (VISA) (Kato et al 
2005; Kato et al 2006; Gitlin et al 2006). Also MDA5 preferentially binds to long, 
HMW poly(I:C), whereas RIG-I binds to LMW poly(I:C) with and without a 5’-
triphosphate end (Kato et al 2008; Hornung et al 2006; Schmidt et al 2009). 5’-
triphosphate ends are incorporated when RNA polymerase initiates transcription 
(Bieger, & Nierlich 1989). In this thesis, we examined whether poly(I:C), which 
signals via the RLRs and the mitochondria (VISA and NLRX1), can regulate 
MMP-13 expression and therefore determine whether mitochondrial potentially 
have a role in controlling MMP-13 expression and therefore cartilage 
destruction. 
Therefore, the effect of both extracellular and transfected poly(I:C) on MMP-13 
mRNA regulation was also assessed (Figure 6.3). When LMW poly(I:C) was 
added extracellularly there was no significant induction of MMP-13 expression, 
therefore it possibly does not activate TLR3, MDA5 or RIG-I in chondrocytes. 
Both extracellular and transfected (intracellular) HMW poly(I:C) stimulated 
MMP-13 expression whereas only transfected LMW poly(I:C) stimulated MMP-
13 expression levels. These results suggest that HMW poly(I:C) can potentially 
activate TLR3 and RLR dependent signalling whereas LMW poly(I:C) can 
potentially activate only RLR dependent signalling in chondrocytes. 
Consequently, stimulation of extracellular and transfected HMW poly(I:C) and 
transfected LMW poly(I:C) was used to determine whether NLRX1 and VISA 
regulate MMP-13 expression.  
A separate study performed in our laboratory, identified that TLR3, RIG-I and 
MDA5 depletion suppresses poly(I:C) stimulated MMP-13 expression in 
chondrocytes (Marta Radwan, unpublished data). However, in the same study, 
MMP-13 expression was also reduced in TLR3-depleted cells transfected with 
HMW and LMW poly(I:C), suggesting that transfected poly(I:C) does not entirely 
bypass TLR3 activation in chondrocytes as suggested in the literature (Kato et 
al 2005; Kato et al 2006; Gitlin et al 2006). Interestingly, this study has also 
shown that MMP-13 induction by naked poly(I:C) is also dependent on RIG-I 
and MDA5 (Marta Radwan, unpublished data). A limitation of stimulation with 
transfected poly(I:C) is that not all of the poly(I:C) might be taken up by the 
liposomes of the transfection reagent and therefore some poly(I:C) might act 
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extracellularly. Additionally, liposomal transfection utilises the endosomes 
therefore transfected poly(I:C) can also activate TLR3 in the endosomes. 
Collectively these findings suggest that induction of MMP-13 expression by 
poly(I:C) in chondrocytes depends on both TLR3 and RLR signalling regardless 
of the cytosolic or extracellular delivery of poly(I:C) in chondrocytes. Therefore, 
induction of MMP-13 expression in chondrocytes poly(I:C) might be regulated 
by TLR3 dependent signalling, RLR dependent signalling or both, or via a 
common pathway involving both TLR3 and RLR receptors, which could also 
potentially signal via the mitochondria. Additionally, poly(I:C) could bind both 
TLR3 and RLRs by binding first to high-mobility group box (HMGB) proteins, 
HMGB1 and HMGB2, which have been reported to be required for subsequent 
recognition of poly(I:C) from PAMPs, in order to activate innate immune 
responses (Yanai et al 2009). 
6.5.3 VISA regulates basal MMP-13 expression only in SW1353 cells 
siRNA depletion of VISA in both SW1353 and HAC did not alter poly(I:C) 
induced MMP-13 mRNA expression levels (Figure 6.4 and 6.5). In HAC, VISA 
depletion did not consistently affect basal MMP-13 expression. However, in 
SW1353 cells, VISA depletion consistently and significantly decreased basal 
MMP-13 mRNA expression (Figure 6.5). This suggests that VISA is not 
essential for poly(I:C)-induced MMP-13 expression in chondrocytes. However it 
may be important for maintaining the basal level of MMP-13. 
6.5.4 NLRX1 regulates basal MMP-13 expression in both HAC and 
SW1353 cells 
As mentioned previously, NLRX1 has been identified to regulate the NF-κB 
pathway via inhibition of VISA but also via the regulation of ROS production 
(Moore et al 2008; Tattoli et al 2008). Since NLRX1 mRNA levels have been 
shown to be upregulated in OA (Figure 6.1) and due to its mitochondrial 
localisation, its role in regulating MMP-13 levels and ROS production in 
chondrocytes was assessed in this thesis.  
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Under basal conditions, NLRX1 depletion increased MMP-13 mRNA expression 
in HAC and SW1353 cells although it did not significantly alter poly(I:C) induced 
MMP-13 mRNA expression in HAC or SW1353 cells (Figure 6.6 and 6.7). As 
with VISA, NLRX1 appears to have a role in regulating basal MMP-13 mRNA 
levels however, our data suggests that NLRX1 does not regulate poly(I:C) 
mediated induction of MMP-13 in chondrocytes. A recent report suggested that 
NLRX1 regulates basal NF-κB activation by interacting with TRAF-6 in a TLR-
dependent fashion (Xia et al 2011; Allen et al 2011). 
6.5.5 NLRX1 regulates basal NF-κB activation in SW1353 cells 
To begin to address how NLRX1 was regulating basal MMP-13 we examined 
whether NLRX1 regulates NF-κB activation. As mentioned previously, NLRX1 
has been shown to activate NF-κB by regulation of VISA as well as by 
regulating ROS production (Moore et al 2008; Tattoli et al 2008). In 
chondrocytes, NF-κB transcription factors have been shown to regulate TNF-α 
and IL-1 induced MMP-13 expression as inhibition of the NF-κB by curcumin, 
antioxidant pyrrolidine dithiocarbamate, Bay-11-7085 (which prevents 
phosphorylation of the NF-κB inhibitor IκB), and inhibitors of the ubiquitin–
proteasome pathway (which prevent the ubiquitin-dependent degradation of the 
NF-κB inhibitor IκB), resulted in suppression of the IL-1 and TNF-α induced 
MMP-13 expression (Liacini et al 2002; Liacini et al 2003; Zhang et al 2008). 
NLRX1 was overexpressed in SW1353 cells and NF-κB activation was 
assessed using NF-κB promoter-driven luciferase activation. The results are in 
agreement with our previous findings on MMP-13. NLRX1 can regulate basal 
NF-κB activity levels but does not regulate poly(I:C) mediated NF-κB induction 
in SW1353 cells (Figure 6.8).  
Firstly, these findings can be partly explained by the fact that VISA does not 
regulate poly(I:C) induced MMP-13 expression in chondrocytes. Therefore, 
inhibition of VISA and subsequently NF-κB by NLRX1, as suggested by Moore 
et al (Moore et al 2008), will not affect poly(I:C) induced MMP-13 expression in 
chondrocytes. Moreover, a separate study suggested that NLRX1 does not 
interact with VISA at all and therefore it doesn’t regulate NF-κB activation via 
inhibition of VISA (Rebsamen et al 2011). Furthermore, a recent study by Allen 
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et al, suggested that NLRX1 attenuates IFN-I and NF-κB, through separate 
pathways in a cell type- and pathogen-specific manner (Allen 2011). 
Consequently, the regulation of MMP-13 by NLRX1 might be affected by the 
cell type-specific regulation of innate immunity signalling by NLRX1.  
6.5.6 NLRX1 regulates poly(I:C) induced ROS levels in HAC 
In order to investigate the role of NLRX1 in ROS regulation, the ROS levels in 
HAC were assessed after NLRX1 depletion and extracellular poly(I:C) 
stimulation. NLRX1 depletion did not affect basal ROS levels in HAC. Poly(I:C), 
however, significantly stimulated ROS levels. Depletion of NLRX1 significantly 
reduced poly(I:C) induced ROS levels suggesting that NLRX1 is a positive 
regulator of poly(I:C) mediated ROS production in HAC as reported previously 
in other systems (Tattoli et al 2008; Abdul-Sater et al 2010), although we were 
unable to demonstrate an alteration in the expression of poly(I:C) sensitive 
genes, such as MMP-13 (Figure 6.9). 
Previous studies reported that NLRX1 regulated ROS production via interaction 
with the mitochondrial UQCRC2 (Arnoult et al 2009; Rebsamen et al 2011). In 
this thesis, the regulation of ROS production by NLRX1 was evaluated by 
assessing its role in SOD2 regulation in HAC and SW1353 cells. NLRX1 
depletion did not alter poly(I:C) mediated SOD2 induction (Figure 6.10 and 
6.11). SOD2 mRNA expression is induced by only extracellular poly(I:C) in HAC 
possibly because HAC are difficult to transfect although it can also suggest that 
poly(I:C)-induced SOD2 expression is possibly TLR3 dependent. Additionally, 
SOD2 mRNA expression is induced by both extracellular and transfected 
poly(I:C) in SW1353 cells. Therefore, from these results we can conclude that 
poly(I:C) stimulates SOD2 mRNA expression however this is not regulated by 
NLRX1 in either HAC or SW1353 cells. Consequently, NLRX1 does not 
regulate ROS production in chondrocytes by altering SOD2 expression. The 
exact mechanism of ROS regulation by NLRX1 in HAC has to be investigated 
further and it will be interesting to determine whether ROS are regulated via 
interaction with the mitochondrial UQCRC2 as suggested by other groups 
(Arnoult et al 2009; Rebsamen et al 2011). 
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6.6 Conclusions 
Taken together, these findings suggest that mitochondria in chondrocytes might 
not function as innate immunity signalling platforms to regulate MMP-13 
expression. MMP-13 expression in chondrocytes is regulated by the activation 
of innate immunity signalling by dsRNA (in this case poly(I:C)). VISA is a 
positive regulator of basal MMP-13 expression in SW1353 cells and possibly in 
HAC, however it does not regulate poly(I:C) induced MMP-13 expression. 
NLRX1 is a negative regulator of basal MMP-13 expression in both HAC and 
SW1353 cells however, similarly to VISA, it does not regulate poly(I:C) induced 
MMP-13 expression. Interestingly, NLRX1 is a positive regulator of poly(I:C) 
induced ROS production in HAC but the mechanism of ROS regulation does not 
act via regulation of SOD2 expression. Further work can potentially uncover the 
exact mechanism of ROS regulation by NLRX1 in HAC as well as its role in 
basal MMP-13 regulation and also identify more pathways involved in the 
regulation of SOD2 expression in osteoarthritic and healthy cartilage. 
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Chapter 7. General Discussion 
Mitochondria are considered the powerhouse of the cells, being the major site 
of ATP production via OXPHOS. In addition, they are also involved in Δψm 
regulation, Ca2+ handling and apoptosis and in the regulation of cell toxicity by 
mainly regulating ROS production as well as inhibition (Landolfi et al 1998; 
Newmeyer et al 1994; Mitchell, & Moyle 1969; Turrens, & Boveris 1980; 
Cadenas et al 1977). SOD2 is localized in the mitochondrial matrix and 
dismutases O2
- to H2O2. SOD2 deficiency increases mitochondrial superoxide 
levels in mice and leads to prenatal or neonatal lethality (Melov et al 1999; Li et 
al 1995). This phenotype is associated with severe neurological and cardiac 
phenotypes and linked to decreased Complex I and II activity as well as 
mitochondrial aconitase deficiencies, lipid peroxidation and oxidative gDNA 
damage in brain, heart, skeletal muscle and liver (Morten et al 2006; Huang et 
al 2001; Li et al 1995; Lebovitz et al 1996; Melov et al 1999). 
OA is a degenerative joint disease mainly characterised by cartilage 
degradation due to changes in the molecular structure of the sole cell in 
cartilage, the chondrocyte and the composition of the extracellular matrix 
(Brandt et al 2006). The involvement of mitochondria in the pathogenesis of OA 
has been considered. Their direct role in ROS regulation, ATP production and 
apoptosis has been linked to cartilage degeneration. A decrease in complex II 
and III activity has been observed in OA chondrocytes as well as mitochondrial 
depolarisation (Maneiro et al 2003). The 4977bp mtDNA deletion has been 
identified in OA and mtDNA repair capacity as well as mtDNA integrity being 
reduced in OA chondrocytes (Chang et al 2005; Grishko et al 2008). SOD2 
expression is also downregulated in OA cartilage compared to control both at 
the mRNA and protein level (Scott et al 2010; Ruiz-Romero et al 2009; Aigner 
et al 2006). 
A more comprehensive understanding of mitochondrial function and dysfunction 
in OA and NOF chondrocytes and the functional role of SOD2 in chondrocytes 
would contribute to research into the pathology of OA and other diseases. 
Accordingly, the aim of this thesis was to compare the levels of oxidative 
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damage and mitochondrial function in OA and NOF chondrocytes and assess 
the role of SOD2 downregulation to these events. 
7.1 Mitochondria as an innate signalling platform 
Mitochondria have been considered to act as a signalling platform regulating 
processes and signalling pathways including Ca2+ signalling and handling 
(Jouaville et al 1999; Landolfi et al 1998; Dumollard et al 2004), ROS signalling 
(Kamata et al 2005; Kwon et al 2004; Lee et al 1998; Levinthal, & Defranco 
2005; Meng et al 2002) and apoptosis (Wachlin et al 2003; Kamata et al 2005). 
More recently their contribution to innane immunity signalling was also 
suggested as two mitochondrially localised proteins, NLRX1 and VISA, were 
identified to regulate TLR3 and RLR innate immune responses (Xu et al 2005; 
Kawai, & Akira 2006; Moore et al 2008; Tattoli et al 2008; Xia et al 2011). TLR3 
and NLRX1 expression were found to be upregulated in OA suggesting a 
possible role of these proteins in OA progression (Zhang et al 2008)(David 
Young, unpublished data, Figure 6.1). TLR3 has been shown to upregulate NF-
κB mediated MMP-1 and MMP-13 induction suggesting a role in matrix 
degradation (Zhang et al 2008). In this thesis the role of NLRX1 in MMP-13 
expression, ROS induction as well as SOD2 expression was assessed.  
NLRX1 has been suggested to inhibit innate immune responses via inhibition of 
VISA and the VISA-RIG-I interaction as well as by interacting with TRAF6 and 
IκB kinase (Moore et al 2008; Xia et al 2011; Allen et al 2011). However, 
NLRX1 was also reported as a positive regulator of innate immune responses 
by stimulating ROS production and amplification of NF-κB and JNK dependent 
pathways (Tattoli et al 2008). In NLRX1-depleted HAC and SW1353 cells the 
MMP-13 mRNA levels were upregulated significantly under basal conditions 
(section 6.4.4, Figure 6.6, Figure 6.7). However NLRX1 depletion followed by 
stimulation with poly(I:C) did not significantly change MMP-13 expression 
(section 6.4.4, Figure 6.6, Figure 6.7). NLRX1 appears to have a role in 
regulating basal MMP-13 mRNA levels however, our data suggests that NLRX1 
does not regulate poly(I:C) mediated induction of MMP-13 in chondrocytes. Also 
NLRX1 can regulate basal NF-κB activity levels but does not regulate poly(I:C) 
mediated NF-κB induction in SW1353 cells (section 6.4.5, Figure 6.8). 
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SW1353 chondrosarcoma cells are considered a substitute for a chondrocytic 
experimental system. However, a study comparing the gene expression profile 
of SW1353 cells and HAC reported that SW1353 cells have very limited 
similarities in gene expression compared to HAC (Gebauer et al 2005). The 
authors suggested that SW1353 cells could be used to study the induction of 
MMPs however their potential to mimic HAC function is limited. The results 
acquired in this thesis using SW1353 chondrosarcoma cells as a model system 
for chondrocytes have to be interpreted carefully in terms of their relevance to 
mimic the function in HAC and the use of these cells in some experiments is a 
limitation of this thesis. 
Previous studies reported that NLRX1 regulated ROS production via interaction 
with the mitochondrial UQCRC2 (Arnoult et al 2009; Rebsamen et al 2011). 
Depletion of NLRX1 reduced poly(I:C) induced ROS levels (section 6.4.6, 
Figure 6.9) suggesting that NLRX1 is a positive regulator of poly(I:C) mediated 
ROS production in HAC as reported previously in other systems (Tattoli et al 
2008; Abdul-Sater et al 2010). The role of NLRX1 in SOD2 regulation in HAC 
and SW1353 cells was also evaluated. NLRX1 depletion did not alter poly(I:C) 
mediated SOD2 induction in chondrocytes (section 6.4.7, Figure 6.10, Figure 
6.11) suggesting that NLRX1 does not regulate ROS production in 
chondrocytes by altering SOD2 expression and poly(I:C) induced SOD2 
expression is possibly TLR3 dependent. 
These findings suggest that mitochondria in chondrocytes might not function as 
innate immunity signalling platforms to regulate MMP-13 expression. However, 
NLRX1 is a positive regulator of poly(I:C) induced ROS production in HAC but 
the mechanism of ROS regulation does not act via regulation of SOD2 
expression suggesting a different mechanism of ROS regulation by NLRX1.  
Conversely, inhibition of complexes III and V of the mitochondrial respiratory 
chain in HAC induces the production of other proinflammatory stimuli, including 
IL-1, IL-6 and IL-18, prostaglandin E2 (PGE2) as well as MMP-1, MMP-3 and 
MMP-13 (Lopez-Armada et al 2006). These results can partially explain the role 
of mitochondria in some inflammatory pathways implicated in OA pathogenesis. 
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In order to address the changes in signalling pathways in OA and NOF 
chondrocytes, construction of a luciferase vector driven by the SOD2 promoter 
and enhancer was attempted however, isolation of the complete promoter 
region was not successful due to the presence of deletions within a highly GC-
rich region of the SOD2 promoter. This was possibly due to a single stranded 
nucleotide loop within that GC-rich region of the promoter that prevents 
accurate amplification of the SOD2 promoter and deletion within this region 
significantly decreases promoter activity (Xu et al 2007). Since this region is 
essential for efficient promoter activity, the cloning of the complete promoter into 
a luciferase vector was not performed (Xu et al 2007). 
7.2 Oxidative stress and mtDNA damage in OA 
As mentioned previously (section 1.1.9), SOD2 is essential for cell viability and 
normal mitochondrial activity and regulation of oxidative damage in the cell 
(Huang et al 2001; Li et al 1995; Lebovitz et al 1996; Melov et al 1999; Morten 
et al 2006). The expression of all three SODs (SOD1, SOD2 and SOD3) is 
downregulated in OA cartilage compared to NOF (Scott et al 2010; Ruiz-
Romero et al 2009; Aigner et al 2006). High levels of O2
- and nitrogen oxide 
(NO) have been reported in OA, which lead to higher levels of H2O2 and ONOO
- 
(Hiran et al 1997; Loeser et al 2002; Tiku et al 1998). Additionally, ROS have 
been implicated in matrix degradation and have been shown to lead to the 
cleavage of collagen and hyaluronan (Gao et al 2008; Petersen et al 2004; 
Henrotin et al 2005). Consequently, firstly in this thesis, the effect of SOD2 
downregulation on O2
- levels in HAC was established. The results 
demonstrated that, similar to other systems, SOD2 downregulation in HAC 
leads to an increase in the mitochondrial O2
- levels (section 3.4.6, Figure 3.12, 
Figure 3.13).  
Previous in vitro studies suggested that lipid peroxidation is higher in OA and 
can contribute to the oxidation and loss of collagen matrix (Tiku et al 2000; 
Shah et al 2005; Tiku et al 2007). High levels of O2
- and nitrogen oxide (NO) 
have been reported in OA and have been implicated in matrix degradation and 
have been shown to lead to the cleavage of collagen and hyaluronan (Hiran et 
al 1997; Loeser et al 2002; Tiku et al 1998; Gao et al 2008; Petersen et al 2004; 
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Henrotin et al 2005). Bonner et al demonstrated that lipids, especially 
polyunsaturated fatty acids, accumulate with normal ageing of human articular 
cartilage (Bonner et al 1975). Therefore, the higher levels of lipid peroxidation, 
can lead to the accumulation of oxidised collagen matrix and lead to matrix 
degradation and OA. In this thesis, lipid peroxidation was measured in OA 
cartilage and compared to NOF. In agreement with the in vitro studies, OA 
cartilage had higher levels of lipid peroxidation compared to NOF (section 3.4.7, 
Figure 3.15). Also, SOD2 depletion increased the levels of lipid peroxidation in 
SW1353 cells (section 3.4.7, Figure 3.16) suggesting that SOD2 
downregulation can potentially contribute to the overall increase of lipid 
peroxidation in OA cartilage compared to NOF.  
Both nuclear and mitochondrial DNA damage, as mentioned above, has also 
been suggested to be higher in OA and in SOD2 knockout mice (Hiran et al 
1997; Loeser et al 2002; Tiku et al 1998; Chang et al 2005; Chen et al 2008; 
Kim et al 2009; Melov et al 1999). mtDNA damage has been reported in livers 
of SOD2 heterozygous mice at 2–4 months of age (Williams et al 1998). 
Although this was a good model to study mtDNA damage due to ROS, the 
young age of the mice make it difficult to relate to our model, that includes 
samples from old individuals. Also in human cartilage SOD2 levels are 
decreasing with ageing (Scott et al 2010) thus comparison with a SOD2 
heterozygous mouse model is not appropriate. However, until recently, there 
were no reports of examination of cartilage in SOD2 heterozygous mice. In a 
recent study, the effect of exercise on cartilage in heterozygote SOD2-deficient 
mice was assessed (Baur et al 2011). Elevated levels of 15-F2t-isoprostane and 
nitrotyrosine were detected in articular cartilage of SOD2 +/- mice compared to 
wild type possibly due the increased O2
- levels in SOD2 +/- mice. The levels of 
these molecules in articular cartilage were increased in both SOD2 +/+ and 
SOD2 +/- after aerobic running exercise due to the fact that ROS levels were 
possibly induced by electron leakage from the MRC (Baur et al 2011). However, 
these changes had no effect on cartilage morphology, structure and function 
and SOD2 +/- mice did not show any features of OA suggesting that SOD2 
downregulation might not have a direct effect on OA progression and might be a 
secondary effect of changes in cell signalling in mice. 
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In Chapter 3 of this thesis, the role of SOD2 downregulation in mtDNA damage 
in chondrocytes has been examined. SOD2 depletion caused a significant 
increase in mtDNA strand breaks (section 3.4.8, Figure 3.17), suggesting that 
SOD2 downregulation in chondrocytes contributes to oxidative mtDNA damage 
as reported in other systems previously (Hiran et al 1997; Loeser et al 2002; 
Tiku et al 1998; Chang et al 2005; Chen et al 2008; Kim et al 2009; Melov et al 
1999). This suggests that SOD2 downregulation is chondrocytes can potentially 
lead to accumulation of mtDNA damage in OA cartilage. Then in Chapter 4, 
accumulation of mtDNA damage in the form of large-scale deletions was 
evaluated in OA and NOF cartilage and chondrocytes. 
OA and NOF cartilage were screened for mtDNA strand breaks in the same 
assay used to screen SOD2 depleted cells. No significant difference in mtDNA 
strand breaks was identified between NOF and OA cartilage samples (section 
4.4.1, Figure 4.1). Then cartilage sections and chondrocytes were screened for 
MRC dysfunction using the COX-SDH assay. Identification of COX-deficient 
cells is a useful indicator of mtDNA involvement in mitochondrial dysfunction 
(Old, & Johnson 1989; Johnson et al 1993). COX-SDH histochemistry was 
firstly performed on cartilage sections although the reaction was weak (section 
4.5.2). This could be due to low permeability of cartilage to the COX-SDH 
incubation media or due to low expression of the MRC enzymes in those 
chondrocytes. COX-SDH histochemistry on cartilage sections is important in 
establishing mitochondrial function and screening for mtDNA deletions in 
different cartilage zones in both OA and NOF tissue and this thesis is weaker 
without such analysis. A priority of future work would be to establish a working 
assay on cartilage tissue in order to be able to examine mitochondrial function 
in different zones of OA and NOF cartilage.  
COX-SDH activity was then assessed in freshly extracted HAC. COX-deficient 
chondrocytes were found but their number was very low (≤1%) compared to the 
COX- positive cells (section 4.5.4, Figure 4.3Figure 4.4Figure 4.5. Analysis of 
the mtDNA of isolated chondrocytes revealed no correlation of mtDNA copy 
number abnormality or mtDNA deletions with COX activity in HAC (sections 
4.4.3 and 4.4.4, Figure 4.4, Figure 4.5, Table 4.1). 
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Since by using the mtDNA strand break assay the exact nature of the damage 
cannot be determined and also because the COX-SDH assay was inconsistent 
in terms of the correlation between the COX activity and the deletions present, 
mtDNA from OA and NOF cartilage was also screened for mtDNA deletions 
using a long amplification PCR assay (section 4.4.5, Figure 4.6). Low levels of 
two large-scale mtDNA deletions were identified in two OA hip samples (one in 
each patient) and two were identified in one OA knee sample (section 4.4.5, 
Figure 4.7, Table 4.2). No amplicons were sequenced from NOF because the 
intensity of the amplicons was very weak compared to the OA. None of the 
deletions identified included the 4977bp mtDNA common deletion identified by 
Chang et al in OA knee cartilage and aged non-OA cartilage (Chang et al 2005; 
Schon et al 1989; Shoffner et al 1989; Cortopassi et al 1992). Additionally, one 
of the deletions identified from patient C (OA knee cartilage) had a similar 5’ 
breakpoint to the deletion identified from patient B (OA hip cartilage) at 
nucleotides 6783 and 6782 for the OA knee and OA hip respectively. 
All of the sequences of the deletions identified were also analysed for the 
presence of repeat sequences (section 4.4.5, Table 4.2). Majority of the mtDNA 
deletions created by slip-replication, recombination or double strand break 
repair, are flanked by direct repeats suggesting a role of the repeats in the 
generation of the deletions (Mita et al 1990; Shoffner et al 1989; Krishnan et al 
2008). However, a recent study suggested that repeats do not cause deletions 
but deletions can be generated due to long and stable duplexes formed 
between distant segments of the mtDNA (Guo et al 2010). The 7425bp deletion 
identified in patient A (Table 4.2, Figure 4.7) is very similar to a deletion 
reported previously in other diseases including cardiomyopathies, cirrhotic liver 
in hepatic tumour, Pearson syndrome and skeletal muscle in chronic fatigue 
(Hayakawa et al 1992; Rötig et al 1995; Yamamoto et al 1992; Zhang et al 
1995). The only difference compared to the deletion identified in this thesis is 
that in these studies one of 12bp repeat-sequences flanking the deleted region 
is located within the deleted fragments whereas in our study both repeat 
sequences were outside the deleted fragment (section 4.4.5, Table 4.2). Since 
in our analysis, only one OA hip sample demonstrated a direct repeat flanking 
the deletion, it implies that in cartilage, as in Guo et al 2010, direct repeats 
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possibly do not have a significant role in deletion generation and other 
mechanisms might be involved (Guo et al 2010). 
In this thesis, due to the low levels of mtDNA deletions present compared to 
wild type mtDNA molecules, we predict that the deletions possibly have no 
biochemical effect as the amount of mutated mtDNA is below the threshold 
required to cause a biochemical defect and respiratory dysfunction (Chinnery et 
al 1997; Sciacco et al 1994). mtDNA copy number was also assessed in the 
same samples and no significant difference was identified between OA hip 
cartilage and NOF (section 4.4.7, Figure 4.10).  
Taken together, these results suggest that the SOD2 downregulation observed 
in OA cartilage compared to NOF can lead to an increase in mitochondrial O2
- 
in chondrocytes and potentially contribute to the higher levels of lipid 
peroxidation in OA cartilage. Although SOD2 downregulation can cause mtDNA 
deletions in chondrocytes, this damage does not accumulate in OA 
chondrocytes. However, the absence of mtDNA deletions can also be due to 
the loss of cartilage tissue during disease progression and therefore the total 
mutation levels identified are reduced. Other factors such as mtDNA haplogrous 
have been linked to the risk of developing OA. Haplogroup J has been 
demonstrated to protect against knee and hip OA whereas carriers with 
haplogroups H and U have an increased risk of developing OA (Rego-Perez et 
al 2008; Rego et al 2009; Rego-Perez et al 2010; Rego-Perez et al 2011). 
Therefore although mtDNA oxidative damage might not contribute to the OA 
phenotype, the mtDNA haplogroup might contribute to increased risk of 
developing OA. 
7.3 Mitochondrial respiratory activity and membrane potential in OA 
OXPHOS is driven by transfer of electrons along electron carriers in the MRC to 
reduce molecular oxygen to water and it is coupled to the transfer of protons 
into the mitochondrial intermembrane space thus creating a protonmotive force 
that drives ATP synthesis through the ATP synthase (Complex V). However, 
protons can leak across the membrane independently of ATP synthase (Brand 
et al 1994). Previous studies suggested that increased proton leak can be a 
reaction to counteract the effects of increasing ROS levels (Brookes 2005) or 
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even as a consequence of damaged membranes due to lipid peroxidation 
(Kokoszka et al 2001). 
Chondrocytes produce approximately 25% of their total ATP production by 
OXPHOS and the remaining by glycolysis (Stockwell 1983; Lee, & Urban 1997). 
A decrease in complex II and III activity has been observed in OA chondrocytes 
as well as an increase in the mitochondrial mass (Maneiro et al 2003). OA 
chondrocytes contained more depolarised mitochondria than normal and this 
could be due to the lower activity of the mitochondrial complex III (Maneiro et al 
2003). Despite the absence of mtDNA deletions in OA, the higher O2
- levels 
and lipid peroxidation observed in OA can potentially affect the respiratory 
activity of mitochondria in chondrocytes. Consequently the mitochondrial 
respiratory activity was evaluated in OA chondrocytes and compared to NOF 
chondrocytes. The potential effect of SOD2 downregulation on mitochondrial 
respiration and membrane potential was also examined.  
HAC respiration was compared to the respiration of SW1353 cells (section 
5.4.1, Figure 5.1). Although this experiment was performed once, it suggested 
that SW1353 cell respiration is higher compared to HAC. However, HAC have 
higher SRC, higher respiratory control ratio and lower proton leak than SW1353 
cells suggesting that HAC can respond better to changes in energy demands 
compared to SW1353 cells and also they have a more efficient MRC as well 
(section 5.4.1, Figure 5.1) (Brand, & Nicholls 2011; Choi et al 2009; Yadava, & 
Nicholls 2007). These findings highlight another difference between HAC and 
SW1353 and demonstrate that results acquired by SW1353 cells have to be 
interpreted carefully in terms of their relevance to mimic the function in HAC 
(Gebauer et al 2005). However, these results are weaker without analysis of 
repeat experiments and therefore more experimental repeats will be performed 
in the future. HAC and SW1353 basal respiration was also compared to other 
cells based on data from other studies. HAC respiration was compared to other 
post-mitotic cells and was approximately 3-fold, 5-fold and 4-fold lower 
compared to mouse cortical synaptosomes, neonatal rat ventricular myocytes 
and RMS-13 myoblasts respectively (Flynn et al 2011; Hill et al 2009; Civitarese 
et al 2010). SW1353 basal respiration was compared to other cancer cell lines 
and was approximately 1.5-fold higher, 2.4-fold higher and at similar levels 
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compared to 2008-ovarian cancer cells, H460 lung cancer cells, MDA-MB468 
breast cancerous cells (Verschoor et al 2010; Amoêdo et al 2011; Kristiansen et 
al 2011). Direct comparison of HAC and SW1353 with other post-mitotic and 
cancer cell lines respectively is not feasible due to the different experimental 
conditions and models (some are mouse cells) that have been followed. 
Although this comparison can provide us with an indication of the respiration of 
HAC compared to other cells, no definite conclusions can be drawn. 
NOF respiration was then compared to OA respiration using two different 
respirometers, which produced very similar results (sections 5.4.2 and 5.4.3). 
OA chondrocytes respired significantly more than NOF chondrocytes at basal 
levels, after oligomycin inhibition and after FCCP uncoupling as they used more 
O2 than NOF cells at these stages of the experiment (Figure 5.2, Figure 5.4). 
Analysis of respiration using respiratory parameters (Figure 5.3, Figure 5.5) 
suggested firstly that OA chondrocytes have a significantly lower SRC 
compared to NOF, therefore OA HAC possibly work closer to their bioenergetic 
limit compared to NOF and have a lower capacity to respond to changes in 
energy demands (Choi et al 2009). OA HAC also have a significantly higher 
proton leak compared to NOF. This suggests that OA mitochondria are slightly 
uncoupled which can be due to changes in the proton conductance of the inner 
membrane and changes in the Δψm (Yadava, & Nicholls 2007). OA 
chondrocytes have been reported to have more depolarized mitochondria 
compared to healthy controls; therefore this can partially explain the increase in 
proton leak (Maneiro et al 2003; Fukui, & Zhu 2010; Kokoszka et al 2001). The 
cell respiratory control ratio values, which take into account both the capacity 
and proton leak of the cells, showed that OA chondrocytes have a lower 
respiratory control ratio compared to NOF, which suggests that their MRC is 
more dysfunctional due to the higher proton leak and lower SRC (Brand, & 
Nicholls 2011). 
Nitric oxide can also potentially affect mitochondrial respiration although this 
hypothesis was not tested in this thesis. iNOS (inducible NO synthase) is up-
regulated in OA, resulting in production of NO (Amin et al 1995). NO has been 
demonstrated to inhibit the activity of the complex IV in human articular 
chondrocytes and to contribute to the depolarization of the Δψm (Maneiro et al 
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2005). Addtionally, a gradual 2-fold increase in NO levels in guinea pig 
chondrocytes has resulted in a 50% decrease in the levels of ATP produced 
(Johnson et al 2004). In the same study, to confirm that the cause of ATP 
depletion was mitochondrial dysfunction, they found an increase in the lactate: 
pyruvate ratio, a compensation reaction to mitochondrial dysfunction. Cillero 
Pastor et al also demonstrated that NO induced mitochondrial depolarization 
and cell death in human OA synoviocytes (Cillero-Pastor et al 2011). NO 
treatment also reduced mitochondrial mass and ATP turnover and decreased 
Bcl-2, Mcl-1 and pro-caspase-3 protein expression in the same cells (Cillero-
Pastor et al 2011). 
Glycolysis was also analysed in NOF and OA HAC (section 5.4.4, Figure 5.6). 
Although there was no difference in glycolysis between NOF and OA HAC, 
general comparison of mitochondrial to glycolysis suggested that HAC rely 
almost as much on the MRC and OXPHOS for their ATP production as in 
glycolysis. When only ATP producing mitochondrial respiration is taken into 
account, the ratio of OXPHOS dependent ATP production to glycolytic ATP 
production is possibly lower (approximately 33% ATP produced by OXPHOS 
and 67% by glycolysis) and therefore similar to the 25% ATP production by 
OXPHOS suggested previously (Stockwell 1983; Lee, & Urban 1997). 
One limitation of this experiment is the requirement to culture HAC for three 
days prior to respiratory analysis for the reason that freshly isolated HAC did not 
respire possibly due to the physiological stresses that the cells were under after 
the long collagenase treatment. A 20-fold increase in the concentration of 
mitochondrial transcripts for cyt B, CO II and CO III has been reported in 
chondrocytes in culture compared to the levels in cartilage suggesting that the 
mitochondrial properties of chondrocytes change when transferred in an 
artificial culture environment (Mignotte et al 1991). Therefore the findings of this 
experiment might have been affected by the prior culture of HAC. 
The effect of SOD2 downregulation on respiratory activity was also assessed in 
HAC (sections 5.4.5 and 5.4.6). A recent study performed on SOD2 null mice, 
suggested that SOD2 depletion leads to a decrease in SRC in cortical 
synaptosomes due to increased levels of oxidative stress in the mitochondria 
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(Flynn et al 2011). Reduced SRC has been suggested as a consequence of 
mild uncoupling of the MRC in cerebellar granule neurons in order to reduce 
O2
- levels in the mitochondrial matrix (Johnson-Cadwell et al 2007). A study by 
the same group also suggested that an impaired SRC also regulates glutamate 
toxicity upon complex I inhibition (Yadava, & Nicholls 2007). In this thesis, 
SOD2 downregulation in HAC increases (not significantly) respiration compared 
to control (Figure 5.8). SOD2 depleted HAC have significantly lower SRC 
compared to controls (Figure 5.9), however the levels of impairment was much 
lower in our study compared to the study by Flynn et al possibly due to the 
approximately 3-fold higher level of respiration of in cortical synaptosomes 
compared to HAC (Flynn et al 2011). SOD2 downregulation also increased 
proton leak in HAC (Figure 5.9). Combined with the lower SRC, these results 
suggest that SOD2 downregulation causes a mild uncoupling of the MRC, 
possibly to decrease O2
- levels in the mitochondrial matrix, however at the 
same time it caused impairment of the SRC which can potentially expose the 
cells to calcium deregulation and glutamate-induced toxicity reported previously 
in OA models (Jean et al 2006; Johnson et al 2000). 
Previous studies reported that SOD2 downregulation in neurons causes Δψm 
depolarization possibly due to increase in proton leak and lipid peroxidation 
(Fukui, & Zhu 2010; Kokoszka et al 2001). Similarly, it has been reported that 
OA chondrocytes have more depolarized mitochondria compared to healthy 
controls (Maneiro et al 2003). In this thesis Δψm was measured by TMRM 
under basal conditions and after oligomycin and FCCP treatments (section 
5.4.7, Figure 5.13). HAC transfected with siRNA against SOD2 had a lower 
intensity compared to controls at basal levels and also after oligomycin and 
FCCP treatment. Oligomycin treatment caused depolarization in both siSOD2 
and siCON cells which possibly indicates a dysfunctional MRC (Brand, & 
Nicholls 2011). Mitochondria depolarised further after FCCP treatment however 
this effect could be due to the prior oligomycin treatment and its depolarising 
effect on HAC mitochondria in this experiment. Therefore, mitochondrial 
membrane depolarization in OA can potentially be due to SOD2 downregulation 
in HAC (Maneiro et al 2003). 
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It also has to be emphasised that these experiments were performed under 
normal O2 conditions in order to stimulate the respiratory activity of the cells, 
therefore if oxygen levels similar to the cartilage (hypoxia) were used the results 
could differ. This thesis is weaker without such analysis and a priority of future 
work would be to determine mitochondrial respiratory activity in HAC under 
anoxic conditions. Previous work has shown that bovine articular chondrocytes 
and cartilage consume oxygen at a rate of 10nmoles/hour/million cells under 
high oxygen tensions (5%-21%) compared to the rate of 2.4nmoles/hour/million 
cells measured in this thesis (Zhou et al 2004). Lower oxygen tension (<5%) 
resulted in lower oxygen consumption (Zhou et al 2004). 
Another important factor that has been reported to have a role in regulating 
mitochondrial function and ROS in chondrocytes is NO. It has been suggested 
that NO induces apoptosis in chondrocytes by decreasing the activity of 
Complex IV and decreasing the mitochondrial Δψm (Maneiro et al 2005; 
Johnson et al 2000). NO also has additional effects on mitochondria by inducing 
ROS and mtDNA damage, which have roles in cell death (Blanco et al 2011). 
Therefore, the effect of NO induction together with SOD2 downregulation in OA 
can potentially induce mitochondrial dysfunction in HAC and contribute to the 
development of OA. 
In summary, these findings show that OA chondrocytes have a dysfunctional 
respiratory activity due to the lower spare respiratory capacity and higher proton 
leak partially as a consequence of SOD2 downregulation and higher superoxide 
levels. Although these changes may be a response to reduce the effect of 
higher O2
- levels, inflammatory and apoptotic pathways can also be potentially 
activated in chondrocytes that can lead to collagenase activation and cartilage 
degradation. 
7.4 Future directions 
The results and discussion presented in this thesis have furthered the 
understanding of mitochondrial dysfunction and oxidative damage in OA. 
However, a number of questions remain outstanding: 
Chapter 7                                                                                General Discussion 
 
245 
 Does mechanical stress or joint injury contribute to oxidative stress and 
mitochondrial dysfunction? Cartilage from DMM (Destabilization of 
Medial meniscus) OA mouse models (Glasson et al 2007) could be used 
to evaluate SOD2 expression and the levels of ROS and lipid 
peroxidation and as well as the possible accumulation of mtDNA damage 
and mitochondrial respiratory dysfunction. 
 Does SOD2 downregulation cause mitochondrial dysfunction and 
oxidative damage in cartilage and potentially OA and does it contribute to 
further OA progression? SOD2 +/- or cartilage specific (COL2A1-CRE-
SOD2 null) DMM mouse models could be used to further assess the 
contribution of SOD2 downregulation to OA progression and assess the 
levels of oxidative damage, mtDNA damage and mitochondrial 
dysfunction in cartilage. 
 Does diminished mtDNA repair capacity affect OA progression? POLG 
mutator DMM or POLG mutator normal ageing mouse models could be 
used to assess the role of mtDNA repair in OA progression. 
 Are the levels of mtDNA damage different in the different zones of 
cartilage? The COX-SDH protocol would be optimised to detect reactivity 
on cartilage sections. Chondrocytes would be isolated from the different 
zones according to COX activity and screened for mtDNA damage. 
 Does mitochondrial respiratory activity in isolated NOF and OA 
chondrocytes differ under anoxic conditions? Isolated HAC would be 
cultured under anoxic conditions to simulate the oxygen levels in 
cartilage and mitochondrial respiratory activity would be assessed and 
compared to the activity under normoxic conditions. 
 What changes in cell signalling regulate differential SOD2 expression in 
NOF and OA? SOD2 promoter constructs, kindly donated by Dr Nick 
Harry, would be sub-cloned into a luciferase vector and then transfected 
into NOF and OA HAC to compare the expression levels. Then different 
signalling pathways known to be altered in OA would be stimulated or 
inhibited and assess the effect on SOD2 expression. 
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 Is SOD2 expression regulated by differential H3K27 acetylation in OA 
and NOF? H3K27 acetylation a marker of active transcription regions 
and enhancers. Chromatin immunoprecipitation (ChIP) with antibody 
against H3K27 acetylation will be performed on OA and NOF 
chondrocytes. Then PCR will be performed to the SOD2 locus in order to 
identify differences in SOD2 transcriptional activity between NOF and 
OA. Previously ChIP was difficult to perform without vast numbers of 
cells, however newer techniques allow the use of less cells and therefore 
it is suitable for analyzing HAC (Collas 2010). 
7.5 Summary 
The findings of the thesis were the following. SOD2 downregulation increased 
mitochondrial O2
- levels in HAC. Measurement of lipid peroxidation levels in OA 
and NOF cartilage showed that OA cartilage has higher levels of lipid 
peroxidation compared to NOF possibly as a consequence of SOD2 
downregulation and higher O2
- levels. Additionally, SOD2 depletion led to a 
significant increase in mtDNA strand breaks in SW1353 cells although there 
was no difference detected in OA compared to NOF mtDNA. However, large-
scale mtDNA deletions were identified in OA cartilage and other OA joint tissues 
but the low levels of mutated mtDNA observed were not considered to be 
pathologically relevant. OA chondrocytes showed less spare respiratory 
capacity, higher non-phosphorylating respiration and higher proton leak 
compared to NOF, possibly as a consequence of SOD2 downregulation. 
Indeed, SOD2-depleted HAC also showed a lower spare respiratory capacity 
and higher proton leak as well as mitochondrial depolarisation. HAC 
demonstrated a very low mitochondrial/glycolysis ratio, suggesting that HAC are 
highly glycolytic cells. NLRX1 was also identified to regulate basal levels of 
(MMP-13) and ds RNA- induced ROS levels in chondrocytes. 
Taken together, these findings suggest that SOD2 depletion in chondrocytes 
leads to oxidative damage and mitochondrial dysfunction caused by increasing 
ROS levels. As a consequence, these effects can potentially lead towards 
alterations in cell signalling pathways, cellular dysfunction and cartilage 
degradation.  
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Together with the findings on the role of NO and other inflammatory mediators 
on mitochondrial function and mtDNA, as well as with the identification of 
mtDNA haplogroups with increased or lower risk in developing OA, the findings 
of this thesis will contribute to research focused on understanding how 
mitochondrial function and ROS regulate chondrocyte function and 
homeostasis. The development of animal models that mimic the effects 
identified in human cartilage and chondrocytes is also essential to be able to 
identify potential therapies for OA. In particular, with the significant role of 
mitochondria and ROS in disease, identification of the effects of oxidative stress 
and mitochondrial dysfunction in OA will aid understanding of the disease 
pathology and contribute to the identification of potential targets for the 
treatment and prevention of OA. 
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Appendix I. Patient data 
Patient 
ID 
Age Gender Joint 
type 
Tissue Experiments 
DTOS 1599 72 MALE OA KNEE CARTILAGE Innate Immunity 
 
DTOS 1759 67 MALE OA KNEE CARTILAGE Innate Immunity 
 
DTOS 1876 81 FEMALE OA KNEE CARTILAGE Innate Immunity 
 
DTOS 1891 74 FEMALE OA KNEE CARTILAGE Innate Immunity 
 
DTOS 2123 70 FEMALE OA KNEE CARTILAGE Innate Immunity 
 
T002 73 MALE NOF CARTILAGE Mitochondrial 
respiration 
T004 83 MALE NOF CARTILAGE Mitochondrial 
respiration 
T005 69 MALE NOF CARTILAGE Mitochondrial 
respiration 
T010 86 MALE NOF CARTILAGE Mitochondrial 
respiration 
T015 78 MALE NOF CARTILAGE Mitochondrial 
respiration 
T032 82 FEMALE NOF CARTILAGE Mitochondrial 
respiration 
T042 91 FEMALE NOF CARTILAGE Mitochondrial 
respiration 
T045 78 MALE NOF CARTILAGE Mitochondrial 
respiration 
T046 79 MALE NOF CARTILAGE Mitochondrial 
respiration 
DTOS 1744 50 MALE OA KNEE CARTILAGE Mitochondrial 
respiration, ROS 
DTOS 1773 62 MALE OA KNEE CARTILAGE Mitochondrial 
respiration, ROS 
DTOS 1779 83 MALE OA HIP CARTILAGE Mitochondrial 
respiration, ROS 
DTOS 1791 58 MALE OA HIP CARTILAGE Mitochondrial 
respiration, ROS 
DTOS 1840 76 MALE OA HIP CARTILAGE Mitochondrial 
respiration, ROS 
DTOS 2035 68 FEMALE OA HIP CARTILAGE Mitochondrial 
respiration, ROS 
DTOS 2098 75 FEMALE OA HIP CARTILAGE Mitochondrial 
respiration, ROS 
39833 69 MALE OA KNEE CANC BONE mtDNA deletions, 
mtDNA copy number 
234515 58 MALE OA KNEE FAT PAD mtDNA deletions, 
mtDNA copy number 
234515 58 MALE OA KNEE LIGAMENT mtDNA deletions, 
mtDNA copy number 
333031 75 MALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
333031 75 MALE OA KNEE MENISCUS mtDNA deletions, 
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mtDNA copy number 
333031 75 MALE OA KNEE MENISCUS mtDNA deletions, 
mtDNA copy number 
333031 75 MALE OA KNEE MENISCUS mtDNA deletions, 
mtDNA copy number 
333031 75 MALE OA KNEE FAT PAD mtDNA deletions, 
mtDNA copy number 
957390 60 MALE OA HIP SYNOVIUM mtDNA deletions, 
mtDNA copy number 
1284908 82 FEMALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
8011503 54 FEMALE OA HIP LIGAMENT mtDNA deletions, 
mtDNA copy number 
8048367 85 MALE OA HIP CANC BONE mtDNA deletions, 
mtDNA copy number 
8048367 85 MALE OA HIP CANC BONE mtDNA deletions, 
mtDNA copy number 
8048367 85 MALE OA HIP CORT BONE mtDNA deletions, 
mtDNA copy number 
8048367 85 MALE OA HIP CORT BONE mtDNA deletions, 
mtDNA copy number 
8048367 85 MALE OA HIP CORT BONE mtDNA deletions, 
mtDNA copy number 
8048367 85 MALE OA HIP CORT BONE mtDNA deletions, 
mtDNA copy number 
8048367 85 MALE OA HIP CORT BONE mtDNA deletions, 
mtDNA copy number 
8048367 85 MALE OA HIP OSTEOPHYTES mtDNA deletions, 
mtDNA copy number 
8048367 85 MALE OA HIP OSTEOPHYTES mtDNA deletions, 
mtDNA copy number 
8048367 85 MALE OA HIP OSTEOPHYTES mtDNA deletions, 
mtDNA copy number 
8048367 85 MALE OA HIP OSTEOPHYTES mtDNA deletions, 
mtDNA copy number 
8098004 72 FEMALE OA HIP CORT BONE mtDNA deletions, 
mtDNA copy number 
8098004 72 FEMALE OA HIP CANC BONE mtDNA deletions, 
mtDNA copy number 
8117954 62 MALE OA KNEE FAT PAD mtDNA deletions, 
mtDNA copy number 
8157410 82 FEMALE OA KNEE FAT PAD mtDNA deletions, 
mtDNA copy number 
8157410 82 FEMALE OA KNEE MENISCUS mtDNA deletions, 
mtDNA copy number 
DTOS 1718 72 FEMALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1724 74 MALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1744 50 MALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1744 50 MALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1757 58 FEMALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1762 80 FEMALE OA HIP CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1782 79 MALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1814 53 MALE OA KNEE CARTILAGE mtDNA deletions, 
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mtDNA copy number 
DTOS 1818 60 MALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1819 67 MALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1820 76 FEMALE OA HIP CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1820 76 FEMALE OA HIP CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1820 76 FEMALE OA HIP CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1820 76 FEMALE OA HIP CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1820 76 FEMALE OA HIP CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1822 85 MALE OA HIP CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1823 79 MALE OA KNEE FAT PAD mtDNA deletions, 
mtDNA copy number 
DTOS 1823 79 MALE OA KNEE SYNOVIUM mtDNA deletions, 
mtDNA copy number 
DTOS 1823 79 MALE OA KNEE SYNOVIUM mtDNA deletions, 
mtDNA copy number 
DTOS 1828 57 FEMALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1850 50 FEMALE OA KNEE CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1850 50 FEMALE OA KNEE FAT PAD mtDNA deletions, 
mtDNA copy number 
T004 83 MALE NOF CARTILAGE mtDNA deletions, 
mtDNA copy number 
T005 69 FEMALE NOF CARTILAGE mtDNA deletions, 
mtDNA copy number 
T005 69 FEMALE NOF CARTILAGE mtDNA deletions, 
mtDNA copy number 
T010 86 MALE NOF CARTILAGE mtDNA deletions, 
mtDNA copy number 
T015 78 MALE NOF CARTILAGE mtDNA deletions, 
mtDNA copy number 
T016 79 FEMALE NOF CARTILAGE mtDNA deletions, 
mtDNA copy number 
T023 68 FEMALE NOF CARTILAGE mtDNA deletions, 
mtDNA copy number 
DTOS 1596 76 FEMALE OA HIP CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
DTOS 1622 67 FEMALE OA HIP CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
DTOS 1683 78 FEMALE OA HIP CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
DTOS 1734 83 FEMALE OA HIP CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
DTOS 1842 82 FEMALE OA HIP CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
DTOS 1906 72 FEMALE OA HIP CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
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number 
DTOS 1908 83 FEMALE OA HIP CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T006 69 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T007 71 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T012 81 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T013 72 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T014 84 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T018 94 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T020 84 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T021 84 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T023 68 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T024 80 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T026 86 MALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T031 89 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
T037 83 FEMALE NOF CARTILAGE mtDNA deletions, 
TBARS, mtDNA copy 
number 
 
